This is a Validated Antibody Database (VAD) review about human E-cadherin, based on 1474 published articles (read how Labome selects the articles), using E-cadherin antibody in all methods. It is aimed to help Labome visitors find the most suited E-cadherin antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
E-cadherin synonym: Arc-1; BCDS1; CD324; CDHE; ECAD; LCAM; UVO

Invitrogen
rat monoclonal (DECMA-1)
  • flow cytometry; mouse; 1:250; loading ...; fig 5c
Invitrogen E-cadherin antibody (Thermo-Fisher Scientific, 53-3249-80) was used in flow cytometry on mouse samples at 1:250 (fig 5c). Nat Commun (2021) ncbi
rat monoclonal (DECMA-1)
  • immunocytochemistry; mouse; 1:500; loading ...; fig 3b
Invitrogen E-cadherin antibody (Thermo Fisher Scientific, 14-3249-80) was used in immunocytochemistry on mouse samples at 1:500 (fig 3b). elife (2020) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - frozen section; human; loading ...; fig 2
Invitrogen E-cadherin antibody (Thermo Fisher, 33-4000) was used in immunohistochemistry - frozen section on human samples (fig 2). Arch Toxicol (2020) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:50; loading ...; fig s t3
Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on human samples at 1:50 (fig s t3). Mod Pathol (2020) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:200; loading ...; fig 1f
Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunohistochemistry on human samples at 1:200 (fig 1f). J Clin Med (2019) ncbi
rat monoclonal (DECMA-1)
  • flow cytometry; human; 1:50; fig 3a, 3b
Invitrogen E-cadherin antibody (eBioscience/Thermo, 50-3249-82) was used in flow cytometry on human samples at 1:50 (fig 3a, 3b). Stem Cells (2019) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry; mouse; 1:500; loading ...; fig s1c
Invitrogen E-cadherin antibody (eBioscience, 14-3249-82) was used in immunohistochemistry on mouse samples at 1:500 (fig s1c). Science (2019) ncbi
mouse monoclonal (4A2C7)
  • western blot; human; 1:500; loading ...; fig 4e
Invitrogen E-cadherin antibody (Thermo Fisher Scientific, 33-4000) was used in western blot on human samples at 1:500 (fig 4e). elife (2019) ncbi
mouse monoclonal (NCH-38)
  • western blot; human; loading ...; fig 4f
Invitrogen E-cadherin antibody (Thermo Fisher, MA5-12547) was used in western blot on human samples (fig 4f). Cancer Cell Int (2019) ncbi
mouse monoclonal (67A4)
  • flow cytometry; human; 1:100; loading ...; fig s12b, s12a
  • immunocytochemistry; human; 1:100; loading ...; fig s1d
Invitrogen E-cadherin antibody (Life Technologies, A15757) was used in flow cytometry on human samples at 1:100 (fig s12b, s12a) and in immunocytochemistry on human samples at 1:100 (fig s1d). Nat Commun (2019) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human; loading ...; fig 7i
Invitrogen E-cadherin antibody (Thermo Fisher, SHE78-7) was used in blocking or activating experiments on human samples (fig 7i). Front Immunol (2018) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4d
Invitrogen E-cadherin antibody (eBiosciences, 50-C3249-C80) was used in immunohistochemistry - paraffin section on mouse samples (fig 4d). Oncogene (2019) ncbi
rat monoclonal (DECMA-1)
  • flow cytometry; mouse; loading ...; fig 1b
  • immunocytochemistry; mouse; loading ...; fig s1b
Invitrogen E-cadherin antibody (ThermoFisher Scientific, 50-3249-82) was used in flow cytometry on mouse samples (fig 1b) and in immunocytochemistry on mouse samples (fig s1b). Cell Stem Cell (2017) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2e
Invitrogen E-cadherin antibody (Invitrogen, 33-4000) was used in immunohistochemistry - paraffin section on mouse samples (fig 2e). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry; mouse; 1:800; loading ...; fig 6a
Invitrogen E-cadherin antibody (Thermo Pierce, DECMA-1) was used in immunohistochemistry on mouse samples at 1:800 (fig 6a). Dev Biol (2017) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:1000; fig 5g
In order to study the effect of angiocrine factors on retinal pigment epithelium basement membrane and barrier function, Invitrogen E-cadherin antibody (Thermo Fisher Scientific, 131700) was used in western blot on human samples at 1:1000 (fig 5g). Nat Commun (2017) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; fig 1c
In order to test if MUC1 contributes to epithelial tubular cell plasticity and kidney fibrosis, Invitrogen E-cadherin antibody (ThermoFisher, 13-1700) was used in immunohistochemistry on human samples (fig 1c). Biochim Biophys Acta Mol Basis Dis (2017) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry; mouse; 1:700; loading ...; fig s6c
Invitrogen E-cadherin antibody (eBiosciences, 14-3249-82) was used in immunohistochemistry on mouse samples at 1:700 (fig s6c). Nature (2017) ncbi
domestic rabbit recombinant (5H6L18)
  • immunocytochemistry; human; 1:100; loading ...; fig 1c
In order to test if chemotherapy affects the epithelial-mesenchymal transition of osteosarcoma cells, Invitrogen E-cadherin antibody (Thermo Fisher, 701134) was used in immunocytochemistry on human samples at 1:100 (fig 1c). Oncol Lett (2016) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; tbl 1
In order to describe the molecular typing of hobnail variant of papillary thyroid carcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples (tbl 1). Endocr Relat Cancer (2017) ncbi
mouse monoclonal (4A2C7)
  • western blot; human; 1:500; loading ...; fig 4d
In order to find that the 'steady step' level of engulfed extracellular miRNA and its subsequent activity is dependent on the presence of a donor cell and XRN1 exonuclease, Invitrogen E-cadherin antibody (Invitrogen, 33-4000) was used in western blot on human samples at 1:500 (fig 4d). Nucleic Acids Res (2017) ncbi
rat monoclonal (DECMA-1)
  • immunocytochemistry; mouse; 1:200; fig 3g
In order to discuss how NLRC3 protects against colorectal cancer by modulating mTor signaling, Invitrogen E-cadherin antibody (Affymetrix eBioscience, 53-3249-80) was used in immunocytochemistry on mouse samples at 1:200 (fig 3g). Nature (2016) ncbi
mouse monoclonal (67A4)
  • immunocytochemistry; human; 1:100; loading ...; fig 4a
In order to investigate the role of TGF-beta in cancer-associated fibroblasts from oral squamous cell carcinomas, Invitrogen E-cadherin antibody (Thermo Fisher, A15757) was used in immunocytochemistry on human samples at 1:100 (fig 4a). Carcinogenesis (2017) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...
  • western blot; human; loading ...; fig 3c
In order to suggest that EGFR promotes survival of prostate tumor-initiating cells and circulating tumor cells that metastasize to bone, whereas HER2 supports the growth of prostate cancer cells once they are established at metastatic sites, Invitrogen E-cadherin antibody (ThermoFisher, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 and in western blot on human samples (fig 3c). Cancer Res (2017) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:1000; fig 1a
In order to generate an iPSC line from a patient with Kleefstra syndrome, Invitrogen E-cadherin antibody (Thermo Fisher, 13-1700) was used in immunohistochemistry on human samples at 1:1000 (fig 1a). Stem Cell Res (2016) ncbi
mouse monoclonal (DH01 (DCS-266))
  • western blot; human; loading ...; fig 5d
In order to identify homologous to the E6-AP carboxyl terminus as a ubiquitin ligase for modulator of apoptosis protein 1, Invitrogen E-cadherin antibody (Thermo Scientific, MS-1116-P) was used in western blot on human samples (fig 5d). Oncogene (2017) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 2 ug/ml; loading ...; fig 4e
  • western blot; human; loading ...; fig 4b
In order to investigate the alternative splicing of E-cadherin mRNA, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples at 2 ug/ml (fig 4e) and in western blot on human samples (fig 4b). J Cell Physiol (2017) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 1a
In order to discuss the defects observed in the neosquamous epithelium after ablation of Barrett's esophagus, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in western blot on human samples (fig 1a). Dig Dis Sci (2016) ncbi
mouse monoclonal (4A2C7)
  • western blot; human; fig 1a
In order to discuss the defects observed in the neosquamous epithelium after ablation of Barrett's esophagus, Invitrogen E-cadherin antibody (Zymed Laboratories, 33-4000) was used in western blot on human samples (fig 1a). Dig Dis Sci (2016) ncbi
rat monoclonal (DECMA-1)
  • immunocytochemistry; human; 5 ug/ml; fig 5
In order to describe the effects of HER2 overexpression in breast cancer cells, Invitrogen E-cadherin antibody (eBioscience, 53-3249-82) was used in immunocytochemistry on human samples at 5 ug/ml (fig 5). Nat Commun (2016) ncbi
mouse monoclonal (4A2C7)
  • western blot; human; 1:500; fig s8
In order to describe the effects of HER2 overexpression in breast cancer cells, Invitrogen E-cadherin antibody (Life Technologies, 33-4,000) was used in western blot on human samples at 1:500 (fig s8). Nat Commun (2016) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:80; fig 3
In order to identify CYR61 and TAZ as predictive markers of Barrett's malignant progression, Invitrogen E-cadherin antibody (Invitrogen, 33-4000) was used in immunohistochemistry - paraffin section on human samples at 1:80 (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (DH01 (DCS-266))
  • western blot; human; 1:500; fig s2
In order to describe a novel irreversible DNA-damage response in antephase, Invitrogen E-cadherin antibody (Neo, ms 1116-p1) was used in western blot on human samples at 1:500 (fig s2). Nat Commun (2016) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:1000; fig 1A
In order to develop strategies to assess and characterize sporadic cases of Alzheimer's disease, Invitrogen E-cadherin antibody (Thermo Fisher Scientific, 13-1700) was used in immunocytochemistry on human samples at 1:1000 (fig 1A). Stem Cell Res (2016) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:1000; fig 1A
In order to develop methods to study and characterize sporadic cases of Alzheimer's disease, Invitrogen E-cadherin antibody (Thermo Fisher Scientific, 13-1700) was used in immunocytochemistry on human samples at 1:1000 (fig 1A). Stem Cell Res (2016) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:1000; fig 1A
In order to present methods to characterize cells from sporadic cases of Alzheimer's disease, Invitrogen E-cadherin antibody (Thermo Fisher Scientific, 13-1700) was used in immunocytochemistry on human samples at 1:1000 (fig 1A). Stem Cell Res (2016) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:1000; fig 1A
In order to present a technique to study sporadic cases of Alzheimer's disease, Invitrogen E-cadherin antibody (Thermo Fisher Scientific, 13-1700) was used in immunocytochemistry on human samples at 1:1000 (fig 1A). Stem Cell Res (2016) ncbi
mouse monoclonal (SHE78-7)
  • immunocytochemistry; human; loading ...; fig 6d
In order to test if E-cadherin is a biomarker for the detection of epithelial cancer cells, Invitrogen E-cadherin antibody (Invitrogen, 13-5700) was used in immunocytochemistry on human samples (fig 6d). Colloids Surf B Biointerfaces (2016) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry - frozen section; mouse; 1:800; loading ...; fig 6e
In order to develop tools to examine the fate and dynamics of stem cells during mammary gland and prostate development, Invitrogen E-cadherin antibody (eBioscience, 14-3249-82) was used in immunohistochemistry - frozen section on mouse samples at 1:800 (fig 6e). Genes Dev (2016) ncbi
mouse monoclonal (SHE78-7)
  • western blot; human; fig 7
In order to analyze control of MT1-MMP endocytic and E-cadherin polarized golgi trafficking to promote invasive breast cancer programs by RAB2A, Invitrogen E-cadherin antibody (ThermoFisher Scientific, SHE78-7) was used in western blot on human samples (fig 7). EMBO Rep (2016) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 3
In order to characterize the effects on the APC/beta-catenin pathway in the normal colorectal mucosa of colorectal adenoma patients with supplemental vitamin D and calcium, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 3). Mol Carcinog (2017) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2
In order to test if BiP and CHOP expressions correlate with pre-malignant lesion progression, Invitrogen E-cadherin antibody (Life Technologies, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 2). Virchows Arch (2016) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:800; loading ...; tbl 1
In order to examine the association between pretreatment molecular and clinical factors and axillary lymph node metastases in early breast cancer, Invitrogen E-cadherin antibody (Zymed, 4A2c7) was used in immunohistochemistry - paraffin section on human samples at 1:800 (tbl 1). Medicine (Baltimore) (2016) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 2
In order to assess the promotion of CAR-dependent migration of leukocytes across epithelial monolayers by TNF-alpha, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in western blot on human samples (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 2
  • immunohistochemistry; human; 1:500; fig 5
  • western blot; human; fig 2
In order to elucidate regulation of E-cadherin and CD24 by determination of cell fate transition and impeding tumor initiation and progression in breast cancer via HOXA5, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunocytochemistry on human samples (fig 2), in immunohistochemistry on human samples at 1:500 (fig 5) and in western blot on human samples (fig 2). Oncogene (2016) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; dogs; 1:100; loading ...; fig 1a
In order to examine E-cadherin and beta-catenin localization during implantation in dogs, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on dogs samples at 1:100 (fig 1a). Theriogenology (2016) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:300; fig 2
In order to utilize the model system of primary human hepatocyte spheroids for drug-induced liver injury, disease, and liver function, Invitrogen E-cadherin antibody (Thermo Scientific, 13-1700) was used in immunocytochemistry on human samples at 1:300 (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; loading ...
In order to report the clinicopathological features and prognostic factors of pregnancy-associated gastric cancer, Invitrogen E-cadherin antibody (Invitrogen, 4 A2C7) was used in immunohistochemistry on human samples . Gut Liver (2016) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; fig s2
In order to study expression levels of CA125, CA19-9, CEA, and EpCAM in pseudomyxoma peritonei, Invitrogen E-cadherin antibody (ThermoFisher Scientific, HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig s2). Hum Pathol (2016) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:7000; fig 2
  • western blot; human; fig 4
In order to characterize the functional and prognostic importance of MAP4K5 in pancreatic cancer, Invitrogen E-cadherin antibody (Life Tech, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:7000 (fig 2) and in western blot on human samples (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (SHE78-7)
  • western blot; human; fig 1
In order to identify cleavage sites for helicobacter pylori HtrA with E-cadherin signature motifs, Invitrogen E-cadherin antibody (Invitrogen, SHE78-7) was used in western blot on human samples (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human; fig 5
In order to learn how invasion is limited of candida albicans through active penetration and endocytosis in the early stages of the interaction of the fungus with the intestinal barrier by intestinal cell tight junctions, Invitrogen E-cadherin antibody (Invitrogen, SHE78-7) was used in blocking or activating experiments on human samples (fig 5). PLoS ONE (2016) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:7000; fig 7
In order to study a decrease in expression of miR-205 in inflammatory breast cancer due to MicroRNA expression profiling, Invitrogen E-cadherin antibody (Life Technologies, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:7000 (fig 7). Mod Pathol (2016) ncbi
rat monoclonal (DECMA-1)
  • immunocytochemistry; mouse; 1:100; fig 2
Invitrogen E-cadherin antibody (Ebiosciences, 14-3249-80) was used in immunocytochemistry on mouse samples at 1:100 (fig 2). Stem Cell Reports (2016) ncbi
domestic rabbit monoclonal (EP700Y)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to characterize the prognostic role of myoferlin expression in non-small cell lung cancer in correlation with VEGFR-2 expression, Invitrogen E-cadherin antibody (Thermo Fisher, MA5-14458) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Oncol Lett (2016) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1c
In order to identify factors that contribute to the epithelial-mesenchymal transition using 16 colorectal cancer cell lines, Invitrogen E-cadherin antibody (Life Technologies, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1c). Cancer Sci (2016) ncbi
rat monoclonal (DECMA-1)
  • flow cytometry; mouse; 1:150
In order to assess the role of NLRC5 to NK-T-cell crosstalk, Invitrogen E-cadherin antibody (eBioscience, DECMA-1) was used in flow cytometry on mouse samples at 1:150. Nat Commun (2016) ncbi
mouse monoclonal (4A2C7)
  • western blot; human; 1:500; fig 3
In order to prevent the effects of Pseudomonas aeruginosa on airway epithelial tight junctions and restriction of hyperglycaemia-induced bacterial growth by metformin, Invitrogen E-cadherin antibody (Life Technologies, 33-4000) was used in western blot on human samples at 1:500 (fig 3). J Cell Mol Med (2016) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:2; fig 1
In order to investigate the contribution of ZEB1 in intrahepatic cholangiocarcinoma, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on human samples at 1:2 (fig 1). J Clin Pathol (2016) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:1000; fig 4
In order to assess the induction of epithelial-to-mesenchymal transition and the increase in invasiveness in rectal cancer due to therapy-induced cellular senescence, Invitrogen E-cadherin antibody (Life Technologies, HECD-1) was used in immunocytochemistry on human samples at 1:1000 (fig 4). Clin Colorectal Cancer (2016) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; dogs; 10 ug/ml; fig 4
In order to study timed-pregnant guinea pigs and gestation age dependent transfer of human immunoglobulins across placenta, Invitrogen E-cadherin antibody (Life Technologies, 4A2C7) was used in immunocytochemistry on dogs samples at 10 ug/ml (fig 4). Placenta (2015) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
In order to test if lysophosphatidic acid stimulates uPAR expression and activity in ovarian epithelial cancer cells, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunocytochemistry on human samples . Anticancer Res (2015) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; mouse
  • chromatin immunoprecipitation; mouse
In order to investigate E-cadherin expression and its relationship to those transcriptional repressors in the progression from carcinoma 'in situ' to invasion to lymph node metastasis in spontaneously arising canine invasive micropapillary carcinoma, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on mouse samples and in chromatin immunoprecipitation on mouse samples . J Comp Pathol (2015) ncbi
mouse monoclonal (HECD-1)
  • western blot; mouse
In order to investigate the role of LZTFL1 in lung oncogenesis, Invitrogen E-cadherin antibody (Life Technologies, 13-1700) was used in western blot on mouse samples . Oncogene (2016) ncbi
mouse monoclonal (4A2C7)
  • western blot; human
In order to determine the role of growth factors in EMT, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in western blot on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (7H12)
  • western blot; mouse
In order to investigate the involvement of doublecortin-like kinase 1 in colitis, Invitrogen E-cadherin antibody (Life Technologies, MA5-15711) was used in western blot on mouse samples . PLoS ONE (2015) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; mouse; 1:100; fig 2
In order to study how mitigation of Alzheimer's disease pathology occurs by breaking immune tolerance by targeting Foxp3(+) regulatory T cells, Invitrogen E-cadherin antibody (Invitrogen, 33-4000) was used in immunohistochemistry on mouse samples at 1:100 (fig 2). Nat Commun (2015) ncbi
rat monoclonal (DECMA-1)
  • flow cytometry; mouse; 1:200; loading ...; fig 3a
Invitrogen E-cadherin antibody (eBioscience, 50-3249-80) was used in flow cytometry on mouse samples at 1:200 (fig 3a). Stem Cell Reports (2015) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human
In order to review cases and literature involving solid-pseudopapillary neoplasm of the pancreas, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples . Indian J Pathol Microbiol (2015) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to assess the safety and efficacy of selumetinib on pancreatic ductal adenocarcinoma, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Clin Cancer Res (2016) ncbi
rat monoclonal (DECMA-1)
  • immunocytochemistry; human; loading ...; fig 2b
Invitrogen E-cadherin antibody (eBioscience, 53-3249) was used in immunocytochemistry on human samples (fig 2b). Cell Death Dis (2015) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
In order to assess the involvement of lysophosphatidic acid in epithelial ovarian carcinoma, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; tbl 2
In order to characterize the morphological features and mucin expression profile of breast carcinomas with signet-ring cell differentiation, Invitrogen E-cadherin antibody (Zymed/Invitrogen,, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Pathol Res Pract (2015) ncbi
mouse monoclonal (HECD-1)
  • western blot; mouse
In order to discuss the role and regulation of cell-cell adhesion in prostate cancer aggressiveness, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in western blot on mouse samples . Cancer Med (2015) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; mouse; fig 7
In order to identify an integrin-independent role of ERI complexes during keratinocyte differentiation, Invitrogen E-cadherin antibody (Life Technologies, 33-4000) was used in immunocytochemistry on mouse samples (fig 7). Mol Biol Cell (2015) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; dogs; 1:25
Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on dogs samples at 1:25. Res Vet Sci (2015) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; tbl 2
In order to analyze breast cancer subtypes and retrospective analysis of metastatic behaviour, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100. Clin Epigenetics (2015) ncbi
mouse monoclonal (NCH-38)
  • western blot; human
Invitrogen E-cadherin antibody (Chemicon, MA5-12547) was used in western blot on human samples . Oncol Lett (2015) ncbi
mouse monoclonal (DH01 (DCS-266))
  • western blot; human
In order to study the effect of MASTL on cyclin B1 degradation and its mechanism, Invitrogen E-cadherin antibody (Neomarkers, MS-1116-P1) was used in western blot on human samples . Biol Open (2015) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:200
In order to identify and characterize vessels that encapsulated tumor clusters in hepatocellular carcinoma sections, Invitrogen E-cadherin antibody (Life Technologies, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:200. Hepatology (2015) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:1200; fig 2
In order to report and characterize an unusual case of a microcystic stromal tumor of the ovary with a beta-catenin mutation, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:1200 (fig 2). Int J Gynecol Pathol (2015) ncbi
mouse monoclonal (DH01 (DCS-266))
  • immunoprecipitation; human; 1:500
In order to explore how Nek2 isoform A affects anaphase-promoting complex/cyclosome containing Cdc20, Invitrogen E-cadherin antibody (Neomarkers, MS1116-p1) was used in immunoprecipitation on human samples at 1:500. J Cell Sci (2015) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:100
  • western blot; human; 1:500
In order to examine Notch localization and activation in non-small cell lung cancer, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in western blot on human samples at 1:500. J Hematol Oncol (2015) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; black ferret; 1:100; tbl 3
In order to use of ferrets to characterize immunohistochemical and histochemical levels of chordoma, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on black ferret samples at 1:100 (tbl 3). J Vet Med Sci (2015) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human
Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples . BMC Gastroenterol (2015) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to investigate the expression and role of HYAL1 and HYAL2 in normal tissues, precancerous endometrial tissues, and endometrial carcinomas, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Gynecol Oncol (2015) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:3000
Invitrogen E-cadherin antibody (Zymed Laboratories, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:3000. Hum Pathol (2015) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human
Invitrogen E-cadherin antibody (Zymed/Invitrogen, 4A2C7) was used in immunohistochemistry on human samples . BMC Vet Res (2014) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - frozen section; human
In order to study the expression and dynamics of the tight junction proteins during the disruption of desmosomes in Hailey-Hailey disease and Darier's disease lesions, Invitrogen E-cadherin antibody (Zymed Laboratories, 33-4000) was used in immunohistochemistry - frozen section on human samples . Dermatol Reports (2009) ncbi
mouse monoclonal (4A2C7)
  • western blot; mouse
In order to elucidate the molecular mechanisms underlying paranodal junction assembly, Invitrogen E-cadherin antibody (Life Technologies, 4A2C7) was used in western blot on mouse samples . Nat Neurosci (2014) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:100; fig 4
In order to determine the localization of NLRP7 and KHDC3L in human oocytes and preimplantation embryos, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunocytochemistry on human samples at 1:100 (fig 4). Hum Reprod (2015) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:800
Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:800. Endocr Pathol (2015) ncbi
rat monoclonal (DECMA-1)
  • flow cytometry; mouse; fig 6
In order to determine the role of Foxm1 in bronchopulmonary dysplasia-associated pulmonary inflammation, Invitrogen E-cadherin antibody (eBiosciences, DECMA-1) was used in flow cytometry on mouse samples (fig 6). Am J Respir Cell Mol Biol (2015) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
In order to study the effect of HNF4alpha on the chemosensitivity to oxaliplatin and 5-FU in renal cell carcinoma, Invitrogen E-cadherin antibody (Life Technologies, 13-1700) was used in immunocytochemistry on human samples . J Pharm Sci (2014) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:3000
In order to generate and assess primary pancreatic adenocarcinoma cell lines for colony forming capacity, tumourigenicity, expression of known cancer cell surface markers and cancer stem-like characteristics, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunohistochemistry on human samples at 1:3000. PLoS ONE (2014) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:2500; tbl 3
In order to analyze LRIG3 expression through immunohistochemical studies in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer and the association with tumor markers, hormones, high-risk HPV infection, smoking, and patient outcome, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:2500 (tbl 3). Eur J Histochem (2014) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; mouse
Invitrogen E-cadherin antibody (Zymed Laboratories, HECD-1) was used in immunohistochemistry on mouse samples . Head Neck (2015) ncbi
mouse monoclonal (SHE78-7)
  • western blot; human; loading ...; fig 1b
Invitrogen E-cadherin antibody (Invitrogen, INV135700) was used in western blot on human samples (fig 1b). Mol Carcinog (2015) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 3
In order to identify serines in the beta-catenin-binding domain of E-cadherin that are phosphorylated, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples (fig 3). Mol Biol Cell (2014) ncbi
mouse monoclonal (HECD-1)
  • flow cytometry; human; 1:50
In order to investigate the effect of glycosylation on tumor cell adhesion and invasion and its mechanism, Invitrogen E-cadherin antibody (Zymed Labs, HECD-1) was used in flow cytometry on human samples at 1:50. PLoS ONE (2014) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; mouse
Invitrogen E-cadherin antibody (Zymed Laboratories Inc, HECD-1) was used in immunohistochemistry - paraffin section on mouse samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
  • western blot; human
In order to study the localization of Helicobacter pylori on the apical surface of gastrointestinal epithelium and its damaging effect on the mucosal barrier, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunocytochemistry on human samples and in western blot on human samples . Helicobacter (2014) ncbi
mouse monoclonal (4A2C7)
  • western blot; rat; 1:1000
In order to characterize transmural intestinal wall permeability in severe ischemia after enteral protease inhibition, Invitrogen E-cadherin antibody (Invitrogen, 33-4000) was used in western blot on rat samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:25
Invitrogen E-cadherin antibody (Thermo Fisher Scientific, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:25. Am J Clin Pathol (2014) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human
Invitrogen E-cadherin antibody (Invitrogen, SHE78-7) was used in blocking or activating experiments on human samples . J Cell Sci (2014) ncbi
mouse monoclonal (HECD-1)
  • western blot; human
In order to study the release of soluble giant cadherin Fat1 from pancreatic cancer cells, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:2000
Invitrogen E-cadherin antibody (Zymed Laboratories, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:2000. Hum Pathol (2014) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; dogs; 1:50
In order to determine the expression of E-cadherin, beta-catenin, and Ki-67 in canine prostatic lesions, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on dogs samples at 1:50. Pak J Biol Sci (2013) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:100; fig 7
In order to explore interactions between human tumor cells and a humanized bone microenvironment, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunohistochemistry on human samples at 1:100 (fig 7). Clin Exp Metastasis (2014) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human
  • immunocytochemistry; human
  • western blot; human; 1:1000
Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on human samples , in immunocytochemistry on human samples and in western blot on human samples at 1:1000. Br J Cancer (2014) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:400
Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:400. Hum Pathol (2014) ncbi
mouse monoclonal (4A2C7)
  • western blot; rat; 1:1000
In order to investigate the effect of intestinal contents on hemorrhagic shock, Invitrogen E-cadherin antibody (Invitrogen, 33-4000) was used in western blot on rat samples at 1:1000. Physiol Rep (2013) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; pigs ; fig 1
In order to examine the effects of fumonisin B1 and deoxynivalenol in the intestine, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on pigs samples (fig 1). Toxins (Basel) (2013) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; Clostridioides difficile; fig 5
In order to describe how Clostridium difficile toxin A and B contribute to colonization, Invitrogen E-cadherin antibody (Invitrogen, 33-4000) was used in immunocytochemistry on Clostridioides difficile samples (fig 5). J Infect Dis (2014) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; dogs; fig 3
  • western blot; dogs; fig 7
In order to study the molecular mechanisms underlying the reversible effects of capsaicin on tight junction permeability, Invitrogen E-cadherin antibody (Invitrogen, 33-4000) was used in immunocytochemistry on dogs samples (fig 3) and in western blot on dogs samples (fig 7). PLoS ONE (2013) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 5
In order to study the efficacy and tolerability of the irreversible tyrosine kinase inhibitor dacomitinib in human bladder cancer models, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 5). Mol Med (2013) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human
In order to describe histological features of a tumor from a patient with pleuropulmonary blastoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples . Fetal Pediatr Pathol (2014) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the prognostic significance of the epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100. J Clin Pathol (2014) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; dogs
Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on dogs samples . J Comp Pathol (2014) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:200; fig 9
In order to describe the magnetic levitation method of 3D cell culturing, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunohistochemistry on human samples at 1:200 (fig 9). Nat Protoc (2013) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; mouse; fig 1
In order to report that upregulation of BCL2 is not involved in lobular breast carcinogenesis, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on mouse samples (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; pigs ; fig 2
In order to examine the effects of Helicobacter spp. infection on gastric morphology in pigs, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on pigs samples (fig 2). J Comp Pathol (2013) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 1
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to review the contribution of Yes Associated Protein to various types of cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 1) and in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Cell Oncol (Dordr) (2013) ncbi
mouse monoclonal (4A2C7)
  • western blot; mouse; fig 4
In order to report that Snai1 inhibits beta4 transcription by increasing repressive histone modification and that Id2 regulates Snai1, Invitrogen E-cadherin antibody (Invitrogen, 334000) was used in western blot on mouse samples (fig 4). Mol Cell Biol (2013) ncbi
mouse monoclonal (4A2C7)
  • western blot; human; 1:1000
In order to investigate the regulation of ZO-1 by p38delta mitogen-activated protein kinase in differentiating human epidermal keratinocytes, Invitrogen E-cadherin antibody (Invitrogen, 33-4000) was used in western blot on human samples at 1:1000. Arch Dermatol Res (2014) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 1
In order to reduce the inter-observer variability of the calculated proliferative index observed in breast cancer samples using a cocktail of antibodies against E-Cadherin and Ki-67, Invitrogen E-cadherin antibody (Zymed laboratories, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 1). Pathol Oncol Res (2013) ncbi
mouse monoclonal (HECD-1)
  • western blot; mouse; fig 1
In order to elucidate the role of Snail in pancreatic cancer development, Invitrogen E-cadherin antibody (Life Technologies, 13-1700) was used in western blot on mouse samples (fig 1). Mol Cancer Res (2013) ncbi
mouse monoclonal (HECD-1)
  • western blot; mouse; fig 2
In order to study listeriosis in wild-type mice using InlA that has been "murinized" to interact with mouse Ecad, Invitrogen E-cadherin antibody (Invitrogen, clone HECD-1) was used in western blot on mouse samples (fig 2). PLoS Pathog (2013) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:200; fig 1
In order to investigate the contribution of p120 to breast cancer metastasis, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:200 (fig 1). Cancer Res (2013) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to test if EMT-related proteins alterations are associated with the clinicopathological features and prognosis in lung adenocarcinoma, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Diagn Pathol (2013) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to study E-cadherin dysregulation in gastric cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Biochim Biophys Acta (2013) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 2
In order to discuss the roles of E-cadherin and beta-catenin in cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 2). Urol Int (2013) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human; 10 ug/ml
In order to correlate the ability to form colospheres with tumor aggressiveness, Invitrogen E-cadherin antibody (Invitrogen, SHE78-7) was used in blocking or activating experiments on human samples at 10 ug/ml. Br J Cancer (2013) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to compare expression of Dsg3, E-cadherin, and syndecan-1 in acantholytic squamous cell carcinoma and squamous cell carcinoma, Invitrogen E-cadherin antibody (Invitrogen, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Am J Clin Pathol (2013) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; Japanese crane; fig 4
In order to describe the cancers found in a red-crowned crane, Invitrogen E-cadherin antibody (Invitrogen, clone 4A2C7) was used in immunohistochemistry - paraffin section on Japanese crane samples (fig 4). J Vet Med Sci (2013) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:100; fig 1
In order to examine E-cadherin-negative ductal carcinoma, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry on human samples at 1:100 (fig 1). Histopathology (2013) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to study the relationship between cyclooxygenase enzymes and E-cadherin in the prediction of survival in optimally cytoreduced serous ovarian cancer patients, Invitrogen E-cadherin antibody (Zymed, 4A2c7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Asian Pac J Cancer Prev (2012) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - frozen section; human; 1:200; fig 5
In order to ask if cross talk between stromal and cancerous cells correlates with the invasive phenotype of breast tumor cells, Invitrogen E-cadherin antibody (Invitrogen, clone 4A2C7) was used in immunohistochemistry - frozen section on human samples at 1:200 (fig 5). PLoS ONE (2012) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; fig 3
In order to identify new genes involved in gastric cancer, Invitrogen E-cadherin antibody (Invitrogen, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig 3). J Pathol (2013) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 1
In order to assess if the EphA2/ephrin-A1 signaling axis is altered in psoriasis, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in western blot on human samples (fig 1). J Invest Dermatol (2013) ncbi
mouse monoclonal (SHE78-7)
  • western blot; human; fig 5
In order to report that oncogenic B-RAF(V600E) regulates genes associated with epithelial-mesenchymal transition in normal cutaneous human melanocytes, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in western blot on human samples (fig 5). J Invest Dermatol (2013) ncbi
mouse monoclonal (SHE78-7)
  • immunocytochemistry; human; fig 3
In order to explore the collective cell behavior of migrating human corneal limbal-epithelial cell sheets, Invitrogen E-cadherin antibody (Invitrogen, SHE78-7) was used in immunocytochemistry on human samples (fig 3). PLoS ONE (2012) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:200; fig 4
In order to compare the invasiveness of a collection of colorectal cancer cell lines with varying RhoA, Rac1, and Cdc42 activities, Invitrogen E-cadherin antibody (ZYMED, HECD1) was used in immunocytochemistry on human samples at 1:200 (fig 4). PLoS ONE (2012) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human; 2 ug/ml
In order to study the contribution of extracellular vesicles to the epithelial-to-mesenchymal transition to cancer, Invitrogen E-cadherin antibody (Invitrogen, clone SHE78-7) was used in blocking or activating experiments on human samples at 2 ug/ml. J Biol Chem (2012) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 2 ug/ml
In order to discuss methods to identify yessotoxin, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in western blot on human samples at 2 ug/ml. Chemosphere (2013) ncbi
mouse monoclonal (SHE78-7)
  • immunocytochemistry; human; 5 ug/ml; fig 3
In order to elucidate the relationship between the multiple drug resistance and invasion, Invitrogen E-cadherin antibody (Zymed, 13-5700) was used in immunocytochemistry on human samples at 5 ug/ml (fig 3). Eur Rev Med Pharmacol Sci (2012) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; fig s3
In order to characterise novel sinonasal undifferentiated carcinoma cell lines, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry on human samples (fig s3). Clin Cancer Res (2012) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 4
In order to report that lethal toxin targets alveolar epithelial cells, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunocytochemistry on human samples (fig 4). Infect Immun (2012) ncbi
mouse monoclonal (4A2C7)
  • western blot; human; fig 3
In order to report that lethal toxin targets alveolar epithelial cells, Invitrogen E-cadherin antibody (Invitrogen, 4A-2C7) was used in western blot on human samples (fig 3). Infect Immun (2012) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 6
In order to evaluate the effectiveness of VEGF restriction on orthotopic tumor growth and elucidate the mechanism of treatment resistance, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6). Neuro Oncol (2012) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:50; fig 2
In order to examine the effects of calcium and vitamin D on adenomatous polyposis coli, beta-catenin, and E-cadherin expression in patients with sporadic colorectal adenoma, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunohistochemistry on human samples at 1:50 (fig 2). Cancer Prev Res (Phila) (2012) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 4
In order to examine the effects of rapamycin treatment using an organotypic culture of human skin explants, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4). Arch Dermatol Res (2013) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; mouse; 1:150
Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on mouse samples at 1:150. Environ Toxicol (2014) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to identify molecular alterations that contribute to the development of pulmonary carcinoids, Invitrogen E-cadherin antibody (Zymed Laboratories, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Int J Oncol (2012) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:400; fig 1
In order to examine E-cadherin expression in phyllodes tumors, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1). Hum Pathol (2012) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; dogs; fig 2
In order to study the expression and localization of E-cadherin in canine round cell tumors, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry - paraffin section on dogs samples (fig 2). Vet J (2012) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 4
In order to examine distribution of the GCTM-5 antigen in normal tissues and disease states and characterize the antigen biochemically, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunocytochemistry on human samples (fig 4). Stem Cells (2012) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 1
In order to correlate the of CADM4, E-cadherin, and Ki-67 in colorectal adenocarcinomas, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 1). J Clin Pathol (2012) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:200; fig 2
In order to study the association of nuclear Kaiso with high grade and invasive triple negative breast cancers and cytoplasmic Kaiso with invasive lobular carcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:200 (fig 2). PLoS ONE (2012) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to correlate the expression of cyclin D1 to various breast cancer features, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Hum Pathol (2012) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 2
In order to develop and characterize a model for Hailey-Hailey disease using normal keratinocytes, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 2). Exp Dermatol (2012) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 1
In order to investigate the effect of lysophosphatidic acid on E-cadherin junctional integrity, Invitrogen E-cadherin antibody (Zymed, hecd-1) was used in immunocytochemistry on human samples (fig 1). J Oncol (2012) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; human; fig 6
In order to elucidate the relationship between normal fibroblasts and epithelial cancer cells, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunocytochemistry on human samples (fig 6). Anticancer Res (2012) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 2
In order to examine APC/beta-catenin signaling pathway members as biomarkers for the risk of colorectal neoplasms, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 2). Cancer Epidemiol Biomarkers Prev (2012) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to assess the risk of relapse for lobular carcinoma in situ patients, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Breast (2012) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 3
In order to assess the incidence and prognostic significance of the epithelial to mesenchymal transition in cancer of unknown primary, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 3). Anticancer Res (2012) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:2500; tbl 1
In order to develop and characterize a new 3-D spheroid cell culture system that mimics solid tumors, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples at 1:2500 (tbl 1). Exp Cell Res (2012) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:25; fig 1
In order to describe a histologic, molecular, and immunophenotypic analysis of patients with sporadic early-onset of colorectal carcinoma, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:25 (fig 1). Mod Pathol (2012) ncbi
mouse monoclonal (HECD-1)
  • flow cytometry; mouse; 1:100
In order to test if destabilization accounts for the pathogenicity of E-cadherin missense mutations in hereditary diffuse gastric cancer, Invitrogen E-cadherin antibody (Zymed Laboratories, HECD1) was used in flow cytometry on mouse samples at 1:100. PLoS ONE (2012) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; fig 3
In order to identify and describe Franceschetti corneal dystrophy, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on human samples (fig 3). Am J Ophthalmol (2012) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; dogs; fig 1
In order to examine the effect of treating epithelial cells with an inhibitor of the lipid kinase PIKfyve, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunocytochemistry on dogs samples (fig 1). PLoS ONE (2012) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to investigate the case of a boy with psychomotor delay and dysmorphic features, Invitrogen E-cadherin antibody (Zymed, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Gene (2012) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 1
In order to investigate the involvement of the tumor microenvironment in the epigenetic control of genes critical to cancer progression, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunocytochemistry on human samples (fig 1). Epigenetics (2012) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; fig 2
In order to characterize pulmonary adenocarcinoma with a micropapillary pattern samples, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on human samples (fig 2). Histopathology (2011) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to discuss the role of MLH1 in gastric cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). BMC Gastroenterol (2011) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - frozen section; human; fig 3
In order to establish and characterize a three-dimensional organotypic model of the human airway mucosa, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry - frozen section on human samples (fig 3). Am J Physiol Lung Cell Mol Physiol (2012) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:2500; tbl 3
In order to study the effect of contraceptive choices on cervical intraepithelial neoplasia, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:2500 (tbl 3). Contraception (2012) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 1
In order to study the EGF-induced, ADAM10-dependent shedding of E-cadherin by prostate epithelial cells, Invitrogen E-cadherin antibody (Invitrogen, clone HECD-1) was used in western blot on human samples (fig 1). Cell Signal (2012) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; mouse; fig 5
In order to test if CDH11 is increased in pulmonary fibrosis and contributes its development, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunocytochemistry on mouse samples (fig 5). FASEB J (2012) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; mouse; fig 5
In order to test if CDH11 is increased in pulmonary fibrosis and contributes its development, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunocytochemistry on mouse samples (fig 5). FASEB J (2012) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; mouse; fig 1
In order to investigate how Listeria monocytogenes crosses the epithelium, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry on mouse samples (fig 1). J Exp Med (2011) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to test if miRNA dysregulation is detected during progression from lobular carcinoma in situ to invasive lobular carcinoma, Invitrogen E-cadherin antibody (Zymed/Invitrogen, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). J Pathol (2012) ncbi
mouse monoclonal (SHE78-7)
  • immunoprecipitation; human; fig 5
  • immunocytochemistry; human; fig 6
In order to study the effect of alpha-catenin-p120 interactions, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in immunoprecipitation on human samples (fig 5) and in immunocytochemistry on human samples (fig 6). Mol Biol Cell (2011) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; pigs ; 1:50; fig 5
In order to examine the effects of mycotoxins on the intestinal function of pigs, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on pigs samples at 1:50 (fig 5). Br J Nutr (2012) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; fig 6
  • western blot; human; 1:500; fig 3
In order to test in endothelial cells contribute to the epithelial to mesenchymal transition, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples (fig 6) and in western blot on human samples at 1:500 (fig 3). PLoS ONE (2011) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:1000; fig 1
In order to identify cell surface protein biomarkers that discriminate between low-risk adenomas and normal colons from high-risk adenomas and colorectal cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples at 1:1000 (fig 1). Gut (2012) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 7
  • immunohistochemistry - paraffin section; human; 1:500; fig 7
In order to determine the role of kindlin-1 in cancer, Invitrogen E-cadherin antibody (Invitrogen, clone 4A2C7) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 7) and in immunohistochemistry - paraffin section on human samples at 1:500 (fig 7). J Natl Cancer Inst (2011) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - frozen section; human; 1:300; tbl 1
In order to discuss immunohistochemical analysis of the olfactory epithelium, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in immunohistochemistry - frozen section on human samples at 1:300 (tbl 1). Laryngoscope (2011) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 2
In order to discuss the contribution of epithelial-to-mesenchymal transition to invasive and metastatic carcinomas, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunocytochemistry on human samples (fig 2). Mol Cancer (2011) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human
In order to establish a mouse model to study choriocarcinoma, Invitrogen E-cadherin antibody (ZYMED, 334000) was used in immunohistochemistry - paraffin section on human samples . Am J Pathol (2011) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; dogs; 1:25; fig 1
In order to demonstrate that ESCRT proteins are required to maintain polarity in mammalian epithelial cells, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunocytochemistry on dogs samples at 1:25 (fig 1). Mol Biol Cell (2011) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; mouse; fig 2
In order to establish and characterize a new cell line derived from the kidney of a bank vole, Myodes glareolus, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on mouse samples (fig 2). Virol J (2011) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; mouse; fig 3
In order to generate and characterize a new cell line derived from a head and neck squamous cell carcinoma, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on mouse samples (fig 3). Oral Oncol (2011) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; mouse; fig s3
In order to determine the role of NRP2 in mouse mammary gland development, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry on mouse samples (fig s3). Development (2011) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 2
In order to investigate the relationship between gastric cancer and renal cell carcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 2). Oncol Rep (2011) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:2500; tbl 1
In order to investigate the interactions among LRIG1, LRIG2, and other cancer markers as diagnostics in CIN, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:2500 (tbl 1). Gynecol Oncol (2011) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to investigate the relationship between endothelium-coated tumor clusters and severity of liver cancer patients, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Cancer (2011) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; fig 4
In order to examine barrier function in the esophageal epithelium of patients with gastroesophageal reflux disease, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunohistochemistry on human samples (fig 4). Am J Gastroenterol (2011) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; fig 4
In order to examine barrier function in the esophageal epithelium of patients with gastroesophageal reflux disease, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry on human samples (fig 4). Am J Gastroenterol (2011) ncbi
mouse monoclonal (SHE78-7)
  • western blot; human; fig s1b
In order to determine the function of the strand-swap and X dimer interfaces of E-cadherin, Invitrogen E-cadherin antibody (Invitrogen, SHE78-7) was used in western blot on human samples (fig s1b). J Cell Biol (2011) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to study the relationship between atypical ductal mammary hyperplasia and malignant neoplastic transformation in dogs, Invitrogen E-cadherin antibody (Zymed/Invitrogen, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Vet Pathol (2012) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; rat; 1:120; fig 7
In order to investigate the contribution of B12 to inflammatory bowel disease pathogenesis, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on rat samples at 1:120 (fig 7). J Cell Mol Med (2011) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:1000; fig 5
In order to use the SW620 secretome to identify novel biomarker candidates, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in western blot on human samples at 1:1000 (fig 5). Proteomics Clin Appl (2007) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; tbl 1
In order to establish and characterize an epithelial cell line derived from a breast carcinoma from a patient with a strong family history of breast cancer but no known breast cancer susceptibility mutation, Invitrogen E-cadherin antibody (Zymed, HECD1) was used in immunocytochemistry on human samples (tbl 1). In Vitro Cell Dev Biol Anim (2011) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to discuss the consequences of cadherin switching, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). PLoS ONE (2010) ncbi
mouse monoclonal (SHE78-7)
  • flow cytometry; mouse; fig 1
In order to study how E-cadherin and N-cadherin regulate embryonic stem cell differentiation, Invitrogen E-cadherin antibody (Invitrogen, SHE78.7) was used in flow cytometry on mouse samples (fig 1). Methods Mol Biol (2011) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 1
  • immunohistochemistry; human; fig 1
In order to investigate how trafficking of E-cadherin contributes to breast cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples (fig 1) and in immunohistochemistry on human samples (fig 1). Anticancer Res (2010) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human; 2 ug/ml
In order to discuss methods to culture embryonic stem cells, Invitrogen E-cadherin antibody (Invitrogen, SHE78.7) was used in blocking or activating experiments on human samples at 2 ug/ml. PLoS ONE (2010) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:200; fig 1
In order to investigate E-cadherin expression in morphologically typical invasive lobular carcinomas, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry on human samples at 1:200 (fig 1). Am J Surg Pathol (2010) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:50; fig 6
In order to examine the mRNA splicing pattern of CD44 in normal stomach and gastric cancer cell lines, Invitrogen E-cadherin antibody (Invitrogen, clone 4A2C7) was used in immunohistochemistry on human samples at 1:50 (fig 6). Lab Invest (2010) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to report the clinicopathological and immunohistochemical features of goblet cell carcinoid, Invitrogen E-cadherin antibody (Neomarker, A42C7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Int J Surg Pathol (2010) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:200; fig s1
In order to use a novel 3D culture system to assess cell-matrix interactions that contribute to carcinogenesis, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples at 1:200 (fig s1). Biomaterials (2010) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
In order to investigate if the epithelial-to-mesenchymal transition contributes to metaplastic breast carcinomas with chondroid differentiation, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Appl Immunohistochem Mol Morphol (2010) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:100; fig 2
In order to determine the expression and prognostic role of E-cadherin in ovarian cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:100 (fig 2). Anticancer Res (2010) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 2
In order to study the in vitro transformation of rat cholangiocytes, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 2). Exp Mol Pathol (2010) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 4
In order to report that membrane type 1-matrix metalloproteinase cleaves the extracellular matrix and causes cellular aggregation of keratinocytes and squamous cell carcinoma cells, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples (fig 4). J Biol Chem (2010) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:800; fig 3
In order to examine the expression and association of stromal CD10 with E-cadherin and beta-catenin in breast carcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:800 (fig 3). Histopathology (2010) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human; 1:50; fig s2
In order to elucidate the molecular mechanisms that coordinate adhesion and cytoskeleton at the zonula adherens, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in blocking or activating experiments on human samples at 1:50 (fig s2). Nat Cell Biol (2010) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; mouse; 1:50; fig 1
In order to elucidate the role of partitioning defective genes in trophectoderm differentiation and blastocyst formation, Invitrogen E-cadherin antibody (Invitrogen, 33-4000) was used in immunocytochemistry on mouse samples at 1:50 (fig 1). Biol Reprod (2010) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to elucidate the contribution of epithelial-mesenchymal transition in the progression of cholangiocarcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Am J Pathol (2010) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 0.2 ug/ul; fig 1
In order to develop an in vitro model for experimental studies of cancer cell invasion, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry on human samples at 0.2 ug/ul (fig 1). Eur J Oral Sci (2010) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:200; fig 4
In order to study the expression pattern of stem cells in the bulbar conjunctival epithelium, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:200 (fig 4). J Cell Physiol (2010) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 3
In order to investigate protein modification of beta-catenin, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples (fig 3). PLoS ONE (2010) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 6
In order to elucidate the function of alpha3beta1 integrin, Invitrogen E-cadherin antibody (Invitrogen, 13-1700) was used in western blot on human samples (fig 6). Wound Repair Regen (2010) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 7
In order to study barrier integrity and tight junction protein expression using in vitro lung epithelial barrier model, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunocytochemistry on human samples (fig 7). Immunobiology (2011) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:40; fig 1
In order to present six cases of lobular neoplasia with comedo necrosis, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:40 (fig 1). Pathol Res Pract (2010) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:100; tbl 1
In order to characterize the expression of a number of proteins in tissues from pseudomyxoma peritonei patients, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:100 (tbl 1). Hum Pathol (2010) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to identify a prognostic immunohistochemical signature indicative of risk of early metastasis in node-negative breast carcinomas and use this information to develop targeted therapies, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Int J Oncol (2010) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 4
In order to study the morphologic spectrum of columnar cell lesions in canine mammary gland, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4). BMC Cancer (2010) ncbi
mouse monoclonal (HECD-1)
  • flow cytometry; human; 1:100
In order to examine the effect of uPAR modulation on oral squamous cell carcinoma, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in flow cytometry on human samples at 1:100. Mol Cancer Res (2010) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to measure the expression of tenascin-C, osteopontin, and fibronectin in inflammatory myofibroblastic tumor of the lung, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). APMIS (2010) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human
In order to present two cases of metastatic carcinoma strikingly simulating angiosarcoma in the liver, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples . Pathol Res Pract (2010) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:2500; tbl 1
In order to study tissue tumor marker expression in smokers with cervical intraepithelial neoplasia or normal squamous cervical epithelium, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:2500 (tbl 1). Am J Obstet Gynecol (2010) ncbi
mouse monoclonal (HECD-1)
  • blocking or activating experiments; human
In order to discuss the effects of E-cadherin overexpression in highly malignant inflammatory breast cancer, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in blocking or activating experiments on human samples . BMC Cancer (2009) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:100; fig 3
In order to present the clinicopathologic, immunohistochemical, and molecular features of a rare aggressive variant of the papillary thyroid carcinomas showing prominent hobnail features, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:100 (fig 3). Am J Surg Pathol (2010) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 6
  • western blot; human; 1:500; fig 3
In order to investigate the regulation of the epithelial-mesenchymal transition in hypoxia and determine the importance of Snail in cell migration and clinical outcome in breast cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6) and in western blot on human samples at 1:500 (fig 3). Br J Cancer (2009) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; human; fig 5
In order to study the effect on inflammatory breast cancer tumorigenicity and metastasis when the EGFR pathway is blocked, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunocytochemistry on human samples (fig 5). Clin Cancer Res (2009) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100
In order to discuss the prognostic value of large-core needle biopsy of the breast and vacuum-assisted breast biopsy, Invitrogen E-cadherin antibody (Zymed CliniSciences, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100. Eur J Surg Oncol (2010) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to determine if survival and E-cadherin expression by the neoplastic cells in a group of dogs with anal sac gland carcinomas are associated, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Vet Comp Oncol (2007) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to study the prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Eur J Cancer Prev (2010) ncbi
mouse monoclonal (SHE78-7)
  • western blot; human; fig 5b
In order to investigate the effect of BCSC-1 expression on malignant behaviors of CNE-2L2 cells, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in western blot on human samples (fig 5b). Cancer Sci (2009) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - frozen section; human; fig 2
  • western blot; human; fig 1
In order to test if intercellular adhesion affects beta-catenin signaling, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in immunohistochemistry - frozen section on human samples (fig 2) and in western blot on human samples (fig 1). J Cell Biol (2009) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 5
In order to characterize a three-dimensional multicellular colorectal tumor model, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 5). Br J Cancer (2009) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; dogs; fig 1
In order to review canine cutaneous histiocytoma, Invitrogen E-cadherin antibody (Zymed Laboratory, 4A2C7) was used in immunohistochemistry on dogs samples (fig 1). Anticancer Res (2009) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human; 4 mg/ml; fig 3A
In order to test if cadherin adhesion receptors are required for planar spindle orientation in mammalian epithelia, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in blocking or activating experiments on human samples at 4 mg/ml (fig 3A). Mol Biol Cell (2009) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
In order to elucidate the relationship between contact inhibition of growth and growth factors, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples . Proc Natl Acad Sci U S A (2009) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:50; fig 1
In order to review metastatic penoscrotal extramammary Paget's disease, Invitrogen E-cadherin antibody (Zymed Laboratories, 4A2C7) was used in immunohistochemistry on human samples at 1:50 (fig 1). Br J Dermatol (2009) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to study surgically resected cases of extrahepatic bile duct adenocarcinoma to clarify clinicopathological significance of syndecan-1/E-cadherin expression, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Biomed Res (2009) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human; 5 ug/ml
In order to test if PTEN contributes to the maintenance of tissue integrity, Invitrogen E-cadherin antibody (Zymed Laboratories, SHE78-7) was used in blocking or activating experiments on human samples at 5 ug/ml. Cancer Res (2009) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 4a
In order to develop a new evanescent-wave fluorescence excitation method for biological samples, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples (fig 4a). Opt Express (2009) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; human; 1 ug/ml; fig 1
In order to ascertain the roles of human nucleoside transporters in mediating transepithelial fluxes of adenosine, 2'-deoxyadenosine, and three purine nucleoside anti-cancer drugs, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunocytochemistry on human samples at 1 ug/ml (fig 1). Am J Physiol Renal Physiol (2009) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human
In order to identify prognostic immunohistochemical molecular signatures indicative of disease outcome in triple-negative breast cancers, Invitrogen E-cadherin antibody (Neomarkers, 4A2C7) was used in immunohistochemistry on human samples . Int J Oncol (2009) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; tbl 4
In order to measure the different second hits in CDH1 occurring in neoplastic lesions from hereditary diffuse gastric cancer patients, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples (tbl 4). Gastroenterology (2009) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; human; fig 1b
In order to explore the functional implication of different cadherins in breast cancer biology, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunocytochemistry on human samples (fig 1b). BMC Cancer (2009) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 1b
In order to explore the functional implication of different cadherins in breast cancer biology, Invitrogen E-cadherin antibody (Zymed, HECD1) was used in immunocytochemistry on human samples (fig 1b). BMC Cancer (2009) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 2
In order to assess the sensitivity of 18 squamous cell carcinoma of the head and neck cell lines to gefitinib, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in western blot on human samples (fig 2). J Pathol (2009) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 5
  • western blot; human; 1:1000; fig 3
In order to discuss markers to diagnosis of diabetic nephropathy, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 5) and in western blot on human samples at 1:1000 (fig 3). Diabetes Metab Res Rev (2009) ncbi
mouse monoclonal (4A2C7)
  • western blot; dogs; fig 1
  • western blot; human; fig 1
In order to assess the contribution of N-glycosylation of E-cadherin to canine mammary gland adenoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in western blot on dogs samples (fig 1) and in western blot on human samples (fig 1). Biochem Biophys Res Commun (2009) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - frozen section; human; 1:100; fig 1
In order to study the expression of adherens junction and tight junction components in human peripheral nerve endoneurium, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 1). J Histochem Cytochem (2009) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to identify prognostic signatures in breast carcinomas using quantitative immunocytochemical assays, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Int J Cancer (2009) ncbi
mouse monoclonal (SHE78-7)
  • immunocytochemistry; human; 1 ug/ml; fig 2
  • western blot; human; fig 2
In order to ascertain the effects of tamoxifen and fulvestrant treatment on invasive signaling and compared this with the effects of oestrogen withdrawal, Invitrogen E-cadherin antibody (Invitrogen, SHE-78) was used in immunocytochemistry on human samples at 1 ug/ml (fig 2) and in western blot on human samples (fig 2). Breast Cancer Res (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:50
In order to determine the expression of several adhesion molecules and MUC1 in samples from patients with unifocal or multifocal bladder urothelial cell carcinoma in situ, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:50. Int J Surg Pathol (2009) ncbi
mouse monoclonal (HECD-1)
  • western blot; human
In order to examine the effects of connexin-43 expression in breast cancer cells, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in western blot on human samples . Clin Exp Metastasis (2008) ncbi
mouse monoclonal (SHE78-7)
  • immunocytochemistry; human; fig 5
In order to ascertain the role of epithelial cadherin in gamete interaction, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in immunocytochemistry on human samples (fig 5). Mol Hum Reprod (2008) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 20 ug/ml; fig 4
  • western blot; human; fig 3
In order to ascertain the role of epithelial cadherin in gamete interaction, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples at 20 ug/ml (fig 4) and in western blot on human samples (fig 3). Mol Hum Reprod (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:2000
In order to discuss the morphological diversity of glioblastomas, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:2000. Cancer (2008) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
  • western blot; human
In order to study Rac-dependent cyclin D1 expression, Invitrogen E-cadherin antibody (Zymed Laboratories, 13-1700) was used in immunocytochemistry on human samples and in western blot on human samples . J Biol Chem (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 2.5 ug/ml; fig 2
In order to assess the methylation status of the E-cadherin gene and its protein expression in a prostate tissue biopsy specimen, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 2.5 ug/ml (fig 2). Prostate (2008) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:200
In order to use mass spectroscopy to identify proteins that contribute to adhesion of human embryonic stem cells, Invitrogen E-cadherin antibody (Zymed Laboratories, HECD-1) was used in immunocytochemistry on human samples at 1:200. Stem Cells (2008) ncbi
mouse monoclonal (SHE78-7)
  • immunoprecipitation; human; fig 4
In order to investigate the involvement of p120-catenin complexes in cadherin-based adhesion and signaling, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in immunoprecipitation on human samples (fig 4). Mol Biol Cell (2008) ncbi
mouse monoclonal (4A2C7)
  • western blot; human; 1:1000; fig 5a
In order to assess if E- and N-cadherin expression has diagnostic value for intrahepatic cholangiocarcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in western blot on human samples at 1:1000 (fig 5a). Mod Pathol (2009) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human
  • flow cytometry; human; 1:200
  • western blot; human; 1:2000
In order to study the role of the E7 oncogene in restoring E-cadherin expression in human papillomavirus 16-transformed keratinocytes, Invitrogen E-cadherin antibody (Zymed Laboratories, HECD-1) was used in immunohistochemistry - paraffin section on human samples , in flow cytometry on human samples at 1:200 and in western blot on human samples at 1:2000. Carcinogenesis (2008) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:200; tbl 2
In order to study the genomic and immunophenotypical features of pure invasive micropapillary carcinomas, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry on human samples at 1:200 (tbl 2). J Pathol (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 2
In order to characterize pleomorphic lobular carcinomas, Invitrogen E-cadherin antibody (Zymed, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). J Pathol (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:50
In order to use the D2-40 antibody to detect lymphatic endothelial cells during the lymphovascular invasion of breast cancer, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:50. Ann Clin Lab Sci (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:40
In order to measure Twist and E- and N-cadherin expression in human primary bladder tumor from tobacco and non-tobacco users and evaluate their prognostic value, Invitrogen E-cadherin antibody (Zymed Laboratories, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:40. Urol Oncol (2009) ncbi
mouse monoclonal (HECD-1)
  • immunoprecipitation; human
  • western blot; human
In order to examine the role of E-cadherin and ADAM15 in ErbB receptor signaling, Invitrogen E-cadherin antibody (Zymed Laboratories, HECD-1) was used in immunoprecipitation on human samples and in western blot on human samples . J Biol Chem (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - frozen section; human; fig 2
In order to examine the expression of Bcl-2 in tumoral cells from a patient with papillary tumor of the pineal region, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - frozen section on human samples (fig 2). Neuropathology (2008) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:100
In order to examine the expression and localization of the BRCA1 protein and assess its prognostic value in breast carcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:100. Hum Pathol (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:100; tbl 2
In order to examine the diagnostic agreement of cytokeratin 5/6 and E-cadherin in non-invasive proliferative breast lesions, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:100 (tbl 2). Histopathology (2008) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human; 10 ug/ml
In order to investigate the role of P-cadherin in bladder transitional cell carcinomas, Invitrogen E-cadherin antibody (Zymed, 13-5700) was used in blocking or activating experiments on human samples at 10 ug/ml. J Pathol (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:200
In order to study the use of tissue microarrays for immunohistochemical analysis of squamous cell carcinoma markers, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:200. Virchows Arch (2008) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 3c
In order to examine cadherin expression in mouse fibroblast-like synoviocytes, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples (fig 3c). Arthritis Rheum (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:200; fig 5
In order to study the mechanism by which E-cadherin loss promotes ovarian cancer metastasis, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 5). Cancer Res (2008) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; tbl 2
In order to identify key matrix components required for ex vivo maintenance of human hepatic progenitors, Invitrogen E-cadherin antibody (ZYMED, 13-1700) was used in immunohistochemistry on human samples (tbl 2). Tissue Eng Part A (2008) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:20; fig 1a
  • western blot; human; fig 3a
In order to test if heat shock proteins interact functionally with the cadherin-catenin cell adhesion system in breast cancer, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:20 (fig 1a) and in western blot on human samples (fig 3a). Cell Stress Chaperones (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:200; fig 4
In order to elucidate the role of Wnt-5a in human cancers, Invitrogen E-cadherin antibody (ZYMED, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4). Dig Liver Dis (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - frozen section; human; 1:100
In order to evaluate different fixation and antigen retrieval methods for immmunohistochemical studies on frozen tissues, Invitrogen E-cadherin antibody (Invitrogen/Zymed, 4A2C7) was used in immunohistochemistry - frozen section on human samples at 1:100. Am J Clin Pathol (2008) ncbi
mouse monoclonal (4A2C7)
  • western blot; human; fig 6
In order to find that basic fibroblast growth factor downregulates typical cadherin expression on the surface of human umbilical vein endothelial cells via FGF receptor 1 signaling, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in western blot on human samples (fig 6). Exp Cell Res (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; rat; fig 3
In order to assess the mechanism of hepatic fibrosis of the polycystic kidney rat via pathological cholangiocytes, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on rat samples (fig 3). Am J Pathol (2007) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 1a
In order to study the role E-cadherin expression in the intercellular adhesion of metastatic prostate cancer cells in bone, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Prostate (2008) ncbi
mouse monoclonal (HECD-1)
  • flow cytometry; human; 2.5 ug/ml
In order to study adhesion molecules responsible for rBM-driven versus spontaneous spheroid formation in breast tumor cell lines relevant for antitumor drug testing, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in flow cytometry on human samples at 2.5 ug/ml. Int J Oncol (2007) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 6
In order to identify and characterize a new type of adherens junction in human meningiomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 6). Cell Tissue Res (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:200
In order to analyze the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis, Invitrogen E-cadherin antibody (Zymed Laboratories, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:200. Liver Int (2007) ncbi
mouse monoclonal (HECD-1)
  • blocking or activating experiments; human
  • western blot; human; 1:1000
In order to assess whether E-cadherin-dependent cell-cell contact mediates CaSki cell apoptosis during multicellular tumor spheroid formation, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in blocking or activating experiments on human samples and in western blot on human samples at 1:1000. Apoptosis (2008) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human
In order to assess whether E-cadherin-dependent cell-cell contact mediates CaSki cell apoptosis during multicellular tumor spheroid formation, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in blocking or activating experiments on human samples . Apoptosis (2008) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:5000
In order to postulate a role for extracellular matrix-integrin regulation of the Rac1-c-jun-N-terminal kinase pathway in estrogen-regulated proliferation in estrogen receptor positive breast cancer cells, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples at 1:5000. Breast Cancer Res Treat (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human
In order to describe a protocol for automated image analysis detailing morphological protein marker profiling of tumoroid cross section images, Invitrogen E-cadherin antibody (Zymed Laboratories, 4A2C7) was used in immunohistochemistry - paraffin section on human samples . BMC Med Imaging (2007) ncbi
mouse monoclonal (4A2C7)
  • western blot; human; 1:1500; fig 3
In order to test if recombinant human interferon-beta reduces the motility and invasiveness of poorly differentiated prostate cancer cells, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in western blot on human samples at 1:1500 (fig 3). J Interferon Cytokine Res (2007) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 5
In order to determine interaction affinities of E-cadherin dimers on both cell surfaces and agarose beads, Invitrogen E-cadherin antibody (Zymed Laboratories, HECD-1) was used in immunocytochemistry on human samples (fig 5). Mol Biol Cell (2007) ncbi
mouse monoclonal (SHE78-7)
  • immunocytochemistry; human; fig 5
In order to determine interaction affinities of E-cadherin dimers on both cell surfaces and agarose beads, Invitrogen E-cadherin antibody (Zymed Laboratories, SHE78-7) was used in immunocytochemistry on human samples (fig 5). Mol Biol Cell (2007) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:2000; tbl 3
In order to investigate the sub-classification invasive breast carcinoma patients and its prognostic significance, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:2000 (tbl 3). Cancer (2007) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200
In order to assess the clinical significance of E-cadherin and p120ctn expression in esophageal squamous cell carcinoma, Invitrogen E-cadherin antibody (Zymed Laboratories, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:200. Ann Surg Oncol (2007) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; dogs; 1:100
In order to quantify E-cadherin, P-cadherin and beta-catenin expression in canine malignant mammary tumors, Invitrogen E-cadherin antibody (Zymed Laboratory, 4A2C7) was used in immunohistochemistry on dogs samples at 1:100. Vet J (2008) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; dogs; fig 3
In order to quantify sialyl Lewis x expression in canine malignant mammary tumors and to examine if the presence of sialyl Lewis x correlates with the expression of E-Cadherin, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on dogs samples (fig 3). BMC Cancer (2007) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; fig 1
In order to assess the use of E-cadherin and beta-catenin as markers of nodal metastasis in oral squamous cell carcinoma, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig 1). Oral Dis (2007) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to quantify the expression of E-cadherin and a- and b-catenins that form the cadherin-catenin complex in tumoral vascular invasion in metastatic sentinel lymph node patients, Invitrogen E-cadherin antibody (Zymed, ECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Pathol Res Pract (2007) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human
In order to investigate the significance of flat epithelial atypia of the breast in breast biopsy specimens, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples . Histopathology (2007) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:320
In order to discuss the contribution of E-cadherin mutations to hereditary diffuse gastric cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:320. Ann Surg (2007) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to correlate the expression of E-cadherin and beta-catenin with the mode of growth and metastatic capacity of canine malignant mammary tumors, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). APMIS (2007) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:50
In order to assess the prognostic significance of p53, Ki-67, epithelial cadherin, and matrix metalloproteinase-9 in primary penile cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:50. BJU Int (2007) ncbi
mouse monoclonal (SHE78-7)
In order to report that E-cadherin and catenins but not activated EGFR contribute to human prostate metastases to the liver, Invitrogen E-cadherin antibody (Zymed Laboratory, SHE78-7) was used . Br J Cancer (2007) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; human; 1:200; fig 2D
  • western blot; human; 1:1000; fig 3C
In order to report that the hDlg1-MPP7 complex promotes epithelial cell polarity and tight junction formation, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunocytochemistry on human samples at 1:200 (fig 2D) and in western blot on human samples at 1:1000 (fig 3C). Mol Biol Cell (2007) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:4000; fig 1
In order to study the effects of matrix-induced integrin clustering on proteinase-catalyzed E-cadherin ectodomain shedding and identify a role for MMP-9, Invitrogen E-cadherin antibody (Invitrogen, HECD-1) was used in western blot on human samples at 1:4000 (fig 1). Cancer Res (2007) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; human; 1:300; fig 5
In order to study the effects of matrix-induced integrin clustering on proteinase-catalyzed E-cadherin ectodomain shedding and identify a role for MMP-9, Invitrogen E-cadherin antibody (Invitrogen, 4A2C7) was used in immunocytochemistry on human samples at 1:300 (fig 5). Cancer Res (2007) ncbi
mouse monoclonal (4A2C7)
  • western blot; human; fig 3
In order to explore the role of heat shock proteins in cytoskeletal stabilization of mesothelial cells in experimental peritoneal dialysis, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in western blot on human samples (fig 3). Am J Physiol Renal Physiol (2007) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
In order to demonstrate that the RhoA pathway mediates COX-2 signaling and alters the formation of adherens junctions to increase cell motility, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples . Cancer Res (2006) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:100; tbl 1
In order to discuss therapy options for triple-negative breast cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:100 (tbl 1). Cancer (2007) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:200; tbl 1
In order to investigate the therapeutic targeting of FGFR1 in lobular breast carcinomas, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:200 (tbl 1). Clin Cancer Res (2006) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to study the effect of taurolidine/heparin treatment on E-cadherin, beta1-integrin, and CD44, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). J Surg Res (2007) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - frozen section; human
In order to assess the expression of epithelial markers on healthy and diseased synovial lining tissue, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - frozen section on human samples . Arthritis Res Ther (2006) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; dogs; fig S1
In order to elucidate the role of podoplanin in cell migration or invasiveness, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunocytochemistry on dogs samples (fig S1). J Cell Sci (2006) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; fig 2h
In order to report the methylation profile of CpG islands in cutaneous squamous cell carcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples (fig 2h). Br J Dermatol (2006) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; dogs; 1:200; fig 5
In order to investigate genes regulated by Snail, Slug, and E47 transcription factors, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on dogs samples at 1:200 (fig 5). Cancer Res (2006) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 2
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 3
In order to determine the expression and role of Twist in hepatocellular carcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 2), in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 3). Clin Cancer Res (2006) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:200
In order to test if refractoriness to TGF-beta is a contributing factor to intraepithelial lymphocyte retention, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:200. Histopathology (2006) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:100
  • ELISA; human
  • western blot; human; 1:500
In order to measure CDH1 mRNA and protein in a series of normal and neoplastic testes, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry on human samples at 1:100, in ELISA on human samples and in western blot on human samples at 1:500. APMIS (2006) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
In order to investigate the role of secreted protein acidic and rich in cysteine in primary tumor development, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples . Cancer Res (2006) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human
In order to examine the first family diagnosed with hereditary diffuse gastric cancer in Spain for mutations in the E-cadherin gene, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples . Eur J Surg Oncol (2006) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; rhesus macaque
In order to characterize mammary gland lesions in cynomolgus and rhesus macaques, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on rhesus macaque samples . Vet Pathol (2006) ncbi
mouse monoclonal (SHE78-7)
  • flow cytometry; human
In order to discuss intrauterine human cytomegalovirus infection, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in flow cytometry on human samples . Placenta (2007) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 6
  • immunohistochemistry; human; fig 1
In order to discuss the consequences of CDH1 germline mutations in the general population and in patients with hereditary diffuse gastric cancer, Invitrogen E-cadherin antibody (Zymed, HECD?\1) was used in immunocytochemistry on human samples (fig 6) and in immunohistochemistry on human samples (fig 1). J Med Genet (2006) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 20 ug/ml; fig 5
In order to clarify how PI3KC2beta regulates the migration and survival of human tumor cells, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples at 20 ug/ml (fig 5). Mol Biol Cell (2006) ncbi
mouse monoclonal (HECD-1)
  • immunoprecipitation; human; fig 5
  • immunocytochemistry; human; fig 4
In order to study E-cadherin dimer assembly, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunoprecipitation on human samples (fig 5) and in immunocytochemistry on human samples (fig 4). Mol Biol Cell (2006) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 1
  • immunocytochemistry; hamsters; fig 2
  • western blot; hamsters; fig 2
In order to discuss assays to study the effects of Rap1 on cadherin-dependent adhesion in epithelia, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples (fig 1), in immunocytochemistry on hamsters samples (fig 2) and in western blot on hamsters samples (fig 2). Methods Enzymol (2006) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:300
In order to discuss how H-ras contributes to the transformation of human mammary epithelial cells, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:300. Cancer Cell Int (2006) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:600
In order to discover if N-cadherin expression is associated with the bladder tumor progression, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:600. Clin Cancer Res (2006) ncbi
mouse monoclonal (SHE78-7)
  • western blot; human; fig 6
In order to report that Notch1 signaling drives the vertical growth phase of primary melanoma, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in western blot on human samples (fig 6). Cancer Res (2006) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:1000; fig 1
In order to assess the relationship between E-cadherin status and gene expression levels in human mammary cell lines, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples at 1:1000 (fig 1). Br J Cancer (2006) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to clarify the prognostic role of E-cadherin and beta- and gamma-catenins and discuss their relationship to CD44 in epithelial ovarian carcinoma, Invitrogen E-cadherin antibody (Zymed, HECD?\1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). J Clin Pathol (2006) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:100; tbl 7
In order to study the morphological and immunophenotypic features of breast carcinomas with basal and myoepithelial differentiation, Invitrogen E-cadherin antibody (Zymed Laboratories, clone ZHECD-1) was used in immunohistochemistry on human samples at 1:100 (tbl 7). J Pathol (2006) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human
In order to report on a case of soft tissue sacrococcygeal chordoma with intracytoplasmic filamentous inclusions, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples . Pathol Res Pract (2005) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:400; fig 1
In order to assess E-cadherin expression in mammary lobular carcinomas and ductal carcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1). World J Surg Oncol (2005) ncbi
mouse monoclonal (4A2C7)
  • western blot; human; 1:500; fig 3
In order to characterize a retinoblastoma-inactivated breast cancer cell line that overexpresses cyclin E, Invitrogen E-cadherin antibody (Zymed, 33-4,000) was used in western blot on human samples at 1:500 (fig 3). Cancer Res (2005) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:200; fig 4B
  • western blot; human; 1:1000; fig 3B
In order to investigate the mechanism of copper-induced internalization of cellular prion protein in neuronal cells, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunocytochemistry on human samples at 1:200 (fig 4B) and in western blot on human samples at 1:1000 (fig 3B). J Cell Sci (2005) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; fig 1C
  • immunocytochemistry; human; fig 4Ac
  • western blot; human; fig 3B
In order to investigate the relationship between hepatocyte growth factor and E-cadherin in gastric carcinoma, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig 1C), in immunocytochemistry on human samples (fig 4Ac) and in western blot on human samples (fig 3B). Ann Surg (2005) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 2
In order to present the clinicopathological features of three cases of primary invasive micropapillary carcinoma of the colon and review the literature, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 2). Histopathology (2005) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human; 2 ug/ml; fig 6
In order to study the role of notch-1 and E-cadherin in the bone metastasis of malignant prostate cancers, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in blocking or activating experiments on human samples at 2 ug/ml (fig 6). Cancer Res (2005) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:1000
In order to report on three cases of polymorphous adenocarcinoma of the breast, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Virchows Arch (2006) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; human; fig 5
In order to examine the roles of hK4 and prostate-specific antigen in the progression of prostate cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunocytochemistry on human samples (fig 5). Endocr Relat Cancer (2005) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 5
In order to examine the roles of hK4 and prostate-specific antigen in the progression of prostate cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples (fig 5). Endocr Relat Cancer (2005) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 2
In order to investigate beta-catenin transactivation in large-cell neuroendocrine carcinomas and small-cell lung carcinomas , Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 2). Virchows Arch (2005) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:400
  • western blot; human; 1:1000
  • western blot; rat; 1:1000
In order to test if SLUG activation contributes to the Ras-induced loss of E-cadherin, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples at 1:400, in western blot on human samples at 1:1000 and in western blot on rat samples at 1:1000. Surgery (2005) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; fig 2
In order to study how abrogation of E-cadherin-mediated adhesion modifies the behavior and phenotype of squamous cell carcinoma, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples (fig 2). Int J Cancer (2006) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 2
In order to show a functional role of MAPK activation in the motility and invasion of placental site trophoblastic tumors, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples (fig 2). Am J Pathol (2005) ncbi
mouse monoclonal (4A2C7)
  • western blot; human
In order to investigate the structure-function relationship between E-cadherin and alpha(E)beta(7), Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in western blot on human samples . J Immunol (2005) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:1000
In order to compare clinicopathological characteristics and immunohistochemical profiles of simultaneous bilateral breast cancer and corresponding lymph node metastases, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Histol Histopathol (2005) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to assess the clinicopathological and prognostic value of E-cadherin in non-lobular types of breast carcinoma, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Histopathology (2005) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; fig 1
In order to describe the features of the epithelial-mesenchymal transition in renal transplants that developed tubular atrophy and interstitial fibrosis, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig 1). Am J Transplant (2005) ncbi
mouse monoclonal (HECD-1)
  • ELISA; human; fig 1
In order to assess the use of an 80 kDa fragment of the cell adhesion molecule e-cadherin as a serum biomarker for prostate cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in ELISA on human samples (fig 1). Br J Cancer (2005) ncbi
mouse monoclonal (SHE78-7)
  • western blot; human; fig 5
In order to investigate the effect of COX-2 overexpression on inhibiting proliferation, apoptosis and differentiation, Invitrogen E-cadherin antibody (Zymed, 13-5700) was used in western blot on human samples (fig 5). Int J Cancer (2005) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:40
In order to study the significance of E-cadherin methylation in multistep hepatocarcinogenesis, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:40. J Korean Med Sci (2005) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:10-1:20
In order to discuss revising the classification systems for breast cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:10-1:20. Int J Cancer (2005) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:300; fig 1
In order to determine CD44s, CD44v6, and E-cadherin expression in primary tumors and metastases, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 1). Oncol Rep (2005) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
In order to elucidate the mechanisms of actin reorganization that drive the establishment of apical junctional complex, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples . Mol Biol Cell (2005) ncbi
mouse monoclonal (SHE78-7)
  • western blot; human; 2 ug/ml; fig 8
In order to characterize human thyroid cancer cell lines of different histotypes for their responsiveness to contact inhibition and elucidate the mechanism, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in western blot on human samples at 2 ug/ml (fig 8). Carcinogenesis (2005) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 2
In order to study the role of E-cadherin/beta-catenin dysregulation in pulmonary neuroendocrine tumors, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 2). Cancer (2005) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 2
In order to study the role of E-cadherin/beta-catenin dysregulation in pulmonary neuroendocrine tumors, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 2). Cancer (2005) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:1000; fig 1
In order to test if immunohistochemical staining for oestrogen receptor alpha, progesterone receptor, and E-cadherin distinguishes metastatic breast carcinoma from primary gastric carcinoma, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:1000 (fig 1). Histopathology (2005) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to study the category subdivision of pT1a and pT1b in renal cell carcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (tbl 1). BJU Int (2005) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:300; fig 3
In order to develop and characterize a triple co-culture model of the human airway barrier, Invitrogen E-cadherin antibody (Zymed, 13-1,700) was used in immunocytochemistry on human samples at 1:300 (fig 3). Am J Respir Cell Mol Biol (2005) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 1
In order to study 16q22.1 in breast carcinoma and identify potential tumor suppressor genes, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). Int J Cancer (2005) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human
In order to correlate histologic grade in invasive lobular carcinoma with known prognostic and predictive markers, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples . Mod Pathol (2005) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:40
In order to characterize twenty-seven cases of tubulolobular carcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:40. Am J Surg Pathol (2004) ncbi
mouse monoclonal (SHE78-7)
  • immunohistochemistry - paraffin section; human; 1:5; fig 2
In order to determine osteopontin expression is related to tumor infiltration by macrophages and the adhesive capacity of pancreatic ductal adenocarcinomas, undifferentiated pancreatic carcinomas, and osteoclast-like giant cells, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in immunohistochemistry - paraffin section on human samples at 1:5 (fig 2). Virchows Arch (2005) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 1
In order to hypothesize that the E-cad(100) fragment abrogates survival of LNCaP cells following induction of apoptosis, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 1). Prostate (2005) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:500
  • immunocytochemistry; human; 1:100
In order to identify PA2.26 as a novel biomarker for oral squamous cell carcinomas, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:500 and in immunocytochemistry on human samples at 1:100. Int J Cancer (2005) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; human; fig 4
In order to investigate the effects of estrogen on transcervical tight-junctional resistance, Invitrogen E-cadherin antibody (Zymed, 33-4000) was used in immunocytochemistry on human samples (fig 4). J Clin Endocrinol Metab (2004) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:600
In order to identify biomarkers for accelerated radiotherapy, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:600. Radiother Oncol (2004) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - frozen section; human; 1:300
  • immunohistochemistry - paraffin section; human; 1:300
In order to assess the presence and localization of E-cadherin and beta-catenin in normal fetal germ cells and germ cell tumors, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - frozen section on human samples at 1:300 and in immunohistochemistry - paraffin section on human samples at 1:300. J Pathol (2004) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human
In order to study the involvement of the E-cadherin-catenin adhesion system in the progression of human cutaneous squamous cell carcinoma, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples . Am J Dermatopathol (2004) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 3
  • western blot; human; 1:1000; fig 1
In order to test if overexpression of E-cadherin prevents Ras-induced malignant transformation and suppresses intestinal cell growth, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples at 1:1000 (fig 1). Surgery (2004) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:50; fig 3
In order to test if cell size is related to HER-2/neu status and to Akt activation in breast carcinomas, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples at 1:50 (fig 3). Histopathology (2004) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 1
In order to measure the E- and N-cadherin and beta- and alpha-catenin expression in benign and malignant epithelial neoplasms of the ovary and correlate expression with tumor staging, histological grade, and presence of metastases during evolution, Invitrogen E-cadherin antibody (ZYMED, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 1). Gynecol Oncol (2004) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 4
In order to test if carcinoma cells form gap junctions with bone cells and assess the function of this interaction, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in western blot on human samples (fig 4). Int J Cancer (2004) ncbi
mouse monoclonal (SHE78-7)
  • flow cytometry; human; fig 2
  • immunoprecipitation; human; fig 1
  • western blot; human; fig 1
In order to suggest that E-cadherin-mediated cell adhesion is required for keratinocyte-mediated control of melanocytic cells, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in flow cytometry on human samples (fig 2), in immunoprecipitation on human samples (fig 1) and in western blot on human samples (fig 1). Exp Cell Res (2004) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:100
In order to describe three cases of a new clinicopathological entity entitled low-grade tubular myxoid renal tumor with a benign clinical course, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:100. Int J Surg Pathol (2004) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:1000
In order to examine the expression of S100A4 and E-cadherin in a panel of primary and metastatic malignant melanoma and correlate their expression levels to clinicopathological parameters, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Mod Pathol (2004) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to elucidate the relation between the macroscopic growth patterns of gastric carcinoma and the abnormal expression of E-cadherin and alpha- and beta-catenins, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). J Clin Gastroenterol (2004) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; fig 2A
In order to test if hypermethylation in the CDH1 promoter region correlates with poor prognosis of patients with surgically resected, node-positive, diffuse gastric cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig 2A). Clin Cancer Res (2004) ncbi
mouse monoclonal (SHE78-7)
  • western blot; human; 1:1000; fig 1
In order to assess the permissiveness of cells to estrogen receptor alpha activation functions, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in western blot on human samples at 1:1000 (fig 1). J Biol Chem (2004) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
  • western blot; human; 1:1000; fig 4
In order to determine the expression pattern of p120 in breast cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1) and in western blot on human samples at 1:1000 (fig 4). Oncogene (2004) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; 1:50; fig 1
In order to study E-cadherin, ZO-1, uroplakin, and chondroitin sulfate in interstitial cystitis samples, Invitrogen E-cadherin antibody (Zymed, 4A2 C7) was used in immunohistochemistry on human samples at 1:50 (fig 1). J Urol (2004) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:75; tbl 2
In order to report on a case of pilomatrix carcinoma with lymph node metastases, Invitrogen E-cadherin antibody (ZYMED, HECD-1) was used in immunohistochemistry on human samples at 1:75 (tbl 2). J Cutan Pathol (2004) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:100
In order to examine E-cadherin gene promoter hypermethylation in gastric carcinomas and its correlation with E-cadherin protein expression, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:100. Ann Oncol (2004) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human; 1 ug/ml
In order to elucidate the role of epidermal growth factor receptor and other tyrosine kinases in regulating p120 function, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in blocking or activating experiments on human samples at 1 ug/ml. J Cell Sci (2004) ncbi
mouse monoclonal (HECD-1)
  • immunoprecipitation; human; fig 4
  • western blot; human; 2.0 ug/ml; fig 2
In order to clarify the role of E-cadherin in prostate cancer progression, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunoprecipitation on human samples (fig 4) and in western blot on human samples at 2.0 ug/ml (fig 2). J Cell Biochem (2004) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 1
In order to examine the role of promoter methylation in regulating E-cadherin expression in oral squamous cell carcinoma, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples (fig 1). Biochem Biophys Res Commun (2004) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to clarify the clinicopathological significance of fibrous bodies present in the sparsely granulated variant of GH-producing pituitary adenomas, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Clin Endocrinol (Oxf) (2003) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; domestic rabbit; fig 7
In order to characterize the barrier governing permeability across the junctions of rabbit esophageal epithelium, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on domestic rabbit samples (fig 7). Am J Physiol Gastrointest Liver Physiol (2004) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:400
In order to study sixteen cases of invasive micropapillary carcinoma of the breast, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:400. Pathol Int (2004) ncbi
mouse monoclonal (HECD-1)
  • western blot; human
In order to evaluate an 80 kDa proteolytic fragment of E-cadherin as a potential biomarker for prostate cancer progression and identify proteases responsible for E-cadherin cleavage, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples . Clin Cancer Res (2003) ncbi
mouse monoclonal (HECD-1)
  • western blot; human
In order to test if suppression of Smad3 expression mediates the key oncogenic properties of TGF-beta in gastric cancer, Invitrogen E-cadherin antibody (Zymed, 13?C1700) was used in western blot on human samples . Oncogene (2004) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:10000; fig 3
In order to study how inhibitor of beta-catenin and TCF-4 suppresses beta-catenin function, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples at 1:10000 (fig 3). Am J Physiol Cell Physiol (2004) ncbi
mouse monoclonal (SHE78-7)
  • immunocytochemistry; human; 1 ug/ml; fig 4
In order to study how p120-catenin stabilizes epithelial cadherin, Invitrogen E-cadherin antibody (Zymed, SHE78?C7) was used in immunocytochemistry on human samples at 1 ug/ml (fig 4). J Cell Biol (2003) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 2
In order to explore cadherin-cadherin interactions, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples (fig 2). Mol Cell Biol (2003) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 4
In order to derive and characterize a Wilms' tumour cell line, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 4). Int J Cancer (2003) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:20; fig 1
In order to study expression of E- and N-cadherin in mesotheliomas and adenocarcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:20 (fig 1). Hum Pathol (2003) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:50
  • western blot; human; 1:50
In order to discuss the role of the E-cadherin-catenin adhesion complex in cancer, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:50 and in western blot on human samples at 1:50. Mol Pathol (2003) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to examine E-cadherin inactivation in various types of breast cancer, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Mod Pathol (2003) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human
In order to study carriers of the I1307K APC mutation, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples . Dig Dis Sci (2003) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to test if E-cadherin loss alters the APC/beta-catenin pathway to permit oncogenic beta-catenin signaling in breast cancer, Invitrogen E-cadherin antibody (Zymed, clone 4A2C7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Int J Cancer (2003) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:200; tbl 1
In order to report the immunohistochemical and molecular genetic features of the cadherins/catenins complex in thyroid carcinoma, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry on human samples at 1:200 (tbl 1). Histopathology (2003) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 3a
  • western blot; human; fig 3b
In order to elucidate the mechanism of matrilysin in repair, Invitrogen E-cadherin antibody (Zymed, HECD-1)) was used in immunocytochemistry on human samples (fig 3a) and in western blot on human samples (fig 3b). Am J Pathol (2003) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:1000
In order to study how cell-matrix interactions influence the invasive behavior of a novel, primary peritoneal carcinosarcoma cell line, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples at 1:1000. Gynecol Oncol (2003) ncbi
mouse monoclonal (HECD-1)
  • flow cytometry; human; tbl 3
  • immunocytochemistry; human; fig 5
  • western blot; human; 0.5 ug/ml; fig 8
In order to assess the morphogenetic activities of c-erbB and retinoids on human mammary epithelial cells, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in flow cytometry on human samples (tbl 3), in immunocytochemistry on human samples (fig 5) and in western blot on human samples at 0.5 ug/ml (fig 8). J Cell Physiol (2003) ncbi
mouse monoclonal (4A2C7)
  • immunocytochemistry; mouse; 1:100
In order to test if N-cadherin is required for normal myocyte structure and function, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunocytochemistry on mouse samples at 1:100. J Cell Sci (2003) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human
In order to determine the role of MMP-19 in skin cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples . Int J Cancer (2003) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human
In order to examine the relationship between paranuclear E-cadherin distribution and the histopathologic characteristics of gastric adenocarcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples . Am J Clin Pathol (2002) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human
In order to report that three fibroadenomasfrom one patient simultaneously gave rise to breast carcinoma in situ, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples . J Clin Pathol (2002) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:2000; tbl 2
In order to measure protein expression of adenomatous polyposis coli in primary and metastatic serous ovarian carcinoma, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (tbl 2). Int J Surg Pathol (2002) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 6
In order to study the existence of novel routes of tumour spread via open channels of pseudoangiomatous stromal hyperplasia, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 6). Histopathology (2002) ncbi
mouse monoclonal (HECD-1)
  • western blot; human
In order to report that activation of the ET-1/ET(B) pathway downregulates E-cadherin in human melanocytes and melanoma cells, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples . J Clin Invest (2002) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:1000; tbl 1
  • western blot; human; tbl 3
In order to determine the expression pattern and contribution of cell adhesion molecules in adrenal tumors, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 1) and in western blot on human samples (tbl 3). Endocr Pathol (2002) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human; tbl 2
In order to discuss and characterize 2 distinct variants of intraepithelial neoplasia, Invitrogen E-cadherin antibody (Zymed Laboratories, clone 4A2C7) was used in immunohistochemistry on human samples (tbl 2). Hum Pathol (2002) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; fig 3
In order to optimize E-cadherin immunostaining in paraffin sections to detect variants of ductal infiltrating breast cancer, Invitrogen E-cadherin antibody (Zymed Labs, HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig 3). Histopathology (2002) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 4
In order to explore the relationship between anti-apoptotic signaling and N-cadherin, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples (fig 4). J Biol Chem (2002) ncbi
mouse monoclonal (HECD-1)
  • blocking or activating experiments; human
In order to investigate how Cas phosphorylation and Src kinase activation regulate TGF-beta signal transduction, Invitrogen E-cadherin antibody (Zymed Laboratories, HECD-1) was used in blocking or activating experiments on human samples . J Biol Chem (2002) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to investigate the relationship between primary mucoepidermoid carcinoma of the thyroid and papillary thyroid carcinoma, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Virchows Arch (2002) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:100; fig 1
  • western blot; human; 1:1000; fig 1
In order to study the regulation of adherens junctions, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunocytochemistry on human samples at 1:100 (fig 1) and in western blot on human samples at 1:1000 (fig 1). Nat Cell Biol (2002) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 2
  • western blot; mouse; 1:1000; fig 1
In order to explore the effect of cadherin specificity on cardiac structure and function, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2) and in western blot on mouse samples at 1:1000 (fig 1). J Cell Sci (2002) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
In order to investigate the expression of E-, N-, and P-cadherin in ductal carcinoma in situ of the breast, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2). Virchows Arch (2002) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human
In order to review the national action plan of the Breast Cancer Workshop on Multicultural Aspects of Breast Cancer Etiology, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples . Cancer (2002) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry; human
In order to review the national action plan of the Breast Cancer Workshop on Multicultural Aspects of Breast Cancer Etiology, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry on human samples . Cancer (2002) ncbi
mouse monoclonal (HECD-1)
  • blocking or activating experiments; human
In order to study beta1-integrin during cell movement, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in blocking or activating experiments on human samples . Cancer Res (2002) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:5000
In order to investigate the cis sequences and transcription factors that regulate E-cadherin expression in breast cancer cells, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples at 1:5000. Cancer Res (2002) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:200
In order to examine epithelial-type cadherin and neural-type cadherin as diagnostic markers of malignant noncarcinomatous neoplasms, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples at 1:200. Arch Pathol Lab Med (2002) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human
In order to examine epithelial-type cadherin and neural-type cadherin as diagnostic markers of malignant noncarcinomatous neoplasms, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples . Arch Pathol Lab Med (2002) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 2
In order to determine how adhesion systems contribute to enterocyte differentiation, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 2). J Cell Sci (2002) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:100
In order to evaluate optimal specimen preparation for the immunostaining of effusion samples, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples at 1:100. Diagn Cytopathol (2002) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 5
In order to investigate immortalized human ovarian surface epithelial, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples (fig 5). Clin Cancer Res (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human
In order to report that E-CD expression in human breast cancer has minimal prognostic value, but may serves as a phenotypic marker, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples . Br J Cancer (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; fig 3
In order to test if tight junction antigens are present in adult and developing human epidermis, Invitrogen E-cadherin antibody (Zymed, 13?C1700) was used in immunohistochemistry - paraffin section on human samples (fig 3). J Invest Dermatol (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - frozen section; human; 1:200
In order to examine the prevalence and nature of E-cadherin alterations in sporadic gastric carcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - frozen section on human samples at 1:200. Mod Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:1000
In order to study different genes involved in oncogenesis of colon and rectal cancers and examine their prognostic value, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:1000. J Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:20; fig 1
  • western blot; human; fig 2
In order to assess E-cadherin expression in primary cultures and determine the relationship between E-cadherin expression and prostate-specific antigen secretion, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:20 (fig 1) and in western blot on human samples (fig 2). Urol Res (2001) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human; 1:50; fig 4
In order to study lobular carcinoma in situ, Invitrogen E-cadherin antibody (Zymed, clone 4A2 C7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4). Cancer (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to discuss using expression of cadherins and catenins as prognosis markers for cancer, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples (tbl 1). J Mammary Gland Biol Neoplasia (2001) ncbi
mouse monoclonal (4A2C7)
  • immunohistochemistry - paraffin section; human
In order to determine the immunoexpression of deleted in colon cancer, p53, E-cadherin, and beta-catenin in the duodenal mucosa of children with coeliac disease, Invitrogen E-cadherin antibody (Zymed, 4A2C7) was used in immunohistochemistry - paraffin section on human samples . J Clin Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:800
In order to describe a patient affected by endometrial cancer and treated primarily with leuprolide, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:800. Br J Cancer (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; fig 1
In order to determine E-cadherin expression in a broad range of prostate tissue, Invitrogen E-cadherin antibody (Zymed Laboratories, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig 1). Hum Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; fig 1
In order to describe the clinicopathological features of papillary thyroid carcinoma, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry on human samples (fig 1). J Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • blocking or activating experiments; human
  • immunoprecipitation; human; fig 3d
  • immunohistochemistry; human; fig 3f
  • western blot; human; fig 2
In order to study lymphovascular invasion in breast cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in blocking or activating experiments on human samples , in immunoprecipitation on human samples (fig 3d), in immunohistochemistry on human samples (fig 3f) and in western blot on human samples (fig 2). Cancer Res (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - frozen section; human; 1:10
In order to examine connexin expression in the developing human epidermis, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - frozen section on human samples at 1:10. Arch Dermatol Res (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200
In order to elucidate the role of MUC1 in breast carcinoma, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200. Cancer (2001) ncbi
mouse monoclonal (HECD-1)
  • western blot; human
In order to examine adhesion- versus a beta-catenin signaling-dependent mechanisms of E-cadherin tumor suppressor activity, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples . J Cell Biol (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:2000; fig 2
In order to analyze the morphological, kinetic, and molecular characteristics of low-grade and high-grade dysplasias in comparison with intestinal metaplasia type III, normal mucosa, and early gastric cancer of the intestinal type, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 2). Int J Oncol (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:100
In order to discuss the classification and grading systems for ductal carcinoma in situ of the breast, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:100. Am J Clin Pathol (2001) ncbi
mouse monoclonal (SHE78-7)
  • flow cytometry; human
  • western blot; human
In order to assess the functional significance of N-cadherin in melanoma cells, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in flow cytometry on human samples and in western blot on human samples . Cancer Res (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:500
In order to study E cadherin expression in lobular carcinoma in situ, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:500. Mol Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 1
In order to identify genetic alterations in lobular carcinoma in situ, Invitrogen E-cadherin antibody (Zymed Laboratories, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1). Hum Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:1000; tbl 3
In order to study genetic alterations in tubular carcinomas of the breast, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:1000 (tbl 3). Hum Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • western blot; human
In order to investigate E-cadherin in prostate cancer samples, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples . Cancer Res (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200
In order to determine E-cadherin expression in in situ and invasive carcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200. Am J Clin Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:100; fig 5
In order to study E-cadherin in in situ carcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:100 (fig 5). Am J Surg Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:200
In order to discuss the relationship between the adhesive characteristics of hematopoietic cells and their maturation, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples at 1:200. Arch Pathol Lab Med (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; mouse; 1:100
In order to investigate the role of N-cadherin in cardiogenesis, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Development (2001) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human
In order to characterize a human midgut carcinoid tumor after transplantation into nude mice, Invitrogen E-cadherin antibody (zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples . Am J Pathol (2001) ncbi
mouse monoclonal (HECD-1)
  • western blot; human
In order to study E-cadherin in hematopoietic tissues, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in western blot on human samples . Clin Cancer Res (2000) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human
In order to examine stromelysin-2 and other matrix metalloproteinase expression during wound healing, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry on human samples . J Invest Dermatol (2000) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
  • western blot; human; fig 2
In order to investigate how time at confluence affects cultured human retinal pigment epithelium cells, Invitrogen E-cadherin antibody (Zymed Laboratories, clone HECD-1) was used in immunocytochemistry on human samples and in western blot on human samples (fig 2). Invest Ophthalmol Vis Sci (2000) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - frozen section; bovine
  • immunohistochemistry; bovine
In order to determine the distribution of Na/K ATPase and E-cadherin in retinal pigment epithelium cells, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - frozen section on bovine samples and in immunohistochemistry on bovine samples . Invest Ophthalmol Vis Sci (2000) ncbi
mouse monoclonal (SHE78-7)
  • immunohistochemistry - frozen section; bovine
  • immunohistochemistry; bovine
In order to determine the distribution of Na/K ATPase and E-cadherin in retinal pigment epithelium cells, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in immunohistochemistry - frozen section on bovine samples and in immunohistochemistry on bovine samples . Invest Ophthalmol Vis Sci (2000) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human
In order to examine the role of E-cadherin in melanoma-keratinocyte interaction, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in blocking or activating experiments on human samples . Am J Pathol (2000) ncbi
mouse monoclonal (HECD-1)
  • flow cytometry; human
In order to examine the role of E-cadherin in melanoma-keratinocyte interaction, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in flow cytometry on human samples . Am J Pathol (2000) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human
In order to study the Ig-like fold of E-cadherin, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in blocking or activating experiments on human samples . J Exp Med (2000) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:500; tbl 1
In order to measure the expression of p53, p21, bcl-2 bax, pRb, and cyclin D1 for evaluation of their roles in colon-cancer progression, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in immunohistochemistry - paraffin section on human samples at 1:500 (tbl 1). Virchows Arch (2000) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; fig 1
In order to study the cellular origin of bladder carcinosarcoma, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig 1). Eur Urol (2000) ncbi
mouse monoclonal (SHE78-7)
  • western blot; human; fig 4
In order to test if truncation of E-cadherin results in epithelial apoptosis during prostate and mammary involution, Invitrogen E-cadherin antibody (Zymed, clone SHE78-7) was used in western blot on human samples (fig 4). J Biol Chem (2000) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human
In order to determine if p21 contributes to anchorage-dependent growth control, Invitrogen E-cadherin antibody (Zymed, clone SHE78-7) was used in blocking or activating experiments on human samples . Cancer Res (2000) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - frozen section; human
In order to validate the use of polymerase chain reaction-amplified full-length cDNA as a substitute for mRNA in nucleic acid array and gene expression analysis, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - frozen section on human samples . Invest Ophthalmol Vis Sci (1999) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human
In order to analyze 40 human lobular breast cancers for loss of heterozygosity and other mutations, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples . Br J Cancer (1999) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human
In order to test if cadherin-cadherin interactions modulate keratinocyte differentiation, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in blocking or activating experiments on human samples . J Cell Sci (1999) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:400
In order to determine the role of tyrosine phosphorylation in regulating intercellular adhesion of intestinal cells, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples at 1:400. Biochim Biophys Acta (1999) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
In order to test if retinal pigment epithelial express E-cadherin, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples . Invest Ophthalmol Vis Sci (1999) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; fig 3
In order to discuss the role of cadherins in tumor development, Invitrogen E-cadherin antibody (Zymed, clone HECD-1) was used in immunohistochemistry - paraffin section on human samples (fig 3). Cancer (1999) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - frozen section; human; fig 1
In order to determine the localization of type XIII collagen in normal human skin and cultured keratinocytes, Invitrogen E-cadherin antibody (Zymed, 13?C1700) was used in immunohistochemistry - frozen section on human samples (fig 1). J Invest Dermatol (1999) ncbi
mouse monoclonal (HECD-1)
  • immunoprecipitation; human; fig 2
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 2
In order to report the gain of N-cadherin and loss of E-cadherin by invasive prostate carcinoma cell lines, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunoprecipitation on human samples (fig 2), in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 2). Am J Pathol (1999) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:800; fig 1
In order to assess the loss of E-cadherin expression in early gastric carcinomas, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:800 (fig 1). Histopathology (1999) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
In order to study the relationship of cadherins E, N and P to ovarian surface epithelium morphology, growth patterns and differentiation, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples . Int J Cancer (1999) ncbi
mouse monoclonal (HECD-1)
  • western blot; human
In order to assess the role of E-cadherin and retinoblastoma tumor suppressor in cell survival and programed cell death, Invitrogen E-cadherin antibody (Zymed, 13-1700) was used in western blot on human samples . J Biol Chem (1999) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human
In order to assess the role of E-cadherin and retinoblastoma tumor suppressor in cell survival and programed cell death, Invitrogen E-cadherin antibody (Zymed, 13-5700) was used in blocking or activating experiments on human samples . J Biol Chem (1999) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
In order to characterize the localization and function of the EDA protein, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2). Exp Dermatol (1998) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; mouse
In order to study the growth suppressor activity of E-cadherin, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in blocking or activating experiments on mouse samples . J Cell Biol (1998) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human
In order to report that cadherin-mediated intercellular adhesions promote anchorage-independent growth and suppresses apoptosis, Invitrogen E-cadherin antibody (Zymed, SHE78-7) was used in blocking or activating experiments on human samples . J Biol Chem (1998) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
In order to propose that ubiquitin-conjugating E2 enzyme variant proteins control differentiation by altering cell cycle distribution, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunocytochemistry on human samples . Mol Cell Biol (1998) ncbi
mouse monoclonal (HECD-1)
  • flow cytometry; human; 1:1000; fig 2
In order to determine the effect of UV radiation on Langerhans' cells co-stimulatory molecules in vivo, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in flow cytometry on human samples at 1:1000 (fig 2). Eur J Immunol (1997) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human
In order to identify markers to determine lymph node metastases in patients with gastric cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples . Br J Cancer (1996) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 5 ug/ml
In order to assess E-cadherin expression in paraffin-embedded whole prostates and metastatic prostate cancer, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in immunohistochemistry - paraffin section on human samples at 5 ug/ml. Am J Pathol (1996) ncbi
mouse monoclonal (HECD-1)
  • flow cytometry; human
In order to determine the expression of cellular adhesion molecules on different human prostate tumor cell lines, Invitrogen E-cadherin antibody (Zymed, HECD-1) was used in flow cytometry on human samples . Prostate (1995) ncbi
Abcam
domestic rabbit monoclonal (SP64)
  • western blot; human; 1:4000; loading ...; fig 4m
Abcam E-cadherin antibody (Abcam, ab227639) was used in western blot on human samples at 1:4000 (fig 4m). Clin Transl Med (2021) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; loading ...; fig 6f
Abcam E-cadherin antibody (Abcam, ab40772) was used in western blot on human samples (fig 6f). J Cancer (2021) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:2000; loading ...; fig 4a
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples at 1:2000 (fig 4a). Sci Adv (2021) ncbi
domestic rabbit monoclonal
  • western blot; mouse; 1:5000; fig 3a
Abcam E-cadherin antibody (abcam, ab51034) was used in western blot on mouse samples at 1:5000 (fig 3a). J Nutr (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3c
Abcam E-cadherin antibody (Abcam, ab15148) was used in western blot on mouse samples at 1:1000 (fig 3c). Oncol Lett (2021) ncbi
mouse monoclonal (M168)
  • western blot; mouse; 1:100; loading ...; fig 4c
Abcam E-cadherin antibody (Abcam, ab76055) was used in western blot on mouse samples at 1:100 (fig 4c). Oxid Med Cell Longev (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 2c
Abcam E-cadherin antibody (Abcam, ab15148) was used in western blot on human samples at 1:500 (fig 2c). Cancer Cell Int (2021) ncbi
mouse monoclonal (M168)
  • immunohistochemistry - frozen section; chicken; 1:250; fig 5m
Abcam E-cadherin antibody (Abcam, ab76055) was used in immunohistochemistry - frozen section on chicken samples at 1:250 (fig 5m). elife (2021) ncbi
mouse monoclonal (4A2)
  • western blot; rat; loading ...; fig 3b
Abcam E-cadherin antibody (Abcam, ab231303) was used in western blot on rat samples (fig 3b). Oxid Med Cell Longev (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1e
Abcam E-cadherin antibody (Abcam, ab15148) was used in western blot on human samples (fig 1e). Cancers (Basel) (2021) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:1000; loading ...; fig 1b
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples at 1:1000 (fig 1b). Sci Rep (2021) ncbi
mouse monoclonal (M168)
  • western blot; human; 1:1000; loading ...; fig 4j
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig 5d
Abcam E-cadherin antibody (Abcam, ab76055) was used in western blot on human samples at 1:1000 (fig 4j) and in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 5d). elife (2021) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2e
Abcam E-cadherin antibody (Abcam, ab11512) was used in immunohistochemistry - frozen section on mouse samples (fig 2e). Front Cell Dev Biol (2021) ncbi
mouse monoclonal (M168)
  • western blot; human; loading ...; fig 3c, 3d
Abcam E-cadherin antibody (Abcam, ab76055) was used in western blot on human samples (fig 3c, 3d). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 7a
Abcam E-cadherin antibody (Abcam, ab76319) was used in immunohistochemistry - paraffin section on mouse samples (fig 7a). Front Immunol (2021) ncbi
mouse monoclonal (4A2)
  • immunohistochemistry; human; loading ...; fig 2k
  • western blot; human; loading ...; fig 2g, 3g
Abcam E-cadherin antibody (Abcam, ab231303) was used in immunohistochemistry on human samples (fig 2k) and in western blot on human samples (fig 2g, 3g). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal
  • immunohistochemistry; human; loading ...; fig 1a
Abcam E-cadherin antibody (Abcam, ab76319) was used in immunohistochemistry on human samples (fig 1a). Am J Clin Exp Urol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s3d
Abcam E-cadherin antibody (Abcam, ab15148) was used in western blot on human samples at 1:1000 (fig s3d). Hepatology (2021) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:1000; loading ...; fig 2b
Abcam E-cadherin antibody (abcam, ab1416) was used in western blot on human samples at 1:1000 (fig 2b). Cell Death Dis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 2e
Abcam E-cadherin antibody (Abcam, ab15148) was used in western blot on human samples at 1:500 (fig 2e). Aging (Albany NY) (2021) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry; zebrafish ; 1:100; loading ...; fig 3e
Abcam E-cadherin antibody (Abcam, ab11512) was used in immunohistochemistry on zebrafish samples at 1:100 (fig 3e). elife (2021) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; 1:10,000; loading ...; fig 5a
Abcam E-cadherin antibody (Abcam, ab40772) was used in western blot on human samples at 1:10,000 (fig 5a). Int J Mol Med (2020) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; domestic rabbit; 1:50; loading ...; fig 5c
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on domestic rabbit samples at 1:50 (fig 5c). Invest Ophthalmol Vis Sci (2020) ncbi
mouse monoclonal (M168)
  • western blot; mouse; 1:1000; loading ...; fig 4a
Abcam E-cadherin antibody (Abcam, ab76055) was used in western blot on mouse samples at 1:1000 (fig 4a). Front Immunol (2020) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:200; loading ...; fig 4h
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples at 1:200 (fig 4h). Cell Res (2020) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:1000; loading ...; fig 6h
  • western blot; human; 1:1000; loading ...; fig 2f
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples at 1:1000 (fig 6h) and in western blot on human samples at 1:1000 (fig 2f). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; loading ...; fig 1g
Abcam E-cadherin antibody (Abcam, ab194982) was used in western blot on human samples (fig 1g). BMC Cancer (2020) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:200; loading ...; fig 4g
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples at 1:200 (fig 4g). Cell Tissue Res (2020) ncbi
domestic rabbit monoclonal (EP700Y)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig ev3b
  • flow cytometry; human; 1:500; loading ...; fig ev3a
Abcam E-cadherin antibody (Abcam, EP700Y) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig ev3b) and in flow cytometry on human samples at 1:500 (fig ev3a). EMBO Rep (2020) ncbi
mouse monoclonal (M168)
  • western blot; human; 1:1000; loading ...; fig 3e
Abcam E-cadherin antibody (Abcam, ab76055) was used in western blot on human samples at 1:1000 (fig 3e). Front Oncol (2020) ncbi
domestic rabbit monoclonal (EP700Y)
  • immunohistochemistry; mouse; loading ...; fig 4f
  • western blot; rat; loading ...; fig 1d
Abcam E-cadherin antibody (Abcam, ab40772) was used in immunohistochemistry on mouse samples (fig 4f) and in western blot on rat samples (fig 1d). Aging (Albany NY) (2020) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2c
Abcam E-cadherin antibody (Abcam, ab11512) was used in immunohistochemistry - paraffin section on mouse samples (fig 2c). Int J Mol Sci (2020) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:1000; loading ...; fig 4g
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples at 1:1000 (fig 4g). Mol Cancer (2020) ncbi
mouse monoclonal (HECD-1)
  • western blot; mouse; 1:1000; loading ...; fig 3b
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on mouse samples at 1:1000 (fig 3b). Oncogenesis (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3b
Abcam E-cadherin antibody (Abcam, ab15148) was used in western blot on mouse samples at 1:1000 (fig 3b). Oncogenesis (2020) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; 1:1000; loading ...; fig 3a
Abcam E-cadherin antibody (Abcam, ab194982) was used in western blot on human samples at 1:1000 (fig 3a). Biosci Rep (2020) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:500; loading ...; fig 7a, 7b
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples at 1:500 (fig 7a, 7b). Oncol Rep (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a, 3c
Abcam E-cadherin antibody (Abcam, ab15148) was used in western blot on human samples (fig 3a, 3c). Aging (Albany NY) (2020) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; rat; 1:1000; loading ...; fig s1b
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on rat samples at 1:1000 (fig s1b). J Neuroinflammation (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:100; loading ...; fig 6d
Abcam E-cadherin antibody (Abcam, ab15148) was used in immunohistochemistry on human samples at 1:100 (fig 6d). Sci Adv (2020) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; 1:5000; loading ...; fig 8d
Abcam E-cadherin antibody (Abcam, ab40772) was used in western blot on human samples at 1:5000 (fig 8d). Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 2j
  • western blot; mouse; 1:500; loading ...; fig 4f
Abcam E-cadherin antibody (Abcam, ab15148) was used in western blot on human samples at 1:500 (fig 2j) and in western blot on mouse samples at 1:500 (fig 4f). Cancer Cell Int (2020) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:100; loading ...; fig 1s1c
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples at 1:100 (fig 1s1c). elife (2020) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; loading ...; fig 1b, 7a
  • western blot; human; loading ...; fig 1a
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples (fig 1b, 7a) and in western blot on human samples (fig 1a). Nat Commun (2020) ncbi
mouse monoclonal (M168)
  • western blot; mouse; 1:1000; loading ...; fig s2i
Abcam E-cadherin antibody (Abcam, Ab76055) was used in western blot on mouse samples at 1:1000 (fig s2i). Nat Commun (2020) ncbi
mouse monoclonal (M168)
  • immunocytochemistry; mouse; 1:300; loading ...; fig e1b
  • immunocytochemistry; human; 1:300; loading ...; fig e1b
Abcam E-cadherin antibody (Abcam, ab76055) was used in immunocytochemistry on mouse samples at 1:300 (fig e1b) and in immunocytochemistry on human samples at 1:300 (fig e1b). Nature (2020) ncbi
domestic rabbit monoclonal (EP700Y)
  • immunohistochemistry; mouse; fig 2a
Abcam E-cadherin antibody (AbCam, EP700Y) was used in immunohistochemistry on mouse samples (fig 2a). BMC Genomics (2020) ncbi
mouse monoclonal (HECD-1)
Abcam E-cadherin antibody (Abcam, Ab1416) was used . Oncol Lett (2020) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; 1:100; loading ...
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunohistochemistry on human samples at 1:100. J Cell Biol (2020) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; loading ...; fig s1d
Abcam E-cadherin antibody (Abcam, ab194982) was used in western blot on human samples (fig s1d). BMC Cancer (2019) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - frozen section; human; 1:500; loading ...; fig 1a
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunohistochemistry - frozen section on human samples at 1:500 (fig 1a). Aging Cell (2020) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; loading ...; fig 5c
Abcam E-cadherin antibody (Abcam, ab40772) was used in western blot on human samples (fig 5c). Br J Cancer (2019) ncbi
rat monoclonal (DECMA-1)
  • immunocytochemistry; mouse; 1:200; loading ...; fig e9f
Abcam E-cadherin antibody (Abcam, Ab11512) was used in immunocytochemistry on mouse samples at 1:200 (fig e9f). Nature (2019) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry; human; loading ...; fig 1f
Abcam E-cadherin antibody (Abcam, ab11512) was used in immunohistochemistry on human samples (fig 1f). Cell (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3b
Abcam E-cadherin antibody (Abcam, ab15148) was used in western blot on human samples (fig 3b). Exp Ther Med (2019) ncbi
rat monoclonal (DECMA-1)
  • immunocytochemistry; human; 1:500; loading ...; fig 2a
Abcam E-cadherin antibody (Abcam, ab11512) was used in immunocytochemistry on human samples at 1:500 (fig 2a). Science (2019) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; loading ...; fig 2c
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples (fig 2c). Cancer Cell Int (2019) ncbi
mouse monoclonal (M168)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 8c
Abcam E-cadherin antibody (Abcam, ab76055) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 8c). Oncotarget (2019) ncbi
mouse monoclonal (M168)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1c
Abcam E-cadherin antibody (Abcam, ab76055) was used in immunohistochemistry - frozen section on mouse samples (fig 1c). Cell Rep (2019) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; loading ...; fig 1a
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples (fig 1a). Stem Cells Int (2019) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 5 ug/ml; loading ...; fig 6a
  • western blot; human; 1:50; loading ...; fig 3b
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples at 5 ug/ml (fig 6a) and in western blot on human samples at 1:50 (fig 3b). Cancer Cell Int (2019) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; loading ...; fig 3a, 3c
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples (fig 3a, 3c). Breast Cancer (2019) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:2000; loading ...; fig 3e, 3f
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples at 1:2000 (fig 3e, 3f). Biosci Rep (2019) ncbi
mouse monoclonal (M168)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2f
  • immunocytochemistry; human; loading ...; fig 1f
  • western blot; human; loading ...; fig 2d
Abcam E-cadherin antibody (Abcam, ab76055) was used in immunohistochemistry - paraffin section on human samples (fig 2f), in immunocytochemistry on human samples (fig 1f) and in western blot on human samples (fig 2d). Biomed Res Int (2019) ncbi
domestic rabbit monoclonal (EP700Y)
  • immunohistochemistry - paraffin section; rat; 1:500; loading ...; fig 3
Abcam E-cadherin antibody (Abcam, ab40772) was used in immunohistochemistry - paraffin section on rat samples at 1:500 (fig 3). Biosci Rep (2019) ncbi
mouse monoclonal (M168)
  • immunocytochemistry; human; 1:400; loading ...; fig 3d
  • western blot; human; loading ...; fig 6h
Abcam E-cadherin antibody (Abcam, ab76055) was used in immunocytochemistry on human samples at 1:400 (fig 3d) and in western blot on human samples (fig 6h). J Clin Invest (2019) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:3000; fig 2b
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples at 1:3000 (fig 2b). Mol Med Rep (2019) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; loading ...; fig 3a
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples (fig 3a). J Mol Med (Berl) (2019) ncbi
domestic rabbit monoclonal (EP700Y)
  • immunohistochemistry; mouse; loading ...; fig 6h
Abcam E-cadherin antibody (Abcam, ab40772) was used in immunohistochemistry on mouse samples (fig 6h). EMBO Rep (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; fig 4a
Abcam E-cadherin antibody (Abcam, ab15148) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 4a). elife (2018) ncbi
mouse monoclonal (mAbcam22744)
  • western blot; human; 1:10,000; loading ...; fig 1c
  • western blot; mouse; 1:10,000; loading ...; fig s2b
Abcam E-cadherin antibody (Abcam, AB22744) was used in western blot on human samples at 1:10,000 (fig 1c) and in western blot on mouse samples at 1:10,000 (fig s2b). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; loading ...; fig 3c
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples (fig 3c). J Exp Clin Cancer Res (2018) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:100; loading ...; fig 1c
Abcam E-cadherin antibody (Abcam, Ab1416) was used in immunocytochemistry on human samples at 1:100 (fig 1c). PLoS ONE (2018) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:100; loading ...; fig 1b
Abcam E-cadherin antibody (AbCam, Ab1416) was used in western blot on human samples at 1:100 (fig 1b). Oncotarget (2017) ncbi
mouse monoclonal (M168)
  • immunocytochemistry; human; loading ...; fig 3b
Abcam E-cadherin antibody (Abcam, ab76055) was used in immunocytochemistry on human samples (fig 3b). Prostate (2018) ncbi
domestic rabbit monoclonal
  • western blot; mouse; 1:250; fig s1a
Abcam E-cadherin antibody (Abcam, ab76319) was used in western blot on mouse samples at 1:250 (fig s1a). Development (2018) ncbi
mouse monoclonal (M168)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s3
Abcam E-cadherin antibody (Abcam, ab76055) was used in immunohistochemistry - paraffin section on mouse samples (fig s3). Cancer Res (2018) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:1000; loading ...; fig 1b
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples at 1:1000 (fig 1b). Mol Med Rep (2017) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry; human; loading ...; fig 6i
  • western blot; human; loading ...; fig 5d
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunohistochemistry on human samples (fig 6i) and in western blot on human samples (fig 5d). J Biol Chem (2017) ncbi
mouse monoclonal (mAbcam22744)
  • immunocytochemistry; human; loading ...; fig s5d
In order to research the role of manganese efflux transporters in the maintenance of manganese homeostasis, Abcam E-cadherin antibody (Abcam, ab22744) was used in immunocytochemistry on human samples (fig s5d). PLoS Genet (2017) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; fig 2a
Abcam E-cadherin antibody (Abcam, 40772) was used in western blot on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; 1:2000; loading ...; fig 1b
Abcam E-cadherin antibody (Abcam, ab40772) was used in western blot on human samples at 1:2000 (fig 1b). Am J Transl Res (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4a
Abcam E-cadherin antibody (Abcam, ab15148) was used in western blot on human samples (fig 4a). PLoS ONE (2017) ncbi
mouse monoclonal (HECD-1)
  • flow cytometry; human; loading ...; fig s4b
Abcam E-cadherin antibody (Abcam, ab1416) was used in flow cytometry on human samples (fig s4b). MBio (2017) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; 1:250; loading ...; fig 1e
Abcam E-cadherin antibody (Abcam, ab40772) was used in western blot on human samples at 1:250 (fig 1e). Int J Mol Med (2017) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; loading ...; fig 2e
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples (fig 2e). Cancer Lett (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1d
In order to explore the contribution of epithelial cells to systemic sclerosis pathogenesis, Abcam E-cadherin antibody (Abcam, ab15148) was used in western blot on human samples (fig 1d). J Exp Med (2017) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:50; loading ...; fig s7c
In order to show low doses of acetaminophen disrupts the integrity of tight junction and cell-matrix adhesions, Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples at 1:50 (fig s7c). Sci Rep (2017) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; loading ...; fig 1a
  • western blot; human; loading ...; fig 1f
Abcam E-cadherin antibody (Abcam, HECD-1) was used in immunocytochemistry on human samples (fig 1a) and in western blot on human samples (fig 1f). Matrix Biol (2017) ncbi
mouse monoclonal (M168)
  • western blot; human; 1:500; loading ...; fig 3c
Abcam E-cadherin antibody (Abcam, ab76055) was used in western blot on human samples at 1:500 (fig 3c). Mol Med Rep (2017) ncbi
mouse monoclonal (mAbcam22744)
  • western blot; rat; loading ...; fig 3b
In order to ask if SK channels in the mitochondria inner membrane play an important role in regulating mitochondrial function in chronic cardiac diseases, Abcam E-cadherin antibody (Abcam, ab22744) was used in western blot on rat samples (fig 3b). Cardiovasc Res (2017) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:100; loading ...; fig 7a
In order to develop a method to generate semi-interpenetrating networks of polyacrylamide and recombinant basement membrane to culture human embryonic stem cells, Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples at 1:100 (fig 7a). Biomaterials (2017) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; 1:3000; loading ...; fig 6d
Abcam E-cadherin antibody (Abcam, ab40772) was used in western blot on human samples at 1:3000 (fig 6d). Sci Rep (2016) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; loading ...; fig 1h
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples (fig 1h). Biochem Biophys Res Commun (2016) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:50; loading ...; fig 4a
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples at 1:50 (fig 4a). Int J Cancer (2017) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; loading ...; fig 1d
  • immunohistochemistry; human; fig 1h
  • western blot; human; loading ...; fig 1e
Abcam E-cadherin antibody (Abcam, HECD-1) was used in immunocytochemistry on human samples (fig 1d), in immunohistochemistry on human samples (fig 1h) and in western blot on human samples (fig 1e). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; loading ...; fig 4a
Abcam E-cadherin antibody (Abcam, ab40772) was used in western blot on human samples (fig 4a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; 1:300; fig 4
Abcam E-cadherin antibody (Abcam, ab40772) was used in western blot on human samples at 1:300 (fig 4). Oncol Lett (2016) ncbi
mouse monoclonal (M168)
  • western blot; human; fig 5
Abcam E-cadherin antibody (Abcam, ab76055) was used in western blot on human samples (fig 5). Cancer Cell Int (2016) ncbi
mouse monoclonal (M168)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 7c
  • western blot; mouse; 1:1000; loading ...; fig 7a
In order to assess the effects of dietary protein using a model of colitis, Abcam E-cadherin antibody (Abcam, ab76055) was used in immunohistochemistry on mouse samples at 1:200 (fig 7c) and in western blot on mouse samples at 1:1000 (fig 7a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 3
Abcam E-cadherin antibody (abcam, ab1416) was used in western blot on human samples (fig 3). Cancer Gene Ther (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; fig 2
Abcam E-cadherin antibody (Abcam, ab15148) was used in immunohistochemistry - paraffin section on human samples (fig 2). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:500; loading ...; fig 7
  • western blot; human; loading ...; fig 5a
In order to clarify the link between miR-152 and CDH1 function, Abcam E-cadherin antibody (Abcam, ab15148) was used in immunocytochemistry on human samples at 1:500 (fig 7) and in western blot on human samples (fig 5a). Exp Cell Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Abcam E-cadherin antibody (Abcam, ab15148) was used in western blot on human samples (fig 4). World J Surg Oncol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Abcam E-cadherin antibody (Abcam, ab16505) was used in western blot on human samples (fig 5). Cell Res (2016) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 5c
Abcam E-cadherin antibody (Abcam, DECMA-1) was used in immunohistochemistry - frozen section on mouse samples (fig 5c). PLoS Pathog (2016) ncbi
mouse monoclonal (M168)
  • immunocytochemistry; human; fig 8
  • western blot; human; 1:200; fig 10a
Abcam E-cadherin antibody (Abcam, ab76055) was used in immunocytochemistry on human samples (fig 8) and in western blot on human samples at 1:200 (fig 10a). Cancer Cell Int (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 4d
Abcam E-cadherin antibody (Abcam, 15148) was used in western blot on human samples at 1:500 (fig 4d). Aging (Albany NY) (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; fig s1
Abcam E-cadherin antibody (abcam, ab15148) was used in immunohistochemistry - paraffin section on human samples (fig s1). Sci Rep (2016) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:200; fig 1
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples at 1:200 (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; fig 3D
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples (fig 3D). Onco Targets Ther (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 1a
In order to investigate the differentiated vs stem-like properties of cancer cells., Abcam E-cadherin antibody (Abcam, ab15148) was used in immunocytochemistry on human samples (fig 1a). Breast Dis (2016) ncbi
rat monoclonal (DECMA-1)
  • immunocytochemistry; human; 1:100; fig 2
Abcam E-cadherin antibody (Abcam, ab11512) was used in immunocytochemistry on human samples at 1:100 (fig 2). Cell Cycle (2016) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; 1:10,000; fig 5
Abcam E-cadherin antibody (abcam, EP700Y) was used in western blot on human samples at 1:10,000 (fig 5). Onco Targets Ther (2016) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry; human; 1:200; fig 5
In order to discover the unique lipid dynamics in cytotrophoblast cells due to real-time tracking of BODIPY-C12 long-chain fatty acid in human term placenta, Abcam E-cadherin antibody (Abcam, ab11512) was used in immunohistochemistry on human samples at 1:200 (fig 5). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; 1:6000; loading ...; fig 5d
Abcam E-cadherin antibody (Abcam, ab40772) was used in western blot on human samples at 1:6000 (fig 5d). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:250; fig 1
Abcam E-cadherin antibody (Abcam, 16505) was used in western blot on human samples at 1:250 (fig 1). Virology (2016) ncbi
mouse monoclonal (M168)
  • immunocytochemistry; human; 1:100; fig 4
  • western blot; human; fig 4
Abcam E-cadherin antibody (Abcam, ab76055) was used in immunocytochemistry on human samples at 1:100 (fig 4) and in western blot on human samples (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (M168)
  • immunohistochemistry - frozen section; rat; 1:200; fig 3
In order to study pregnancy in a rat model using bioengineered uterine tissue, Abcam E-cadherin antibody (Abcam, ab76055) was used in immunohistochemistry - frozen section on rat samples at 1:200 (fig 3). Fertil Steril (2016) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 4
  • western blot; mouse; fig 4
In order to characterize the association with pancreatic islet redistribution of cell adhesion molecules (CAMS) and reduced insulin secretion function in diabetic mice after prolonged high-fat diet, Abcam E-cadherin antibody (Abcam, ab11512) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 4) and in western blot on mouse samples (fig 4). Histochem Cell Biol (2016) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; fig 1
In order to identify cleavage sites for helicobacter pylori HtrA with E-cadherin signature motifs, Abcam E-cadherin antibody (Abcam, ab40772) was used in western blot on human samples (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:50; fig 8
  • immunocytochemistry; human; 1:50; fig 6
  • western blot; human; 1:50; fig 6
Abcam E-cadherin antibody (Abcam, Ab1416) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 8), in immunocytochemistry on human samples at 1:50 (fig 6) and in western blot on human samples at 1:50 (fig 6). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; zebrafish ; 1:50,000; fig 2
Abcam E-cadherin antibody (abcam, ab16505) was used in western blot on zebrafish samples at 1:50,000 (fig 2). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig s3b
In order to identify the enzymes and mechanisms responsible for human telomerase RNA degradation, Abcam E-cadherin antibody (Abcam, ab16505) was used in immunocytochemistry on human samples (fig s3b). Nat Struct Mol Biol (2016) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; fig 9
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunohistochemistry - paraffin section on human samples (fig 9). J Orthop Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; zebrafish ; 1:50,000; fig 5
Abcam E-cadherin antibody (Abcam, ab16505) was used in western blot on zebrafish samples at 1:50,000 (fig 5). PLoS ONE (2016) ncbi
mouse monoclonal (M168)
  • immunocytochemistry; human; 1:250; fig 2
  • western blot; human; 1:2500; fig 2
Abcam E-cadherin antibody (Abcam, ab76055) was used in immunocytochemistry on human samples at 1:250 (fig 2) and in western blot on human samples at 1:2500 (fig 2). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; zebrafish ; 1:50,000; fig 5
Abcam E-cadherin antibody (Abcam, ab16505) was used in western blot on zebrafish samples at 1:50,000 (fig 5). Int J Mol Sci (2016) ncbi
mouse monoclonal (M168)
  • immunohistochemistry - paraffin section; human; fig 2
In order to study human lacrimal epithelium and histatin-1 expression, Abcam E-cadherin antibody (Abcam, ab76055) was used in immunohistochemistry - paraffin section on human samples (fig 2). PLoS ONE (2016) ncbi
mouse monoclonal (M168)
  • western blot; human; loading ...; fig 7a
Abcam E-cadherin antibody (Abcam, ab76055) was used in western blot on human samples (fig 7a). Onco Targets Ther (2016) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - frozen section; human; fig 1
Abcam E-cadherin antibody (Abcam, HECD-1) was used in immunohistochemistry - frozen section on human samples (fig 1). J Invest Dermatol (2016) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; fig s7a
In order to present the role of SFRP2 in WNT16B signaling, Abcam E-cadherin antibody (abcam, ab1416) was used in immunocytochemistry on human samples (fig s7a). Oncogene (2016) ncbi
domestic rabbit monoclonal (EP700Y)
  • immunocytochemistry; human; fig s1a
  • western blot; human; 1:1000; fig 2d
Abcam E-cadherin antibody (Abcam, ab40772) was used in immunocytochemistry on human samples (fig s1a) and in western blot on human samples at 1:1000 (fig 2d). Sci Rep (2016) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; fig s1
Abcam E-cadherin antibody (Abcam, ab40772) was used in western blot on human samples (fig s1). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:1000; fig 7
  • western blot; human; loading ...; fig 5a
Abcam E-cadherin antibody (Abcam, ab15148) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 7) and in western blot on human samples (fig 5a). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:200; fig 7
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples at 1:200 (fig 7). elife (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:250; fig 3
Abcam E-cadherin antibody (Abcam, 15148) was used in western blot on human samples at 1:250 (fig 3). Mol Med Rep (2016) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1c
Abcam E-cadherin antibody (Abcam, Ab1416) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1c). PLoS ONE (2015) ncbi
rat monoclonal (DECMA-1)
  • immunocytochemistry; human
In order to study stretch-activated channels to set cytosolic calcium levels controlled by transmembrane proteoglycans, Abcam E-cadherin antibody (Abcam, DECMA-1) was used in immunocytochemistry on human samples . J Cell Biol (2015) ncbi
mouse monoclonal (HECD-1)
  • immunoprecipitation; human; fig 4b
  • western blot; human; fig 4d
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunoprecipitation on human samples (fig 4b) and in western blot on human samples (fig 4d). Oncotarget (2015) ncbi
rat monoclonal (DECMA-1)
  • immunocytochemistry; bovine; 1:100
Abcam E-cadherin antibody (Abcam, ab11512) was used in immunocytochemistry on bovine samples at 1:100. Anim Reprod Sci (2015) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; rhesus macaque; 1:500; fig 2
  • western blot; rhesus macaque; 1:500; fig 8
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on rhesus macaque samples at 1:500 (fig 2) and in western blot on rhesus macaque samples at 1:500 (fig 8). PLoS ONE (2015) ncbi
mouse monoclonal (HECD-1)
  • immunohistochemistry - paraffin section; human; 1:300; fig 4
  • western blot; human; 1:600; fig 7
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 4) and in western blot on human samples at 1:600 (fig 7). Respir Res (2015) ncbi
mouse monoclonal (M168)
  • immunocytochemistry; human; 1:400; loading ...; fig 5
  • western blot; human; 1:400; loading ...; fig 4
Abcam E-cadherin antibody (Abcam, ab76055) was used in immunocytochemistry on human samples at 1:400 (fig 5) and in western blot on human samples at 1:400 (fig 4). Int J Med Sci (2015) ncbi
domestic rabbit monoclonal (EP700Y)
  • immunohistochemistry; human
  • western blot; human
In order to investigate the epithelial homeostasis during oral submucous fibrosis progression to cancer, Abcam E-cadherin antibody (Abcam, ab40772) was used in immunohistochemistry on human samples and in western blot on human samples . J Clin Pathol (2015) ncbi
domestic rabbit monoclonal (EP700Y)
  • immunocytochemistry; human; 1:100
Abcam E-cadherin antibody (Abcam, AB40772) was used in immunocytochemistry on human samples at 1:100. Cell Mol Bioeng (2015) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry - frozen section; mouse; 1:200; fig 2
Abcam E-cadherin antibody (Abcam, DECMA-1) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 2). J Cell Biol (2015) ncbi
mouse monoclonal (M168)
  • immunocytochemistry; human; fig 5
  • western blot; human
Abcam E-cadherin antibody (Abcam, ab76055) was used in immunocytochemistry on human samples (fig 5) and in western blot on human samples . Nat Commun (2015) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
Abcam E-cadherin antibody (Abcam, clone HECD-1) was used in immunocytochemistry on human samples . Cancer Res (2015) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; loading ...; fig 2e
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples (fig 2e). PLoS ONE (2015) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry - paraffin section; mouse; fig s2b
  • immunocytochemistry; mouse; fig s2b
Abcam E-cadherin antibody (Abcam, ab11512) was used in immunohistochemistry - paraffin section on mouse samples (fig s2b) and in immunocytochemistry on mouse samples (fig s2b). Reprod Sci (2015) ncbi
domestic rabbit monoclonal (EP700Y)
  • immunocytochemistry; human
In order to study the mechanism for the metastasis of ErbB2-positive breast cancer cells, Abcam E-cadherin antibody (AbCam, ab40772) was used in immunocytochemistry on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (HECD-1)
  • western blot; human; 1:1000; fig 3
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples at 1:1000 (fig 3). Med Oncol (2015) ncbi
domestic rabbit monoclonal (EP700Y)
  • western blot; human; 1:20,000; fig 3
Abcam E-cadherin antibody (Abcam, ab40772) was used in western blot on human samples at 1:20,000 (fig 3). Int J Oncol (2015) ncbi
domestic rabbit monoclonal (EPR699)
  • western blot; human
Abcam E-cadherin antibody (Epitomics, 5409-1) was used in western blot on human samples . PLoS Genet (2014) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:100
In order to investigate the role of Zbed3 in malignant phenotype of lung cancer, Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples at 1:100. Mol Carcinog (2015) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:50
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples at 1:50. PLoS ONE (2014) ncbi
mouse monoclonal (HECD-1)
  • western blot; human
Abcam E-cadherin antibody (Abcam, ab1416) was used in western blot on human samples . Int J Oncol (2014) ncbi
domestic rabbit monoclonal (EP700Y)
  • immunohistochemistry; human
Abcam E-cadherin antibody (Abcam, ab40772) was used in immunohistochemistry on human samples . Diagn Pathol (2013) ncbi
domestic rabbit monoclonal (EP700Y)
  • immunohistochemistry - paraffin section; human
  • immunocytochemistry; human
Abcam E-cadherin antibody (Abcam, ab40772) was used in immunohistochemistry - paraffin section on human samples and in immunocytochemistry on human samples . Breast Cancer Res (2013) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
Abcam E-cadherin antibody (Abcam, ab1416) was used in immunocytochemistry on human samples . Fertil Steril (2013) ncbi
mouse monoclonal (HECD-1)
  • flow cytometry; human; 1:400
  • immunocytochemistry; human; 1:400
  • western blot; human
Abcam E-cadherin antibody (Abcam, HECD-1) was used in flow cytometry on human samples at 1:400, in immunocytochemistry on human samples at 1:400 and in western blot on human samples . Oncogene (2014) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human; 1:500; fig s2
In order to study the GNAS locus as a driver in 20q amplified breast cancer found in an siRNA screen, Abcam E-cadherin antibody (Abcam, Ab1416) was used in immunocytochemistry on human samples at 1:500 (fig s2). Oncogene (2014) ncbi
mouse monoclonal (M168)
  • western blot; mouse; 1:1000
In order to study the ability of adenosine A2A receptor activation to inhibit epithelial-mesenchymal transition and the development of renal interstitial fibrosis in a murine model, Abcam E-cadherin antibody (Abcam, ab76055) was used in western blot on mouse samples at 1:1000. PLoS ONE (2013) ncbi
Santa Cruz Biotechnology
mouse monoclonal (2Q663)
  • western blot; human; 1:1000; loading ...; fig 3a
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-71008) was used in western blot on human samples at 1:1000 (fig 3a). Sci Rep (2021) ncbi
mouse monoclonal (CH-19)
  • immunohistochemistry; mouse; loading ...; fig 3a
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-59876) was used in immunohistochemistry on mouse samples (fig 3a). EMBO J (2021) ncbi
mouse monoclonal (67A4)
  • western blot; human; 1:500; loading ...; fig 5a
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-21791) was used in western blot on human samples at 1:500 (fig 5a). Cancers (Basel) (2021) ncbi
mouse monoclonal (G-10)
  • western blot; human; 1:1000; loading ...; fig 5c
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-8426) was used in western blot on human samples at 1:1000 (fig 5c). Front Cell Dev Biol (2021) ncbi
mouse monoclonal (G-10)
  • immunocytochemistry; human; 1:100; loading ...; fig 4b
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-8426) was used in immunocytochemistry on human samples at 1:100 (fig 4b). Proc Natl Acad Sci U S A (2021) ncbi
mouse monoclonal (67A4)
  • western blot; human; 1:1000; loading ...; fig 5j
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-21791) was used in western blot on human samples at 1:1000 (fig 5j). Oncogenesis (2020) ncbi
mouse monoclonal (G-10)
  • western blot; human; 1:200; loading ...; fig 2a
Santa Cruz Biotechnology E-cadherin antibody (Santa, sc-8426) was used in western blot on human samples at 1:200 (fig 2a). World J Surg Oncol (2020) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry; human; loading ...; fig 1f
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, DECMA-1) was used in immunohistochemistry on human samples (fig 1f). Oncogene (2020) ncbi
rat monoclonal (DECMA-1)
  • western blot; human; 1:300; loading ...; fig 6b
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-59778) was used in western blot on human samples at 1:300 (fig 6b). PLoS ONE (2020) ncbi
mouse monoclonal (G-10)
  • western blot; human; 1:2000; loading ...; fig 5a
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, G-10) was used in western blot on human samples at 1:2000 (fig 5a). BMC Cancer (2019) ncbi
mouse monoclonal
  • western blot; human; 1:2000; loading ...; fig 5a
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, G-10) was used in western blot on human samples at 1:2000 (fig 5a). BMC Cancer (2019) ncbi
mouse monoclonal (2Q663)
  • western blot; human; 1:1000; loading ...; fig 3f
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-71008) was used in western blot on human samples at 1:1000 (fig 3f). Med Sci Monit (2019) ncbi
mouse monoclonal (67A4)
  • flow cytometry; human; 1:5; loading ...; fig s3a
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-21791) was used in flow cytometry on human samples at 1:5 (fig s3a). Sci Adv (2019) ncbi
mouse monoclonal (5F133)
  • immunocytochemistry; human; 1:500; fig 1c
  • western blot; human; fig 2a
Santa Cruz Biotechnology E-cadherin antibody (SantaCruz, sc-71007) was used in immunocytochemistry on human samples at 1:500 (fig 1c) and in western blot on human samples (fig 2a). Exp Ther Med (2018) ncbi
mouse monoclonal (1.B.54)
  • western blot; human; 1:500; loading ...; fig 4a
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-71009) was used in western blot on human samples at 1:500 (fig 4a). Exp Cell Res (2018) ncbi
mouse monoclonal (1.B.54)
  • western blot; human; loading ...; fig 4d
Santa Cruz Biotechnology E-cadherin antibody (SantaCruz, sc-71009) was used in western blot on human samples (fig 4d). Oncotarget (2017) ncbi
mouse monoclonal (CH-19)
  • western blot; mouse; loading ...; fig 4a
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-59876) was used in western blot on mouse samples (fig 4a). J Clin Invest (2017) ncbi
mouse monoclonal (G-10)
  • western blot; human; 1:500; loading ...; fig 4e
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-8426) was used in western blot on human samples at 1:500 (fig 4e). Int J Mol Med (2017) ncbi
mouse monoclonal (G-10)
  • immunocytochemistry; human; 2 ug/ml; loading ...; fig s1
In order to research the involvement of protein IQGAP1 in the regulation of actin networks, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, SC-8426) was used in immunocytochemistry on human samples at 2 ug/ml (fig s1). Biol Open (2017) ncbi
mouse monoclonal (Sec11)
  • western blot; human; fig 1c
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-59780) was used in western blot on human samples (fig 1c). Biosci Rep (2017) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry - paraffin section; rat; 1:50; loading ...; fig st7
  • immunohistochemistry - paraffin section; dogs; 1:50; loading ...; fig st7
In order to outline the protocols for antibodies used for immunohistochemical studies, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, SC-59778) was used in immunohistochemistry - paraffin section on rat samples at 1:50 (fig st7) and in immunohistochemistry - paraffin section on dogs samples at 1:50 (fig st7). J Toxicol Pathol (2017) ncbi
mouse monoclonal (5F133)
  • western blot; human; 1:200; loading ...; fig 5a
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, Inc., sc-71007) was used in western blot on human samples at 1:200 (fig 5a). Mol Med Rep (2017) ncbi
rat monoclonal (DECMA-1)
  • immunocytochemistry; mouse; fig S1b
In order to describe a cardiovascular progenitor population derived during embryonic stem cell differentiation, Santa Cruz Biotechnology E-cadherin antibody (Santa cruz, DECMA-1) was used in immunocytochemistry on mouse samples (fig S1b). Stem Cells Int (2016) ncbi
mouse monoclonal (67A4)
  • western blot; rat; 1:1000; loading ...; fig s1
In order to test if A2A receptor signaling governs the blood-brain barrier dynamics in sleep-restricted rats, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-21791) was used in western blot on rat samples at 1:1000 (fig s1). PLoS ONE (2016) ncbi
mouse monoclonal (67A4)
  • flow cytometry; human; loading ...
In order to elucidate how CELF1 governs the epithelial-to-mesenchymal transition, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-21791) was used in flow cytometry on human samples . Nat Commun (2016) ncbi
mouse monoclonal (G-10)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 6a
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, G-10) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 6a). Sci Rep (2016) ncbi
mouse monoclonal (G-10)
  • western blot; human; 1:1000; fig 3B
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-8426) was used in western blot on human samples at 1:1000 (fig 3B). Oncol Lett (2016) ncbi
mouse monoclonal (G-10)
  • western blot; human; 1:1000; fig 4
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-8426) was used in western blot on human samples at 1:1000 (fig 4). BMC Res Notes (2016) ncbi
mouse monoclonal (MB2)
  • western blot; mouse; fig 5
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-59905) was used in western blot on mouse samples (fig 5). PLoS ONE (2016) ncbi
mouse monoclonal (67A4)
  • western blot; human; fig 2
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-21791) was used in western blot on human samples (fig 2). Oncotarget (2016) ncbi
mouse monoclonal (2Q663)
  • western blot; human; loading ...; fig 2b
Santa Cruz Biotechnology E-cadherin antibody (SantaCruz, sc-71008) was used in western blot on human samples (fig 2b). Oncol Lett (2016) ncbi
mouse monoclonal (1.B.54)
  • western blot; human; fig 6
In order to analyze repression of tumorigenesis and modulation of epithelial-to-mesenchymal transition in bladder carcinoma cells by prostate-derived ets factor, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, 1.B.54) was used in western blot on human samples (fig 6). Cancer Lett (2016) ncbi
mouse monoclonal (G-10)
  • western blot; mouse; fig 8
  • western blot; human; fig 4
In order to learn about inhibition of stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/beta-catenin signaling axis via cucurbitacin B, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, SC-8426) was used in western blot on mouse samples (fig 8) and in western blot on human samples (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (G-10)
  • western blot; human; fig 3
In order to study how ZEB1 drives the epithelial-mesenchymal transition-related resistance to EGFR-tyrosine kinases inhibitors in non-small cell lung cancer, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc8426) was used in western blot on human samples (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (67A4)
  • immunohistochemistry; human; fig 1
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-21791) was used in immunohistochemistry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (G-10)
  • western blot; human; 1:500; fig 2a
In order to characterize two clones from triple negative breast MDA-MB-231 cancer cells, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, G10) was used in western blot on human samples at 1:500 (fig 2a). Exp Cell Res (2015) ncbi
mouse monoclonal (G-10)
  • western blot; human; fig 5
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-8426) was used in western blot on human samples (fig 5). Mar Drugs (2015) ncbi
mouse monoclonal (G-10)
  • western blot; mouse
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-8426) was used in western blot on mouse samples . Cell Physiol Biochem (2015) ncbi
mouse monoclonal (1.B.54)
  • western blot; human; fig 7a
In order to analyze growth differentiation factor-15 as a p53- and demehtylation-upregulating gene that represses invasion, cell proliferation, and tumorigenesis in bladder carcinoma cells, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, 1.B.54) was used in western blot on human samples (fig 7a). Sci Rep (2015) ncbi
mouse monoclonal (G-10)
  • western blot; human
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-8426) was used in western blot on human samples . Am J Physiol Lung Cell Mol Physiol (2015) ncbi
mouse monoclonal (G-10)
  • immunocytochemistry; rat; fig 5
  • western blot; rat; fig 2
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, SC-8426) was used in immunocytochemistry on rat samples (fig 5) and in western blot on rat samples (fig 2). Int J Mol Sci (2015) ncbi
mouse monoclonal (67A4)
  • immunohistochemistry - paraffin section; human; fig 6
  • western blot; human; loading ...; fig 3
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-21791) was used in immunohistochemistry - paraffin section on human samples (fig 6) and in western blot on human samples (fig 3). Mol Med Rep (2015) ncbi
mouse monoclonal (G-10)
  • western blot; human; fig s2a
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-8426) was used in western blot on human samples (fig s2a). Oncotarget (2015) ncbi
mouse monoclonal (G-10)
  • western blot; human; fig 6
Santa Cruz Biotechnology E-cadherin antibody (santa Cruz, sc-8426) was used in western blot on human samples (fig 6). PLoS ONE (2015) ncbi
rat monoclonal (DECMA-1)
  • western blot; human; 1:500
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotech, sc-59778) was used in western blot on human samples at 1:500. Biochem Biophys Res Commun (2015) ncbi
mouse monoclonal (G-10)
  • western blot; human; 1:1000; fig 3
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-8426) was used in western blot on human samples at 1:1000 (fig 3). Oncol Lett (2015) ncbi
mouse monoclonal (G-10)
  • immunohistochemistry - paraffin section; mouse; fig 6
  • immunohistochemistry - paraffin section; human; fig 6
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-8426) was used in immunohistochemistry - paraffin section on mouse samples (fig 6) and in immunohistochemistry - paraffin section on human samples (fig 6). Cell Cycle (2015) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry - paraffin section; mouse; 1:1000
In order to evaluate an in vitro murine-derived fundic organoids for the study of gastric physiology, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc59778) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000. J Physiol (2015) ncbi
mouse monoclonal (G-10)
  • immunocytochemistry; domestic rabbit; 5 ug/ml
In order to create an in vitro primary lung co-culture platform derived from New Zealand white rabbits, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-8426) was used in immunocytochemistry on domestic rabbit samples at 5 ug/ml. In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (CH-19)
  • western blot; mouse; 1:4000; loading ...; fig 5c
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-59876) was used in western blot on mouse samples at 1:4000 (fig 5c). Nat Neurosci (2014) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry - frozen section; mouse; 1:100
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-59778) was used in immunohistochemistry - frozen section on mouse samples at 1:100. Cell Res (2014) ncbi
mouse monoclonal (1.B.54)
  • western blot; human; 1:100
In order to determine the role and function of NDRG1 in oral squamous cell carcinoma, Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, 1.B.54) was used in western blot on human samples at 1:100. Cancer Lett (2014) ncbi
mouse monoclonal (2Q663)
  • immunocytochemistry; human
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-71008) was used in immunocytochemistry on human samples . Biol Reprod (2014) ncbi
mouse monoclonal (67A4)
  • immunocytochemistry; human
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, SC-21791) was used in immunocytochemistry on human samples . Mol Biol Cell (2014) ncbi
mouse monoclonal (67A4)
  • immunocytochemistry; human; 1:100
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, sc-21791) was used in immunocytochemistry on human samples at 1:100. Mol Carcinog (2014) ncbi
mouse monoclonal (2Q663)
  • immunocytochemistry; human
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz, sc-71008) was used in immunocytochemistry on human samples . Cell Death Dis (2013) ncbi
mouse monoclonal (G-10)
  • western blot; human; fig 2
Santa Cruz Biotechnology E-cadherin antibody (Santa Cruz Biotechnology, SC-8426) was used in western blot on human samples (fig 2). PLoS ONE (2013) ncbi
BioLegend
rat monoclonal (DECMA-1)
  • flow cytometry; mouse; 1:200
BioLegend E-cadherin antibody (BioLegend, 147307) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2021) ncbi
mouse monoclonal (67A4)
  • flow cytometry; human; loading ...; fig 2a
BioLegend E-cadherin antibody (BioLegend, 324106) was used in flow cytometry on human samples (fig 2a). Nat Commun (2021) ncbi
rat monoclonal (DECMA-1)
  • flow cytometry; pigs ; loading ...; fig 4a
BioLegend E-cadherin antibody (BioLegend, 147319) was used in flow cytometry on pigs samples (fig 4a). Animals (Basel) (2021) ncbi
rat monoclonal (DECMA-1)
BioLegend E-cadherin antibody (BioLegend, DECMA-1) was used . Nature (2020) ncbi
rat monoclonal (DECMA-1)
  • flow cytometry; mouse; 1:200; loading ...; fig s7a
BioLegend E-cadherin antibody (Biolegend, 147309) was used in flow cytometry on mouse samples at 1:200 (fig s7a). Physiol Rep (2020) ncbi
mouse monoclonal (67A4)
  • flow cytometry; human; loading ...; fig s3
BioLegend E-cadherin antibody (BioLegend, 324107) was used in flow cytometry on human samples (fig s3). Stem Cell Reports (2020) ncbi
mouse monoclonal (67A4)
  • flow cytometry; human; loading ...; fig 1b
BioLegend E-cadherin antibody (Biolegend, 324108) was used in flow cytometry on human samples (fig 1b). Stem Cell Res Ther (2019) ncbi
mouse monoclonal (67A4)
  • flow cytometry; human; loading ...; fig 4b
BioLegend E-cadherin antibody (BioLegend, 67A4) was used in flow cytometry on human samples (fig 4b). J Immunol (2018) ncbi
rat monoclonal (DECMA-1)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 2f
BioLegend E-cadherin antibody (Biolegend, Decma-1) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 2f). Science (2018) ncbi
rat monoclonal (DECMA-1)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend E-cadherin antibody (BioLegend, DECMA-1) was used in flow cytometry on mouse samples (fig 3c). J Exp Med (2018) ncbi
rat monoclonal (DECMA-1)
  • flow cytometry; mouse; loading ...; fig 2b
In order to examine the role of herpes virus entry mediator in corneal disease during viral infection, BioLegend E-cadherin antibody (BioLegend, DECMA-1) was used in flow cytometry on mouse samples (fig 2b). Invest Ophthalmol Vis Sci (2017) ncbi
rat monoclonal (DECMA-1)
  • western blot; mouse; loading ...; fig 4g
In order to describe how epithelial polarity proteins suppress malignant outgrowth, BioLegend E-cadherin antibody (BioLegend, 147302) was used in western blot on mouse samples (fig 4g). J Exp Med (2017) ncbi
mouse monoclonal (67A4)
  • flow cytometry; human; loading ...
In order to elucidate how CELF1 governs the epithelial-to-mesenchymal transition, BioLegend E-cadherin antibody (BioLegend, 324108) was used in flow cytometry on human samples . Nat Commun (2016) ncbi
mouse monoclonal (67A4)
  • flow cytometry; human; loading ...; fig 6a
BioLegend E-cadherin antibody (Biolegend, 324101) was used in flow cytometry on human samples (fig 6a). Oncotarget (2016) ncbi
mouse monoclonal (67A4)
  • flow cytometry; human
  • immunocytochemistry; human
In order to use a multi-omics strategy to elucidate the cellular programs altered by Staphylococcus aureus alpha-toxin, BioLegend E-cadherin antibody (BioLegend, 324106) was used in flow cytometry on human samples and in immunocytochemistry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (67A4)
  • flow cytometry; human; fig 2
BioLegend E-cadherin antibody (Biolegend, 67A4) was used in flow cytometry on human samples (fig 2). Blood (2015) ncbi
mouse monoclonal (67A4)
  • flow cytometry; human; fig 4
In order to analyze cancer cell plasticity autonomous stimulation by human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells, BioLegend E-cadherin antibody (Biolegend, 67A4) was used in flow cytometry on human samples (fig 4). PLoS ONE (2014) ncbi
Novus Biologicals
mouse monoclonal (7H12)
  • western blot; human; loading ...; fig 3a
Novus Biologicals E-cadherin antibody (Novus, NBP2-19051SS) was used in western blot on human samples (fig 3a). Front Immunol (2021) ncbi
mouse monoclonal (7H12)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4b
  • western blot; mouse; loading ...; fig 4a
Novus Biologicals E-cadherin antibody (Novus, NBP2-19051) was used in immunohistochemistry - paraffin section on mouse samples (fig 4b) and in western blot on mouse samples (fig 4a). Cancer Res (2017) ncbi
Enzo Life Sciences
rat monoclonal (ECCD-2)
  • western blot; mouse; 1:1000; fig 2
Enzo Life Sciences E-cadherin antibody (Enzo, ALX-804- 202-C100) was used in western blot on mouse samples at 1:1000 (fig 2). Nat Commun (2015) ncbi
mouse monoclonal (SHE78-7)
  • blocking or activating experiments; human; 1 ug/ml; fig 7d
  • immunocytochemistry; human; fig 7a
  • western blot; human; fig 7c
Enzo Life Sciences E-cadherin antibody (Enzo, SHE78-7) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 7d), in immunocytochemistry on human samples (fig 7a) and in western blot on human samples (fig 7c). PLoS ONE (2015) ncbi
mouse monoclonal (SHE78-7)
  • immunocytochemistry; human; 1:100
  • western blot; human; 1:1000
  • immunocytochemistry; hamsters; 1:100
  • western blot; hamsters; 1:1000
Enzo Life Sciences E-cadherin antibody (Enzo Life Sciences, SHE78-7) was used in immunocytochemistry on human samples at 1:100, in western blot on human samples at 1:1000, in immunocytochemistry on hamsters samples at 1:100 and in western blot on hamsters samples at 1:1000. Eur J Hum Genet (2014) ncbi
mouse monoclonal (HECD-1)
  • immunocytochemistry; human
Enzo Life Sciences E-cadherin antibody (Enzo Life Sciences, ALX-804-201-C100) was used in immunocytochemistry on human samples . Exp Cell Res (2013) ncbi
R&D Systems
domestic goat polyclonal
  • immunohistochemistry; mouse; fig 2m
R&D Systems E-cadherin antibody (R&D Systems, AF748) was used in immunohistochemistry on mouse samples (fig 2m). Front Cell Dev Biol (2021) ncbi
domestic goat polyclonal
  • immunohistochemistry; mouse; 1:500; loading ...; fig s2a
R&D Systems E-cadherin antibody (R&D Systems, AF748) was used in immunohistochemistry on mouse samples at 1:500 (fig s2a). Development (2021) ncbi
domestic goat polyclonal
  • immunocytochemistry; mouse
R&D Systems E-cadherin antibody (R&D, AF748) was used in immunocytochemistry on mouse samples . Nature (2021) ncbi
Miltenyi Biotec
mouse monoclonal (67A4)
  • flow cytometry; human; loading ...; fig 2c
Miltenyi Biotec E-cadherin antibody (Miltenyi Biotec, 130-099-141) was used in flow cytometry on human samples (fig 2c). Sci Rep (2018) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology E-cadherin antibody (CST, 24E10) was used in western blot on human samples at 1:1000 (fig 3a). J Cancer (2021) ncbi
  • immunocytochemistry; mouse; fig 5c
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 9961) was used in immunocytochemistry on mouse samples (fig 5c). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse; 1:5000; loading ...
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on mouse samples at 1:5000. Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; fig 4c
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry on mouse samples (fig 4c). iScience (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:200; loading ...; fig 2c
  • western blot; human; 1:1000; loading ...; fig 2b
Cell Signaling Technology E-cadherin antibody (Cell Signalling, 3195) was used in immunocytochemistry on human samples at 1:200 (fig 2c) and in western blot on human samples at 1:1000 (fig 2b). NPJ Breast Cancer (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 5a, 5c
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 5a, 5c). Mol Med Rep (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 6c, 6f
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on human samples (fig 6c, 6f). Mol Ther Nucleic Acids (2021) ncbi
mouse monoclonal (4A2)
  • western blot; human; fig 5a
  • western blot; rat; fig 2a
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 14472) was used in western blot on human samples (fig 5a) and in western blot on rat samples (fig 2a). Front Pharmacol (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; fig 3d
  • western blot; human; 1:1000; loading ...; fig 2b
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in immunohistochemistry - paraffin section on human samples (fig 3d) and in western blot on human samples at 1:1000 (fig 2b). Nat Commun (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; pigs ; 1:1000; loading ...; fig s2d
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on pigs samples at 1:1000 (fig s2d). Virulence (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; 1:200; fig 1l
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry on human samples at 1:200 (fig 1l). Nat Commun (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse; fig 5b
Cell Signaling Technology E-cadherin antibody (CST, 3195S) was used in western blot on mouse samples (fig 5b). Clin Transl Med (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 6a, 6b
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195S) was used in western blot on human samples (fig 6a, 6b). Clin Transl Med (2021) ncbi
mouse monoclonal (4A2)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 1d
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 4A2) was used in immunohistochemistry on mouse samples at 1:100 (fig 1d). Nat Commun (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse; loading ...; fig s2g
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on mouse samples (fig s2g). Nat Commun (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:250; fig 7a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195s) was used in immunohistochemistry on mouse samples at 1:250 (fig 7a). Curr Res Toxicol (2021) ncbi
mouse monoclonal (4A2)
  • immunohistochemistry; mouse; loading ...; fig 3a
Cell Signaling Technology E-cadherin antibody (CST, 14472) was used in immunohistochemistry on mouse samples (fig 3a). Cell Death Dis (2021) ncbi
mouse monoclonal (4A2)
  • western blot; human; 1:1000; loading ...; fig 2g
Cell Signaling Technology E-cadherin antibody (CST, 14472S) was used in western blot on human samples at 1:1000 (fig 2g). Int J Biol Sci (2021) ncbi
mouse monoclonal (4A2)
  • western blot; human; 1:1000; loading ...; fig 4c, 4d
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 14472) was used in western blot on human samples at 1:1000 (fig 4c, 4d). Acta Pharm Sin B (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; pigs ; loading ...; fig s4
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195S) was used in immunohistochemistry on pigs samples (fig s4). Sci Rep (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; loading ...; fig 3b
  • western blot; mouse; loading ...; fig 3d
Cell Signaling Technology E-cadherin antibody (CST, 3195S) was used in immunohistochemistry on mouse samples (fig 3b) and in western blot on mouse samples (fig 3d). Theranostics (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 6d
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples (fig 6d). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; rhesus macaque; 1:1000; fig 4a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195S) was used in immunohistochemistry on rhesus macaque samples at 1:1000 (fig 4a). BMC Biol (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 3e
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples at 1:1000 (fig 3e). Oncogene (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 2h
Cell Signaling Technology E-cadherin antibody (CST, 3195s) was used in western blot on human samples at 1:1000 (fig 2h). Cancer Gene Ther (2022) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:3000; loading ...; fig 5e
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples at 1:3000 (fig 5e). Nat Commun (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 2s
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on mouse samples at 1:200 (fig 2s). Nat Commun (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 2i
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on human samples at 1:1000 (fig 2i). Front Oncol (2021) ncbi
mouse monoclonal (4A2)
  • immunohistochemistry; human; fig 4j
  • western blot; human; loading ...; fig 4f 4h
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 14472) was used in immunohistochemistry on human samples (fig 4j) and in western blot on human samples (fig 4f 4h). Theranostics (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse; 1:1000; loading ...; fig s10a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on mouse samples at 1:1000 (fig s10a). NPJ Breast Cancer (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples (fig 3b). Biomol Ther (Seoul) (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; loading ...; fig s6b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on human samples (fig s6b). Cell Stem Cell (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 4a
  • western blot; mouse; 1:500; loading ...; fig 4b
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195T) was used in immunohistochemistry on mouse samples at 1:500 (fig 4a) and in western blot on mouse samples at 1:500 (fig 4b). Redox Biol (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; loading ...; fig s5-1e
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on human samples (fig s5-1e). elife (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:100; loading ...; fig s4a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on mouse samples at 1:100 (fig s4a). Cell Rep (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; mouse; 1:100; fig s2l
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195S) was used in immunocytochemistry on mouse samples at 1:100 (fig s2l). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - frozen section; human; 1:200; fig 4b
  • western blot; human; fig 3a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - frozen section on human samples at 1:200 (fig 4b) and in western blot on human samples (fig 3a). PLoS ONE (2021) ncbi
mouse monoclonal (4A2)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 6d
  • western blot; mouse; 1:1000; loading ...; fig 4b
Cell Signaling Technology E-cadherin antibody (CST, 14472S) was used in immunohistochemistry on mouse samples at 1:100 (fig 6d) and in western blot on mouse samples at 1:1000 (fig 4b). Am J Cancer Res (2021) ncbi
mouse monoclonal (4A2)
  • western blot; human; loading ...; fig 3e
Cell Signaling Technology E-cadherin antibody (CST (Cell Signaling Technology), 14472) was used in western blot on human samples (fig 3e). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...; fig 4d
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in immunocytochemistry on human samples (fig 4d) and in western blot on human samples (fig 4b). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse; loading ...; fig 4a
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on mouse samples (fig 4a). Nat Commun (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; loading ...; fig s3b
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry on mouse samples (fig s3b). Cell Rep (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 3e, 5c
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 3e, 5c). Neoplasma (2021) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 4c
  • western blot; mouse; 1:1000; loading ...; fig s11b
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 4c), in western blot on mouse samples at 1:1000 (fig s11b) and in western blot on human samples at 1:1000 (fig 4b). Nat Commun (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 4b). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 3b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 3b). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 3e
Cell Signaling Technology E-cadherin antibody (CST, 3195S) was used in western blot on human samples at 1:1000 (fig 3e). J Cancer (2021) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse; loading ...; fig 3a
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on mouse samples (fig 3a). Oxid Med Cell Longev (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on human samples (fig 3c). Cancer Sci (2021) ncbi
mouse monoclonal (32A8)
  • western blot; human; loading ...; fig s1b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 5296) was used in western blot on human samples (fig s1b). Adv Sci (Weinh) (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 1g
Cell Signaling Technology E-cadherin antibody (Cell signaling Technology, 24E10) was used in western blot on human samples at 1:1000 (fig 1g). elife (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 6e
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195S) was used in western blot on human samples at 1:1000 (fig 6e). Front Oncol (2020) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:500; loading ...; fig s1-3a
Cell Signaling Technology E-cadherin antibody (CST, 3195S) was used in immunocytochemistry on human samples at 1:500 (fig s1-3a). elife (2020) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:500; loading ...; fig s6-2a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on mouse samples at 1:500 (fig s6-2a). elife (2020) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 3e
Cell Signaling Technology E-cadherin antibody (CST, 3195S) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 3e). Cancer Cell Int (2020) ncbi
mouse monoclonal (4A2)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 6e
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 14472) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 6e). Oncol Rep (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 3e
Cell Signaling Technology E-cadherin antibody (CST, 31958) was used in western blot on human samples at 1:1000 (fig 3e). Cancer Cell Int (2020) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:200; loading ...; fig 3h
  • western blot; human; 1:1000; loading ...; fig 3g
Cell Signaling Technology E-cadherin antibody (CST, 3195S) was used in immunocytochemistry on human samples at 1:200 (fig 3h) and in western blot on human samples at 1:1000 (fig 3g). Signal Transduct Target Ther (2020) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; rhesus macaque; 1:300; loading ...; fig s8b
Cell Signaling Technology E-cadherin antibody (CST, 3199S) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:300 (fig s8b). Science (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 6b, 8b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 6b, 8b). Commun Biol (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 6g
Cell Signaling Technology E-cadherin antibody (CST, 3195s) was used in western blot on human samples at 1:1000 (fig 6g). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 1s4a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in immunohistochemistry on mouse samples at 1:500 (fig 1s4a). elife (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:500; loading ...; fig 2g
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples at 1:500 (fig 2g). Oncogene (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 5i
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on human samples (fig 5i). CNS Neurosci Ther (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 2c
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 2c). Biosci Rep (2020) ncbi
mouse monoclonal (4A2)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 4b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 14472) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4b). J Cancer (2020) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6a
  • western blot; mouse; 1:500; loading ...; fig 2f
Cell Signaling Technology E-cadherin antibody (CST, 24E10) was used in immunohistochemistry - paraffin section on mouse samples (fig 6a) and in western blot on mouse samples at 1:500 (fig 2f). Cancer Manag Res (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 8a
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on human samples (fig 8a). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on human samples (fig 3c). Int J Biol Sci (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 3c
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in western blot on human samples (fig 3c). Oncogenesis (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 7d
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on human samples (fig 7d). Am J Cancer Res (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 2g: 2h, 2i
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on human samples at 1:1000 (fig 2g: 2h, 2i). Am J Cancer Res (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3f
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on human samples (fig 3f). Int J Biol Sci (2020) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 6e
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 6e). Dis Model Mech (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 2f
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples (fig 2f). Aging (Albany NY) (2020) ncbi
mouse monoclonal (4A2)
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 14472) was used in western blot on human samples at 1:1000 (fig 5c). Oncogene (2020) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 3a
  • western blot; mouse; 1:5000; loading ...; fig 3h
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 3a) and in western blot on mouse samples at 1:5000 (fig 3h). Cancer Cell (2020) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:200; loading ...; fig s1c
Cell Signaling Technology E-cadherin antibody (CST, 24E10) was used in immunocytochemistry on human samples at 1:200 (fig s1c). Sci Rep (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:500; loading ...; fig 4b
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on human samples at 1:500 (fig 4b). J Cancer (2020) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig 2i
  • western blot; human; 1:1000; loading ...; fig 2g
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 24E10) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 2i) and in western blot on human samples at 1:1000 (fig 2g). Front Oncol (2019) ncbi
mouse monoclonal (4A2)
  • immunocytochemistry; human; loading ...; fig 3d
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology E-cadherin antibody (CST, 14472) was used in immunocytochemistry on human samples (fig 3d) and in western blot on human samples (fig 3c). Cell Death Dis (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3i
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 3i). Mol Oncol (2020) ncbi
mouse monoclonal (4A2)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4b
  • western blot; human; loading ...; fig 5d
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 4A2) was used in immunohistochemistry - paraffin section on human samples (fig 4b) and in western blot on human samples (fig 5d). Cell Commun Signal (2019) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 5b
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on human samples at 1:1000 (fig 5b). Nat Commun (2019) ncbi
domestic rabbit monoclonal (24E10)
  • flow cytometry; mouse; 1:200; loading ...; fig 2i
  • immunocytochemistry; mouse; 1:200; loading ...; fig 2i
  • western blot; mouse; 1:1000; loading ...; fig 2f
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in flow cytometry on mouse samples at 1:200 (fig 2i), in immunocytochemistry on mouse samples at 1:200 (fig 2i) and in western blot on mouse samples at 1:1000 (fig 2f). Sci Adv (2019) ncbi
mouse monoclonal (4A2)
  • western blot; human; 1:2000; fig 3b
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 14472) was used in western blot on human samples at 1:2000 (fig 3b). Int J Mol Med (2019) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:200; loading ...; fig 3b
Cell Signaling Technology E-cadherin antibody (Cell Signal Technology, 3195) was used in western blot on human samples at 1:200 (fig 3b). BMC Ophthalmol (2019) ncbi
mouse monoclonal (4A2)
  • western blot; human; 1:1000; loading ...; fig 2f
Cell Signaling Technology E-cadherin antibody (CST, 14472) was used in western blot on human samples at 1:1000 (fig 2f). Biosci Rep (2019) ncbi
mouse monoclonal (4A2)
  • western blot; human; 1:1000; fig 1a
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 14472) was used in western blot on human samples at 1:1000 (fig 1a). PLoS Pathog (2019) ncbi
mouse monoclonal (4A2)
  • western blot; human; loading ...; fig 4e
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 14472) was used in western blot on human samples (fig 4e). Oncogene (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 2d
  • western blot; mouse; 1:1000; loading ...; fig s6f
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on human samples at 1:1000 (fig 2d) and in western blot on mouse samples at 1:1000 (fig s6f). Science (2019) ncbi
mouse monoclonal (4A2)
  • western blot; human; 1:1000; loading ...; fig 4f
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 14472S) was used in western blot on human samples at 1:1000 (fig 4f). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; fig s3b
  • immunocytochemistry; human; fig 2g
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in immunohistochemistry - paraffin section on human samples (fig s3b) and in immunocytochemistry on human samples (fig 2g). Oncogene (2020) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195S) was used in western blot on human samples at 1:1000 (fig 1a). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...; fig 5e
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in immunocytochemistry on human samples (fig 5e) and in western blot on human samples (fig 5a). BMC Cancer (2019) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 2c
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on mouse samples at 1:100 (fig 2c). Nature (2019) ncbi
mouse monoclonal (4A2)
  • western blot; mouse; 1:1000; loading ...; fig 2c
Cell Signaling Technology E-cadherin antibody (CST, 14472) was used in western blot on mouse samples at 1:1000 (fig 2c). elife (2019) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on human samples (fig 2a). Cell Commun Signal (2019) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in western blot on human samples (fig 3d). J Exp Clin Cancer Res (2019) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:100; loading ...; fig s1e
  • western blot; mouse; 1:1000; loading ...; fig s1j
Cell Signaling Technology E-cadherin antibody (CST, 3199) was used in immunohistochemistry on mouse samples at 1:100 (fig s1e) and in western blot on mouse samples at 1:1000 (fig s1j). Sci Adv (2019) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...; fig 2a
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples (fig 2a) and in western blot on human samples (fig 2b). Theranostics (2019) ncbi
mouse monoclonal (4A2)
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 14472) was used in western blot on human samples at 1:1000 (fig 3c). Nature (2019) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 4i
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 4i). Biosci Rep (2019) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 52 ng/ml; loading ...; fig 5d
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in western blot on human samples at 52 ng/ml (fig 5d). Science (2019) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 2a
Cell Signaling Technology E-cadherin antibody (Cell Signalling Technology, 3195) was used in western blot on human samples at 1:1000 (fig 2a). EMBO Mol Med (2019) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples at 1:1000 (fig 4a). Nat Commun (2019) ncbi
domestic rabbit monoclonal (24E10)
  • mass cytometry; human; loading ...; fig 3a
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technologies, 3195) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 1b, 4d
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195s) was used in western blot on human samples at 1:1000 (fig 1b, 4d). Nat Commun (2019) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 5a
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 24E10) was used in western blot on human samples (fig 5a). Biomed Res Int (2019) ncbi
mouse monoclonal (4A2)
  • immunocytochemistry; human; loading ...; fig s2
  • western blot; human; 1:1000; loading ...; fig 3b
  • western blot; rat; 1:1000; loading ...; fig 6b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 14472) was used in immunocytochemistry on human samples (fig s2), in western blot on human samples at 1:1000 (fig 3b) and in western blot on rat samples at 1:1000 (fig 6b). EBioMedicine (2019) ncbi
mouse monoclonal (4A2)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 14472) was used in western blot on human samples at 1:1000 (fig 3a). J Cell Mol Med (2019) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse; loading ...; fig 5f
  • western blot; human; loading ...; fig 1f
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on mouse samples (fig 5f) and in western blot on human samples (fig 1f). Cancer Lett (2019) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 4a
  • western blot; mouse; 1:200; loading ...; fig 4c
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 24E10) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 4a) and in western blot on mouse samples at 1:200 (fig 4c). J Allergy Clin Immunol (2019) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195S) was used in western blot on human samples at 1:1000 (fig 3a). Biosci Rep (2018) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...; fig 3c
  • western blot; human; loading ...; fig s1f
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples (fig 3c) and in western blot on human samples (fig s1f). Cell Death Differ (2019) ncbi
domestic rabbit monoclonal (24E10)
  • other; human; loading ...; fig 4c
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 3b). J Cell Mol Med (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s3d
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 4068) was used in western blot on human samples (fig s3d). Cancer Res (2018) ncbi
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 2b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 9961) was used in immunohistochemistry on mouse samples at 1:1000 (fig 2b). Development (2018) ncbi
mouse monoclonal (4A2)
  • western blot; human; loading ...; fig 1f
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 4A2) was used in western blot on human samples (fig 1f). Cancer Res (2018) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 1a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 1a). Mol Med Rep (2018) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 6g
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 6g). Biol Reprod (2018) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 3c). Cancer Res (2018) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; loading ...; fig 3a2
Cell Signaling Technology E-cadherin antibody (Cell Signalling, 24E10) was used in immunohistochemistry on human samples (fig 3a2). Stem Cells Int (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 3b
Cell Signaling Technology E-cadherin antibody (CST, 24E10) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 3b). Life Sci (2018) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...
In order to research a paradigm for generation of all major ectodermal lineages from human pluripotent stem cells, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technologies, 3195) was used in immunocytochemistry on human samples . Cell Stem Cell (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 2j
In order to investigate the oncogenic effect of miR-210-3p in prostate cancer and bone metastasis and its mechanism, Cell Signaling Technology E-cadherin antibody (cell signalling, 3195) was used in western blot on human samples (fig 2j). Mol Cancer (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...; fig 6b
  • western blot; human; loading ...; fig 6a
In order to study the effect of symplekin on cellular proliferation and dedifferentiation, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195S) was used in immunocytochemistry on human samples (fig 6b) and in western blot on human samples (fig 6a). Sci Rep (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 7b
  • immunocytochemistry; human; loading ...; fig 6d
  • western blot; human; fig 6a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195s) was used in immunohistochemistry - paraffin section on human samples (fig 7b), in immunocytochemistry on human samples (fig 6d) and in western blot on human samples (fig 6a). EBioMedicine (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1g
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in immunohistochemistry - frozen section on mouse samples (fig 1g). Dev Biol (2017) ncbi
mouse monoclonal (4A2)
  • immunohistochemistry - paraffin section; human; 1:100; fig 9d
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 14472) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 9d) and in western blot on human samples at 1:1000 (fig 3a). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 8a
Cell Signaling Technology E-cadherin antibody (Cell signaling, 4068) was used in western blot on human samples at 1:1000 (fig 8a). Development (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6a
  • western blot; human; loading ...; fig s3a-b
In order to investigate the oncogenic functions of CHD4, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on human samples (fig 6a) and in western blot on human samples (fig s3a-b). Cancer Cell (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:200; fig 2a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on mouse samples at 1:200 (fig 2a). J Clin Invest (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; mouse; 1:250; fig 3c
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on mouse samples at 1:250 (fig 3c). J Cell Biol (2017) ncbi
mouse monoclonal (4A2)
  • western blot; mouse; loading ...; fig 7b
In order to determine the mechanism by which tiron functions, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 14472) was used in western blot on mouse samples (fig 7b). Clin Exp Pharmacol Physiol (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:500; loading ...; fig 2a
In order to elucidate the mechanism of Pin1 overexpression in hepatocellular carcinoma, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technolog, 3195 S) was used in western blot on human samples at 1:500 (fig 2a). Sci Rep (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 5c
In order to identify genes that contribute to human papilloma virus-16 associated oropharyngeal cancer, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in western blot on human samples (fig 5c). Sci Rep (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse; 1:1000; loading ...; fig 4b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in western blot on mouse samples at 1:1000 (fig 4b). Nat Commun (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 7b
In order to identify conditions in which low-passage ARPE-19 cells express genes specific to native human RPE cells, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 7b). Mol Vis (2017) ncbi
mouse monoclonal (4A2)
  • immunocytochemistry; human; loading ...; fig 4b
  • western blot; human; loading ...; fig 1c
In order to investigate the relationship between thymidylate synthase and epithelial-to-mesenchymal transition, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 4A2) was used in immunocytochemistry on human samples (fig 4b) and in western blot on human samples (fig 1c). J Pathol (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:100; fig 3b
In order to investigate how LACTB suppresses breast cancer cell growth, Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in immunocytochemistry on human samples at 1:100 (fig 3b). Nature (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 2g
In order to observe that chronic presence of internalized Escherichia coli leads to enhanced oncogenicity in colon cancer cells, Cell Signaling Technology E-cadherin antibody (cell signalling, 3195) was used in western blot on human samples (fig 2g). Cell Death Dis (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 6d
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 6d). Int J Mol Med (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 2c
In order to find RE1 silencing transcription factor regulates epithelial-mesenchymal transition and neuroendecrin cell stemness acquisition in hormone-refractory prostate cancer, Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in western blot on human samples (fig 2c). Sci Rep (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4b
In order to show that induction p53 loss in Krt8(+) mammary luminal cells leads to their clonal expansion without directly affecting their luminal identity, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4b). Nat Commun (2017) ncbi
mouse monoclonal (4A2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2a
  • western blot; mouse; loading ...; fig s3e
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 14472) was used in immunohistochemistry - paraffin section on mouse samples (fig 2a) and in western blot on mouse samples (fig s3e). Nature (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig s2
In order to evaluate the physical and functional interaction of elongation factor, RNA polymerase II, 2 with retinoblastoma in prostate cancer, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig s2). Neoplasia (2017) ncbi
mouse monoclonal (4A2)
  • immunohistochemistry; rat; 1:100; fig 3a
  • western blot; rat; 1:1000; fig 4a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 4A2) was used in immunohistochemistry on rat samples at 1:100 (fig 3a) and in western blot on rat samples at 1:1000 (fig 4a). Invest Ophthalmol Vis Sci (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples . Neoplasia (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 3d). Cell Rep (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; fig 6b
  • western blot; human; loading ...; fig 7a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples (fig 6b) and in western blot on human samples (fig 7a). Oncogene (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3e
Cell Signaling Technology E-cadherin antibody (Cell signaling, 24E10) was used in western blot on human samples (fig 3e). Oncoimmunology (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 5a). Biomed Pharmacother (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...; fig 4d
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in immunocytochemistry on human samples (fig 4d). Sci Rep (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples at 1:1000 (fig 5c). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse; loading ...; fig 5b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195p) was used in western blot on mouse samples (fig 5b). PLoS Genet (2017) ncbi
mouse monoclonal (4A2)
  • immunocytochemistry; human; loading ...; fig 4b
  • western blot; human; 1:1000; loading ...; fig 1i
Cell Signaling Technology E-cadherin antibody (Cell signaling, 14472) was used in immunocytochemistry on human samples (fig 4b) and in western blot on human samples at 1:1000 (fig 1i). Nat Commun (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 10
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 24E10) was used in western blot on human samples (fig 10). Oncotarget (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:2000; fig 4b
  • western blot; human; 1:2000; loading ...; fig 1b
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195S) was used in immunocytochemistry on human samples at 1:2000 (fig 4b) and in western blot on human samples at 1:2000 (fig 1b). Nat Commun (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 4g
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 4g). Cell Death Dis (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2c
In order to study the architecture of the mouse mammary gland using high-resolution 3D imaging, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples (fig 2c). Breast Cancer Res (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; loading ...; fig 3f
In order to suggest that planar cell polarity signaling governs directed epithelial evaginations to form crypts for implantation in mice, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195s) was used in immunohistochemistry on mouse samples (fig 3f). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 5a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 5b
In order to investigate the role of IL-1beta/caspase-1 signaling in bleomycin lung toxicity and in pleural mesothelial cell transformation, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in western blot on human samples (fig 5b). Respir Res (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...; fig 6a
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples (fig 6a) and in western blot on human samples (fig 5c). Cell Cycle (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig s3e
In order to elucidate how CELF1 governs the epithelial-to-mesenchymal transition, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig s3e). Nat Commun (2016) ncbi
mouse monoclonal (4A2)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6a
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology E-cadherin antibody (Cell signaling, 14472S) was used in immunohistochemistry - paraffin section on human samples (fig 6a) and in western blot on human samples (fig 5a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig s13b
In order to examine the expression and role of major facilitator super family domain containing 2a in liver regeneration, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig s13b). Nat Commun (2016) ncbi
mouse monoclonal (32A8)
  • western blot; human; loading ...; fig 1e
Cell Signaling Technology E-cadherin antibody (cell signalling, 5296S) was used in western blot on human samples (fig 1e). Oncotarget (2017) ncbi
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 9961) was used in western blot on human samples (fig 2c). Oxid Med Cell Longev (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 1c
In order to examine the differentiation potential of adult mammary stem cells, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3,195) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 1c). Nat Commun (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 6a
In order to demonstrate that SUSD2 inhibits migration, epithelial-to-mesenchymal transition, and mesothelial clearance of high-grade serous ovarian carcinomas, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 6a). Oncogenesis (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 7a
  • immunohistochemistry; human; 1:200; loading ...; fig 7b
In order to study mycobacterial granuloma formation using zebrafish, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 7a) and in immunohistochemistry on human samples at 1:200 (fig 7b). Immunity (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig s1c
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig s1c). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; loading ...; fig 3b
  • western blot; human; loading ...; fig s2a
  • western blot; mouse; fig s2a
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry on human samples (fig 3b), in western blot on human samples (fig s2a) and in western blot on mouse samples (fig s2a). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; loading ...; fig 1
  • western blot; human; loading ...; fig 1d
Cell Signaling Technology E-cadherin antibody (cell signalling, 3195S) was used in immunohistochemistry on human samples (fig 1) and in western blot on human samples (fig 1d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig s1b
In order to elucidate the role of DUOX1 silencing in lung cancer development or progression, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig s1b). Oncogenesis (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2e
  • immunocytochemistry; human; 1:200; loading ...; fig 3e
  • western blot; human; 1:500; loading ...; fig 3d
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2e), in immunocytochemistry on human samples at 1:200 (fig 3e) and in western blot on human samples at 1:500 (fig 3d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (28E12)
  • immunoprecipitation; human; fig 5
  • western blot; human; fig 4
Cell Signaling Technology E-cadherin antibody (Cell signaling, 4073) was used in immunoprecipitation on human samples (fig 5) and in western blot on human samples (fig 4). Mol Ther Methods Clin Dev (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse; 1:2000; fig 3d
In order to report that CEACAM1 regulates the epithelial-mesenchymal transition via beta-catenin phosphorylation, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on mouse samples at 1:2000 (fig 3d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; 1:400; loading ...; fig 2c
In order to study the role of RB1 in cancer cell proliferation., Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in immunohistochemistry on human samples at 1:400 (fig 2c). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:200; fig 6
In order to characterize the interaction between VAR2CSA and chondroitin sulfate proteoglycans, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples at 1:200 (fig 6). PLoS Pathog (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6c
  • western blot; mouse; loading ...; fig 6a
In order to assess the role of EphA2 signaling in mice with lipopolysaccharide-induced lung injury, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technologies, 3195) was used in immunohistochemistry - paraffin section on mouse samples (fig 6c) and in western blot on mouse samples (fig 6a). Clin Sci (Lond) (2016) ncbi
  • immunohistochemistry; zebrafish ; fig 5
In order to report that ZNF644 is a co-regulator of G9a/H3K9me2-mediated gene silencing during neuronal differentiation, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 9961) was used in immunohistochemistry on zebrafish samples (fig 5). Stem Cell Reports (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195P) was used in western blot on human samples (fig 2b). J Biol Chem (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:300; fig 2
In order to investigate the roles of NF2, LATS1/2, and YAP in the branching morphogenesis of the mouse kidney, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on mouse samples at 1:300 (fig 2). Nat Commun (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 2a
In order to report how PTEN alters breast cancer metastatic behavior, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 2a). Anticancer Res (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:500; fig 5
  • western blot; human; 1:1000; fig 3
In order to analyze the mediation of the STAT3 signaling pathway by sinomenine that inhibits A549 human lung cancer cell invasion, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples at 1:500 (fig 5) and in western blot on human samples at 1:1000 (fig 3). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 2b
In order to demonstrate that Rock regulates Hippo signaling and ensures the correct subcellular localization Amot in outer cells, Cell Signaling Technology E-cadherin antibody (Cell Signalling, 3195) was used in immunohistochemistry on mouse samples at 1:500 (fig 2b). Reprod Biomed Online (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 1
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples (fig 1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; loading ...; fig 2c
In order to identify signaling pathways that mediate the EGF-induced epithelial to mesenchymal transition, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on human samples (fig 2c). J Proteomics (2017) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 4a). Drug Des Devel Ther (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; loading ...; fig 4a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on mouse samples (fig 4a). Oncogene (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; fig s3
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on human samples (fig s3). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 5m
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 5m). Sci Rep (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 1b
In order to explore the interaction between ARF and MMP7 in prostate cancer, Cell Signaling Technology E-cadherin antibody (cell signalling, 24E10) was used in immunohistochemistry on mouse samples at 1:400 (fig 1b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:500; loading ...; fig 2e
In order to propose that the NKX3.1-G9a-UTY transcriptional regulatory network is essential for prostate differentiation, Cell Signaling Technology E-cadherin antibody (cell signalling, 3195) was used in immunocytochemistry on human samples at 1:500 (fig 2e). Science (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse; 1:500; fig s7
In order to analyze preservation of epithelial polarity and epithelial barrier by alix-mediated assembly of the actomyosin-tight junction polarity complex, Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in western blot on mouse samples at 1:500 (fig s7). Nat Commun (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...; fig 2c
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples (fig 2c) and in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology E-cadherin antibody (Cell Signaling Tech, 3195S) was used in western blot on human samples at 1:1000 (fig 1). BMC Biol (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:6000; loading ...; fig 1d
Cell Signaling Technology E-cadherin antibody (cell signalling, 3195) was used in western blot on human samples at 1:6000 (fig 1d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; loading ...; fig 1a
  • western blot; human; loading ...; fig 1d
In order to elucidate how E-cadherin, tight junctions, and the epithelial-to-mesenchymal transition regulates hepatitis C virus entry, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on human samples (fig 1a) and in western blot on human samples (fig 1d). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (32A8)
  • immunohistochemistry; human; loading ...; fig 1a
  • western blot; human; loading ...; fig 1d
In order to elucidate how E-cadherin, tight junctions, and the epithelial-to-mesenchymal transition regulates hepatitis C virus entry, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 5296) was used in immunohistochemistry on human samples (fig 1a) and in western blot on human samples (fig 1d). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse; 1:1000; fig 7
In order to assess the transiently formed junctional nexuses during post-natal mammary gland development by E-cadherins, connexins, beta-catenin, and claudin-7, Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195s) was used in western blot on mouse samples at 1:1000 (fig 7). Dev Biol (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 8a
In order to determine how C3G controls tumorigenesis, Cell Signaling Technology E-cadherin antibody (cell signaling, 3195S) was used in immunohistochemistry - paraffin section on human samples (fig 8a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 3b
In order to demonstrate that miR-150 is a novel Wnt effector in colorectal cells, Cell Signaling Technology E-cadherin antibody (CST, 3195S) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:3000; loading ...; fig 5b
In order to investigate the impact of protein arginine methyltransferase 5 in lung and breast cancer, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:3000 (fig 5b). Oncogene (2017) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 2
Cell Signaling Technology E-cadherin antibody (Cell Signaling Tech, 3195) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 2). J Exp Clin Cancer Res (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3g
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples (fig 3g). FEBS Open Bio (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 1
  • western blot; mouse; 1:1000; fig 1
In order to investigate regulation of actin cytoskeleton organization by Yes-associated protein impacting adherens junction assembly, Cell Signaling Technology E-cadherin antibody (CST, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 1) and in western blot on mouse samples at 1:1000 (fig 1). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 5
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in western blot on human samples (fig 5). J Biol Chem (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 7a
In order to investigate the role of growth hormone in colon cancer, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 7a). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 6e
In order to examine the effects of the FAM83H mutation on the keratin cytoskeleton and desmosomes in ameloblasts, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in immunocytochemistry on human samples (fig 6e). Sci Rep (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 5d
Cell Signaling Technology E-cadherin antibody (cell signalling, 3195P) was used in western blot on human samples at 1:1000 (fig 5d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:400; fig 6f
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 6f). Int J Biol Sci (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; fig s3
In order to analyze the rescue of intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation due to ERK5 signaling, Cell Signaling Technology E-cadherin antibody (Cell signaling, 24E10) was used in immunohistochemistry - paraffin section on mouse samples (fig s3). Nat Commun (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 4a
In order to study the role of Skp2 in paclitaxel-resistant prostate cancer cells, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 4a). Oncol Rep (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5f
In order to study the contribution of CCL7-induced epithelial-mesenchymal transition signaling to the progression and metastasis of colon cancer, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on human samples (fig 5f). Oncotarget (2016) ncbi
mouse monoclonal (4A2)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 4A2) was used in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 5
Cell Signaling Technology E-cadherin antibody (Cell Signalling, 3195) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (4A2)
  • western blot; human; fig 7
Cell Signaling Technology E-cadherin antibody (Cell Signaling Tech, 14472S) was used in western blot on human samples (fig 7). Cell Signal (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 3
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 23E10) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3). elife (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 4
In order to characterize attenuation of triple negative breast cancer cells metastatic potential by the vitamin D analog, MART-10, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples at 1:1000 (fig 4). Int J Mol Sci (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:2000; fig 3
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples at 1:2000 (fig 3). Nat Commun (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 4
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:500; tbl 2
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:500 (tbl 2). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; mouse; 1:100; fig 2
In order to study a decrease in glutathione and SOX17 and toxin biliastresone that causes mouse extrahepatic cholangiocyte damage and fibrosis, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10 3195S) was used in immunocytochemistry on mouse samples at 1:100 (fig 2). Hepatology (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 5). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:400; fig 2
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 2). Endocrinology (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:250; fig 7
In order to maintain adherens junction stability and tension by neogenin recruitment of the WAVE regulatory complex, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunocytochemistry on human samples at 1:250 (fig 7). Nat Commun (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4c
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples (fig 4c). Int J Biol Sci (2016) ncbi
mouse monoclonal (32A8)
  • western blot; human; fig 1
In order to investigate the role of sciellin in colorectal cancer, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 5296) was used in western blot on human samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; fig 3
In order to utilize a model of metastatic HPV+ oropharyngeal squamous cell carcinoma to displays heterogeneity in tumor metastasis, Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in immunohistochemistry - paraffin section on human samples (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (4A2)
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 14472) was used in western blot on human samples (fig 6a). Mol Cell Biochem (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; mouse; loading ...; fig 4g
  • western blot; mouse; loading ...; fig 4f
  • immunocytochemistry; human; loading ...; fig 4b
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195S) was used in immunocytochemistry on mouse samples (fig 4g), in western blot on mouse samples (fig 4f), in immunocytochemistry on human samples (fig 4b) and in western blot on human samples (fig 4a). Nat Commun (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 1
In order to identify cleavage sites for helicobacter pylori HtrA with E-cadherin signature motifs, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in western blot on human samples (fig 1). Sci Rep (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - frozen section; mouse; 1:250; fig 1
In order to learn the origin of development of lung macrophage diversity, Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195S) was used in immunohistochemistry - frozen section on mouse samples at 1:250 (fig 1). Development (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 2
  • western blot; mouse; 1:1000; fig 6
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in western blot on human samples at 1:1000 (fig 2) and in western blot on mouse samples at 1:1000 (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; 1:200; fig 1c
  • western blot; human; 1:1000; loading ...; fig s3b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on human samples at 1:200 (fig 1c) and in western blot on human samples at 1:1000 (fig s3b). Science (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 4d
Cell Signaling Technology E-cadherin antibody (Cell signalling technology, 3195S) was used in western blot on human samples (fig 4d). Nucleic Acids Res (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 3d). Sci Rep (2016) ncbi
domestic rabbit monoclonal (24E10)
  • flow cytometry; mouse; fig 3
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3199) was used in flow cytometry on mouse samples (fig 3). Stem Cell Reports (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 4b
In order to identify factors that contribute to the epithelial-mesenchymal transition using 16 colorectal cancer cell lines, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in western blot on human samples (fig 4b). Cancer Sci (2016) ncbi
mouse monoclonal (32A8)
  • western blot; human; fig 5
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 5296) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 4
In order to study the interaction between EGFR and delta catenin, which leads to delta catenin phosphorylation and EGFR signaling enhancement, Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in immunocytochemistry on human samples (fig 4). Sci Rep (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 6
  • immunohistochemistry; human; fig 4
  • western blot; human; fig 6
In order to elucidate the role of BCORL1 as an independent prognostic marker and a contributor to cell migrations and invasion in human hepatocellular carcinoma, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunocytochemistry on human samples (fig 6), in immunohistochemistry on human samples (fig 4) and in western blot on human samples (fig 6). BMC Cancer (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; fig 3
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). Oncogene (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; fig 2
  • western blot; human; fig 1
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in immunohistochemistry - paraffin section on human samples (fig 2) and in western blot on human samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; fig 1
In order to elucidate neuropathic pain and the critical role of intracellular mGluR5, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 4068) was used in western blot on rat samples at 1:1000 (fig 1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (24E10)
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used . Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (4A2)
  • immunocytochemistry; mouse; fig 5
  • western blot; mouse; fig 5
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 14472) was used in immunocytochemistry on mouse samples (fig 5) and in western blot on mouse samples (fig 5). J Cell Mol Med (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; 1:75; fig 4c
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in immunohistochemistry on human samples at 1:75 (fig 4c). Histopathology (2016) ncbi
domestic rabbit polyclonal
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 4068) was used . PLoS ONE (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:100; fig 3
In order to study regulation of adhesion and cell migration by recruitment to the leading edge by human phosphatase CDC14A, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples at 1:100 (fig 3). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:5000; fig 4
In order to determine the mechanisms of resistance to the pan-HER family inhibitor AZD8931, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:5000 (fig 4). Dis Model Mech (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:100; fig 4
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on mouse samples at 1:100 (fig 4). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig s3
  • western blot; human; fig 6
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in immunocytochemistry on human samples (fig s3) and in western blot on human samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 4h
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 4h). Int J Oncol (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 1b
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples at 1:1000 (fig 1b). Endocr Relat Cancer (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:500; fig 4
In order to analyze high-grade serous epithelial ovarian cancer cell lines that show sporadic and hereditary disease and the molecular diversity, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples at 1:500 (fig 4). Genes Cancer (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 4
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 3
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 3). Oncogene (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:200; fig 5
  • western blot; human; 1:200; fig 5
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples at 1:200 (fig 5) and in western blot on human samples at 1:200 (fig 5). Oncotarget (2016) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to analyze a model for ductal pancreatic cancer and drug screening, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Nat Med (2015) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; fig 6
  • western blot; human; fig 1
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on human samples (fig 6) and in western blot on human samples (fig 1). Oncotarget (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 5
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 5). Mol Cancer (2015) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:200; loading ...; fig s3c
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195S) was used in immunocytochemistry on human samples at 1:200 (fig s3c). J Cell Biol (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse; fig 2b
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on mouse samples (fig 2b). Stem Cells Dev (2016) ncbi
domestic rabbit monoclonal (24E10)
  • flow cytometry; human; 1:200; tbl 4
  • immunocytochemistry; human; 1:500; tbl 4
  • western blot; human; 1:1000; tbl 4
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in flow cytometry on human samples at 1:200 (tbl 4), in immunocytochemistry on human samples at 1:500 (tbl 4) and in western blot on human samples at 1:1000 (tbl 4). Sci Rep (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 4
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology , #3195) was used in western blot on human samples at 1:1000 (fig 4). Int J Cancer (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 3). Nature (2015) ncbi
mouse monoclonal (4A2)
  • immunocytochemistry; human; fig 3b
In order to demonstrate that LRIG1 functions as a growth suppressor in breast cancer cells, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 14472) was used in immunocytochemistry on human samples (fig 3b). Oncogene (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 3a
In order to demonstrate that LRIG1 functions as a growth suppressor in breast cancer cells, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples (fig 3a). Oncogene (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 3d
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 3d). Dig Dis Sci (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 8
In order to report the effect of c-Met inhibition using neuroendocrine tumor cells, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 8). Neuroendocrinology (2016) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 1
Cell Signaling Technology E-cadherin antibody (Cell Signal, 24E10) was used in western blot on human samples (fig 1). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse; 1:4000; fig 1
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in western blot on mouse samples at 1:4000 (fig 1). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 3
In order to examine the effects of vitamin D on anaplastic thyroid cancer, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 3). Cancer Lett (2015) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human
In order to study OGR1-mediated, pH-dependent signaling pathways in intestinal epithelial cells, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunocytochemistry on human samples . Am J Physiol Gastrointest Liver Physiol (2015) ncbi
mouse monoclonal (4A2)
  • immunocytochemistry; human; loading ...; fig 2b
  • western blot; human; 1:500; loading ...; fig s4c
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 14472) was used in immunocytochemistry on human samples (fig 2b) and in western blot on human samples at 1:500 (fig s4c). Cell Death Dis (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human
Cell Signaling Technology E-cadherin antibody (CST, #3195) was used in western blot on human samples . Oncol Rep (2015) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 1
Cell Signaling Technology E-cadherin antibody (Sigma, 3195) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 1). Int J Mol Med (2015) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:100; loading ...; tbl 1
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195S) was used in immunocytochemistry on human samples at 1:100 (tbl 1). Oncotarget (2015) ncbi
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 9961) was used in western blot on human samples at 1:1000 (fig 5). PLoS ONE (2015) ncbi
mouse monoclonal (32A8)
  • immunohistochemistry - paraffin section; human; 1:200
In order to develop a 3D model for studying tumors by co-culturing HT-29 tumor spheroids with CCD-18co fibroblasts, Cell Signaling Technology E-cadherin antibody (Cell signaling, 5296) was used in immunohistochemistry - paraffin section on human samples at 1:200. Exp Cell Res (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 1
Cell Signaling Technology E-cadherin antibody (Cell Signaling Tech, 3195s) was used in western blot on human samples (fig 1). Int J Mol Med (2015) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 5
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 5). Nat Commun (2015) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 6
  • western blot; mouse; 1:1000; fig 6
In order to assess the effects of Shenling Baizhu San on colitis-associated colorectal cancer, Cell Signaling Technology E-cadherin antibody (CST, 24E10) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 6) and in western blot on mouse samples at 1:1000 (fig 6). BMC Complement Altern Med (2015) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; mouse; 1:400; fig 6
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 24E10) was used in immunocytochemistry on mouse samples at 1:400 (fig 6). BMC Dev Biol (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; 1:500
In order to study the tissue factor protein and metastasis initiating cell markers during thrombocytosis, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in western blot on human samples at 1:500. BMC Cancer (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 3
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples (fig 3). Sci Rep (2015) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; 1:400; fig 4
  • western blot; human; 1:1000; fig 4
In order to demonstrate that the p53-R248Q mutant targets the proteasome activator REGgamma to promote endometrial cancer progression, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry on human samples at 1:400 (fig 4) and in western blot on human samples at 1:1000 (fig 4). Cancer Lett (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 3
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195P) was used in western blot on human samples (fig 3). Int J Gynecol Cancer (2015) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; mouse
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in immunohistochemistry on mouse samples . PLoS ONE (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 5
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 5). Mol Oncol (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 3
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in western blot on human samples (fig 3). Ann Surg Oncol (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 6
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in western blot on human samples (fig 6). Mol Cell Proteomics (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 4
In order to investigate the roles and mechanisms of the RSPO-LGR system in oncogenesis, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 4). Oncogene (2015) ncbi
domestic rabbit monoclonal (24E10)
  • flow cytometry; human
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 5
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in western blot on human samples (fig 5). Oncotarget (2015) ncbi
  • immunohistochemistry; mouse; 1:500; fig 2, 4, 5
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 9961) was used in immunohistochemistry on mouse samples at 1:500 (fig 2, 4, 5). J Biol Chem (2015) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 3b
Cell Signaling Technology E-cadherin antibody (Cell signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 3b). Int J Cancer (2015) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; 1:100
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 24E10) was used in immunohistochemistry on human samples at 1:100. BMC Vet Res (2014) ncbi
domestic rabbit monoclonal (24E10)
  • flow cytometry; mouse; 1:50; fig 9
In order to assess MTV-Wnt1 tumors and how Wnt5a suppresses tumor formation and redirects tumor phenotype, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in flow cytometry on mouse samples at 1:50 (fig 9). PLoS ONE (2014) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; mouse; 1:200
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on mouse samples at 1:200. J Clin Invest (2014) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry; human; 1:400; fig 4
In order to determine the effects of targeting the VEGF and c-met pathways in clear cell renal cell carcinoma models, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry on human samples at 1:400 (fig 4). Mol Cancer Ther (2015) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 4
In order to demonstrate the transcriptional repression of ANXA2 by ERG in prostate epithelial cells and discuss how this interaction relates to prostate cancer, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples (fig 4). Mol Cancer Res (2015) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; human
  • western blot; human
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunocytochemistry on human samples and in western blot on human samples . J Biol Chem (2014) ncbi
domestic rabbit monoclonal (28E12)
  • western blot; mouse
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 28E12) was used in western blot on mouse samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in western blot on human samples (fig 4b). Mol Biol Cell (2014) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; fig 3
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). J Biol Chem (2014) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human
Cell Signaling Technology E-cadherin antibody (Cell Signalling Technology, 3195S) was used in western blot on human samples . Cell Prolif (2014) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human
In order to study how phosphorylation alters COP1-binding sites of oncoproteins, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 3195) was used in western blot on human samples . Cancer Cell (2014) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human
Cell Signaling Technology E-cadherin antibody (Cell Signaling technology, 3195P) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:600
  • western blot; human; 1:800
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:600 and in western blot on human samples at 1:800. Urol Oncol (2014) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; mouse; 1:100
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in immunocytochemistry on mouse samples at 1:100. Exp Eye Res (2014) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human
Cell Signaling Technology E-cadherin antibody (Cell Signal Technology, 24E10) was used in western blot on human samples . Biochim Biophys Acta (2014) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human; fig 5b
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in western blot on human samples (fig 5b). Oncotarget (2014) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human
In order to show that uPAR regulates nasopharyngeal carcinoma NPC progression, Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in western blot on human samples . Cell Cycle (2014) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:500
In order to study the ability of miRNA-100 to promote epithelial-to-mesenchymal transition but also to inhibit mammary tumor cell invasiveness and tumorogenesis, Cell Signaling Technology E-cadherin antibody (Cell signaling Technology, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:500. PLoS Genet (2014) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; human
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 24E10) was used in western blot on human samples . Br J Cancer (2014) ncbi
domestic rabbit monoclonal (24E10)
  • immunocytochemistry; mouse; fig 6h
In order to assess intrinsic age-dependent changes in tubular epithelial proliferation in young and old mice, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in immunocytochemistry on mouse samples (fig 6h). PLoS ONE (2014) ncbi
  • western blot; rat; 1:1000
In order to study the effect of pomegranate juice on oxidative stress and nigrostriatal degeneration in Parkinson disease, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 9961L) was used in western blot on rat samples at 1:1000. Neurobiol Aging (2014) ncbi
mouse monoclonal (32A8)
  • western blot; human; fig 5
In order to identify miRNAs that contribute to prostate cancer, Cell Signaling Technology E-cadherin antibody (Cell Signaling, 5296) was used in western blot on human samples (fig 5). Oncogene (2014) ncbi
domestic rabbit monoclonal (24E10)
  • western blot; mouse
Cell Signaling Technology E-cadherin antibody (Cell Signaling, 24E10) was used in western blot on mouse samples . Mol Cancer Ther (2013) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse
Cell Signaling Technology E-cadherin antibody (Cell signaling, 24E10) was used in immunohistochemistry - paraffin section on mouse samples . EMBO Mol Med (2013) ncbi
domestic rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; fig 3
Cell Signaling Technology E-cadherin antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). PLoS Genet (2013) ncbi
Dako
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; tbl 2
Dako E-cadherin antibody (DAKO, NCH 38) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Cancers (Basel) (2019) ncbi
mouse monoclonal (NCH-38)
  • western blot; mouse; 1:50; fig 5c
In order to examine whether p140Cap protein levels in ERBB2-amplified breast cancer patients correlate with survival, Dako E-cadherin antibody (Dako, M3612) was used in western blot on mouse samples at 1:50 (fig 5c). Nat Commun (2017) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; mouse; 5 ug/ml
  • immunohistochemistry - paraffin section; human; 5 ug/ml
  • immunohistochemistry; human; fig 99
In order to outline the protocols for antibodies used for immunohistochemical studies, Dako E-cadherin antibody (Dako, M3612,) was used in immunohistochemistry - paraffin section on mouse samples at 5 ug/ml, in immunohistochemistry - paraffin section on human samples at 5 ug/ml and in immunohistochemistry on human samples (fig 99). J Toxicol Pathol (2017) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
Dako E-cadherin antibody (Dako, M3612) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). J Clin Pathol (2017) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry; human; 1:25; loading ...; fig 2d
Dako E-cadherin antibody (DAKO, M3612) was used in immunohistochemistry on human samples at 1:25 (fig 2d). Development (2016) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; 1:250; fig 1
Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to classify triple-negative breast cancer into subtypes, Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Oncol Lett (2016) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 3
In order to assess claudin-5 expression in ependymoma, Dako E-cadherin antibody (Dako, M3612) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 3). Pathol Oncol Res (2017) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; 1:100; fig 3
In order to determine mediation of differentiation and cisplatin chemotherapy resistance by biased expression of the FOXP3delta3 isoform in aggressive bladder cancer, Dako E-cadherin antibody (Dako, M3612) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3). Clin Cancer Res (2016) ncbi
mouse monoclonal (NCH-38)
  • western blot; human; loading ...; fig 1b
Dako E-cadherin antibody (Dako, NCH-38) was used in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
mouse monoclonal (NCH-38)
  • western blot; bovine; fig 3
In order to study two bovine mammary epithelial cell lines in 2D and 3D models for functional and phenotypic characterization, Dako E-cadherin antibody (Dako, M-3612) was used in western blot on bovine samples (fig 3). Am J Physiol Cell Physiol (2016) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; 1:100; fig 5
Dako E-cadherin antibody (Dako, M361229) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 5). PLoS ONE (2015) ncbi
mouse monoclonal (NCH-38)
  • western blot; human; fig 1c
Dako E-cadherin antibody (DAKO, NCH-38) was used in western blot on human samples (fig 1c). Tumour Biol (2016) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1c
Dako E-cadherin antibody (DAKO, NCH-38) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1c). Int J Clin Exp Pathol (2015) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; 1:30; fig 1
In order to characterize triple-negative breast cancer and the role of epithelial-mesenchymal transition markers, Dako E-cadherin antibody (Dako, M3612) was used in immunohistochemistry - paraffin section on human samples at 1:30 (fig 1). Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6c
  • western blot; human; loading ...; fig 1e; 5b
Dako E-cadherin antibody (DAKO, NCH-38) was used in immunohistochemistry - paraffin section on human samples (fig 6c) and in western blot on human samples (fig 1e; 5b). Oncotarget (2015) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; 1:20
In order to identify master regulators of inflammatory breast cancer, Dako E-cadherin antibody (DAKO, M3612) was used in immunohistochemistry - paraffin section on human samples at 1:20. J Transl Med (2015) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; 1:50; fig 5
In order to study a retrospective single-center analysis using ENETS TNM-classification and immunohistochemical markers for risk stratification for neuroendocrine tumors of the pancreas, Dako E-cadherin antibody (Dako, M3612) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 5). BMC Surg (2015) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human
In order to study the breast tumor microenvironment and interleukin-6 and pro inflammatory status, Dako E-cadherin antibody (Dako, NCH38) was used in immunohistochemistry - paraffin section on human samples . World J Surg Oncol (2015) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry; human
Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry; human; 1:30
In order to evaluate the presence of cancer stem cells and EMT markers as prognostic markers for breast metaplastic carcinoma, Dako E-cadherin antibody (Dako, M3612) was used in immunohistochemistry on human samples at 1:30. Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry; human; 1:15
In order to describe a new method for immunohistochemistry optimization, Dako E-cadherin antibody (DakoCytomation, M3612) was used in immunohistochemistry on human samples at 1:15. Histopathology (2015) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; 1:50
In order to use Romanian patients with gastric carcinomas and compare the demographic, clinical, and immunohistochemical aspects of each cancer, Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry - paraffin section on human samples at 1:50. APMIS (2015) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry; human; 1:100
Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry on human samples at 1:100. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; 1:80
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Dako E-cadherin antibody (Dako, M3612) was used in immunohistochemistry - paraffin section on human samples at 1:80. Comp Med (2014) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry; human; fig s1
In order to examine the mechanism of EML4-ALK rearrangement using a novel cell line, Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry on human samples (fig s1). J Thorac Oncol (2014) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 3
In order to study miR-9, and miR-155 expression in breast cancer and how their expression correlates with different features of breast cancer, Dako E-cadherin antibody (DAKO, NCH-48) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 3). Breast Cancer Res Treat (2014) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to study triple negative primary breast cancer biological characteristics and clinical outcome in older women in comparison to their younger counterparts, Dako E-cadherin antibody (Dako, M3612) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). PLoS ONE (2014) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; domestic sheep; 1:100
Dako E-cadherin antibody (Dako Cytomation, NCH-38) was used in immunohistochemistry - paraffin section on domestic sheep samples at 1:100. Virchows Arch (2014) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human; ready-to-use
Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry - paraffin section on human samples at ready-to-use. Ann Diagn Pathol (2014) ncbi
mouse monoclonal (NCH-38)
  • immunocytochemistry; human; 1:50
Dako E-cadherin antibody (Dako, M3612) was used in immunocytochemistry on human samples at 1:50. J Mol Endocrinol (2014) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry - paraffin section; human
Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry - paraffin section on human samples . Int J Gynecol Pathol (2014) ncbi
mouse monoclonal (NCH-38)
  • immunohistochemistry; human; fig 1
In order to study the ability of Met inhibitors to reverse chemoresistance in small cell lung cancer and the role of epithelial-to-mesenchymal transition, Dako E-cadherin antibody (Dako, NCH-38) was used in immunohistochemistry on human samples (fig 1). Clin Cancer Res (2014) ncbi
Takara Bio Inc
monoclonal (ECCD-2)
  • immunohistochemistry; human; 1:200; loading ...; fig 3a
Takara Bio Inc E-cadherin antibody (Takara Bio, M108) was used in immunohistochemistry on human samples at 1:200 (fig 3a). J Histochem Cytochem (2019) ncbi
monoclonal (SHE78-7)
  • western blot; human; loading ...; fig 3b
Takara Bio Inc E-cadherin antibody (Takara Bio, SHE78-7) was used in western blot on human samples (fig 3b). Mol Biol Cell (2014) ncbi
Bioworld
polyclonal (9986)
  • western blot; human; fig 3f
Bioworld E-cadherin antibody (Bioworld Technology, Inc, BS-1097) was used in western blot on human samples (fig 3f). J Exp Clin Cancer Res (2016) ncbi
polyclonal (9986)
  • western blot; human; 1:500; fig 4
Bioworld E-cadherin antibody (Bioworld Technology, BS1097) was used in western blot on human samples at 1:500 (fig 4). Chin J Cancer (2016) ncbi
polyclonal (9986)
  • immunocytochemistry; human; 1:50; fig 6
  • western blot; human; fig 1
Bioworld E-cadherin antibody (Bioworld Technology, BS-1097) was used in immunocytochemistry on human samples at 1:50 (fig 6) and in western blot on human samples (fig 1). Oncotarget (2016) ncbi
Exbio
mouse monoclonal (67A4)
  • flow cytometry; human; tbl 1
Exbio E-cadherin antibody (EXBIO Praha, 1P-588-T100) was used in flow cytometry on human samples (tbl 1). Sci Rep (2016) ncbi
BD Biosciences
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 4b
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples (fig 4b). Biology (Basel) (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; fig 4c
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry on mouse samples (fig 4c). iScience (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; loading ...; fig 2a
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in western blot on mouse samples (fig 2a). Front Pharmacol (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; loading ...; fig 2e
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on mouse samples (fig 2e). Cell Death Dis (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:750; loading ...; fig 3d
BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:750 (fig 3d). elife (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:100; fig s6a
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on human samples at 1:100 (fig s6a). Front Cell Dev Biol (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; pigs ; 1:2000; loading ...; fig 1c
BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in immunohistochemistry - frozen section on pigs samples at 1:2000 (fig 1c). Animals (Basel) (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:200; loading ...; fig 3g
  • immunohistochemistry; mouse; fig s1-1a
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on mouse samples at 1:200 (fig 3g) and in immunohistochemistry on mouse samples (fig s1-1a). elife (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; loading ...; fig 3b
BD Biosciences E-cadherin antibody (BD Pharmingen, 612130) was used in immunohistochemistry on mouse samples (fig 3b). Front Med (Lausanne) (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; zebrafish ; 1:5000; loading ...
BD Biosciences E-cadherin antibody (BD Biosciences, 610,181) was used in immunohistochemistry on zebrafish samples at 1:5000. Prion (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 1d, 4e
BD Biosciences E-cadherin antibody (BD Transduction, 610182) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 1d, 4e). Cell Death Discov (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:4000; loading ...; fig 1a
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:4000 (fig 1a). Cell Mol Gastroenterol Hepatol (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; rat; 1:400; loading ...; fig s3d
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on rat samples at 1:400 (fig s3d). PLoS Genet (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000; loading ...; fig 4c
BD Biosciences E-cadherin antibody (BD Transduction, 610182) was used in western blot on human samples at 1:1000 (fig 4c). Cancer Sci (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:2000; loading ...; fig 4b
  • western blot; human; 1:2000; loading ...; fig 2d
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:2000 (fig 4b) and in western blot on human samples at 1:2000 (fig 2d). J Biol Chem (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 1d
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples (fig 1d). Cancers (Basel) (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; loading ...; fig 3e
  • immunohistochemistry; mouse; 1:500; loading ...; fig 1a
BD Biosciences E-cadherin antibody (BD, 610182) was used in immunocytochemistry on mouse samples (fig 3e) and in immunohistochemistry on mouse samples at 1:500 (fig 1a). Curr Biol (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000; loading ...; fig 2f
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in western blot on human samples at 1:1000 (fig 2f). Commun Biol (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 1j
BD Biosciences E-cadherin antibody (BD Biosciences, 560062) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 1j). Nat Commun (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:500; loading ...; fig 5a
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on human samples at 1:500 (fig 5a). Nat Commun (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; 1:250; loading ...; fig 4d
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry on mouse samples at 1:250 (fig 4d). Stem Cell Res (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; rat; 1:50; fig 4a
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on rat samples at 1:50 (fig 4a). NPJ Regen Med (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:5000; loading ...; fig 5f
BD Biosciences E-cadherin antibody (BD, 610182) was used in western blot on human samples at 1:5000 (fig 5f). elife (2021) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:500; loading ...; fig 4h
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:500 (fig 4h). Cell Stem Cell (2020) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 3a
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples (fig 3a). Dis Markers (2020) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:200; loading ...; fig 1g
  • western blot; human; 1:1000; loading ...; fig 8h
BD Biosciences E-cadherin antibody (BD Bioscience, 36) was used in immunocytochemistry on human samples at 1:200 (fig 1g) and in western blot on human samples at 1:1000 (fig 8h). elife (2020) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; human; 1:500; loading ...; fig 3a
BD Biosciences E-cadherin antibody (BD Biosciences, 610404) was used in western blot on human samples at 1:500 (fig 3a). Int J Oncol (2020) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:2500; loading ...; fig 1b
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples at 1:2500 (fig 1b). Nat Commun (2020) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3f
BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in immunohistochemistry on mouse samples at 1:500 (fig 3f). elife (2020) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:2500; loading ...; fig 5
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples at 1:2500 (fig 5). Oncol Lett (2020) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 4e, 4p, e4l
BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 4e, 4p, e4l). Nature (2020) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:2000; loading ...; fig 1d
  • immunocytochemistry; mouse; 1:100; loading ...; fig 1e
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples at 1:2000 (fig 1d) and in immunocytochemistry on mouse samples at 1:100 (fig 1e). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:500; loading ...; fig 3i
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on mouse samples at 1:500 (fig 3i). Cancer Cell (2020) ncbi
mouse monoclonal (36/E-Cadherin)
  • other; zebrafish ; 1:100; loading ...; fig 2
BD Biosciences E-cadherin antibody (BD Bio transductions, 610182) was used in other on zebrafish samples at 1:100 (fig 2). elife (2020) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; 1:1000; loading ...; fig 6d
BD Biosciences E-cadherin antibody (BD Transduction Labs, 610181) was used in western blot on mouse samples at 1:1000 (fig 6d). Cell Mol Gastroenterol Hepatol (2020) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 1h
BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 1h). Nature (2020) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:5000; loading ...; fig 1
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples at 1:5000 (fig 1). Sci Rep (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; 1:200; loading ...; fig 2c
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry on human samples at 1:200 (fig 2c). Breast Cancer Res (2019) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; human; 1:1000; loading ...
BD Biosciences E-cadherin antibody (BD Biosciences, 610405) was used in western blot on human samples at 1:1000. Nat Commun (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 3b
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples (fig 3b). Cancer Cell (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; loading ...; fig 1d
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on human samples (fig 1d). Cell Stem Cell (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; 1:200; loading ...; fig 4c
BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in immunohistochemistry on human samples at 1:200 (fig 4c). Endocrinology (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 1a
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples (fig 1a). Biol Open (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 3j
BD Biosciences E-cadherin antibody (BD-Transductions, 610182) was used in western blot on human samples (fig 3j). Cell (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 7d
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 7d). Nature (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:100; loading ...; fig 3d, 4g
  • western blot; human; 1:1000; loading ...; fig 3d
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on human samples at 1:100 (fig 3d, 4g) and in western blot on human samples at 1:1000 (fig 3d). EBioMedicine (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1g
BD Biosciences E-cadherin antibody (BD Pharmingen, 610182) was used in immunohistochemistry - paraffin section on mouse samples (fig 1g). Cell Mol Gastroenterol Hepatol (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; 1:500; loading ...; fig 4b
BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry on human samples at 1:500 (fig 4b). Cell (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:100; loading ...; fig 1b
  • western blot; human; 1:1000; loading ...; fig 2f
BD Biosciences E-cadherin antibody (BD, 610181) was used in immunocytochemistry on human samples at 1:100 (fig 1b) and in western blot on human samples at 1:1000 (fig 2f). elife (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:200; loading ...; fig 1a
BD Biosciences E-cadherin antibody (BD, 610182) was used in immunocytochemistry on mouse samples at 1:200 (fig 1a). Nat Cell Biol (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; rat; 1:5000; loading ...; fig s3b
BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in western blot on rat samples at 1:5000 (fig s3b). J Cell Sci (2019) ncbi
mouse monoclonal (34/E-Cadherin)
  • immunocytochemistry; human; loading ...; fig 5b
  • western blot; human; loading ...; fig 5a
BD Biosciences E-cadherin antibody (BD Biosciences, 610404) was used in immunocytochemistry on human samples (fig 5b) and in western blot on human samples (fig 5a). Exp Cell Res (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; loading ...; fig 4c
BD Biosciences E-cadherin antibody (BD, 36/E-Cadherin) was used in immunocytochemistry on human samples (fig 4c). Nat Commun (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 5a
BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on human samples (fig 5a). J Pathol (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000; loading ...; fig 6a
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples at 1:1000 (fig 6a). Nat Commun (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; loading ...; fig 7m
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3d
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunohistochemistry - paraffin section on human samples (fig 7m) and in immunohistochemistry - paraffin section on mouse samples (fig 3d). Cell (2019) ncbi
mouse monoclonal (36/E-Cadherin)
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used . Nature (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000; loading ...; fig 2i
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples at 1:1000 (fig 2i). J Biol Chem (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 6b
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples (fig 6b). Mol Oncol (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; loading ...; fig 4c
  • western blot; human; loading ...; fig 4d
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in immunocytochemistry on human samples (fig 4c) and in western blot on human samples (fig 4d). Sci Rep (2018) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2d
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2d). Mol Biol Cell (2019) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:100; loading ...; fig 8c
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:100 (fig 8c). Oncotarget (2018) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1b
BD Biosciences E-cadherin antibody (BD Biosciences, G10181) was used in immunohistochemistry - paraffin section on mouse samples (fig 1b). J Clin Invest (2018) ncbi
mouse monoclonal (36/E-Cadherin)
  • proximity ligation assay; human; 1:1000; fig 2e
  • immunocytochemistry; human; 1:1000; fig 2d
BD Biosciences E-cadherin antibody (BD, 610181) was used in proximity ligation assay on human samples at 1:1000 (fig 2e) and in immunocytochemistry on human samples at 1:1000 (fig 2d). Oncogene (2018) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; 1:100; loading ...; fig s4c
  • western blot; human; 1:10,000; loading ...; fig 1a
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on human samples at 1:100 (fig s4c) and in western blot on human samples at 1:10,000 (fig 1a). Nat Commun (2018) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 2a
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in western blot on human samples (fig 2a). Oncogene (2018) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; 1:500-1:1000; loading ...; fig 3
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on mouse samples at 1:500-1:1000 (fig 3). Biol Pharm Bull (2018) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 1c
BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 1c). Nature (2018) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 2i
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2i). Genes Dev (2018) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; loading ...; fig 3a
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on mouse samples (fig 3a). Biochim Biophys Acta Mol Basis Dis (2018) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; dogs; loading ...; fig 6e
BD Biosciences E-cadherin antibody (MilliporeBD Transduction Lab, BD610181) was used in western blot on dogs samples (fig 6e). Nature (2018) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1i
BD Biosciences E-cadherin antibody (BD Transduction Laboratory, 610181) was used in immunohistochemistry - frozen section on mouse samples (fig 1i). Cell Stem Cell (2018) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; dogs; 1:1000; loading ...; fig 4c
BD Biosciences E-cadherin antibody (BD Transduction, 61081) was used in western blot on dogs samples at 1:1000 (fig 4c). J Cell Sci (2018) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2a
BD Biosciences E-cadherin antibody (BD, 610182) was used in immunohistochemistry - paraffin section on human samples (fig 2a). Sci Rep (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 5c
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 5c). Development (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 1
BD Biosciences E-cadherin antibody (BD, 610182) was used in immunohistochemistry on mouse samples at 1:1000 (fig 1). Am J Physiol Renal Physiol (2017) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; human; loading ...; fig 3c
BD Biosciences E-cadherin antibody (BD Biosciences, 610404) was used in western blot on human samples (fig 3c). Oncogene (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 7g
BD Biosciences E-cadherin antibody (BD Biosciences, 36/E-Cadherin) was used in immunohistochemistry - paraffin section on mouse samples (fig 7g). Histochem Cell Biol (2017) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; human; loading ...; fig 4b
BD Biosciences E-cadherin antibody (BD Biosciences, 610404) was used in western blot on human samples (fig 4b). Cancer Res (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000; loading ...; fig ex1a
BD Biosciences E-cadherin antibody (BD Biosciences, BD610181) was used in western blot on human samples at 1:1000 (fig ex1a). Nature (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; loading ...; fig 2b
  • western blot; human; loading ...; fig 1d
In order to investigate the effect off miR-509-5p and miR-1243 on gemcitabine efficacy in pancreatic cancer and its mechanism, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples (fig 2b) and in western blot on human samples (fig 1d). Sci Rep (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; 1:200; loading ...; fig s1d
In order to study the spatio-temporal effect of p63 on palatal epithelial cell fate and the prevention of cleft palate, BD Biosciences E-cadherin antibody (BD Bioscience, 36) was used in immunohistochemistry on mouse samples at 1:200 (fig s1d). PLoS Genet (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; dogs; loading ...; fig 6b
BD Biosciences E-cadherin antibody (BDTransduction Laboratories, 610182) was used in western blot on dogs samples (fig 6b). Oncogene (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 7c
In order to investigate the role of Mpdz in ependymal cell integrity and perinatal-onset hydrocephalus in mice, BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 7c). EMBO Mol Med (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; 1:1000; loading ...; fig 7c
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on mouse samples at 1:1000 (fig 7c). J Clin Invest (2017) ncbi
mouse monoclonal (34/E-Cadherin)
  • immunocytochemistry; human; loading ...; fig 3d
  • western blot; human; loading ...; fig 4c
In order to investigate the role of CRB3 downregulation in maintaining breast cancer stem cells, BD Biosciences E-cadherin antibody (BD Biosciences, 610405) was used in immunocytochemistry on human samples (fig 3d) and in western blot on human samples (fig 4c). Oncogenesis (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; loading ...; fig 3c
  • western blot; human; loading ...; fig 3a
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunohistochemistry on human samples (fig 3c) and in western blot on human samples (fig 3a). Oncotarget (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • flow cytometry; human; 1:50; loading ...; fig 5c
In order to analyze the complexing of cellular prion protein with co-chaperone Hsp70/90 organizing protein in glioblastoma stem-like cells, BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in flow cytometry on human samples at 1:50 (fig 5c). Stem Cell Res Ther (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; 1:2000; loading ...; fig 3a
In order to evaluate the effects of alpha-lipoic acid on epithelial-to-mesenchymal transition-mediated renal interstitial fibrosis in mice, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on mouse samples at 1:2000 (fig 3a). Sci Rep (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; loading ...; fig 2c
In order to demonstrate that WHSC1 drives indolent PTEN-null tumors to become metastatic prostate cancer, BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry on mouse samples (fig 2c). J Clin Invest (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; 2.5 ug/ml; tbl s3
In order to research the association of alterations in cytotrophoblasts of the smooth chorion with severe pre-eclampsia, BD Biosciences E-cadherin antibody (BD Biosciences, 36/E-cadherin) was used in immunohistochemistry on human samples at 2.5 ug/ml (tbl s3). Development (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; dogs; 1:200; loading ...; fig 1
  • western blot; dogs; loading ...; fig 7b
In order to find and characterize the interaction between Eps15 and pS227-FIP2, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on dogs samples at 1:200 (fig 1) and in western blot on dogs samples (fig 7b). Mol Biol Cell (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; loading ...; fig 4b
  • western blot; human; 1:10,000; loading ...; fig 4a
In order to test if Dub3 contributes to Snail1 stability in cancer cells, BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in immunocytochemistry on human samples (fig 4b) and in western blot on human samples at 1:10,000 (fig 4a). Nat Commun (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; dogs; 1:500; loading ...; fig st7
  • immunohistochemistry - paraffin section; rat; 1:500; loading ...; fig st7
In order to outline the protocols for antibodies used for immunohistochemical studies, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on dogs samples at 1:500 (fig st7) and in immunohistochemistry - paraffin section on rat samples at 1:500 (fig st7). J Toxicol Pathol (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:5000; loading ...; fig 3A
BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on human samples at 1:5000 (fig 3A). Oncotarget (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig 1d
In order to demonstrate that IGF2 secreted by inhibitor of differentiation-overexpressing oesophageal cancer cells instigates VEGFR1-positive bone marrow cells in the tumor macroenvironment, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples (fig 1d). Nat Commun (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3a
BD Biosciences E-cadherin antibody (BD, 560062) was used in immunohistochemistry - paraffin section on mouse samples (fig 3a). Nature (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; 1:1000; fig 6d
BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on mouse samples at 1:1000 (fig 6d). J Cell Biol (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • flow cytometry; human; fig 1b
In order to evaluate the myogenic potential and proliferative capacity of human alveolar mucosa cells, BD Biosciences E-cadherin antibody (BD Pharmingen, 612130) was used in flow cytometry on human samples (fig 1b). Cell Cycle (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; 1:100; loading ...; fig 3b
In order to establish that migration of carcinoma collectives on fibrillar fibronectin-rich matrices is achieved through alphavbeta6 and alpha9beta1 engagement, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry on human samples at 1:100 (fig 3b). Nat Commun (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; 1:100; loading ...; fig 4a
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry on human samples at 1:100 (fig 4a). Int J Oncol (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; loading ...; fig 4g
In order to describe how epithelial polarity proteins suppress malignant outgrowth, BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on mouse samples (fig 4g). J Exp Med (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; dogs; 0.8 ug/ml; fig 4k
  • western blot; dogs; fig 2
In order to examine tight junction and adherence junction protein expression in the colorectal epithelium of dogs with inflammatory colorectal polyps, BD Biosciences E-cadherin antibody (BD Biosciences, 36/E-cadherin) was used in immunohistochemistry - paraffin section on dogs samples at 0.8 ug/ml (fig 4k) and in western blot on dogs samples (fig 2). J Vet Med Sci (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; zebrafish ; 1:500; loading ...; fig 7D
In order to find Notch signaling is integral for Wnt and Fgf signaling feedback loop coordinating cell migration, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on zebrafish samples at 1:500 (fig 7D). elife (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1e
  • immunocytochemistry; human; 1:100; loading ...; fig 2b
In order to show that the absence of EpCAM in enterocytes results in an aberrant apical domain, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1e) and in immunocytochemistry on human samples at 1:100 (fig 2b). Nat Commun (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:200; fig s7h
In order to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation., BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in immunocytochemistry on human samples at 1:200 (fig s7h). Nature (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000; loading ...; fig 1a
BD Biosciences E-cadherin antibody (Becton Dickinson Biosciences, 610181) was used in western blot on human samples at 1:1000 (fig 1a). J Biol Chem (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:200; fig s2k
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:200 (fig s2k). Autophagy (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 2c
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on mouse samples at 1:500 (fig 2c). Nature (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1a
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on mouse samples (fig 1a). Nature (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 2c
In order to study the architecture of the mouse mammary gland using high-resolution 3D imaging, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 2c). Breast Cancer Res (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; loading ...
  • western blot; human; fig s2b
In order to study the effect of PIK3CA in breast cancer., BD Biosciences E-cadherin antibody (BD Bioscience, 560061) was used in immunohistochemistry - paraffin section on human samples and in western blot on human samples (fig s2b). PLoS ONE (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig s3
In order to characterize conditional knockout mice in which Irf6 is ablated only in the late embryonic oral epithelium, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig s3). J Dent Res (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; 1:500; loading ...; fig st4
In order to identify genes involved in establishing intestinal regional identity, BD Biosciences E-cadherin antibody (BD Transduction Lab, 610181) was used in immunohistochemistry on human samples at 1:500 (fig st4). Development (2017) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; human; 1:1000; loading ...; fig 2a
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 6e
  • western blot; mouse; 1:1000; loading ...; fig 6a
In order to examine the role of Salmonella AvrA during infection, BD Biosciences E-cadherin antibody (BD Bioscience, 610405) was used in western blot on human samples at 1:1000 (fig 2a), in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 6e) and in western blot on mouse samples at 1:1000 (fig 6a). J Biol Chem (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000; loading ...; fig 2
In order to elucidate the mechanisms by which Annexin A1 governs metastatic behavior in prostate cancer cells exposed to hypoxia, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 36/E-Cadherin) was used in western blot on human samples at 1:1000 (fig 2). Cell Adh Migr (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; loading ...; fig s3a
In order to show that ACF7 governs apico-basal polarity in mammalian intestinal cells, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples (fig s3a). J Cell Sci (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 2b
In order to describe the dual roles of TbetaRIII/betaglycan, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples (fig 2b). J Biol Chem (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 1a
In order to characterize the cellular dynamics of lung repair following influenza infection especially keratin 5 positive cells, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 1a). Stem Cell Reports (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; zebrafish ; 1:200; loading ...; fig 4d
In order to study mycobacterial granuloma formation using zebrafish, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on zebrafish samples at 1:200 (fig 4d). Immunity (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 1a
In order to determine the effects of high glucose on the epithelial-mesenchymal transition in retinal pigment epithelial cells, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples (fig 1a). Int J Mol Med (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 4e
BD Biosciences E-cadherin antibody (BD Biosciences, 564186) was used in western blot on human samples (fig 4e). Oncogenesis (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 5
In order to describe a role for ADAMTS9 in ocular morphogenesis, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 4b
  • immunocytochemistry; African green monkey; 2 ug/ml; loading ...; fig 7c
In order to investigate the alternative splicing of E-cadherin mRNA, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples (fig 4b) and in immunocytochemistry on African green monkey samples at 2 ug/ml (fig 7c). J Cell Physiol (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; 1:500; loading ...; fig 3A
In order to find that human lung organoids require a bioartificial microporous poly(lactide-co-glycolide) scaffold niche for successful engraftment, long-term survival, and maturation of lung epithelium in vivo, BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry on human samples at 1:500 (fig 3A). elife (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:25; fig 1
In order to investigate the contribution of DNA methyltransferase 1 to the epithelial-mesenchymal transition and cancer stem cells, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:25 (fig 1). Neoplasia (2016) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; human; fig 6a
  • immunocytochemistry; dogs; fig 6d
  • western blot; dogs; fig 6a
In order to report that TrkC contributes to tumorigenicity, metastasis, and self-renewal traits of metastatic breast cancer, BD Biosciences E-cadherin antibody (BD Transduction, 610405) was used in western blot on human samples (fig 6a), in immunocytochemistry on dogs samples (fig 6d) and in western blot on dogs samples (fig 6a). Sci Rep (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 4a
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 4a). Am J Pathol (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 4
BD Biosciences E-cadherin antibody (BD Bioscience, 610182) was used in western blot on human samples (fig 4). Carcinogenesis (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; loading ...; fig s1c
In order to investigate the role of extracellular vesicles by the choroid plexus epithelium in blood-brain communication, BD Biosciences E-cadherin antibody (BD, 610181) was used in immunocytochemistry on mouse samples (fig s1c). EMBO Mol Med (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; loading ...; fig 2c
  • western blot; human; loading ...; fig 3b, 4c
BD Biosciences E-cadherin antibody (BD BIOSCIENCES, 610181) was used in western blot on mouse samples (fig 2c) and in western blot on human samples (fig 3b, 4c). Oncotarget (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000; loading ...; fig 2
In order to study the impact of ephrin signaling in non-small cell lung cancer, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples at 1:1000 (fig 2). Oncotarget (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig 2a
In order to propose that IL-1beta and Helicobacter pylori CagA target the beta-catenin pathway, BD Biosciences E-cadherin antibody (BD, 610182) was used in immunocytochemistry on human samples (fig 2a). Gastroenterol Res Pract (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; 1:250; loading ...; fig 3a
BD Biosciences E-cadherin antibody (BD Transduction, 610182) was used in immunohistochemistry on human samples at 1:250 (fig 3a). J Cell Sci (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 2e
In order to study how CUB domain-containing protein1 contributes to metastasis and drug resistance, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in western blot on human samples (fig 2e). Breast Cancer Res (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 1b
BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:250; fig 1a
BD Biosciences E-cadherin antibody (BD Biosciences, 61082) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 1a). PLoS ONE (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; 1:300; fig 2
In order to investigate the roles of NF2, LATS1/2, and YAP in the branching morphogenesis of the mouse kidney, BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry on mouse samples at 1:300 (fig 2). Nat Commun (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; loading ...; fig 5d
  • western blot; human; loading ...; fig 5c
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 6c
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 612130) was used in immunocytochemistry on human samples (fig 5d), in western blot on human samples (fig 5c) and in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 6c). Oncotarget (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; loading ...; fig st1
In order to develop a method for super-resolution imaging of the multiscale organization of intact tissues and use it to image the mouse brain, BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry on mouse samples (fig st1). Nat Biotechnol (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; 1:1000; fig 3
In order to study prevention of allergic skin disease by epidermal RAF, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on mouse samples at 1:1000 (fig 3). elife (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 6e
In order to discuss the role of myeloid cells in pancreatic cancer pathogenesis, BD Biosciences E-cadherin antibody (BD Pharmingen, 610181) was used in immunohistochemistry on mouse samples at 1:100 (fig 6e). Gut (2017) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; 1:10,000; fig 5
BD Biosciences E-cadherin antibody (BD Biosciences, 36/E-cadherin) was used in western blot on mouse samples at 1:10,000 (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 3c
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples (fig 3c). Sci Rep (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:1000; loading ...; fig 1
In order to propose that the NKX3.1-G9a-UTY transcriptional regulatory network is essential for prostate differentiation, BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in immunocytochemistry on mouse samples at 1:1000 (fig 1). Science (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to learn of the restriction in brain cell types and possible connection to autism by alphaT-catenin, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). J Mol Psychiatry (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig s5
BD Biosciences E-cadherin antibody (BD Pharmingen, 610182) was used in western blot on human samples (fig s5). Oncotarget (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:50; loading ...; fig 5b
  • western blot; human; loading ...; fig 5a
In order to determine how C3G controls tumorigenesis, BD Biosciences E-cadherin antibody (BD, 610182) was used in immunocytochemistry on human samples at 1:50 (fig 5b) and in western blot on human samples (fig 5a). Oncotarget (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:200; loading ...; fig 2c
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:200 (fig 2c). Pflugers Arch (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; 1:500; loading ...; fig s2a
In order to research the involvement of myeloid translocation genes in colorectal cancer, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunohistochemistry on mouse samples at 1:500 (fig s2a). Oncogene (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; fig 1
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunohistochemistry - paraffin section on human samples (fig 1). Mol Cancer (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig 6
  • western blot; human; fig 6
In order to analyze control of MT1-MMP endocytic and E-cadherin polarized golgi trafficking to promote invasive breast cancer programs by RAB2A, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunocytochemistry on human samples (fig 6) and in western blot on human samples (fig 6). EMBO Rep (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; zebrafish ; 1:100; fig 2
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610,182) was used in immunohistochemistry - frozen section on zebrafish samples at 1:100 (fig 2). Nat Commun (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; mouse; fig s7
  • immunohistochemistry; mouse; fig 4
In order to study the intestinal barrier function using Arhgap17-deficient mice, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - frozen section on mouse samples (fig s7) and in immunohistochemistry on mouse samples (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; hamsters; loading ...; fig s2
  • immunocytochemistry; dogs; loading ...; fig 1a
  • immunocytochemistry; human; loading ...; fig s3
In order to demonstrate that protein kinase C negatively regulates cell-cell adhesion through E-cadherin phosphorylation, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 36) was used in immunocytochemistry on hamsters samples (fig s2), in immunocytochemistry on dogs samples (fig 1a) and in immunocytochemistry on human samples (fig s3). Oncotarget (2016) ncbi
mouse monoclonal (34/E-Cadherin)
  • immunoprecipitation; dogs; loading ...; fig 5f
  • immunocytochemistry; dogs; loading ...; fig 1a
  • western blot; dogs; loading ...; fig s1a
  • immunoprecipitation; human; loading ...; fig 6d
  • immunoprecipitation; hamsters; loading ...; fig 3e
  • western blot; hamsters; loading ...; fig 3e
In order to demonstrate that protein kinase C negatively regulates cell-cell adhesion through E-cadherin phosphorylation, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 34) was used in immunoprecipitation on dogs samples (fig 5f), in immunocytochemistry on dogs samples (fig 1a), in western blot on dogs samples (fig s1a), in immunoprecipitation on human samples (fig 6d), in immunoprecipitation on hamsters samples (fig 3e) and in western blot on hamsters samples (fig 3e). Oncotarget (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 2
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 2). Mol Biol Rep (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 3b
In order to study the contribution of CCL7-induced epithelial-mesenchymal transition signaling to the progression and metastasis of colon cancer, BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:500; loading ...; fig s1i
In order to use naked mole-rat-induced pluripotent stem cells to study mechanisms of cancer resistance, BD Biosciences E-cadherin antibody (BD Pharmingen, 36) was used in immunocytochemistry on mouse samples at 1:500 (fig s1i). Nat Commun (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; mouse; fig s7
In order to identify transcription factors involved in pancreatic ductal adenocarcinoma pathogenesis, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - frozen section on mouse samples (fig s7). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; fig 1
BD Biosciences E-cadherin antibody (BD Pharmingen, 610182) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Cell Rep (2016) ncbi
mouse monoclonal (34/E-Cadherin)
  • immunocytochemistry; human; 1:100; fig 2
  • western blot; human; 1:1000; fig 1
BD Biosciences E-cadherin antibody (Translab, 610404) was used in immunocytochemistry on human samples at 1:100 (fig 2) and in western blot on human samples at 1:1000 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; rat; 1:1000; fig 7
In order to characterize impairment of adhesion by disrupting cell-cell trans-dimerization of Na, K-ATPase beta1 subunits by O-glycosylated ectodomain of FXYD5, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on rat samples at 1:1000 (fig 7). J Cell Sci (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:100; fig 7
  • immunocytochemistry; human; 1:100; fig 3
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 7) and in immunocytochemistry on human samples at 1:100 (fig 3). Tissue Eng Part C Methods (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; zebrafish ; 1:200; fig 3
In order to analyze the mechanism of wound closure in embryonic and adult mammals due to re-epithelialization of cutaneous wounds in adult zebrafish, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on zebrafish samples at 1:200 (fig 3). Development (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:100; fig 5
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on mouse samples at 1:100 (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig 1
  • western blot; human; 1:1000; fig 1
  • immunocytochemistry; pigs ; fig 1
  • western blot; pigs ; 1:1000; fig 1
In order to determine expression of epithelial as well as mesenchymal cell adhesion molecules in 293 cells, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in immunocytochemistry on human samples (fig 1), in western blot on human samples at 1:1000 (fig 1), in immunocytochemistry on pigs samples (fig 1) and in western blot on pigs samples at 1:1000 (fig 1). Int J Mol Med (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 5
In order to characterize androgen receptor-targeted and vitamin D therapy for triple-negative breast cancer, BD Biosciences E-cadherin antibody (BD Biosciences, 61081) was used in western blot on human samples (fig 5). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 2b
BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on human samples (fig 2b). Sci Rep (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; fig 3
  • immunocytochemistry; human; 1:100; fig 3
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on human samples (fig 3) and in immunocytochemistry on human samples at 1:100 (fig 3). Oncol Rep (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig s3
BD Biosciences E-cadherin antibody (BD Transductio, 610181) was used in immunocytochemistry on human samples (fig s3). Oncotarget (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:400; fig 6
In order to investigate breast tumorigenesis due to loss of Panx1 which impairs mammary gland development at lactation, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 6). PLoS ONE (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:50; fig 4
In order to study the contribution to anaerobic sepsis in mice by activation of bacteroides fragilis toxin by a novel bacterial protease, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 36) was used in immunocytochemistry on human samples at 1:50 (fig 4). Nat Med (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:50; fig 1b
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on mouse samples at 1:50 (fig 1b). Stem Cells Int (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:2000; fig 3
  • western blot; mouse; 1:2000; fig 4
  • immunocytochemistry; human; 1:2000; fig 3
In order to study recruitment of PDZD11 to adherens junctions to stabilize nectins via PLEKHA7, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, BD610181) was used in immunocytochemistry on mouse samples at 1:2000 (fig 3), in western blot on mouse samples at 1:2000 (fig 4) and in immunocytochemistry on human samples at 1:2000 (fig 3). J Biol Chem (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; pigs ; 1:100; fig 3
In order to characterize cell junction assembly in early porcine embryo development by ADAM10, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on pigs samples at 1:100 (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; dogs; fig 3
In order to analyze the relationship between Rab35 GTPase cell division and initiation of epithelial apico-basal polarity and lumen opening, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunocytochemistry on dogs samples (fig 3). Nat Commun (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:200; fig 3a
  • immunocytochemistry; human; 1:200; loading ...; fig 3a
BD Biosciences E-cadherin antibody (BD, 560064) was used in immunocytochemistry on mouse samples at 1:200 (fig 3a) and in immunocytochemistry on human samples at 1:200 (fig 3a). Cell Death Differ (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:100; fig 6
  • western blot; human; fig 6
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on human samples at 1:100 (fig 6) and in western blot on human samples (fig 6). Nat Commun (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:250; fig 1
  • western blot; human; 1:1000
In order to maintain adherens junction stability and tension by neogenin recruitment of the WAVE regulatory complex, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in immunocytochemistry on human samples at 1:250 (fig 1) and in western blot on human samples at 1:1000. Nat Commun (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 2
BD Biosciences E-cadherin antibody (BD transduction Laboratories, 610181) was used in western blot on human samples (fig 2). Biochem J (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:300; fig 2
  • western blot; human; 1:300; fig 2
In order to research induction of epithelial-to-mesenchymal transition by Polo-like kinase 1 and promotion of epithelial cell motility by activating CRAF/ERK signaling, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:300 (fig 2) and in western blot on human samples at 1:300 (fig 2). elife (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000; fig 1
In order to analyze attenuation of transforming growth factor-beta signaling and metastatic activity of triple-negative breast cancer cells by Kaiso depletion, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on human samples at 1:1000 (fig 1). Oncogenesis (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; loading ...; fig 1b
BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry on human samples (fig 1b). Int J Oncol (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; fig s3
In order to utilize a novel mouse model with retinal detachment caused by a disruption of protein kinase C, theta, to study retinal pigment epithelium atrophy 1 (rpea1), BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunohistochemistry - paraffin section on mouse samples (fig s3). Invest Ophthalmol Vis Sci (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences E-cadherin antibody (BD, 560061) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:1500; fig s1
In order to utilize ovarian cancer xenograft models to study dynamic modulation of phosphoprotein expression, BD Biosciences E-cadherin antibody (BD sciences, 610181) was used in immunohistochemistry - paraffin section on human samples at 1:1500 (fig s1). BMC Cancer (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:50; fig 2
BD Biosciences E-cadherin antibody (BD Biosciences, 36) was used in immunocytochemistry on mouse samples at 1:50 (fig 2). Bone (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4a
In order to identify nuclear factor-kappa B targeted genes involved in hair follicle development, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4a). Development (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; 1:500; fig 1c
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on human samples at 1:500 (fig 1c). Science (2016) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; human; fig 3d
In order to study the results of proteomic screening that identified calreticulin as a miR-27a direct target that represses MHC clas 1 cell surface exposure in colorectal cancer, BD Biosciences E-cadherin antibody (BD Biosciences, 610405) was used in western blot on human samples (fig 3d). Cell Death Dis (2016) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; human; fig 5
BD Biosciences E-cadherin antibody (BD transduction, BD 610405) was used in western blot on human samples (fig 5). Cell Death Dis (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 3
In order to study a kidney-specific knockout of Sav1 in the mouse suppresses the Hippo pathway which promotes hyperproliferation of renal tubular epithelium, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 3). J Pathol (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; loading ...; fig 2c
  • western blot; human; loading ...; fig 1f
BD Biosciences E-cadherin antibody (BD, 610182) was used in immunocytochemistry on human samples (fig 2c) and in western blot on human samples (fig 1f). Sci Rep (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 6
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples (fig 6). Sci Rep (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000; fig 2
In order to study the interaction with YAP1 in aggressive cancer types by ZEB1 turning into a transcriptional activator, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in western blot on human samples at 1:1000 (fig 2). Nat Commun (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 4
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:500; loading ...; fig 2a
BD Biosciences E-cadherin antibody (BD Biosciences, 36/E-Cadherin) was used in immunocytochemistry on human samples at 1:500 (fig 2a). Cell Cycle (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; mouse; 1:500; fig 5
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 5). Nat Commun (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 1e
In order to study the response of intestinal tuft cells to parasites, BD Biosciences E-cadherin antibody (BD, 36/E-Cadherin) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1e). Science (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:5000; fig 3
In order to maintain phosphorylated p120-catenin in a colon carcinoma cell model by microtubules that inhibit E-cadherin adhesive activity, BD Biosciences E-cadherin antibody (BD Biosciences, 36) was used in western blot on human samples at 1:5000 (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 1
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1). Cancer Med (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 10 ug/ml; fig 2
In order to study a model of immune functions of the mouse blood-cerebrospinal fluid barrier in vitro using primary epithelial cells better suited to study immune cell migration across the brain barrier, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on mouse samples at 10 ug/ml (fig 2). Fluids Barriers CNS (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:1000; fig 6
  • western blot; human; 1:1000; fig 6
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:1000 (fig 6) and in western blot on human samples at 1:1000 (fig 6). Int J Mol Med (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:5000; fig 1
BD Biosciences E-cadherin antibody (bD Bioscience, 610181) was used in western blot on human samples at 1:5000 (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 0.25 ug/ml; fig 1
In order to evaluate the use of hematopoietic stem cell transplantation for cystinotic thyroid and study the underlying mechanisms, BD Biosciences E-cadherin antibody (BD Bioscience, 610 182) was used in immunohistochemistry - paraffin section on mouse samples at 0.25 ug/ml (fig 1). Endocrinology (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:400; fig 4
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on mouse samples at 1:400 (fig 4). Dev Cell (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; fig 5
  • western blot; human; fig 5
In order to analyze AMOTL1 and how it is antagonized by Merlin and promotes breast cancer progression, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on human samples (fig 5) and in western blot on human samples (fig 5). Neoplasia (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; 1:1000; fig 4
In order to show that Bcl-xL promotes metastasis independent of its anti-apoptotic activity, BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on mouse samples at 1:1000 (fig 4). Nat Commun (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 5
In order to investigate how CaSm promotes pancreatic cancer, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples (fig 5). Oncogenesis (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; 1:100; fig e5
In order to study triple-negative breast cancer and BET bromodomain inhibitor response and resistance, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry on human samples at 1:100 (fig e5). Nature (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:50; fig 2
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:50 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; fig s3
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunohistochemistry on mouse samples (fig s3). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; 1:100; fig 2
In order to analyze Crim1 regulations of integrin signaling in lens development of mice, BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in immunohistochemistry on mouse samples at 1:100 (fig 2). Development (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; rat; 1:150; fig 1
  • western blot; rat; fig 2
In order to test the relationship between epithelial mesenchymal transition induced by transforming growth factor beta 1 is blocked by an antagonist of translation factor eIF4E, BD Biosciences E-cadherin antibody (BD Biosciences Pharmingen, 610181) was used in immunocytochemistry on rat samples at 1:150 (fig 1) and in western blot on rat samples (fig 2). Sci Rep (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; chicken; 1:200; loading ...
In order to elucidate the influence of inductive interactions between epithelium and mesenchyme on enteric nervous system development, BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in immunohistochemistry on chicken samples at 1:200. Development (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; dogs; 1:500; fig 5
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on dogs samples at 1:500 (fig 5). elife (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000; fig 2
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples at 1:1000 (fig 2). Mol Med Rep (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
In order to establish and characterize long-term, stable 3D organoid cultures derived from human fallopian tubes, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2). Nat Commun (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; loading ...
  • western blot; human; loading ...; fig s4b
In order to investigate the role of CD73 in endometrial cancer, BD Biosciences E-cadherin antibody (BD Biosciences, 36) was used in immunocytochemistry on human samples and in western blot on human samples (fig s4b). J Clin Invest (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; fig 2
In order to describe a technique to measure cell mechanotype, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on mouse samples (fig 2). Sci Rep (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; fig s2
  • western blot; mouse; fig s2
In order to characterize interference with normal pancreatic islets architecture and promotion of pancreatic neuroendocrine tumor progression by the matricellular protein CYR61, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on mouse samples (fig s2) and in western blot on mouse samples (fig s2). Oncotarget (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:250; fig 4
In order to elucidate a screening that identifies kinases involved in prostate cancer visceral and bone metastasis, BD Biosciences E-cadherin antibody (BD Biosciences, 36) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig 4). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; dogs; 1:200; loading ...; fig 1a
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on dogs samples at 1:200 (fig 1a). Cytoskeleton (Hoboken) (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; fig 3
In order to characterize the exhibition of elongated intestinal microvilli and increased ezrin expression due to vitamin D receptor knockout mice, BD Biosciences E-cadherin antibody (BD Biosciences, BD610182) was used in western blot on mouse samples (fig 3). Nutr Res (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - free floating section; chicken; 1:1000; fig 5
BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry - free floating section on chicken samples at 1:1000 (fig 5). J Cell Biol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 3
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 3). Mol Cancer Ther (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig 5
  • western blot; human; fig 5
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples (fig 5) and in western blot on human samples (fig 5). J Biol Chem (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; fig 2
In order to generate and characterize podocytes derived from iPS cells, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on human samples (fig 2). J Am Soc Nephrol (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; dogs; fig 1c
In order to discover the mRNA and miRNA involved in epithelial-mesenchymal transition in MDCK cells, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in western blot on dogs samples (fig 1c). BMC Genomics (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 2
In order to determine the desmoplastic interface in xenograft tumor in mice comprised of stromal and endothelial cells, BD Biosciences E-cadherin antibody (Transduction Laboratories, 36) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2). Pathol Res Pract (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 1
In order to determine the role of Anakinra in anthrofibrosis knee patients, BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:500; fig 4
  • immunohistochemistry; human; 1:500; fig 6
BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in immunocytochemistry on human samples at 1:500 (fig 4) and in immunohistochemistry on human samples at 1:500 (fig 6). Oncogene (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; fig 7
In order to study postnatal liver maturation and its support by ESRP2 and adult splicing program in hepatocytes, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on mouse samples (fig 7). Nat Commun (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:100; fig 2
In order to analyze the transition from epithelial-mesenchymal induced by transforming growth factor beta, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunocytochemistry on human samples at 1:100 (fig 2). Methods Mol Biol (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; fig 7e
BD Biosciences E-cadherin antibody (BD, 610182) was used in immunohistochemistry on human samples (fig 7e). Oncogene (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; mouse; 1:200; fig 8
In order to investigate the developmental processes that regulate the formation of unique inner ear cell types, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 8). Nat Commun (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse
In order to determine the functions of EHD1, BD Biosciences E-cadherin antibody (BD-Transduction laboratories, 610181) was used in immunohistochemistry on mouse samples . Dev Biol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 1c
In order to elucidate the contribution of SPRY2 to colon cancer, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in western blot on human samples (fig 1c). Oncogene (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:300
In order to evaluate the kidney organoids from human iPS cells, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:300. Nature (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:400; fig 5
In order to discuss Cx26 knockout in DMBA-induced mouse models and breast cancer, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 5). Oncotarget (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; fig st1
BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry - paraffin section on human samples (fig st1). PLoS ONE (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; fig 3
BD Biosciences E-cadherin antibody (BD -Transduction Laboratories, 610182) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; fig 1d
  • western blot; mouse; fig 1d
In order to test if ZO-1-mediated diminution of polarity results in an epithelial-to-mesenchyme transition and increased metastatic potential, BD Biosciences E-cadherin antibody (BD Transduction/BD Biosciences, 610181) was used in immunocytochemistry on mouse samples (fig 1d) and in western blot on mouse samples (fig 1d). Oncogene (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; 1:500
In order to study the effects of Abeta on the functionality of the blood-CSF barrier, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunohistochemistry on mouse samples at 1:500. J Neurosci (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig 4
In order to study structural centrosome aberrations that favor proliferation by abrogation of microtubule-dependent tissue integrity in breast epithelial mammospheres, BD Biosciences E-cadherin antibody (BD, 610181) was used in immunocytochemistry on human samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 2
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on human samples (fig 2). Sci Rep (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 2
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 36) was used in western blot on human samples (fig 2). Int J Cancer (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6b
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples (fig 6b). BMC Cancer (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:500; loading ...; fig 1e
In order to demonstrate that dCas9 activator controls human pluripotent stem cell differentiation into endodermal lineages, BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in immunocytochemistry on human samples at 1:500 (fig 1e). Stem Cell Reports (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000
BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on human samples at 1:1000. PLoS Med (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 1
BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig 1
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples (fig 1). Mol Cancer (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; fig 2
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; dogs; 1:600; fig 2c
In order to assess the contribution of aPKC to epithelial cell transformation, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on dogs samples at 1:600 (fig 2c). Mol Biol Cell (2015) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; human; fig 5
BD Biosciences E-cadherin antibody (BD Biosciences, 610404) was used in western blot on human samples (fig 5). Oncogene (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; tbl 2
BD Biosciences E-cadherin antibody (BD Bioscience, 612130) was used in immunocytochemistry on human samples (tbl 2). Exp Cell Res (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; tbl 2
In order to evaluate the use of e-cadherin as a biomarker for medullary carcinoma, BD Biosciences E-cadherin antibody (BD Bioscience, 36) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 2). Hum Pathol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 3
BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3). Sci Rep (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; fig 2
  • western blot; human; 1:1000; fig 1
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry on human samples (fig 2) and in western blot on human samples at 1:1000 (fig 1). Nat Commun (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5). Cell Death Dis (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human
In order to assess the involvement of lysophosphatidic acid in epithelial ovarian carcinoma, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 36/E-cadherin) was used in immunocytochemistry on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000; fig 2
BD Biosciences E-cadherin antibody (bD Bioscience, 36) was used in western blot on human samples at 1:1000 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; chicken; fig 1
In order to determine how FGF8 contributes to Wolffian duct formation, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on chicken samples (fig 1). Development (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 4
BD Biosciences E-cadherin antibody (BD Science Transduction, 610181) was used in western blot on human samples (fig 4). J Biomed Sci (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:250; fig 1
In order to assess lineage specification constrained by gene expression of the chromatin remodeling protein CHD4, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on mouse samples at 1:250 (fig 1). Development (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:200
In order to study kidney development in Robo2 mouse mutants, BD Biosciences E-cadherin antibody (Becton Dickinson, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Dev Biol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to determine the contributions of Fat1 and Fat4 in eye development, BD Biosciences E-cadherin antibody (Transduction Laboratories, 610182) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Invest Ophthalmol Vis Sci (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; loading ...; fig 2c
  • western blot; human; 1:1000; loading ...; fig 6b
BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in immunohistochemistry on human samples (fig 2c) and in western blot on human samples at 1:1000 (fig 6b). PLoS ONE (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 6
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples (fig 6). Oncotarget (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:5000
BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in western blot on human samples at 1:5000. Int J Cancer (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
  • immunoprecipitation; human; fig 6
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 3
BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1), in immunoprecipitation on human samples (fig 6), in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 3). Oncogenesis (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; fig 5
BD Biosciences E-cadherin antibody (BD Biosciences, BD612131) was used in immunohistochemistry - paraffin section on mouse samples (fig 5). Science (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human
In order to study the role of p120 phosphorylation in tumor transformation, BD Biosciences E-cadherin antibody (BD Pharmingen, 610182) was used in western blot on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:100; fig 4
In order to describe the proxHCR method for the detection of protein interactions and posttranslational modifications in microscopy and flow cytometry, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on human samples at 1:100 (fig 4). Nat Commun (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:100; loading ...; tbl 1
  • western blot; human; 1:2500; loading ...; fig 3B
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on human samples at 1:100 (tbl 1) and in western blot on human samples at 1:2500 (fig 3B). Oncotarget (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; 1:200; fig 5
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on mouse samples at 1:200 (fig 5). Dis Model Mech (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:200
In order to investigate the role of transcription factors SOX4 and SOX9 during the development of bile ducts, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Dev Biol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; 1:100
In order to study mitochondrial dynamics and morphology in myelinating Schwann cells in living mice, BD Biosciences E-cadherin antibody (BD biosciences, 610181) was used in immunohistochemistry on mouse samples at 1:100. Mitochondrion (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse
In order to study the role of heparan sulfate in corneal epithelial homeostasis and wound healing, BD Biosciences E-cadherin antibody (BD Transduction lab, 610181) was used in immunohistochemistry - paraffin section on mouse samples . Invest Ophthalmol Vis Sci (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; fig 1e
BD Biosciences E-cadherin antibody (BD Biosciences, 36/E) was used in immunohistochemistry on mouse samples (fig 1e). Nat Immunol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:50
BD Biosciences E-cadherin antibody (BD Biosciences Pharmingen, BD 610182) was used in immunocytochemistry on mouse samples at 1:50. Biochim Biophys Acta (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; bovine
  • western blot; bovine
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on bovine samples and in western blot on bovine samples . Int J Mol Med (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; fig 3
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). Sci Rep (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human
In order to study the relationship between nuclear LASP-1 and the epigenetic machinery in breast cancer, BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on human samples . Oncogene (2016) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunoprecipitation; human; fig 4
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 4
BD Biosciences E-cadherin antibody (BD, 610182) was used in immunoprecipitation on human samples (fig 4), in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 4). J Cell Biol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig 2
BD Biosciences E-cadherin antibody (BD, 612130) was used in immunocytochemistry on human samples (fig 2). BMC Cancer (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human
  • western blot; human; 1:10000
BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry - paraffin section on human samples and in western blot on human samples at 1:10000. BMC Cancer (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; fig 1
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Cancer Res (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; fig 3
In order to analyze the contribution of genetic alterations and cell type of origin in breast cancer phenotypes, BD Biosciences E-cadherin antibody (BD Bioscience, 560061) was used in immunohistochemistry on human samples (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; fig s5
BD Biosciences E-cadherin antibody (BD Biosciences, 36) was used in immunohistochemistry - paraffin section on human samples (fig s5). Nature (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 3a
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples (fig 3a). Sci Rep (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human
In order to investigate flotillin-1-mediated regulation of insulin-like growth factor-1 signaling, BD Biosciences E-cadherin antibody (BD, 610182) was used in western blot on human samples . J Cell Sci (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 4d
In order to study how pre-transformation MTH1 levels in immortalized cells influence HRASV12-induced oncogenic transformation, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in western blot on human samples (fig 4d). Oncotarget (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; loading ...; fig 2d
BD Biosciences E-cadherin antibody (BD Transduction labs, 610181) was used in immunocytochemistry on mouse samples (fig 2d). Stem Cell Reports (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human
In order to investigate the role of Snail in the cell cycle regulation and epithelial-mesenchymal transition, BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in western blot on human samples . FEBS Lett (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 1
In order to investigate the effects of nicotinamide adenine dinucleotide phosphate reduced oxidase 4 in liver tissues from patients with NASH and mice with steatohepatitis, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on human samples (fig 1). Gastroenterology (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 4
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • flow cytometry; human; 1:100; fig 5
  • immunocytochemistry; human; 1:100; fig 3
  • western blot; human; 1:1000; fig 3
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in flow cytometry on human samples at 1:100 (fig 5), in immunocytochemistry on human samples at 1:100 (fig 3) and in western blot on human samples at 1:1000 (fig 3). EMBO Mol Med (2015) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; human
In order to evaluate the effect of aspirin in mesenchymal to epithelial transition, BD Biosciences E-cadherin antibody (BD Biosciences, 610404) was used in western blot on human samples . Lab Invest (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 4h
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in western blot on human samples (fig 4h). Oncotarget (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:2000; fig 1b
In order to examine an immunoblot-analysis workflow for accuracy and precision, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on human samples at 1:2000 (fig 1b). Sci Signal (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:100
In order to develop a screening strategy to rationally select novel and relevant candidate genes to target therapeutically, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on human samples at 1:100. PLoS ONE (2015) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; mouse
In order to investigate the deficiency of intestine and microbiome in an amyotrophic lateral sclerosis mouse model, BD Biosciences E-cadherin antibody (BD, 610405) was used in western blot on mouse samples . Physiol Rep (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; loading ...; fig 4
  • immunohistochemistry; mouse; loading ...; fig 5b
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry on human samples (fig 4) and in immunohistochemistry on mouse samples (fig 5b). Sci Rep (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; pigs
In order to describe a clinical scale bioreactor that maintains functional porcine and human lungs, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on pigs samples . Biomaterials (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; fig 1
In order to elucidate the contributions of cell-cell adhesion proteins to intercellular force and epithelial tissue dynamics, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunohistochemistry on human samples (fig 1). Nat Cell Biol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human
In order to identify genetic alterations and corresponding stable phenotypes that develop in cancer cells following cyclic hypoxia, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (34/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 2
BD Biosciences E-cadherin antibody (BD Biosciences, 610404) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 2). Development (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • other; human; loading ...; fig 6a
  • western blot; human; loading ...; fig 2a
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in other on human samples (fig 6a) and in western blot on human samples (fig 2a). PLoS ONE (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:200
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in immunocytochemistry on mouse samples at 1:200. PLoS ONE (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; 1:200
In order to investigate using liver-tumor organoids for in vitro modeling of liver metastasis, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry on human samples at 1:200. Ann Biomed Eng (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000; fig s4
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on human samples at 1:1000 (fig s4). Cell (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; loading ...; fig 1a
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on human samples (fig 1a). Oncotarget (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig s6
In order to characterize evolutionarily conserved DNA architecture which determines target specificity of the TWIST family bHLH transcription factors, BD Biosciences E-cadherin antibody (BD, 610182) was used in western blot on human samples (fig s6). Genes Dev (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; rat; 1:200
BD Biosciences E-cadherin antibody (BD Transduction, 36/E-cadherin) was used in immunohistochemistry on rat samples at 1:200. Exp Mol Pathol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunoprecipitation; human
  • western blot; human
  • immunohistochemistry - paraffin section; mouse; 1:100
BD Biosciences E-cadherin antibody (BD Biosciences Dickinson, 610181) was used in immunoprecipitation on human samples , in western blot on human samples and in immunohistochemistry - paraffin section on mouse samples at 1:100. PLoS ONE (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human; 1:100
In order to determine the prognostic role of the Wnt-signaling antagonist SFRP1 in bladder cancer, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on human samples at 1:100. J Cancer Res Clin Oncol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 5
In order to show that fatty acylated cav-2 is a IR tyrosine kinase substrate during insulin signaling, BD Biosciences E-cadherin antibody (BD, 610182) was used in western blot on human samples (fig 5). Biochim Biophys Acta (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; human
BD Biosciences E-cadherin antibody (BD Bioscience, 610182) was used in immunohistochemistry on human samples . J Invest Dermatol (2015) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; mouse
BD Biosciences E-cadherin antibody (BD Bioscience, 34/E-Cadherin) was used in western blot on mouse samples . Neoplasia (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; fig 6
BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in immunohistochemistry - paraffin section on human samples (fig 6). Oncotarget (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; rat; 125 ng/ml
BD Biosciences E-cadherin antibody (BD Bioscience, 610182) was used in western blot on rat samples at 125 ng/ml. Endocrinology (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:50
In order to assess the effects of different cell culturing conditions on the Calu-3 epithelial cell model, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in immunocytochemistry on human samples at 1:50. Eur J Pharm Sci (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:200
In order to examine the role of tropomyosin isoforms in actomyosin biogenesis, BD Biosciences E-cadherin antibody (BD, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Cytoskeleton (Hoboken) (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human
BD Biosciences E-cadherin antibody (BD Transduction Lab, 610181) was used in immunocytochemistry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:4000
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in western blot on human samples at 1:4000. PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; mouse
BD Biosciences E-cadherin antibody (BD Biosciences, 36/E-cadherin) was used in immunohistochemistry - frozen section on mouse samples . J Immunol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:1000
  • western blot; human; 1:1000
In order to study how DLC2 regulates cell junction maintenance and planar spindle positioning, BD Biosciences E-cadherin antibody (BD, 610182) was used in immunocytochemistry on human samples at 1:1000 and in western blot on human samples at 1:1000. Nat Commun (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human
  • western blot; human
In order to investigate the effect of homoharringtonine on intestinal epithelial permeability and its mechanism, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunocytochemistry on human samples and in western blot on human samples . Eur J Pharm Biopharm (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in western blot on mouse samples . Oncogene (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:200
BD Biosciences E-cadherin antibody (BD Bioscience, 612 131) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Endocrinology (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse
BD Biosciences E-cadherin antibody (BD Bioscience, 610182) was used in immunocytochemistry on mouse samples . PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; rat; 1:50; loading ...; fig 3b
In order to characterize a small population of Thy1(+) mesenchymal-epithelial cells present in rat liver., BD Biosciences E-cadherin antibody (BD Biosciences, 61081) was used in immunohistochemistry on rat samples at 1:50 (fig 3b). Am J Pathol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1 ug/ml
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on human samples at 1 ug/ml. J Lab Autom (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:200
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:200. Mol Hum Reprod (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; zebrafish ; 1:200; fig 4
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry on zebrafish samples at 1:200 (fig 4). Nat Commun (2014) ncbi
mouse monoclonal (34/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig 1
  • western blot; mouse; 1:2000; fig 1
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610405) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 1) and in western blot on mouse samples at 1:2000 (fig 1). PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:250
In order to determine the role of Tbx3 in different cell types present in the adult mammary gland, BD Biosciences E-cadherin antibody (BD, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:250. PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:200 or 1:1000
  • immunocytochemistry; human; 1:200 or 1:1000
BD Biosciences E-cadherin antibody (BD, BDB610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 or 1:1000 and in immunocytochemistry on human samples at 1:200 or 1:1000. Cell Res (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:200
  • western blot; human; 1:1000
In order to study the effect of epithelial cadherin expression on the induction of entosis, BD Biosciences E-cadherin antibody (BD Biosciences, BD610181) was used in immunocytochemistry on human samples at 1:200 and in western blot on human samples at 1:1000. Cell Res (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; mouse; fig 7
BD Biosciences E-cadherin antibody (BDbiosciences, 610182) was used in immunohistochemistry - frozen section on mouse samples (fig 7). Mol Cancer Res (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:250
In order to investigate how serotonin regulates calcium during lactation, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:250. PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 1
In order to analyze cancer cell plasticity autonomous stimulation by human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 36) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 1). PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:200; fig 3
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunocytochemistry on mouse samples at 1:200 (fig 3). J Biol Chem (2014) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; human; 1:1000; fig s1
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, BD Biosciences E-cadherin antibody (BD Biosciences, 610404) was used in western blot on human samples at 1:1000 (fig s1). Nat Cell Biol (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; loading ...; fig 2a
  • western blot; human; loading ...; fig 3b
BD Biosciences E-cadherin antibody (BD Biosciences, 36) was used in immunocytochemistry on human samples (fig 2a) and in western blot on human samples (fig 3b). Mol Biol Cell (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; zebrafish ; 1:100; fig 2
In order to demonstrate the importance of Myosin Vb-dependent cell size regulation in epidermal homeostasis, BD Biosciences E-cadherin antibody (BD Transduction, 610182) was used in immunohistochemistry on zebrafish samples at 1:100 (fig 2). PLoS Genet (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:35; fig 5
In order to research aggravation of murine caerulein-induced acute pancreatitis and the favoring of acinar keratin granule formation due to epiplakin deficiency, BD Biosciences E-cadherin antibody (BD Biosciences, 36/E-Cadherin) was used in immunohistochemistry - paraffin section on mouse samples at 1:35 (fig 5). PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse
BD Biosciences E-cadherin antibody (BD BioSciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples . Cancer Res (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; 1:200
In order to investigate mechanisms by which organs coordinate their size and shape, BD Biosciences E-cadherin antibody (Becton Dickinson, 610182) was used in immunohistochemistry on mouse samples at 1:200. Dev Biol (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human
In order to study the mechanism of the activation of focal adhesion protein vinculin by mechanical stress, BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in immunocytochemistry on human samples . Cancer Res (2014) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; human
BD Biosciences E-cadherin antibody (BD, 610405) was used in western blot on human samples . J Exp Clin Cancer Res (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • flow cytometry; human; 1:100
In order to evaluate the osteogenic capacity of bone marrow mesenchymal stream cells and gingiva-derived mesenchymal stromal cells, BD Biosciences E-cadherin antibody (BD, 612131) was used in flow cytometry on human samples at 1:100. Biomed Mater (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human
In order to study using RPMI 2650 cells to create an in vitro model of the nasal mucosa, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in immunocytochemistry on human samples . Pharm Res (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:100
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on human samples at 1:100. J Biol Chem (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:300
  • western blot; human; 1:1000
In order to study the effect of radiation on the progeny of colorectal cancer cells, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on human samples at 1:300 and in western blot on human samples at 1:1000. J Cell Biochem (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human
In order to investigate the localization of POF1B in desmosomes and its role in human intestinal and keratinocyte cell lines, BD Biosciences E-cadherin antibody (Sigma Aldrich, 610181) was used in western blot on human samples . J Invest Dermatol (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; rat
In order to examine the function of R1N1 in regards to Listeria monocytogenes infection, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunocytochemistry on rat samples . Traffic (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; dogs; fig 3
  • western blot; dogs; fig 1
In order to measure the expression of tight junction and adherens junction proteins in duodenal mucosa samples of dogs with inflammatory bowel disease, BD Biosciences E-cadherin antibody (BD Biosciences, 36) was used in immunohistochemistry on dogs samples (fig 3) and in western blot on dogs samples (fig 1). Am J Vet Res (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 0.25 ug/ml
In order to study ezrin, Cx43 and PKA in cell fusion in cytotrophoblasts, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in western blot on human samples at 0.25 ug/ml. J Cell Sci (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:120; fig s1
  • western blot; human; 1:1000; fig 6
In order to determine how loss of Trp53 and Cdh1 in the uterus can induce chronic inflammation with a change in the tumor microenvironment, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:120 (fig s1) and in western blot on human samples at 1:1000 (fig 6). Oncogene (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:200
In order to study the role of BMP in mammary cancer, BD Biosciences E-cadherin antibody (BD, 610182) was used in immunohistochemistry - paraffin section on human samples at 1:200. Oncogene (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; fig 5
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in western blot on human samples (fig 5). Cell (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; dogs; 1:400
In order to test if PAR2 activation affects the structure and function of tight junctions in epithelial cells, BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in immunocytochemistry on dogs samples at 1:400. J Vet Med Sci (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:200
In order to investigate the effect of glycosylation on tumor cell adhesion and invasion and its mechanism, BD Biosciences E-cadherin antibody (BD Biosciences, 36) was used in immunocytochemistry on human samples at 1:200. PLoS ONE (2014) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; human; 1:1000
BD Biosciences E-cadherin antibody (BD, 610404) was used in western blot on human samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse
  • western blot; mouse
In order to study the effect of ankyrin-G on neurogenesis and Wnt signaling and its mechanism, BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in immunohistochemistry on mouse samples and in western blot on mouse samples . Mol Psychiatry (2015) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples . Int J Oncol (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; dogs
In order to compare two treatment regiments for idiopathic inflammatory bowel disease, BD Biosciences E-cadherin antibody (BD, 36) was used in immunohistochemistry on dogs samples . PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:200
In order to study the regulation of autophagosome biogenesis by connexins, BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on mouse samples at 1:200. Nat Cell Biol (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000
In order to study the ability of miRNA-100 to promote epithelial-to-mesenchymal transition but also to inhibit mammary tumor cell invasiveness and tumorogenesis, BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610182) was used in western blot on human samples at 1:1000. PLoS Genet (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human
In order to determine the role of desmoglein 2 in melanoma cells, BD Biosciences E-cadherin antibody (BD Biosciences Pharmingen, clone 36) was used in immunocytochemistry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000; loading ...; fig 1a
BD Biosciences E-cadherin antibody (BD Transduction lab, 610182) was used in western blot on human samples at 1:1000 (fig 1a). Nat Cell Biol (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:100
In order to investigate the role of Mdm2 in the nephrogenic niche, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Dev Biol (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; fig 2
  • western blot; mouse; fig 1
BD Biosciences E-cadherin antibody (BD Transduction Labs, 610181) was used in immunohistochemistry - paraffin section on mouse samples (fig 2) and in western blot on mouse samples (fig 1). Biol Open (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples . Exp Cell Res (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:200
In order to study treatment resistance mechanisms in triple-negative breast cancers, BD Biosciences E-cadherin antibody (BD, 610182) was used in immunocytochemistry on human samples at 1:200. Cancer Discov (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; fig 2
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). Front Physiol (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; 1:200; fig 3
In order to describe a protocol for pluripotent-stem-cell-based renal regeneration, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples at 1:200 (fig 3). Nat Cell Biol (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:300
In order to study the clinical significance of aldehyde dehydrogenase 1 expression in the invasive front of nasopharyngeal carcinoma, BD Biosciences E-cadherin antibody (BD, 36/E) was used in immunohistochemistry - paraffin section on human samples at 1:300. Virchows Arch (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human
BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on human samples . Oncogene (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; pigs ; 1:200
In order to study the effects on piglet colon tight junction composition of a diet high in fibre and fermentable proteins, BD Biosciences E-cadherin antibody (Becton Dickinson Pharmingen, 560062) was used in immunohistochemistry - frozen section on pigs samples at 1:200. Br J Nutr (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; rat
BD Biosciences E-cadherin antibody (BD Transduction Labs, 36) was used in immunohistochemistry on rat samples . Dev Biol (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples . J Biol Chem (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:200
In order to examine the role of chromatin modification in nephrogenesis, BD Biosciences E-cadherin antibody (BD, 610182) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Epigenetics (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse
BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on mouse samples . Reproduction (2014) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:250
In order to study the role of cell migration in the mechanism by which overexpression of Cdc42 promotes developing mammary gland hyperbranching, BD Biosciences E-cadherin antibody (BD Transduction, 610181) was used in immunohistochemistry - paraffin section on mouse samples at 1:250. Breast Cancer Res (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:5000
BD Biosciences E-cadherin antibody (BD Bioscience, 610181) was used in western blot on human samples at 1:5000. Mol Carcinog (2014) ncbi
mouse monoclonal (34/E-Cadherin)
  • western blot; human
BD Biosciences E-cadherin antibody (BD Pharmingen, 610404) was used in western blot on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:200
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on mouse samples at 1:200. Mol Endocrinol (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry; mouse; 1:500
BD Biosciences E-cadherin antibody (BD Pharmingen, 610181) was used in immunohistochemistry on mouse samples at 1:500. Cancer Res (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human
BD Biosciences E-cadherin antibody (BD Bioscience, 610182) was used in western blot on human samples . Evid Based Complement Alternat Med (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; mouse; 1:1000
BD Biosciences E-cadherin antibody (BD, 610181) was used in western blot on mouse samples at 1:1000. PLoS ONE (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human
  • western blot; human
BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in immunocytochemistry on human samples and in western blot on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; dogs; 1:200
In order to study the role of Kif3a in microtubular dynamics, migration and lumen formation of MDCK cells, BD Biosciences E-cadherin antibody (BD Transduction Lab, 610181) was used in immunocytochemistry on dogs samples at 1:200. PLoS ONE (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; human
  • immunohistochemistry - frozen section; mouse
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunohistochemistry - paraffin section on human samples and in immunohistochemistry - frozen section on mouse samples . PLoS ONE (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - paraffin section; mouse; fig 1
BD Biosciences E-cadherin antibody (BD Transduction Laboratories, 610181) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). PLoS Genet (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; rat
BD Biosciences E-cadherin antibody (BD Transduction Labs, 36) was used in western blot on rat samples . Invest Ophthalmol Vis Sci (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human
In order to study the epigenetic changes caused by transient EBV infection and the tumorigenic significance, BD Biosciences E-cadherin antibody (BD Biosciences, 610181) was used in western blot on human samples . Int J Cancer (2013) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; mouse; 1:200
BD Biosciences E-cadherin antibody (BD, 610182) was used in immunocytochemistry on mouse samples at 1:200. Development (2012) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human
  • western blot; human
BD Biosciences E-cadherin antibody (BD Biosciences, 610182) was used in immunocytochemistry on human samples and in western blot on human samples . J Biol Chem (2012) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunocytochemistry; human; fig 3
In order to measure the expression of epithelial-to-mesenchymal transition-associated proteins in renal cell carcinoma and compared expression levels with clinical outcome, BD Biosciences E-cadherin antibody (BD Sciences, 610181) was used in immunocytochemistry on human samples (fig 3). PLoS ONE (2012) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; dogs; 0.05 ug/ml; loading ...; fig 1
  • immunohistochemistry; mouse; 0.8 ug/ml; loading ...; fig 2g
In order to report the expression and localization of tight junction and adherens junction proteins in canine duodenal and colonic mucosa, BD Biosciences E-cadherin antibody (BD Biosciences, 36/E-cadherin) was used in western blot on dogs samples at 0.05 ug/ml (fig 1) and in immunohistochemistry on mouse samples at 0.8 ug/ml (fig 2g). Am J Vet Res (2011) ncbi
mouse monoclonal (36/E-Cadherin)
  • western blot; human; 1:1000
BD Biosciences E-cadherin antibody (BD Laboratories, 610182) was used in western blot on human samples at 1:1000. Cancer Cell (2011) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunohistochemistry - frozen section; human; loading ...; fig 3
BD Biosciences E-cadherin antibody (BD, 36) was used in immunohistochemistry - frozen section on human samples (fig 3). Hum Mol Genet (2011) ncbi
mouse monoclonal (36/E-Cadherin)
  • immunoprecipitation; mouse; 1:2000; fig 1c
  • immunocytochemistry; mouse; 1:2000; loading ...; fig 1a
  • western blot; mouse; 1:2000; fig 6a
In order to investigate the role of Merlin in adheren junction establishment, BD Biosciences E-cadherin antibody (BD, 36) was used in immunoprecipitation on mouse samples at 1:2000 (fig 1c), in immunocytochemistry on mouse samples at 1:2000 (fig 1a) and in western blot on mouse samples at 1:2000 (fig 6a). Dev Cell (2010) ncbi
Leica Biosystems
monoclonal (36B5)
  • immunohistochemistry; human; loading ...; fig st1
Leica Biosystems E-cadherin antibody (Novocastra, 36B5) was used in immunohistochemistry on human samples (fig st1). Oncotarget (2017) ncbi
monoclonal (36B5)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 2e
In order to report the expression pattern of Gpr182 during development and adulthood using knockin mice, Leica Biosystems E-cadherin antibody (Leica, PA0391) was used in immunohistochemistry on mouse samples at 1:1000 (fig 2e). J Clin Invest (2017) ncbi
monoclonal (36B5)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 4a
Leica Biosystems E-cadherin antibody (Leica Biosystems, 36B5) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4a). BMC Cancer (2016) ncbi
monoclonal (36B5)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; tbl 1
In order to study the role of cell polarity determinant human Discs-large in endometrial cancer, Leica Biosystems E-cadherin antibody (Novocastra, 36B5) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 1). Br J Cancer (2016) ncbi
monoclonal (36B5)
  • immunocytochemistry; human; 1:100; fig 1
Leica Biosystems E-cadherin antibody (Novocastra Laboratories, 36B5) was used in immunocytochemistry on human samples at 1:100 (fig 1). Sci Rep (2016) ncbi
monoclonal (36B5)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1c
In order to study markers of the epithelial to mesenchymal transition using invasive lobular carcinoma samples, Leica Biosystems E-cadherin antibody (Novocastra, 36B5) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1c). J Pathol (2016) ncbi
monoclonal (36B5)
  • immunohistochemistry - paraffin section; human; 1:50
Leica Biosystems E-cadherin antibody (Leica, 36B5) was used in immunohistochemistry - paraffin section on human samples at 1:50. Endocr Pathol (2015) ncbi
monoclonal (36B5)
  • immunohistochemistry; human; 1:50
In order to describe the histological features canalicular adenoma, Leica Biosystems E-cadherin antibody (Leica, 36B5) was used in immunohistochemistry on human samples at 1:50. Head Neck Pathol (2015) ncbi
MilliporeSigma
mouse monoclonal (CH-19)
  • immunohistochemistry; rat; 1:500; fig 1d
MilliporeSigma E-cadherin antibody (Sigma-Aldrich, C1821) was used in immunohistochemistry on rat samples at 1:500 (fig 1d). Sci Rep (2021) ncbi
Articles Reviewed
  1. Xia R, Liu T, Li W, Xu X. RNA-binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA. Clin Transl Med. 2021;11:e383 pubmed publisher
  2. Jacquet M, Hervouet E, Baudu T, Herfs M, Parratte C, Feugeas J, et al. GABARAPL1 Inhibits EMT Signaling through SMAD-Tageted Negative Feedback. Biology (Basel). 2021;10: pubmed publisher
  3. Liu W, Feng Q, Liao W, Li E, Wu L. TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a. J Cancer. 2021;12:6905-6920 pubmed publisher
  4. Lin G, Li J, Cai J, Zhang H, Xin Q, Wang N, et al. RNA-binding Protein MBNL2 regulates Cancer Cell Metastasis through MiR-182-MBNL2-AKT Pathway. J Cancer. 2021;12:6715-6726 pubmed publisher
  5. Eritja N, Navaridas R, Ruiz Mitjana A, Vidal Sabanés M, Egea J, Encinas M, et al. Endometrial PTEN Deficiency Leads to SMAD2/3 Nuclear Translocation. Cancers (Basel). 2021;13: pubmed publisher
  6. Passman A, Strauss R, McSpadden S, Finch Edmondson M, Andrewartha N, Woo K, et al. Maraviroc Prevents HCC Development by Suppressing Macrophages and the Liver Progenitor Cell Response in a Murine Chronic Liver Disease Model. Cancers (Basel). 2021;13: pubmed publisher
  7. Fu H, Gui Y, Liu S, Wang Y, Bastacky S, Qiao Y, et al. The hepatocyte growth factor/c-met pathway is a key determinant of the fibrotic kidney local microenvironment. iScience. 2021;24:103112 pubmed publisher
  8. Jung S, Kim D, Choi Y, Kim S, Park H, Lee H, et al. Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer. Sci Rep. 2021;11:19667 pubmed publisher
  9. Sun W, Byon C, Kim D, Choi H, Park J, Joo S, et al. Renoprotective Effects of Maslinic Acid on Experimental Renal Fibrosis in Unilateral Ureteral Obstruction Model via Targeting MyD88. Front Pharmacol. 2021;12:708575 pubmed publisher
  10. Li K, Wu R, Zhou M, Tong H, Luo K. Desmosomal proteins of DSC2 and PKP1 promote cancer cells survival and metastasis by increasing cluster formation in circulatory system. Sci Adv. 2021;7:eabg7265 pubmed publisher
  11. Gyamfi J, Yeo J, Kwon D, Min B, Cha Y, Koo J, et al. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer. NPJ Breast Cancer. 2021;7:129 pubmed publisher
  12. Baeza V, Cifuentes M, Martinez F, Ramírez E, Nualart F, Ferrada L, et al. IIIG9 inhibition in adult ependymal cells changes adherens junctions structure and induces cellular detachment. Sci Rep. 2021;11:18537 pubmed publisher
  13. Chen R, Sheng C, Ma R, Zhang L, Yang L, Chen Y. PLAC1 is an independent predictor of poor survival, and promotes cell proliferation and invasion in cervical cancer. Mol Med Rep. 2021;24: pubmed publisher
  14. Zhang Y, Wen P, Luo J, Ding H, Cao H, He W, et al. Sirtuin 3 regulates mitochondrial protein acetylation and metabolism in tubular epithelial cells during renal fibrosis. Cell Death Dis. 2021;12:847 pubmed publisher
  15. Aryal Y, Kim T, Lee E, An C, Kim J, Yamamoto H, et al. Signaling Modulation by miRNA-221-3p During Tooth Morphogenesis in Mice. Front Cell Dev Biol. 2021;9:697243 pubmed publisher
  16. Sun Z, Sun D, Feng Y, Zhang B, Sun P, Zhou B, et al. Exosomal linc-ROR mediates crosstalk between cancer cells and adipocytes to promote tumor growth in pancreatic cancer. Mol Ther Nucleic Acids. 2021;26:253-268 pubmed publisher
  17. Shi Y, Hu Y, Wang Y, Ma X, Tang L, Tao M, et al. Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis. Front Pharmacol. 2021;12:724141 pubmed publisher
  18. Goel S, Bhatia V, Kundu S, Biswas T, Carskadon S, Gupta N, et al. Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression. Nat Commun. 2021;12:5325 pubmed publisher
  19. Fu Q, North P, Ke X, Huang Y, Fritz K, Majnik A, et al. Adverse Maternal Environment and Postweaning Western Diet Alter Hepatic CD36 Expression and Methylation Concurrently with Nonalcoholic Fatty Liver Disease in Mouse Offspring. J Nutr. 2021;151:3102-3112 pubmed publisher
  20. Cao Q, Wei W, Wang H, Wang Z, Lv Y, Dai M, et al. Cleavage of E-cadherin by porcine respiratory bacterial pathogens facilitates airway epithelial barrier disruption and bacterial paracellular transmigration. Virulence. 2021;12:2296-2313 pubmed publisher
  21. Malenica I, Adam J, Corgnac S, Mezquita L, Auclin E, Damei I, et al. Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade. Nat Commun. 2021;12:5209 pubmed publisher
  22. Wu K, Feng J, Lyu F, Xing F, Sharma S, Liu Y, et al. Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer. Nat Commun. 2021;12:5196 pubmed publisher
  23. La Rocca G, King B, Shui B, Li X, Zhang M, Akat K, et al. Inducible and reversible inhibition of miRNA-mediated gene repression in vivo. elife. 2021;10: pubmed publisher
  24. Gu P, Wang D, Zhang J, Wang X, Chen Z, Gu L, et al. Protective function of interleukin-22 in pulmonary fibrosis. Clin Transl Med. 2021;11:e509 pubmed publisher
  25. Wang C, Yang Z, Xu E, Shen X, Wang X, Li Z, et al. Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway. Clin Transl Med. 2021;11:e522 pubmed publisher
  26. da Silva F, Zhang K, Pinson A, Fatti E, Wilsch Bräuninger M, Herbst J, et al. Mitotic WNT signalling orchestrates neurogenesis in the developing neocortex. EMBO J. 2021;40:e108041 pubmed publisher
  27. Wu Q, Zhang W, Liu Y, Huang Y, Wu H, Ma C. Histone deacetylase 1 facilitates aerobic glycolysis and growth of endometrial cancer. Oncol Lett. 2021;22:721 pubmed publisher
  28. Li T, Yang X, Xu D, Gao Z, Gao Y, Jin F, et al. OC-STAMP Overexpression Drives Lung Alveolar Epithelial Cell Type II Senescence in Silicosis. Oxid Med Cell Longev. 2021;2021:4158495 pubmed publisher
  29. Zhao C, Ling X, Xia Y, Yan B, Guan Q. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis. Cancer Cell Int. 2021;21:441 pubmed publisher
  30. Mateos Quiros C, Garrido Jimenez S, Álvarez Hernán G, Diaz Chamorro S, Barrera Lopez J, Francisco Morcillo J, et al. Junctional Adhesion Molecule 3 Expression in the Mouse Airway Epithelium Is Linked to Multiciliated Cells. Front Cell Dev Biol. 2021;9:622515 pubmed publisher
  31. Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed publisher
  32. Tan X, Tong L, Li L, Xu J, Xie S, Ji L, et al. Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation. Nat Commun. 2021;12:4853 pubmed publisher
  33. Bernardini C, La Mantia D, Salaroli R, Zannoni A, Nauwelaerts N, Deferm N, et al. Development of a Pig Mammary Epithelial Cell Culture Model as a Non-Clinical Tool for Studying Epithelial Barrier-A Contribution from the IMI-ConcePTION Project. Animals (Basel). 2021;11: pubmed publisher
  34. Keil Stietz K, Kennedy C, Sethi S, Valenzuela A, Nunez A, Wang K, et al. In utero and lactational PCB exposure drives anatomic changes in the juvenile mouse bladder. Curr Res Toxicol. 2021;2:1-18 pubmed publisher
  35. Zheng Z, Li C, Shao G, Li J, Xu K, Zhao Z, et al. Hippo-YAP/MCP-1 mediated tubular maladaptive repair promote inflammation in renal failed recovery after ischemic AKI. Cell Death Dis. 2021;12:754 pubmed publisher
  36. Mao C, Jiang S, Wang X, Tao S, Jiang B, Mao C, et al. BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma. Int J Biol Sci. 2021;17:2461-2475 pubmed publisher
  37. Lassiter R, Merchen T, Fang X, Wang Y. Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation. Front Immunol. 2021;12:671025 pubmed publisher
  38. Guillot C, Djeffal Y, Michaut A, Rabe B, Pourquie O. Dynamics of primitive streak regression controls the fate of neuromesodermal progenitors in the chicken embryo. elife. 2021;10: pubmed publisher
  39. Zou J, Zhu X, Xiang D, Zhang Y, Li J, Su Z, et al. LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase. Acta Pharm Sin B. 2021;11:1578-1591 pubmed publisher
  40. Wu Y, Zhang J, Li C, Hu H, Qin B, Wang T, et al. The Activation of ROS/NF-κB/MMP-9 Pathway Promotes Calcium-Induced Kidney Crystal Deposition. Oxid Med Cell Longev. 2021;2021:8836355 pubmed publisher
  41. Lee S, Jung J, Lee Y, Kim S, Kim J, Kim B, et al. Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer. Cancers (Basel). 2021;13: pubmed publisher
  42. Bailey K, Cartwright S, Patel N, Remmers N, Lazenby A, Hollingsworth M, et al. Porcine pancreatic ductal epithelial cells transformed with KRASG12D and SV40T are tumorigenic. Sci Rep. 2021;11:13436 pubmed publisher
  43. Perez García V, Lea G, Lopez Jimenez P, Okkenhaug H, Burton G, Moffett A, et al. BAP1/ASXL complex modulation regulates epithelial-mesenchymal transition during trophoblast differentiation and invasion. elife. 2021;10: pubmed publisher
  44. Shelton W, Thomas S, Alexander H, Thomes C, Conway D, Dubash A. Desmoglein-2 harnesses a PDZ-GEF2/Rap1 signaling axis to control cell spreading and focal adhesions independent of cell-cell adhesion. Sci Rep. 2021;11:13295 pubmed publisher
  45. Zhou Y, Ji H, Xu Q, Zhang X, Cao X, Chen Y, et al. Congenital biliary atresia is correlated with disrupted cell junctions and polarity caused by Cdc42 insufficiency in the liver. Theranostics. 2021;11:7262-7275 pubmed publisher
  46. Cheng X, Wang J, Liu C, Jiang T, Yang N, Liu D, et al. Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway. J Exp Clin Cancer Res. 2021;40:199 pubmed publisher
  47. Rosenkrantz J, Gaffney J, Roberts V, Carbone L, CHAVEZ S. Transcriptomic analysis of primate placentas and novel rhesus trophoblast cell lines informs investigations of human placentation. BMC Biol. 2021;19:127 pubmed publisher
  48. Wu Y, Guo Q, Ju X, Hu Z, Xia L, Deng Y, et al. HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway. Oncogene. 2021;40:4770-4782 pubmed publisher
  49. Stolzer I, Dressel A, Chiriac M, Neurath M, Günther C. An IFN-STAT Axis Augments Tissue Damage and Inflammation in a Mouse Model of Crohn's Disease. Front Med (Lausanne). 2021;8:644244 pubmed publisher
  50. Pollock N, Leighton P, Neil G, Allison W. Transcriptomic analysis of zebrafish prion protein mutants supports conserved cross-species function of the cellular prion protein. Prion. 2021;15:70-81 pubmed publisher
  51. Song M, Zhao G, Sun H, Yao S, Zhou Z, Jiang P, et al. circPTPN12/miR-21-5 p/∆Np63α pathway contributes to human endometrial fibrosis. elife. 2021;10: pubmed publisher
  52. Ianni A, Hofmann M, Kumari P, Tarighi S, Al tamari H, Görgens A, et al. Depletion of Numb and Numblike in Murine Lung Epithelial Cells Ameliorates Bleomycin-Induced Lung Fibrosis by Inhibiting the β-Catenin Signaling Pathway. Front Cell Dev Biol. 2021;9:639162 pubmed publisher
  53. Liu Q, Li H, Yang M, Mei Y, Niu T, Zhou Z, et al. Suppression of tumor growth and metastasis in Shkbp1 knockout mice. Cancer Gene Ther. 2022;29:709-721 pubmed publisher
  54. Lasierra Losada M, Pauler M, Vandamme N, Goossens S, Berx G, Leppkes M, et al. Pancreas morphogenesis and homeostasis depends on tightly regulated Zeb1 levels in epithelial cells. Cell Death Discov. 2021;7:138 pubmed publisher
  55. DeLaForest A, Kohlnhofer B, Franklin O, Stavniichuk R, Thompson C, Pulakanti K, et al. GATA4 Controls Epithelial Morphogenesis in the Developing Stomach to Promote Establishment of Glandular Columnar Epithelium. Cell Mol Gastroenterol Hepatol. 2021;12:1391-1413 pubmed publisher
  56. Yin S, Liu L, Brobbey C, PALANISAMY V, Ball L, Olsen S, et al. PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis. Nat Commun. 2021;12:3444 pubmed publisher
  57. Janmaat V, Nesteruk K, Spaander M, Verhaar A, Yu B, Silva R, et al. HOXA13 in etiology and oncogenic potential of Barrett's esophagus. Nat Commun. 2021;12:3354 pubmed publisher
  58. Monsivais D, Nagashima T, Prunskaite Hyyryläinen R, Nozawa K, Shimada K, Tang S, et al. Endometrial receptivity and implantation require uterine BMP signaling through an ACVR2A-SMAD1/SMAD5 axis. Nat Commun. 2021;12:3386 pubmed publisher
  59. Jiang H, Deng W, Zhu K, Zeng Z, Hu B, Zhou Z, et al. LINC00467 Promotes Prostate Cancer Progression via M2 Macrophage Polarization and the miR-494-3p/STAT3 Axis. Front Oncol. 2021;11:661431 pubmed publisher
  60. Qin X, Li J, Wang S, Lv J, Luan F, Liu Y, et al. Serotonin/HTR1E signaling blocks chronic stress-promoted progression of ovarian cancer. Theranostics. 2021;11:6950-6965 pubmed publisher
  61. Keshvari S, Caruso M, Teakle N, Batoon L, Sehgal A, Patkar O, et al. CSF1R-dependent macrophages control postnatal somatic growth and organ maturation. PLoS Genet. 2021;17:e1009605 pubmed publisher
  62. Muranushi R, Araki K, Yokobori T, Chingunjav B, Hoshino K, Dolgormaa G, et al. High membrane expression of CMTM6 in hepatocellular carcinoma is associated with tumor recurrence. Cancer Sci. 2021;112:3314-3323 pubmed publisher
  63. Goswami S, Balasubramanian I, D Agostino L, Bandyopadhyay S, Patel R, Avasthi S, et al. RAB11A-mediated YAP localization to adherens and tight junctions is essential for colonic epithelial integrity. J Biol Chem. 2021;297:100848 pubmed publisher
  64. Li H, Kurtzeborn K, Kupari J, Gui Y, Siefker E, Lu B, et al. Postnatal prolongation of mammalian nephrogenesis by excess fetal GDNF. Development. 2021;148: pubmed publisher
  65. Wojnarowicz P, Escolano M, Huang Y, Desai B, Chin Y, Shah R, et al. Anti-tumor effects of an ID antagonist with no observed acquired resistance. NPJ Breast Cancer. 2021;7:58 pubmed publisher
  66. Lin C, Tsai M, Chen Y, Liu W, Lin C, Hsu K, et al. Platelet-Derived Growth Factor Receptor-α Subunit Targeting Suppresses Metastasis in Advanced Thyroid Cancer In Vitro and In Vivo. Biomol Ther (Seoul). 2021;29:551-561 pubmed publisher
  67. Yao J, Yang Z, Yang J, Wang Z, Zhang Z. Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis. Aging (Albany NY). 2021;13:13726-13738 pubmed publisher
  68. Eriksen A, Møller R, Makovoz B, Uhl S, tenOever B, Blenkinsop T. SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium. Cell Stem Cell. 2021;28:1205-1220.e7 pubmed publisher
  69. Liu M, Rao H, Liu J, Li X, Feng W, Gui L, et al. The histone methyltransferase SETD2 modulates oxidative stress to attenuate experimental colitis. Redox Biol. 2021;43:102004 pubmed publisher
  70. Hendley A, Rao A, Leonhardt L, Ashe S, Smith J, Giacometti S, et al. Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal tree. elife. 2021;10: pubmed publisher
  71. Liberti D, Kremp M, Liberti W, Penkala I, Li S, Zhou S, et al. Alveolar epithelial cell fate is maintained in a spatially restricted manner to promote lung regeneration after acute injury. Cell Rep. 2021;35:109092 pubmed publisher
  72. Fukunaga I, Oe Y, Chen C, Danzaki K, Ohta S, Koike A, et al. Activin/Nodal/TGF-β Pathway Inhibitor Accelerates BMP4-Induced Cochlear Gap Junction Formation During in vitro Differentiation of Embryonic Stem Cells. Front Cell Dev Biol. 2021;9:602197 pubmed publisher
  73. Delepine C, Pham V, Tsang H, Sur M. GSK3ß inhibitor CHIR 99021 modulates cerebral organoid development through dose-dependent regulation of apoptosis, proliferation, differentiation and migration. PLoS ONE. 2021;16:e0251173 pubmed publisher
  74. Xu Y, Pan S, Chen H, Qian H, Wang Z, Zhu X. MEX3A suppresses proliferation and EMT via inhibiting Akt signaling pathway in cervical cancer. Am J Cancer Res. 2021;11:1446-1462 pubmed
  75. Li X, Lin P, Tao Y, Jiang X, Li T, Wang Y, et al. LECT 2 Antagonizes FOXM1 Signaling via Inhibiting MET to Retard PDAC Progression. Front Cell Dev Biol. 2021;9:661122 pubmed publisher
  76. Zheng H, Zhang Y, He J, Yang Z, Zhang R, Li L, et al. Hydroxychloroquine Inhibits Macrophage Activation and Attenuates Renal Fibrosis After Ischemia-Reperfusion Injury. Front Immunol. 2021;12:645100 pubmed publisher
  77. Wang X, Li X, Lin F, Sun H, Lin Y, Wang Z, et al. The lnc-CTSLP8 upregulates CTSL1 as a competitive endogenous RNA and promotes ovarian cancer metastasis. J Exp Clin Cancer Res. 2021;40:151 pubmed publisher
  78. Chen X, Ma W, Yao Y, Zhang Q, Li J, Wu X, et al. Serum deprivation-response protein induces apoptosis in hepatocellular carcinoma through ASK1-JNK/p38 MAPK pathways. Cell Death Dis. 2021;12:425 pubmed publisher
  79. Oh T, Lee M, Lee Y, Kim G, Lee D, You J, et al. PGC1α Loss Promotes Lung Cancer Metastasis through Epithelial-Mesenchymal Transition. Cancers (Basel). 2021;13: pubmed publisher
  80. Loureiro J, Raimundo L, Calheiros J, Carvalho C, Barcherini V, Lima N, et al. Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance. Cancers (Basel). 2021;13: pubmed publisher
  81. Hill W, Zaragkoulias A, Salvador Barbero B, Parfitt G, Alatsatianos M, Padilha A, et al. EPHA2-dependent outcompetition of KRASG12D mutant cells by wild-type neighbors in the adult pancreas. Curr Biol. 2021;31:2550-2560.e5 pubmed publisher
  82. Srivastava S, Zhou H, Setia O, Liu B, Kanasaki K, Koya D, et al. Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy. Nat Commun. 2021;12:2368 pubmed publisher
  83. Kariya Y, Oyama M, Suzuki T, Kariya Y. αvβ3 Integrin induces partial EMT independent of TGF-β signaling. Commun Biol. 2021;4:490 pubmed publisher
  84. Nishina T, Deguchi Y, Ohshima D, Takeda W, Ohtsuka M, Shichino S, et al. Interleukin-11-expressing fibroblasts have a unique gene signature correlated with poor prognosis of colorectal cancer. Nat Commun. 2021;12:2281 pubmed publisher
  85. Carstens J, Yang S, Correa de Sampaio P, Zheng X, Barua S, McAndrews K, et al. Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer. Cell Rep. 2021;35:108990 pubmed publisher
  86. Fayad R, Rojas M, Partisani M, Finetti P, Dib S, Abélanet S, et al. EFA6B regulates a stop signal for collective invasion in breast cancer. Nat Commun. 2021;12:2198 pubmed publisher
  87. Pascal L, Dhir R, Balasubramani G, Chen W, Hudson C, Srivastava P, et al. E-cadherin expression is inversely correlated with aging and inflammation in the prostate. Am J Clin Exp Urol. 2021;9:140-149 pubmed
  88. Gao S, Gao L, Wang S, Shi X, Yue C, Wei S, et al. ATF3 Suppresses Growth and Metastasis of Clear Cell Renal Cell Carcinoma by Deactivating EGFR/AKT/GSK3β/β-Catenin Signaling Pathway. Front Cell Dev Biol. 2021;9:618987 pubmed publisher
  89. Niu Y, Lin Z, Wan A, Sun L, Yan S, Liang H, et al. Loss-of-function genetic screening identifies ALDOA as an essential driver for liver cancer cell growth under hypoxia. Hepatology. 2021;: pubmed publisher
  90. Zhang L, Li M, Tian C, Wang T, Mi S. CCAAT enhancer binding protein α suppresses proliferation, metastasis, and epithelial-mesenchymal transition of ovarian cancer cells via suppressing the Wnt/β-catenin signaling. Neoplasma. 2021;68:602-612 pubmed publisher
  91. Hocevar S, Liu L, Duncan R. Matrigel is required for efficient differentiation of isolated, stem cell-derived otic vesicles into inner ear organoids. Stem Cell Res. 2021;53:102295 pubmed publisher
  92. Wan L, Wang Y, Zhang Z, Wang J, Niu M, Wu Y, et al. Elevated TEFM expression promotes growth and metastasis through activation of ROS/ERK signaling in hepatocellular carcinoma. Cell Death Dis. 2021;12:325 pubmed publisher
  93. Bilodeau C, Shojaie S, Goltsis O, Wang J, Luo D, Ackerley C, et al. TP63 basal cells are indispensable during endoderm differentiation into proximal airway cells on acellular lung scaffolds. NPJ Regen Med. 2021;6:12 pubmed publisher
  94. Shao G, Fan X, Zhang P, Liu X, Huang L, Ji S. Methylation-dependent MCM6 repression induced by LINC00472 inhibits triple-negative breast cancer metastasis by disturbing the MEK/ERK signaling pathway. Aging (Albany NY). 2021;13:4962-4975 pubmed publisher
  95. Fazio M, van Rooijen E, Dang M, van de Hoek G, Ablain J, Mito J, et al. SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance. elife. 2021;10: pubmed publisher
  96. Takei Y, Yun J, Zheng S, Ollikainen N, Pierson N, White J, et al. Integrated spatial genomics reveals global architecture of single nuclei. Nature. 2021;590:344-350 pubmed publisher
  97. Wijshake T, Zou Z, Chen B, Zhong L, Xiao G, Xie Y, et al. Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  98. Tyagi A, Sharma S, Wu K, Wu S, Xing F, Liu Y, et al. Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung. Nat Commun. 2021;12:474 pubmed publisher
  99. Dilshat R, Fock V, Kenny C, Gerritsen I, Lasseur R, Travnickova J, et al. MITF reprograms the extracellular matrix and focal adhesion in melanoma. elife. 2021;10: pubmed publisher
  100. Lu M, Qin X, Zhou Y, Li G, Liu Z, Geng X, et al. Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p/BCL9L axis. Cell Death Dis. 2021;12:72 pubmed publisher
  101. Jiang Y, Han Q, Zhao H, Zhang J. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis. J Exp Clin Cancer Res. 2021;40:13 pubmed publisher
  102. Ye D, Wang S, Huang Y, Wang X, Chi P. USP43 directly regulates ZEB1 protein, mediating proliferation and metastasis of colorectal cancer. J Cancer. 2021;12:404-416 pubmed publisher
  103. Samuel R, Majd H, Richter M, Ghazizadeh Z, Zekavat S, Navickas A, et al. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men. Cell Stem Cell. 2020;27:876-889.e12 pubmed publisher
  104. Ma Z, Gao Y, Liu W, Zheng L, Jin B, Duan B, et al. CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer. Dis Markers. 2020;2020:8899924 pubmed publisher
  105. Fomicheva M, Macara I. Genome-wide CRISPR screen identifies noncanonical NF-κB signaling as a regulator of density-dependent proliferation. elife. 2020;9: pubmed publisher
  106. Sun Q, Chen J, Xu L, Kang J, Wu X, Ren Y, et al. MUTYH Deficiency Is Associated with Attenuated Pulmonary Fibrosis in a Bleomycin-Induced Model. Oxid Med Cell Longev. 2020;2020:4828256 pubmed publisher
  107. Wang C, Weng M, Xia S, Zhang M, Chen C, Tang J, et al. Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer. Cancer Sci. 2021;112:178-193 pubmed publisher
  108. Hosseini K, Taubenberger A, Werner C, Fischer Friedrich E. EMT-Induced Cell-Mechanical Changes Enhance Mitotic Rounding Strength. Adv Sci (Weinh). 2020;7:2001276 pubmed publisher
  109. Huang Y, Liang C, Ritz D, Coelho R, Septiadi D, Estermann M, et al. Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis. elife. 2020;9: pubmed publisher
  110. Wang T, Gao X, Zhou K, Jiang T, Gao S, Liu P, et al. Role of ARID1A in epithelial‑mesenchymal transition in breast cancer and its effect on cell sensitivity to 5‑FU. Int J Mol Med. 2020;46:1683-1694 pubmed publisher
  111. Zhu W, Liu C, Lu T, Zhang Y, Zhang S, Chen Q, et al. Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer. Front Oncol. 2020;10:1451 pubmed publisher
  112. Aikin T, Peterson A, Pokrass M, Clark H, Regot S. MAPK activity dynamics regulate non-cell autonomous effects of oncogene expression. elife. 2020;9: pubmed publisher
  113. Wang Y, Gao G, Wu Y, Wang Y, Wu X, Zhou Q. S100A4 Silencing Facilitates Corneal Wound Healing After Alkali Burns by Promoting Autophagy via Blocking the PI3K/Akt/mTOR Signaling Pathway. Invest Ophthalmol Vis Sci. 2020;61:19 pubmed publisher
  114. Chen G, Liu B, Yin S, Li S, Guo Y, Wang M, et al. Hypoxia induces an endometrial cancer stem-like cell phenotype via HIF-dependent demethylation of SOX2 mRNA. Oncogenesis. 2020;9:81 pubmed publisher
  115. Oliemuller E, Newman R, Tsang S, Foo S, Muirhead G, Noor F, et al. SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells. elife. 2020;9: pubmed publisher
  116. Xi L, Carroll T, Matos I, Luo J, Polak L, Pasolli H, et al. m6A RNA methylation impacts fate choices during skin morphogenesis. elife. 2020;9: pubmed publisher
  117. Sun Z, Ji N, Ma Q, Zhu R, Chen Z, Wang Z, et al. Epithelial-Mesenchymal Transition in Asthma Airway Remodeling Is Regulated by the IL-33/CD146 Axis. Front Immunol. 2020;11:1598 pubmed publisher
  118. Huang F, Zheng C, Huang L, Lin C, Wang J. USP18 directly regulates Snail1 protein through ubiquitination pathway in colorectal cancer. Cancer Cell Int. 2020;20:346 pubmed publisher
  119. Jiang Z, Zhang C, Liu X, Ma X, Bian X, Xiao X, et al. Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF‑1α and Oct4. Int J Oncol. 2020;57:780-790 pubmed publisher
  120. Li Y, He J, Wang F, Wang X, Yang F, Zhao C, et al. Role of MMP-9 in epithelial-mesenchymal transition of thyroid cancer. World J Surg Oncol. 2020;18:181 pubmed publisher
  121. Hering H, Zoschke C, Kühn M, Gadicherla A, Weindl G, Luch A, et al. TatS: a novel in vitro tattooed human skin model for improved pigment toxicology research. Arch Toxicol. 2020;94:2423-2434 pubmed publisher
  122. Wang W, Wang H, Xiang L, Ni T, Jin F, Deng J, et al. DJ‑1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer. Oncol Rep. 2020;44:77-90 pubmed publisher
  123. Christgen M, Bartels S, van Luttikhuizen J, Bublitz J, Rieger L, Christgen H, et al. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements. Mod Pathol. 2020;33:2483-2498 pubmed publisher
  124. Wu J, Song D, Li Z, Guo B, Xiao Y, Liu W, et al. Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis. Cell Res. 2020;30:794-809 pubmed publisher
  125. Lin Z, Lin X, Zhu L, Huang J, Huang Y. TRIM2 directly deubiquitinates and stabilizes Snail1 protein, mediating proliferation and metastasis of lung adenocarcinoma. Cancer Cell Int. 2020;20:228 pubmed publisher
  126. Wen X, Wan J, He Q, Wang M, Li S, Jiang M, et al. p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer. Signal Transduct Target Ther. 2020;5:81 pubmed publisher
  127. Yang Y, Tai W, Lu N, Li T, Liu Y, Wu W, et al. lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis. Aging (Albany NY). 2020;12:9085-9102 pubmed publisher
  128. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  129. Yamamoto K, Venida A, Yano J, Biancur D, Kakiuchi M, Gupta S, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100-105 pubmed publisher
  130. Wu X, Gardashova G, Lan L, Han S, Zhong C, Marquez R, et al. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis. Commun Biol. 2020;3:193 pubmed publisher
  131. Bozic M, Caus M, Rodrigues Díez R, Pedraza N, Ruiz Ortega M, Garí E, et al. Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis. Nat Commun. 2020;11:1943 pubmed publisher
  132. Vidal V, Jian Motamedi F, Rekima S, Gregoire E, Szenker Ravi E, Leushacke M, et al. R-spondin signalling is essential for the maintenance and differentiation of mouse nephron progenitors. elife. 2020;9: pubmed publisher
  133. Qi J, Liu S, Liu W, Cai G, Liao G. Identification of UAP1L1 as tumor promotor in gastric cancer through regulation of CDK6. Aging (Albany NY). 2020;12:6904-6927 pubmed publisher
  134. Matos I, Asare A, Levorse J, Ouspenskaia T, de la Cruz Racelis J, Schuhmacher L, et al. Progenitors oppositely polarize WNT activators and inhibitors to orchestrate tissue development. elife. 2020;9: pubmed publisher
  135. Tian Q, Yuan P, Quan C, Li M, Xiao J, Zhang L, et al. Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer. Oncogene. 2020;39:3980-3996 pubmed publisher
  136. Liu F, Hu L, Pei Y, Zheng K, Wang W, Li S, et al. Long non-coding RNA AFAP1-AS1 accelerates the progression of melanoma by targeting miR-653-5p/RAI14 axis. BMC Cancer. 2020;20:258 pubmed publisher
  137. Hreha T, Collins C, Daugherty A, Twentyman J, Paluri N, Hunstad D. TGFβ1 orchestrates renal fibrosis following Escherichia coli pyelonephritis. Physiol Rep. 2020;8:e14401 pubmed publisher
  138. Liang W, Gao R, Yang M, Wang X, Cheng K, Shi X, et al. MARCKSL1 promotes the proliferation, migration and invasion of lung adenocarcinoma cells. Oncol Lett. 2020;19:2272-2280 pubmed publisher
  139. Schley G, Grampp S, Goppelt Struebe M. Inhibition of oxygen-sensing prolyl hydroxylases increases lipid accumulation in human primary tubular epithelial cells without inducing ER stress. Cell Tissue Res. 2020;381:125-140 pubmed publisher
  140. Alafate W, Li X, Zuo J, Zhang H, Xiang J, Wu W, et al. Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma. CNS Neurosci Ther. 2020;26:475-485 pubmed publisher
  141. Steins A, van Mackelenbergh M, van der Zalm A, Klaassen R, Serrels B, Goris S, et al. High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1. EMBO Rep. 2020;21:e48780 pubmed publisher
  142. Guo Y, Zhang Z, Wang Z, Liu G, Liu Y, Wang H. Astragalus polysaccharides inhibit ovarian cancer cell growth via microRNA-27a/FBXW7 signaling pathway. Biosci Rep. 2020;40: pubmed publisher
  143. Jin T, Liu M, Liu Y, Li Y, Xu Z, He H, et al. Lcn2-derived Circular RNA (hsa_circ_0088732) Inhibits Cell Apoptosis and Promotes EMT in Glioma via the miR-661/RAB3D Axis. Front Oncol. 2020;10:170 pubmed publisher
  144. Qian W, Cai X, Qian Q. Sirt1 antisense long non-coding RNA attenuates pulmonary fibrosis through sirt1-mediated epithelial-mesenchymal transition. Aging (Albany NY). 2020;12:4322-4336 pubmed publisher
  145. Honarpisheh P, Reynolds C, Blasco Conesa M, Moruno Manchon J, Putluri N, Bhattacharjee M, et al. Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the Brain Amyloid-β in Tg2576 Mice. Int J Mol Sci. 2020;21: pubmed publisher
  146. Zhou X, Cai D, Xiao S, Ning M, Zhou R, Zhang S, et al. InvivoPen: A novel plasma source for in vivo cancer treatment. J Cancer. 2020;11:2273-2282 pubmed publisher
  147. Jin D, Guo J, Wu Y, Yang L, Wang X, Du J, et al. m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC. Mol Cancer. 2020;19:40 pubmed publisher
  148. Wang X, Jian X, Dou J, Wei Z, Zhao F. Decreasing Microtubule Actin Cross-Linking Factor 1 Inhibits Melanoma Metastasis by Decreasing Epithelial to Mesenchymal Transition. Cancer Manag Res. 2020;12:663-673 pubmed publisher
  149. Tian S, Peng P, Li J, Deng H, Zhan N, Zeng Z, et al. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway. Aging (Albany NY). 2020;12:3574-3593 pubmed publisher
  150. Zhang Y, Du P, Li Y, Zhu Q, Song X, Liu S, et al. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway. Int J Biol Sci. 2020;16:739-751 pubmed publisher
  151. Ailiken G, Kitamura K, Hoshino T, Satoh M, Tanaka N, Minamoto T, et al. Post-transcriptional regulation of BRG1 by FIRΔexon2 in gastric cancer. Oncogenesis. 2020;9:26 pubmed publisher
  152. Hu D, Chen H, Lou L, Zhang H, Yang G. SKA3 promotes lung adenocarcinoma metastasis through the EGFR-PI3K-Akt axis. Biosci Rep. 2020;40: pubmed publisher
  153. Chandrasekaran B, Dahiya N, Tyagi A, Kolluru V, Saran U, Baby B, et al. Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells. Oncogenesis. 2020;9:23 pubmed publisher
  154. Liu K, Yu Q, Li H, Xie C, Wu Y, Ma D, et al. BIRC7 promotes epithelial-mesenchymal transition and metastasis in papillary thyroid carcinoma through restraining autophagy. Am J Cancer Res. 2020;10:78-94 pubmed
  155. Li M, Wu P, Yang Z, Deng S, Ni L, Zhang Y, et al. miR-193a-5p promotes pancreatic cancer cell metastasis through SRSF6-mediated alternative splicing of OGDHL and ECM1. Am J Cancer Res. 2020;10:38-59 pubmed
  156. Kluz P, Kolb R, Xie Q, Borcherding N, Liu Q, Luo Y, et al. Cancer cell-intrinsic function of CD177 in attenuating β-catenin signaling. Oncogene. 2020;39:2877-2889 pubmed publisher
  157. Potilinski M, Ortiz G, Salica J, Lopez E, Fernández Acquier M, Chuluyan E, et al. Elucidating the mechanism of action of alpha-1-antitrypsin using retinal pigment epithelium cells exposed to high glucose. Potential use in diabetic retinopathy. PLoS ONE. 2020;15:e0228895 pubmed publisher
  158. Tan S, Swathi Y, Tan S, Goh J, Seishima R, Murakami K, et al. AQP5 enriches for stem cells and cancer origins in the distal stomach. Nature. 2020;578:437-443 pubmed publisher
  159. Feng Y, Ji D, Huang Y, Ji B, Zhang Y, Li J, et al. TGM3 functions as a tumor suppressor by repressing epithelial‑to‑mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer. Oncol Rep. 2020;43:864-876 pubmed publisher
  160. Gu Y, Zhu Z, Pei H, Xu D, Jiang Y, Zhang L, et al. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203. Aging (Albany NY). 2020;12:2333-2346 pubmed publisher
  161. Guoren Z, Zhaohui F, Wei Z, Mei W, Yuan W, Lin S, et al. TFAP2A Induced ITPKA Serves as an Oncogene and Interacts with DBN1 in Lung Adenocarcinoma. Int J Biol Sci. 2020;16:504-514 pubmed publisher
  162. Xiong G, Chen J, Zhang G, Wang S, Kawasaki K, Zhu J, et al. Hsp47 promotes cancer metastasis by enhancing collagen-dependent cancer cell-platelet interaction. Proc Natl Acad Sci U S A. 2020;117:3748-3758 pubmed publisher
  163. Hou K, Li G, Zhao J, Xu B, Zhang Y, Yu J, et al. Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway. J Neuroinflammation. 2020;17:46 pubmed publisher
  164. Carpinelli M, de Vries M, Auden A, Butt T, Deng Z, Partridge D, et al. Inactivation of Zeb1 in GRHL2-deficient mouse embryos rescues mid-gestation viability and secondary palate closure. Dis Model Mech. 2020;13: pubmed publisher
  165. Lin L, Li Y, Liu M, Li Q, Liu Q, Li R. The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation. Aging (Albany NY). 2020;12:1685-1703 pubmed publisher
  166. Brill Karniely Y, Dror D, Duanis Assaf T, Goldstein Y, Schwob O, Millo T, et al. Triangular correlation (TrC) between cancer aggressiveness, cell uptake capability, and cell deformability. Sci Adv. 2020;6:eaax2861 pubmed publisher
  167. McGinn O, Ward A, Fettig L, Riley D, Ivie J, Paul K, et al. Cytokeratin 5 alters β-catenin dynamics in breast cancer cells. Oncogene. 2020;39:2478-2492 pubmed publisher
  168. Cheung E, DeNicola G, Nixon C, Blyth K, Labuschagne C, Tuveson D, et al. Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer. Cancer Cell. 2020;37:168-182.e4 pubmed publisher
  169. Liao S, Chen H, Liu M, Gan L, Li C, Zhang W, et al. Aquaporin 9 inhibits growth and metastasis of hepatocellular carcinoma cells via Wnt/β-catenin pathway. Aging (Albany NY). 2020;12:1527-1544 pubmed publisher
  170. Arora P, Dongre S, Raman R, Sonawane M. Stepwise polarisation of developing bilayered epidermis is mediated by aPKC and E-cadherin in zebrafish. elife. 2020;9: pubmed publisher
  171. Rahman M, Wruck W, Spitzhorn L, Nguyen L, Bohndorf M, Martins S, et al. The FGF, TGFβ and WNT axis Modulate Self-renewal of Human SIX2+ Urine Derived Renal Progenitor Cells. Sci Rep. 2020;10:739 pubmed publisher
  172. Ye D, Zhu J, Zhao Q, Ma W, Xiao Y, Xu G, et al. LMP1 Up-regulates Calreticulin to Induce Epithelial-mesenchymal Transition via TGF-β/Smad3/NRP1 Pathway in Nasopharyngeal Carcinoma Cells. J Cancer. 2020;11:1257-1269 pubmed publisher
  173. Wang H, Ren Y, Qian C, Liu J, Li G, Li Z. Over-expression of CDX2 alleviates breast cancer by up-regulating microRNA let-7b and inhibiting COL11A1 expression. Cancer Cell Int. 2020;20:13 pubmed publisher
  174. Kasendra M, Luc R, Yin J, Manatakis D, Kulkarni G, Lucchesi C, et al. Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model. elife. 2020;9: pubmed publisher
  175. Du X, Zhang Z, Zheng X, Zhang H, Dong D, Zhang Z, et al. An electrochemical biosensor for the detection of epithelial-mesenchymal transition. Nat Commun. 2020;11:192 pubmed publisher
  176. Wang G, Xu J, Zhao J, Yin W, Liu D, Chen W, et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun. 2020;11:220 pubmed publisher
  177. Cai H, Li J, Zhang Y, Liao Y, Zhu Y, Wang C, et al. LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial-Mesenchymal Transition. Front Oncol. 2019;9:1446 pubmed publisher
  178. Diaz Cuadros M, Wagner D, Budjan C, Hubaud A, Tarazona O, Donelly S, et al. In vitro characterization of the human segmentation clock. Nature. 2020;580:113-118 pubmed publisher
  179. Liu X, Ma F, Liu C, Zhu K, Li W, Xu Y, et al. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop. Cell Death Dis. 2020;11:10 pubmed publisher
  180. Zhong W, Myers J, Wang F, Wang K, Lucas J, Rosfjord E, et al. Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors. BMC Genomics. 2020;21:2 pubmed publisher
  181. Liang L, Wu J, Luo J, Wang L, Chen Z, Han C, et al. Oxymatrine reverses 5-fluorouracil resistance by inhibition of colon cancer cell epithelial-mesenchymal transition and NF-κB signaling in vitro. Oncol Lett. 2020;19:519-526 pubmed publisher
  182. Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59 pubmed publisher
  183. Xing T, Benderman L, Sabu S, Parker J, Yang J, Lu Q, et al. Tight Junction Protein Claudin-7 Is Essential for Intestinal Epithelial Stem Cell Self-Renewal and Differentiation. Cell Mol Gastroenterol Hepatol. 2020;9:641-659 pubmed publisher
  184. Wang H, Chen Z, Wang S, Gao X, Qian M, Qiu W, et al. TGFβ1-induced beta-site APP-cleaving enzyme 2 upregulation promotes tumorigenesis through the NF-κB signalling pathway in human gliomas. Mol Oncol. 2020;14:407-425 pubmed publisher
  185. Wan L, Chong S, Xuan F, Liang A, Cui X, Gates L, et al. Impaired cell fate through gain-of-function mutations in a chromatin reader. Nature. 2020;577:121-126 pubmed publisher
  186. Jhang J, Birder L, Jiang Y, Hsu Y, Ho H, Kuo H. Dysregulation of bladder corticotropin-releasing hormone receptor in the pathogenesis of human interstitial cystitis/bladder pain syndrome. Sci Rep. 2019;9:19169 pubmed publisher
  187. Zhang K, Yang L, Wang J, Sun T, Guo Y, Nelson R, et al. Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer. Cell Commun Signal. 2019;17:167 pubmed publisher
  188. Esfahani M, Lee L, Jeon Y, Flynn R, Stehr H, Hui A, et al. Functional significance of U2AF1 S34F mutations in lung adenocarcinomas. Nat Commun. 2019;10:5712 pubmed publisher
  189. Belote R, Simon S. Ca2+ transients in melanocyte dendrites and dendritic spine-like structures evoked by cell-to-cell signaling. J Cell Biol. 2020;219: pubmed publisher
  190. Wu Y, Chen K, Xing G, Li L, Ma B, Hu Z, et al. Phospholipid remodeling is critical for stem cell pluripotency by facilitating mesenchymal-to-epithelial transition. Sci Adv. 2019;5:eaax7525 pubmed publisher
  191. Hu Y, Ma Y, Liu J, Cai Y, Zhang M, Fang X. LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis. BMC Cancer. 2019;19:1157 pubmed publisher
  192. Davaadelger B, Choi M, Singhal H, Clare S, Khan S, Kim J. BRCA1 mutation influences progesterone response in human benign mammary organoids. Breast Cancer Res. 2019;21:124 pubmed publisher
  193. Foster A, El Chami C, O Neill C, Watson R. Osmolyte transporter expression is reduced in photoaged human skin: Implications for skin hydration in aging. Aging Cell. 2020;19:e13058 pubmed publisher
  194. Wu X, Chen S, Lu C. Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway. Int J Mol Med. 2019;: pubmed publisher
  195. Li X, Wang F, Ren M, Du M, Zhou J. The effects of c-Src kinase on EMT signaling pathway in human lens epithelial cells associated with lens diseases. BMC Ophthalmol. 2019;19:219 pubmed publisher
  196. Zhang J, Zhang Z, Sun J, Ma Q, Zhao W, Chen X, et al. MiR-942 regulates the function of breast cancer cell by targeting FOXA2. Biosci Rep. 2019;39: pubmed publisher
  197. Takeuchi H, Sasaki N, Yamaga S, Kuboniwa M, Matsusaki M, Amano A. Porphyromonas gingivalis induces penetration of lipopolysaccharide and peptidoglycan through the gingival epithelium via degradation of junctional adhesion molecule 1. PLoS Pathog. 2019;15:e1008124 pubmed publisher
  198. Chen X, Xiong X, Cui D, Yang F, Wei D, Li H, et al. DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene. 2020;39:1557-1571 pubmed publisher
  199. Wang Z, Li Y, Zhan S, Zhang L, Zhang S, Tang Q, et al. SMAD4 Y353C promotes the progression of PDAC. BMC Cancer. 2019;19:1037 pubmed publisher
  200. Valentiner U, Knips J, Pries R, Clauditz T, Münscher A, Sauter G, et al. Selectin Binding Sites Are Involved in Cell Adhesive Properties of Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2019;11: pubmed publisher
  201. Lu Y, Zheng Y, Coyaud E, Zhang C, Selvabaskaran A, Yu Y, et al. Palmitoylation of NOD1 and NOD2 is required for bacterial sensing. Science. 2019;366:460-467 pubmed publisher
  202. Chen Q, Yang C, Chen L, Zhang J, Ge W, Yuan H, et al. YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathways. Br J Cancer. 2019;121:912-921 pubmed publisher
  203. Tan P, Xu Y, Du Y, Wu L, Guo B, Huang S, et al. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG. Cell Death Dis. 2019;10:794 pubmed publisher
  204. Chen R, Chen X, Xia L, Zhang J, Pan Z, Ma X, et al. N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat Commun. 2019;10:4695 pubmed publisher
  205. Veschi V, Mangiapane L, Nicotra A, Di Franco S, Scavo E, Apuzzo T, et al. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant. Oncogene. 2020;39:987-1003 pubmed publisher
  206. Gomes A, Ilter D, Low V, Rosenzweig A, Shen Z, Schild T, et al. Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization. Cancer Cell. 2019;36:402-417.e13 pubmed publisher
  207. Bi J, Yang S, Li L, Dai Q, Borcherding N, Wagner B, et al. Metadherin enhances vulnerability of cancer cells to ferroptosis. Cell Death Dis. 2019;10:682 pubmed publisher
  208. Jiao X, Ye J, Wang X, Yin X, Zhang G, Cheng X. KIAA1199, a Target of MicoRNA-486-5p, Promotes Papillary Thyroid Cancer Invasion by Influencing Epithelial-Mesenchymal Transition (EMT). Med Sci Monit. 2019;25:6788-6796 pubmed publisher
  209. Li L, Yan S, Zhang H, Zhang M, Huang G, Chen M. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells. BMC Cancer. 2019;19:894 pubmed publisher
  210. Padmanaban V, Krol I, Suhail Y, Szczerba B, Aceto N, Bader J, et al. E-cadherin is required for metastasis in multiple models of breast cancer. Nature. 2019;573:439-444 pubmed publisher
  211. Diaz Osterman C, Ozmadenci D, Kleinschmidt E, Taylor K, Barrie A, Jiang S, et al. FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy. elife. 2019;8: pubmed publisher
  212. Ombrato L, Nolan E, Kurelac I, Mavousian A, Bridgeman V, Heinze I, et al. Metastatic-niche labelling reveals parenchymal cells with stem features. Nature. 2019;572:603-608 pubmed publisher
  213. Jiang S, Zhang M, Zhang Y, Zhou W, Zhu T, Ruan Q, et al. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling. Cell Commun Signal. 2019;17:109 pubmed publisher
  214. Li B, Zhang Q, Sun J, Lai D. Human amniotic epithelial cells improve fertility in an intrauterine adhesion mouse model. Stem Cell Res Ther. 2019;10:257 pubmed publisher
  215. Kim Y, You H, Park S, Kim M, Chae H, Park J, et al. A Mutation in ZNF143 as a Novel Candidate Gene for Endothelial Corneal Dystrophy. J Clin Med. 2019;8: pubmed publisher
  216. Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett P, et al. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells. 2019;37:1293-1306 pubmed publisher
  217. Dumortier J, Le Verge Serandour M, Tortorelli A, Mielke A, de Plater L, Turlier H, et al. Hydraulic fracturing and active coarsening position the lumen of the mouse blastocyst. Science. 2019;365:465-468 pubmed publisher
  218. Li Q, Lai Q, He C, Fang Y, Yan Q, Zhang Y, et al. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer. J Exp Clin Cancer Res. 2019;38:334 pubmed publisher
  219. Dvela Levitt M, Kost Alimova M, Emani M, Kohnert E, Thompson R, Sidhom E, et al. Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy. Cell. 2019;178:521-535.e23 pubmed publisher
  220. van de Vlekkert D, Demmers J, Nguyen X, Campos Y, Machado E, Annunziata I, et al. Excessive exosome release is the pathogenic pathway linking a lysosomal deficiency to generalized fibrosis. Sci Adv. 2019;5:eaav3270 pubmed publisher
  221. Chang Z. Downregulation of SOX2 may be targeted by miR-590-5p and inhibits epithelial-to-mesenchymal transition in non-small-cell lung cancer. Exp Ther Med. 2019;18:1189-1195 pubmed publisher
  222. Low J, Li P, Chew E, Zhou B, Suzuki K, Zhang T, et al. Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular Network. Cell Stem Cell. 2019;25:373-387.e9 pubmed publisher
  223. Buchrieser J, Degrelle S, Couderc T, Nevers Q, Disson O, Manet C, et al. IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise. Science. 2019;365:176-180 pubmed publisher
  224. Haider S, Gamperl M, Burkard T, Kunihs V, Kaindl U, Junttila S, et al. Estrogen Signaling Drives Ciliogenesis in Human Endometrial Organoids. Endocrinology. 2019;160:2282-2297 pubmed publisher
  225. Vazquez Iglesias L, Barcia Castro L, Rodríguez Quiroga M, Páez de la Cadena M, Rodríguez Berrocal J, Cordero O. Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26+ cancer stem cells subsets. Biol Open. 2019;8: pubmed publisher
  226. Du F, Qiao C, Li X, Chen Z, Liu H, Wu S, et al. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR. Theranostics. 2019;9:3879-3902 pubmed publisher
  227. Wang H, Xiang D, Liu B, He A, Randle H, Zhang K, et al. Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer. Cell. 2019;178:135-151.e19 pubmed publisher
  228. Wang X, Liu R, Zhu W, Chu H, Yu H, Wei P, et al. UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis. Nature. 2019;571:127-131 pubmed publisher
  229. Oz Levi D, Olender T, Bar Joseph I, Zhu Y, Marek Yagel D, Barozzi I, et al. Noncoding deletions reveal a gene that is critical for intestinal function. Nature. 2019;: pubmed publisher
  230. Moamer A, Hachim I, Binothman N, Wang N, Lebrun J, Ali S. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis. EBioMedicine. 2019;: pubmed publisher
  231. He W, Tang J, Li W, Li Y, Mei Y, He L, et al. Mutual regulation of JAG2 and PRAF2 promotes migration and invasion of colorectal cancer cells uncoupled from epithelial-mesenchymal transition. Cancer Cell Int. 2019;19:160 pubmed publisher
  232. Dosh R, Jordan Mahy N, Sammon C, Le Maitre C. Interleukin 1 is a key driver of inflammatory bowel disease-demonstration in a murine IL-1Ra knockout model. Oncotarget. 2019;10:3559-3575 pubmed publisher
  233. Hayward A, Aird E, Gordon W. A toolkit for studying cell surface shedding of diverse transmembrane receptors. elife. 2019;8: pubmed publisher
  234. Yin M, Zhou H, Lin C, Long L, Yang X, Zhang H, et al. CD34+KLF4+ Stromal Stem Cells Contribute to Endometrial Regeneration and Repair. Cell Rep. 2019;27:2709-2724.e3 pubmed publisher
  235. Wen H, Gao S, Wang Y, Ray M, Magnuson M, Wright C, et al. Myeloid cell-derived HB-EGF Drives Tissue Recovery After Pancreatitis. Cell Mol Gastroenterol Hepatol. 2019;: pubmed publisher
  236. Fan M, Zou Y, He P, Zhang S, Sun X, Li C. Long non-coding RNA SPRY4-IT1 promotes epithelial-mesenchymal transition of cervical cancer by regulating the miR-101-3p/ZEB1 axis. Biosci Rep. 2019;: pubmed publisher
  237. Ling C, Nishimoto K, Rolfs Z, Smith L, Frey B, Welham N. Differentiated fibrocytes assume a functional mesenchymal phenotype with regenerative potential. Sci Adv. 2019;5:eaav7384 pubmed publisher
  238. Choi J, Zhong X, McAlpine W, Liao T, Zhang D, Fang B, et al. LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. Science. 2019;364: pubmed publisher
  239. Singh R, Peng S, Viswanath P, Sambandam V, Shen L, Rao X, et al. Non-canonical cMet regulation by vimentin mediates Plk1 inhibitor-induced apoptosis. EMBO Mol Med. 2019;: pubmed publisher
  240. Hu J, Guan W, Yan L, Ye Z, Wu L, Xu H. Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma. Stem Cells Int. 2019;2019:9060152 pubmed publisher
  241. Kim E, Lisby A, Ma C, Lo N, Ehmer U, Hayer K, et al. Promotion of growth factor signaling as a critical function of β-catenin during HCC progression. Nat Commun. 2019;10:1909 pubmed publisher
  242. Tang L, Wen J, Wen P, Li X, Gong M, Li Q. Long non-coding RNA LINC01314 represses cell migration, invasion, and angiogenesis in gastric cancer via the Wnt/β-catenin signaling pathway by down-regulating KLK4. Cancer Cell Int. 2019;19:94 pubmed publisher
  243. Gao X, Liu X, Lu Y, Wang Y, Cao W, Liu X, et al. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation. Breast Cancer. 2019;: pubmed publisher
  244. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  245. Stock K, Borrink R, Mikesch J, Hansmeier A, Rehkämper J, Trautmann M, et al. Overexpression and Tyr421-phosphorylation of cortactin is induced by three-dimensional spheroid culturing and contributes to migration and invasion of pancreatic ductal adenocarcinoma (PDAC) cells. Cancer Cell Int. 2019;19:77 pubmed publisher
  246. Liu Y, Xue M, Du S, Feng W, Zhang K, Zhang L, et al. Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT. Nat Commun. 2019;10:1637 pubmed publisher
  247. Li Y, Lu Y, Chen Y. Long non-coding RNA SNHG16 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer via sponging miR-200a-3p. Biosci Rep. 2019;39: pubmed publisher
  248. Lytle N, Ferguson L, Rajbhandari N, Gilroy K, Fox R, Deshpande A, et al. A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. Cell. 2019;177:572-586.e22 pubmed publisher
  249. Zhang D, Zhou H, Liu J, Mao J. Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells. Biomed Res Int. 2019;2019:5437531 pubmed publisher
  250. Fearnley G, Young K, Edgar J, Antrobus R, Hay I, Liang W, et al. The homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell-cell adhesion. elife. 2019;8: pubmed publisher
  251. Li Y, Li H, Duan Y, Cai X, You D, Zhou F, et al. Blockage of TGF-α Induced by Spherical Silica Nanoparticles Inhibits Epithelial-Mesenchymal Transition and Proliferation of Human Lung Epithelial Cells. Biomed Res Int. 2019;2019:8231267 pubmed publisher
  252. Wang M, Xiong L, Jiang L, Lu Y, Liu F, Song L, et al. miR-4739 mediates pleural fibrosis by targeting bone morphogenetic protein 7. EBioMedicine. 2019;41:670-682 pubmed publisher
  253. Jung H, Fattet L, Tsai J, Kajimoto T, Chang Q, Newton A, et al. Apical-basal polarity inhibits epithelial-mesenchymal transition and tumour metastasis by PAR-complex-mediated SNAI1 degradation. Nat Cell Biol. 2019;21:359-371 pubmed publisher
  254. Jalal S, Shi S, Acharya V, Huang R, Viasnoff V, Bershadsky A, et al. Actin cytoskeleton self-organization in single epithelial cells and fibroblasts under isotropic confinement. J Cell Sci. 2019;132: pubmed publisher
  255. Chen X, He Y, Xu A, Deng Z, Feng J, Lu F, et al. Increase of glandular epithelial cell clusters by an external volume expansion device promotes adipose tissue regeneration by recruiting macrophages. Biosci Rep. 2019;39: pubmed publisher
  256. Li Y, Hu Q, Li C, Liang K, Xiang Y, Hsiao H, et al. PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease. J Clin Invest. 2019;129:1129-1151 pubmed publisher
  257. Guan H, Li N, Wang X, Shan X, Li Z, Lin Z. Role of Paip1 on angiogenesis and invasion in pancreatic cancer. Exp Cell Res. 2019;376:198-209 pubmed publisher
  258. Haikala H, Anttila J, Marques E, Raatikainen T, Ilander M, Hakanen H, et al. Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy. Nat Commun. 2019;10:620 pubmed publisher
  259. Paul D, Islam S, Manne R, Dinesh U, Malonia S, Maity B, et al. F-box protein FBXO16 functions as a tumor suppressor by attenuating nuclear β-catenin function. J Pathol. 2019;248:266-279 pubmed publisher
  260. Kast D, Dominguez R. Mechanism of IRSp53 inhibition by 14-3-3. Nat Commun. 2019;10:483 pubmed publisher
  261. Sharon N, Chawla R, Mueller J, Vanderhooft J, Whitehorn L, Rosenthal B, et al. A Peninsular Structure Coordinates Asynchronous Differentiation with Morphogenesis to Generate Pancreatic Islets. Cell. 2019;176:790-804.e13 pubmed publisher
  262. Nerurkar N, Lee C, Mahadevan L, Tabin C. Molecular control of macroscopic forces drives formation of the vertebrate hindgut. Nature. 2019;565:480-484 pubmed publisher
  263. Liu Z, Liu J, Dong X, Hu X, Jiang Y, Li L, et al. Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation. J Cell Mol Med. 2019;23:2083-2092 pubmed publisher
  264. Swain S, Roe M, Sebrell T, Sidar B, Dankoff J, VanAusdol R, et al. CD103 (αE Integrin) Undergoes Endosomal Trafficking in Human Dendritic Cells, but Does Not Mediate Epithelial Adhesion. Front Immunol. 2018;9:2989 pubmed publisher
  265. Aggarwal S, Gabrovsek L, Langeberg L, Golkowski M, Ong S, Smith F, et al. Depletion of dAKAP1-protein kinase A signaling islands from the outer mitochondrial membrane alters breast cancer cell metabolism and motility. J Biol Chem. 2019;294:3152-3168 pubmed publisher
  266. Zhang C, Wang Y. Metformin attenuates cells stemness and epithelial‑mesenchymal transition in colorectal cancer cells by inhibiting the Wnt3a/β‑catenin pathway. Mol Med Rep. 2019;19:1203-1209 pubmed publisher
  267. Zhang Z, Chen J, Huang W, Ning D, Liu Q, Wang C, et al. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma. Mol Oncol. 2019;13:792-810 pubmed publisher
  268. Flood B, Manils J, Nulty C, Flis E, Kenealy S, Barber G, et al. Caspase-11 regulates the tumour suppressor function of STAT1 in a murine model of colitis-associated carcinogenesis. Oncogene. 2019;38:2658-2674 pubmed publisher
  269. Lee C, Cheng Y, Chang C, Lin C, Chang J. Alpha-tubulin acetyltransferase/MEC-17 regulates cancer cell migration and invasion through epithelial-mesenchymal transition suppression and cell polarity disruption. Sci Rep. 2018;8:17477 pubmed publisher
  270. Tang Z, Ding Y, Shen Q, Zhang C, Li J, Nazar M, et al. KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT. J Mol Med (Berl). 2019;97:127-140 pubmed publisher
  271. Yoshimoto R, Aijima R, Ohyama Y, Yoshizumi J, Kitsuki T, Ohsaki Y, et al. Impaired Junctions and Invaded Macrophages in Oral Epithelia With Oral Pain. J Histochem Cytochem. 2019;67:245-256 pubmed publisher
  272. Song X, Chen H, Zhang C, Yu Y, Chen Z, Liang H, et al. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma. Cancer Lett. 2019;442:310-319 pubmed publisher
  273. Pinette J, Mao S, Millis B, Krystofiak E, Faust J, Tyska M. Brush border protocadherin CDHR2 promotes the elongation and maximized packing of microvilli in vivo. Mol Biol Cell. 2019;30:108-118 pubmed publisher
  274. Yang L, Song L, Liu X, Bai L, Li G. KDM6A and KDM6B play contrasting roles in nuclear transfer embryos revealed by MERVL reporter system. EMBO Rep. 2018;19: pubmed publisher
  275. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed publisher
  276. Ke X, Do D, Li C, Zhao Y, Kollarik M, Fu Q, et al. Ras homolog family member A/Rho-associated protein kinase 1 signaling modulates lineage commitment of mesenchymal stem cells in asthmatic patients through lymphoid enhancer-binding factor 1. J Allergy Clin Immunol. 2019;143:1560-1574.e6 pubmed publisher
  277. Eley L, Alqahtani A, MacGrogan D, Richardson R, Murphy L, Salguero Jimenez A, et al. A novel source of arterial valve cells linked to bicuspid aortic valve without raphe in mice. elife. 2018;7: pubmed publisher
  278. Espinoza Sánchez N, Enciso J, Pelayo R, Fuentes Panana E. An NF?B-dependent mechanism of tumor cell plasticity and lateral transmission of aggressive features. Oncotarget. 2018;9:26679-26700 pubmed publisher
  279. Seo B, Cho T, Lee D, Lee J, Lee B, Kim S, et al. LARGE, an intellectual disability-associated protein, regulates AMPA-type glutamate receptor trafficking and memory. Proc Natl Acad Sci U S A. 2018;115:7111-7116 pubmed publisher
  280. Hojo N, Huisken A, Wang H, Chirshev E, Kim N, Nguyen S, et al. Snail knockdown reverses stemness and inhibits tumour growth in ovarian cancer. Sci Rep. 2018;8:8704 pubmed publisher
  281. Lau A, Chung H, Komada T, Platnich J, Sandall C, Choudhury S, et al. Renal immune surveillance and dipeptidase-1 contribute to contrast-induced acute kidney injury. J Clin Invest. 2018;128:2894-2913 pubmed publisher
  282. Klein M, Dickson M, Antonescu C, Qin L, Dooley S, Barlas A, et al. PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence. Oncogene. 2018;37:5066-5078 pubmed publisher
  283. Pommier A, Anaparthy N, Memos N, Kelley Z, Gouronnec A, Yan R, et al. Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science. 2018;360: pubmed publisher
  284. Hsu J, Xia W, Hsu Y, Chan L, Yu W, Cha J, et al. STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. Nat Commun. 2018;9:1908 pubmed publisher
  285. Wang X, Du C, He X, Deng X, He Y, Zhou X. MiR-4463 inhibits the migration of human aortic smooth muscle cells by AMOT. Biosci Rep. 2018;38: pubmed publisher
  286. Zhu Y, Qu C, Hong X, Jia Y, Lin M, Luo Y, et al. Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1. Cell Death Differ. 2019;26:306-320 pubmed publisher
  287. Rademaker G, Hennequière V, Brohée L, Nokin M, Lovinfosse P, Durieux F, et al. Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene. 2018;37:4398-4412 pubmed publisher
  288. Suzuki S, Tanaka A, Nakamura H, Murayama T. Knockout of Ceramide Kinase Aggravates Pathological and Lethal Responses in Mice with Experimental Colitis. Biol Pharm Bull. 2018;41:797-805 pubmed publisher
  289. Zheng C, Wang J, Lin M, Zhang P, Liu L, Lin J, et al. CDK5RAP3 suppresses Wnt/β-catenin signaling by inhibiting AKT phosphorylation in gastric cancer. J Exp Clin Cancer Res. 2018;37:59 pubmed publisher
  290. Perez García V, Fineberg E, Wilson R, Murray A, Mazzeo C, Tudor C, et al. Placentation defects are highly prevalent in embryonic lethal mouse mutants. Nature. 2018;555:463-468 pubmed publisher
  291. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  292. Takai K, Drain A, Lawson D, Littlepage L, Karpuj M, Kessenbrock K, et al. Discoidin domain receptor 1 (DDR1) ablation promotes tissue fibrosis and hypoxia to induce aggressive basal-like breast cancers. Genes Dev. 2018;32:244-257 pubmed publisher
  293. Hsieh W, Ramadesikan S, FEKETE D, Aguilar R. Kidney-differentiated cells derived from Lowe Syndrome patient's iPSCs show ciliogenesis defects and Six2 retention at the Golgi complex. PLoS ONE. 2018;13:e0192635 pubmed publisher
  294. Rogerson C, Gissen P. VPS33B and VIPAR are essential for epidermal lamellar body biogenesis and function. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1609-1621 pubmed publisher
  295. Fang L, Wu J, Huang T, Zhang P, Xin X, Shi Y. TGF-?1 stimulates epithelial-mesenchymal transition mediated by ADAM33. Exp Ther Med. 2018;15:985-992 pubmed publisher
  296. Sallais J, Alahari S, Tagliaferro A, Bhattacharjee J, Post M, Caniggia I. Factor inhibiting HIF1-A novel target of SUMOylation in the human placenta. Oncotarget. 2017;8:114002-114018 pubmed publisher
  297. Vl kov K, Vachtenheim J, R da J, Hor k P, Ondru ov L. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells. J Cell Mol Med. 2018;22:2240-2251 pubmed publisher
  298. Viswanath P, Radoul M, Izquierdo Garcia J, Ong W, Luchman H, Cairncross J, et al. 2-Hydroxyglutarate-Mediated Autophagy of the Endoplasmic Reticulum Leads to an Unusual Downregulation of Phospholipid Biosynthesis in Mutant IDH1 Gliomas. Cancer Res. 2018;78:2290-2304 pubmed publisher
  299. Panaliappan T, Wittmann W, Jidigam V, Mercurio S, Bertolini J, Sghari S, et al. Sox2 is required for olfactory pit formation and olfactory neurogenesis through BMP restriction and Hes5 upregulation. Development. 2018;145: pubmed publisher
  300. Schwab A, Siddiqui A, Vazakidou M, Napoli F, Böttcher M, Menchicchi B, et al. Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells. Cancer Res. 2018;78:1604-1618 pubmed publisher
  301. Capucha T, Koren N, Nassar M, Heyman O, Nir T, Levy M, et al. Sequential BMP7/TGF-β1 signaling and microbiota instruct mucosal Langerhans cell differentiation. J Exp Med. 2018;215:481-500 pubmed publisher
  302. Ekoue D, Ansong E, Liu L, Macias V, Deaton R, Lacher C, et al. Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer. Prostate. 2018;78:279-288 pubmed publisher
  303. Palesch D, Bosinger S, Tharp G, Vanderford T, Paiardini M, Chahroudi A, et al. Sooty mangabey genome sequence provides insight into AIDS resistance in a natural SIV host. Nature. 2018;553:77-81 pubmed publisher
  304. Park G, Kim D. Cigarette smoke-induced EGFR activation promotes epithelial mesenchymal migration of human retinal pigment epithelial cells through regulation of the FAK-mediated Syk/Src pathway. Mol Med Rep. 2018;17:3563-3574 pubmed publisher
  305. Liu L, Wu B, Cai H, Li D, Ma Y, Zhu X, et al. Tiam1 promotes thyroid carcinoma metastasis by modulating EMT via Wnt/?-catenin signaling. Exp Cell Res. 2018;362:532-540 pubmed publisher
  306. Yui S, Azzolin L, Maimets M, Pedersen M, Fordham R, Hansen S, et al. YAP/TAZ-Dependent Reprogramming of Colonic Epithelium Links ECM Remodeling to Tissue Regeneration. Cell Stem Cell. 2018;22:35-49.e7 pubmed publisher
  307. El Zowalaty A, Li R, Chen W, Ye X. Seipin deficiency leads to increased endoplasmic reticulum stress and apoptosis in mammary gland alveolar epithelial cells during lactation. Biol Reprod. 2018;98:570-578 pubmed publisher
  308. Yu R, Longo J, van Leeuwen J, Mullen P, Ba Alawi W, Haibe Kains B, et al. Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins. Cancer Res. 2018;78:1347-1357 pubmed publisher
  309. Spitzhorn L, Rahman M, Schwindt L, Ho H, Wruck W, Bohndorf M, et al. Isolation and Molecular Characterization of Amniotic Fluid-Derived Mesenchymal Stem Cells Obtained from Caesarean Sections. Stem Cells Int. 2017;2017:5932706 pubmed publisher
  310. Van Itallie C, Tietgens A, Aponte A, Gucek M, Cartagena Rivera A, Chadwick R, et al. MARCKS-related protein regulates cytoskeletal organization at cell-cell and cell-substrate contacts in epithelial cells. J Cell Sci. 2018;131: pubmed publisher
  311. Tucker A, Dyer C, Fons Romero J, Teshima T, Fuchs J, Thompson H. Mapping the distribution of stem/progenitor cells across the mouse middle ear during homeostasis and inflammation. Development. 2018;145: pubmed publisher
  312. Ma Q, Wang Y, Zhang T, Zuo W. Notch-mediated Sox9+ cell activation contributes to kidney repair after partial nephrectomy. Life Sci. 2018;193:104-109 pubmed publisher
  313. Brooks J, Fleischmann Mundt B, Woller N, Niemann J, Ribback S, Peters K, et al. Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer. Cancer Res. 2018;78:475-488 pubmed publisher
  314. Ruetz T, Pfisterer U, Di Stefano B, Ashmore J, Beniazza M, Tian T, et al. Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming. Cell Stem Cell. 2017;21:791-805.e9 pubmed publisher
  315. Blom S, Paavolainen L, Bychkov D, Turkki R, Mäki Teeri P, Hemmes A, et al. Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis. Sci Rep. 2017;7:15580 pubmed publisher
  316. You S, Guan Y, Li W. Epithelial?mesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3. Mol Med Rep. 2017;: pubmed publisher
  317. Xue X, Bredell B, Anderson E, Martin A, Mays C, Nagao Kitamoto H, et al. Quantitative proteomics identifies STEAP4 as a critical regulator of mitochondrial dysfunction linking inflammation and colon cancer. Proc Natl Acad Sci U S A. 2017;114:E9608-E9617 pubmed publisher
  318. Zhao X, Huang L, Xu W, Chen X, Shen Y, Zeng W, et al. Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling. Oncotarget. 2017;8:70130-70141 pubmed publisher
  319. Paikari A, D Belair C, Saw D, Blelloch R. The eutheria-specific miR-290 cluster modulates placental growth and maternal-fetal transport. Development. 2017;144:3731-3743 pubmed publisher
  320. Tchieu J, Zimmer B, Fattahi F, Amin S, Zeltner N, Chen S, et al. A Modular Platform for Differentiation of Human PSCs into All Major Ectodermal Lineages. Cell Stem Cell. 2017;21:399-410.e7 pubmed publisher
  321. Hama T, Nakanishi K, Sato M, Mukaiyama H, Togawa H, Shima Y, et al. Aberrant Smad3 phosphoisoforms in cyst-lining epithelial cells in the cpk mouse, a model of autosomal recessive polycystic kidney disease. Am J Physiol Renal Physiol. 2017;:ajprenal.00697.2016 pubmed publisher
  322. Jiang X, Bao Y, Liu H, Kou X, Zhang Z, Sun F, et al. VPS34 stimulation of p62 phosphorylation for cancer progression. Oncogene. 2017;36:6850-6862 pubmed publisher
  323. Rong X, Wang B, Palladino E, de Aguiar Vallim T, Ford D, Tontonoz P. ER phospholipid composition modulates lipogenesis during feeding and in obesity. J Clin Invest. 2017;127:3640-3651 pubmed publisher
  324. Luo W, Tan P, Rodriguez M, He L, Tan K, Zeng L, et al. Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition. J Biol Chem. 2017;292:15525-15537 pubmed publisher
  325. Katsumata O, Mori M, Sawane Y, Niimura T, Ito A, Okamoto H, et al. Cellular and subcellular localization of ADP-ribosylation factor 6 in mouse peripheral tissues. Histochem Cell Biol. 2017;148:577-596 pubmed publisher
  326. Toloczko A, Guo F, Yuen H, Wen Q, Wood S, Ong Y, et al. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway. Cancer Res. 2017;77:4921-4933 pubmed publisher
  327. Ren D, Yang Q, Dai Y, Guo W, Du H, Song L, et al. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-?B signaling pathway. Mol Cancer. 2017;16:117 pubmed publisher
  328. Xia Z, Wei J, Li Y, Wang J, Li W, Wang K, et al. Zebrafish slc30a10 deficiency revealed a novel compensatory mechanism of Atp2c1 in maintaining manganese homeostasis. PLoS Genet. 2017;13:e1006892 pubmed publisher
  329. Viswanathan V, Ryan M, Dhruv H, Gill S, Eichhoff O, Seashore Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453-457 pubmed publisher
  330. Hiramoto H, Muramatsu T, Ichikawa D, Tanimoto K, Yasukawa S, Otsuji E, et al. miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer. Sci Rep. 2017;7:4002 pubmed publisher
  331. Zhang C, Mao H, Cao Y. Nuclear accumulation of symplekin promotes cellular proliferation and dedifferentiation in an ERK1/2-dependent manner. Sci Rep. 2017;7:3769 pubmed publisher
  332. Xu P, Tao X, Zhao C, Huang Q, Chang H, Ban N, et al. DTX3L is upregulated in glioma and is associated with glioma progression. Int J Mol Med. 2017;40:491-498 pubmed publisher
  333. Liang X, Yuan X, Yu J, Wu Y, Li K, Sun C, et al. Histone Chaperone ASF1A Predicts Poor Outcomes for Patients With Gastrointestinal Cancer and Drives Cancer Progression by Stimulating Transcription of β-Catenin Target Genes. EBioMedicine. 2017;21:104-116 pubmed publisher
  334. Richardson R, Mitchell K, Hammond N, Mollo M, Kouwenhoven E, Wyatt N, et al. p63 exerts spatio-temporal control of palatal epithelial cell fate to prevent cleft palate. PLoS Genet. 2017;13:e1006828 pubmed publisher
  335. Zhang K, Myllymäki S, Gao P, Devarajan R, Kytölä V, Nykter M, et al. Oncogenic K-Ras upregulates ITGA6 expression via FOSL1 to induce anoikis resistance and synergizes with αV-Class integrins to promote EMT. Oncogene. 2017;36:5681-5694 pubmed publisher
  336. Cetera M, Leybova L, Woo F, Deans M, Devenport D. Planar cell polarity-dependent and independent functions in the emergence of tissue-scale hair follicle patterns. Dev Biol. 2017;428:188-203 pubmed publisher
  337. Logan C, Rajakaruna S, Bowen C, Radice G, Robinson M, Menko A. N-cadherin regulates signaling mechanisms required for lens fiber cell elongation and lens morphogenesis. Dev Biol. 2017;428:118-134 pubmed publisher
  338. Lu J, Yang Y, Guo G, Liu Y, Zhang Z, Dong S, et al. IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway. Oncotarget. 2017;8:49502-49514 pubmed publisher
  339. Benedicto I, Lehmann G, Ginsberg M, Nolan D, Bareja R, Elemento O, et al. Concerted regulation of retinal pigment epithelium basement membrane and barrier function by angiocrine factors. Nat Commun. 2017;8:15374 pubmed publisher
  340. Rauschenberger V, Bernkopf D, Krenn S, Jalal K, Heller J, Behrens J, et al. The phosphatase Pgam5 antagonizes Wnt/β-Catenin signaling in embryonic anterior-posterior axis patterning. Development. 2017;144:2234-2247 pubmed publisher
  341. Feldner A, Adam M, Tetzlaff F, Moll I, Komljenovic D, Sahm F, et al. Loss of Mpdz impairs ependymal cell integrity leading to perinatal-onset hydrocephalus in mice. EMBO Mol Med. 2017;9:890-905 pubmed publisher
  342. Xia L, Huang W, Bellani M, Seidman M, Wu K, Fan D, et al. CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor Genes. Cancer Cell. 2017;31:653-668.e7 pubmed publisher
  343. Giroux V, Lento A, Islam M, Pitarresi J, Kharbanda A, Hamilton K, et al. Long-lived keratin 15+ esophageal progenitor cells contribute to homeostasis and regeneration. J Clin Invest. 2017;127:2378-2391 pubmed publisher
  344. Hu L, Liang S, Chen H, Lv T, Wu J, Chen D, et al. ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis. Proc Natl Acad Sci U S A. 2017;114:E3964-E3973 pubmed publisher
  345. Olvedy M, Tisserand J, Luciani F, Boeckx B, Wouters J, Lopez S, et al. Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma. J Clin Invest. 2017;127:2310-2325 pubmed publisher
  346. Samson E, Tsao D, Zimak J, McLaughlin R, Trenton N, Mace E, et al. The coordinating role of IQGAP1 in the regulation of local, endosome-specific actin networks. Biol Open. 2017;6:785-799 pubmed publisher
  347. Riemer P, Rydenfelt M, Marks M, van Eunen K, Thedieck K, Herrmann B, et al. Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids. J Cell Biol. 2017;216:1567-1577 pubmed publisher
  348. Li P, Wang Y, Mao X, Jiang Y, Liu J, Li J, et al. CRB3 downregulation confers breast cancer stem cell traits through TAZ/?-catenin. Oncogenesis. 2017;6:e322 pubmed publisher
  349. Jeong S, Lim S, Schevzov G, Gunning P, Helfman D. Loss of Tpm4.1 leads to disruption of cell-cell adhesions and invasive behavior in breast epithelial cells via increased Rac1 signaling. Oncotarget. 2017;8:33544-33559 pubmed publisher
  350. Iglesia R, Prado M, Cruz L, Martins V, Santos T, Lopes M. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells. Stem Cell Res Ther. 2017;8:76 pubmed publisher
  351. Jiang P, Zhang D, Qiu H, Yi X, Zhang Y, Cao Y, et al. Tiron ameliorates high glucose-induced cardiac myocyte apoptosis by PKCδ-dependent inhibition of osteopontin. Clin Exp Pharmacol Physiol. 2017;44:760-770 pubmed publisher
  352. Tan W, Tan Q, Wang T, Lian M, Zhang L, Cheng Z. Calpain 1 regulates TGF-?1-induced epithelial-mesenchymal transition in human lung epithelial cells via PI3K/Akt signaling pathway. Am J Transl Res. 2017;9:1402-1409 pubmed
  353. Yan X, Zhu Z, Xu S, Yang L, Liao X, Zheng M, et al. MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways. Sci Rep. 2017;7:45915 pubmed publisher
  354. Kannan A, Hertweck K, Philley J, Wells R, Dasgupta S. Genetic Mutation and Exosome Signature of Human Papilloma Virus Associated Oropharyngeal Cancer. Sci Rep. 2017;7:46102 pubmed publisher
  355. Cho H, Kim J, Jang H, Lee T, Jung M, Kim T, et al. Alpha-lipoic acid ameliorates the epithelial mesenchymal transition induced by unilateral ureteral obstruction in mice. Sci Rep. 2017;7:46065 pubmed publisher
  356. Gibier J, Hemon B, Fanchon M, Gaudelot K, Pottier N, Ringot B, et al. Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phase. Biochim Biophys Acta Mol Basis Dis. 2017;1863:1336-1349 pubmed publisher
  357. Ahmed S, Macara I. The Par3 polarity protein is an exocyst receptor essential for mammary cell survival. Nat Commun. 2017;8:14867 pubmed publisher
  358. Samuel W, Jaworski C, Postnikova O, Kutty R, Duncan T, Tan L, et al. Appropriately differentiated ARPE-19 cells regain phenotype and gene expression profiles similar to those of native RPE cells. Mol Vis. 2017;23:60-89 pubmed
  359. Siddiqui A, Vazakidou M, Schwab A, Napoli F, Fernandez Molina C, Rapa I, et al. Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells. J Pathol. 2017;242:221-233 pubmed publisher
  360. Shen C, Kuo Y, Chen C, Chen M, Cheng Y. MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer. PLoS ONE. 2017;12:e0174487 pubmed publisher
  361. Liao L, Song M, Li X, Tang L, Zhang T, Zhang L, et al. E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer. Cancer Res. 2017;77:2090-2101 pubmed publisher
  362. Keckesova Z, Donaher J, De Cock J, Freinkman E, Lingrell S, Bachovchin D, et al. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature. 2017;543:681-686 pubmed publisher
  363. Solis N, Swidergall M, Bruno V, Gaffen S, Filler S. The Aryl Hydrocarbon Receptor Governs Epithelial Cell Invasion during Oropharyngeal Candidiasis. MBio. 2017;8: pubmed publisher
  364. Li N, Xue W, Yuan H, Dong B, Ding Y, Liu Y, et al. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis. J Clin Invest. 2017;127:1284-1302 pubmed publisher
  365. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed publisher
  366. Grasso S, Chapelle J, Salemme V, Aramu S, Russo I, Vitale N, et al. The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries. Nat Commun. 2017;8:14797 pubmed publisher
  367. Bi Y, Shen W, Min M, Liu Y. MicroRNA-7 functions as a tumor-suppressor gene by regulating ILF2 in pancreatic carcinoma. Int J Mol Med. 2017;39:900-906 pubmed publisher
  368. Li X, Liu W, Chen X, Wang Y, Shi D, Zhang H, et al. Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer. Int J Mol Med. 2017;39:927-935 pubmed publisher
  369. Li K, Mo C, Gong D, Chen Y, Huang Z, Li Y, et al. DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of β-catenin. Cancer Lett. 2017;400:194-202 pubmed publisher
  370. Chang Y, Lin T, Campbell M, Pan C, Lee S, Lee H, et al. REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer. Sci Rep. 2017;7:42795 pubmed publisher
  371. Garrido Gomez T, Ona K, Kapidzic M, Gormley M, Simon C, Genbacev O, et al. Severe pre-eclampsia is associated with alterations in cytotrophoblasts of the smooth chorion. Development. 2017;144:767-777 pubmed publisher
  372. Zhang L, Liu H, Mu X, Cui J, Peng Z. Dysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial-mesenchymal transition. Biosci Rep. 2017;37: pubmed publisher
  373. Takahashi T, Asano Y, Sugawara K, Yamashita T, Nakamura K, Saigusa R, et al. Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma. J Exp Med. 2017;214:1129-1151 pubmed publisher
  374. Lapierre L, Manning E, Mitchell K, Caldwell C, Goldenring J. Interaction of phosphorylated Rab11-FIP2 with Eps15 regulates apical junction composition. Mol Biol Cell. 2017;28:1088-1100 pubmed publisher
  375. Wu Y, Wang Y, Lin Y, Liu Y, Wang Y, Jia J, et al. Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation. Nat Commun. 2017;8:14228 pubmed publisher
  376. Tao L, Xiang D, Xie Y, Bronson R, Li Z. Induced p53 loss in mouse luminal cells causes clonal expansion and development of mammary tumours. Nat Commun. 2017;8:14431 pubmed publisher
  377. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  378. Wu Q, Yan H, Tao S, Wang X, Mou L, Chen P, et al. XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p. Oncotarget. 2017;8:16784-16800 pubmed publisher
  379. Xu W, Li B, Guan X, Chung S, Wang Y, Yip Y, et al. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression. Nat Commun. 2017;8:14399 pubmed publisher
  380. Genovese G, Carugo A, TEPPER J, Robinson F, Li L, Svelto M, et al. Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. Nature. 2017;542:362-366 pubmed publisher
  381. Qiu X, Pascal L, Song Q, Zang Y, Ai J, O Malley K, et al. Physical and Functional Interactions between ELL2 and RB in the Suppression of Prostate Cancer Cell Proliferation, Migration, and Invasion. Neoplasia. 2017;19:207-215 pubmed publisher
  382. Shu D, Wojciechowski M, Lovicu F. Bone Morphogenetic Protein-7 Suppresses TGF?2-Induced Epithelial-Mesenchymal Transition in the Lens: Implications for Cataract Prevention. Invest Ophthalmol Vis Sci. 2017;58:781-796 pubmed publisher
  383. Zhai S, Liu C, Zhang L, Zhu J, Guo J, Zhang J, et al. PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail. Neoplasia. 2017;19:154-164 pubmed publisher
  384. Gonzalez M, Martin E, Anwar T, Arellano Garcia C, Medhora N, Lama A, et al. Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth. Cell Rep. 2017;18:1215-1228 pubmed publisher
  385. Schiering C, Wincent E, Metidji A, Iseppon A, Li Y, Potocnik A, et al. Feedback control of AHR signalling regulates intestinal immunity. Nature. 2017;542:242-245 pubmed publisher
  386. Mindos T, Dun X, North K, Doddrell R, Schulz A, Edwards P, et al. Merlin controls the repair capacity of Schwann cells after injury by regulating Hippo/YAP activity. J Cell Biol. 2017;216:495-510 pubmed publisher
  387. Scheele C, Hannezo E, Muraro M, Zomer A, Langedijk N, van Oudenaarden A, et al. Identity and dynamics of mammary stem cells during branching morphogenesis. Nature. 2017;542:313-317 pubmed publisher
  388. He Y, Northey J, Pelletier A, Kos Z, Meunier L, Haibe Kains B, et al. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer. Oncogene. 2017;36:3490-3503 pubmed publisher
  389. Gamal W, Treskes P, Samuel K, Sullivan G, Siller R, Srsen V, et al. Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver. Sci Rep. 2017;7:37541 pubmed publisher
  390. Melchionna R, Iapicca P, Di Modugno F, Trono P, Sperduti I, Fassan M, et al. The pattern of hMENA isoforms is regulated by TGF-?1 in pancreatic cancer and may predict patient outcome. Oncoimmunology. 2016;5:e1221556 pubmed publisher
  391. Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, et al. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Biomed Pharmacother. 2017;88:421-429 pubmed publisher
  392. Zorin V, Pulin A, Eremin I, Korsakov I, Zorina A, Khromova N, et al. Myogenic potential of human alveolar mucosa derived cells. Cell Cycle. 2017;16:545-555 pubmed publisher
  393. Edwards R, Kopp S, Ifergan I, Shui J, Kronenberg M, Miller S, et al. Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy. Invest Ophthalmol Vis Sci. 2017;58:282-291 pubmed publisher
  394. Yu M, Lu B, Liu Y, Me Y, Wang L, Li H. Interference with Tim-3 protein expression attenuates the invasion of clear cell renal cell carcinoma and aggravates anoikis. Mol Med Rep. 2017;15:1103-1108 pubmed publisher
  395. Das S, Jackson W, Prasain J, Hanna A, Bailey S, Tucker J, et al. Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signaling. Sci Rep. 2017;7:40773 pubmed publisher
  396. Griggs L, Hassan N, Malik R, Griffin B, Martinez B, Elmore L, et al. Fibronectin fibrils regulate TGF-?1-induced Epithelial-Mesenchymal Transition. Matrix Biol. 2017;60-61:157-175 pubmed publisher
  397. Zhang Y, An J, Lv W, Lou T, Liu Y, Kang W. miRNA-129-5p suppresses cell proliferation and invasion in lung cancer by targeting microspherule protein 1, E-cadherin and vimentin. Oncol Lett. 2016;12:5163-5169 pubmed publisher
  398. Fang S, Yu L, Mei H, Yang J, Gao T, Cheng A, et al. Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail. Oncol Lett. 2016;12:5007-5014 pubmed publisher
  399. Gopal S, Veracini L, Grall D, Butori C, Schaub S, Audebert S, et al. Fibronectin-guided migration of carcinoma collectives. Nat Commun. 2017;8:14105 pubmed publisher
  400. Lango Chavarría M, Chimal Ramírez G, Ruiz Tachiquín M, Espinoza Sánchez N, Suárez Arriaga M, Fuentes Pananá E. A 22q11.2 amplification in the region encoding microRNA-650 correlates with the epithelial to mesenchymal transition in breast cancer primary cultures of Mexican patients. Int J Oncol. 2017;50:432-440 pubmed publisher
  401. Maltabe V, Barka E, Kontonika M, Florou D, Kouvara Pritsouli M, Roumpi M, et al. Isolation of an ES-Derived Cardiovascular Multipotent Cell Population Based on VE-Cadherin Promoter Activity. Stem Cells Int. 2016;2016:8305624 pubmed publisher
  402. Koh J, Kim S, Kim M, Go H, Jeon Y, Chung D. Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma. Oncotarget. 2017;8:13762-13769 pubmed publisher
  403. Hu C, Gan J. TRIM37 promotes epithelial?mesenchymal transition in colorectal cancer. Mol Med Rep. 2017;15:1057-1062 pubmed publisher
  404. Mescher M, Jeong P, Knapp S, Rübsam M, Saynisch M, Kranen M, et al. The epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanoma. J Exp Med. 2017;214:339-358 pubmed publisher
  405. Kim T, Terentyeva R, Roder K, Li W, Liu M, Greener I, et al. SK channel enhancers attenuate Ca2+-dependent arrhythmia in hypertrophic hearts by regulating mito-ROS-dependent oxidation and activity of RyR. Cardiovasc Res. 2017;113:343-353 pubmed publisher
  406. Kechele D, Blue R, Zwarycz B, Espenschied S, Mah A, Siegel M, et al. Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formation. J Clin Invest. 2017;127:593-607 pubmed publisher
  407. Yokoyama N, Ohta H, Kagawa Y, Leela Arporn R, Dermlim A, Nisa K, et al. Expression of apical junction complex proteins in colorectal mucosa of miniature dachshunds with inflammatory colorectal polyps. J Vet Med Sci. 2017;79:456-463 pubmed publisher
  408. Price A, Huang E, Sebastiano V, Dunn A. A semi-interpenetrating network of polyacrylamide and recombinant basement membrane allows pluripotent cell culture in a soft, ligand-rich microenvironment. Biomaterials. 2017;121:179-192 pubmed publisher
  409. Kozlovskaja GumbrienÄ— A, Yi R, Alexander R, Aman A, Jiskra R, Nagelberg D, et al. Proliferation-independent regulation of organ size by Fgf/Notch signaling. elife. 2017;6: pubmed publisher
  410. Salomon J, Gaston C, Magescas J, Duvauchelle B, Canioni D, Sengmanivong L, et al. Contractile forces at tricellular contacts modulate epithelial organization and monolayer integrity. Nat Commun. 2017;8:13998 pubmed publisher
  411. Jiang C, Diao F, Sang Y, Xu N, Zhu R, Wang X, et al. GGPP-Mediated Protein Geranylgeranylation in Oocyte Is Essential for the Establishment of Oocyte-Granulosa Cell Communication and Primary-Secondary Follicle Transition in Mouse Ovary. PLoS Genet. 2017;13:e1006535 pubmed publisher
  412. Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017;541:541-545 pubmed publisher
  413. Liu T, Yu J, Deng M, Yin Y, Zhang H, Luo K, et al. CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. Nat Commun. 2017;8:13923 pubmed publisher
  414. Morandi L, Righi A, Maletta F, Rucci P, Pagni F, Gallo M, et al. Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma. Endocr Relat Cancer. 2017;24:107-117 pubmed publisher
  415. Hichino A, Okamoto M, Taga S, Akizuki R, Endo S, Matsunaga T, et al. Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells. J Biol Chem. 2017;292:2411-2421 pubmed publisher
  416. Eritja N, Chen B, Rodríguez Barrueco R, Santacana M, Gatius S, Vidal A, et al. Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer. Autophagy. 2017;13:608-624 pubmed publisher
  417. McCracken K, Aihara E, Martin B, Crawford C, Broda T, Treguier J, et al. Wnt/β-catenin promotes gastric fundus specification in mice and humans. Nature. 2017;541:182-187 pubmed publisher
  418. Boylan K, Buchanan P, Manion R, Shukla D, Braumberger K, Bruggemeyer C, et al. The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate. Oncotarget. 2017;8:9717-9738 pubmed publisher
  419. Yu J, Lei R, Zhuang X, Li X, Li G, Lev S, et al. MicroRNA-182 targets SMAD7 to potentiate TGF?-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nat Commun. 2016;7:13884 pubmed publisher
  420. Wang S, Cheng Y, Zheng Y, He Z, Chen W, Zhou W, et al. PRKAR1A is a functional tumor suppressor inhibiting ERK/Snail/E-cadherin pathway in lung adenocarcinoma. Sci Rep. 2016;6:39630 pubmed publisher
  421. Zangari J, Ilie M, Rouaud F, Signetti L, Ohanna M, Didier R, et al. Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition. Nucleic Acids Res. 2017;45:4131-4141 pubmed publisher
  422. Han X, Fang Z, Wang H, Jiao R, Zhou J, Fang N. CUL4A functions as an oncogene in ovarian cancer and is directly regulated by miR-494. Biochem Biophys Res Commun. 2016;480:675-681 pubmed publisher
  423. Amoroso M, Matassa D, Agliarulo I, Avolio R, Lu H, Sisinni L, et al. TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition. Cell Death Dis. 2016;7:e2522 pubmed publisher
  424. Harper K, Sosa M, Entenberg D, Hosseini H, Cheung J, Nobre R, et al. Mechanism of early dissemination and metastasis in Her2+ mammary cancer. Nature. 2016;540:588-592 pubmed publisher
  425. Lloyd Lewis B, Davis F, Harris O, Hitchcock J, Lourenco F, Pasche M, et al. Imaging the mammary gland and mammary tumours in 3D: optical tissue clearing and immunofluorescence methods. Breast Cancer Res. 2016;18:127 pubmed
  426. Karki R, Man S, Malireddi R, Kesavardhana S, Zhu Q, Burton A, et al. NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer. Nature. 2016;540:583-587 pubmed publisher
  427. Tang Z, Li J, Shen Q, Feng J, Liu H, Wang W, et al. Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non-small cell lung cancer (NSCLC). Int J Cancer. 2017;140:1620-1632 pubmed publisher
  428. Bhagirath D, Zhao X, Mirza S, West W, Band H, Band V. Mutant PIK3CA Induces EMT in a Cell Type Specific Manner. PLoS ONE. 2016;11:e0167064 pubmed publisher
  429. Gao C, Su Y, Koeman J, Haak E, Dykema K, Essenberg C, et al. Chromosome instability drives phenotypic switching to metastasis. Proc Natl Acad Sci U S A. 2016;113:14793-14798 pubmed publisher
  430. Tamasas B, Cox T. Massively Increased Caries Susceptibility in an Irf6 Cleft Lip/Palate Model. J Dent Res. 2017;96:315-322 pubmed publisher
  431. Tsai Y, Nattiv R, Dedhia P, Nagy M, Chin A, Thomson M, et al. In vitro patterning of pluripotent stem cell-derived intestine recapitulates in vivo human development. Development. 2017;144:1045-1055 pubmed publisher
  432. Yuan J, Cha J, Deng W, Bartos A, Sun X, Ho H, et al. Planar cell polarity signaling in the uterus directs appropriate positioning of the crypt for embryo implantation. Proc Natl Acad Sci U S A. 2016;113:E8079-E8088 pubmed
  433. He X, Liu Z, Xia Y, Xu J, Lv G, Wang L, et al. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs. Oncotarget. 2017;8:1247-1261 pubmed publisher
  434. Burgy O, Bellaye P, Causse S, Beltramo G, Wettstein G, Boutanquoi P, et al. Pleural inhibition of the caspase-1/IL-1? pathway diminishes profibrotic lung toxicity of bleomycin. Respir Res. 2016;17:162 pubmed
  435. Hurtado Alvarado G, Dominguez Salazar E, Velazquez Moctezuma J, Gómez González B. A2A Adenosine Receptor Antagonism Reverts the Blood-Brain Barrier Dysfunction Induced by Sleep Restriction. PLoS ONE. 2016;11:e0167236 pubmed publisher
  436. Bryson B, Junk D, Cipriano R, Jackson M. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence. Cell Cycle. 2017;16:319-334 pubmed publisher
  437. Lin Z, Zhang Y, Xia Y, Xu X, Jiao X, Sun J. Salmonella enteritidis Effector AvrA Stabilizes Intestinal Tight Junctions via the JNK Pathway. J Biol Chem. 2016;291:26837-26849 pubmed publisher
  438. Chaudhury A, Cheema S, Fachini J, Kongchan N, Lu G, Simon L, et al. CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT. Nat Commun. 2016;7:13362 pubmed publisher
  439. Takano M, Shimada K, Fujii T, Morita K, Takeda M, Nakajima Y, et al. Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis. BMC Cancer. 2016;16:903 pubmed
  440. Yang S, Ji Q, Chang B, Wang Y, Zhu Y, Li D, et al. STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling. Oncotarget. 2017;8:5976-5991 pubmed publisher
  441. Pu W, Zhang H, Huang X, Tian X, He L, Wang Y, et al. Mfsd2a+ hepatocytes repopulate the liver during injury and regeneration. Nat Commun. 2016;7:13369 pubmed publisher
  442. Gong F, Guo Y, Niu Y, Jin J, Zhang X, Shi X, et al. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma. Oncotarget. 2017;8:315-328 pubmed publisher
  443. Chou H, Fong Y, Lin H, Tsai E, Chen J, Chang W, et al. An Acetamide Derivative as a Camptothecin Sensitizer for Human Non-Small-Cell Lung Cancer Cells through Increased Oxidative Stress and JNK Activation. Oxid Med Cell Longev. 2016;2016:9128102 pubmed
  444. Weitzenfeld P, Meshel T, Ben Baruch A. Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells. Oncotarget. 2016;7:81123-81143 pubmed publisher
  445. Bizzarro V, Belvedere R, Migliaro V, Romano E, Parente L, Petrella A. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness. Cell Adh Migr. 2017;11:247-260 pubmed publisher
  446. Cirillo N, Hassona Y, Celentano A, Lim K, Manchella S, Parkinson E, et al. Cancer-associated fibroblasts regulate keratinocyte cell-cell adhesion via TGF-β-dependent pathways in genotype-specific oral cancer. Carcinogenesis. 2017;38:76-85 pubmed publisher
  447. Noordstra I, Liu Q, Nijenhuis W, Hua S, Jiang K, Baars M, et al. Control of apico-basal epithelial polarity by the microtubule minus-end-binding protein CAMSAP3 and spectraplakin ACF7. J Cell Sci. 2016;129:4278-4288 pubmed
  448. Day K, Lorenzatti Hiles G, Kozminsky M, Dawsey S, Paul A, Broses L, et al. HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone. Cancer Res. 2017;77:74-85 pubmed publisher
  449. Varga E, Nemes C, Táncos Z, Bock I, Berzsenyi S, Lévay G, et al. Establishment of EHMT1 mutant induced pluripotent stem cell (iPSC) line from a 11-year-old Kleefstra syndrome (KS) patient with autism and normal intellectual performance. Stem Cell Res. 2016;17:531-533 pubmed publisher
  450. JENKINS L, Singh P, Varadaraj A, Lee N, Shah S, Flores H, et al. Altering the Proteoglycan State of Transforming Growth Factor ? Type III Receptor (T?RIII)/Betaglycan Modulates Canonical Wnt/?-Catenin Signaling. J Biol Chem. 2016;291:25716-25728 pubmed
  451. Davis F, Lloyd Lewis B, Harris O, Kozar S, Winton D, Muresan L, et al. Single-cell lineage tracing in the mammary gland reveals stochastic clonal dispersion of stem/progenitor cell progeny. Nat Commun. 2016;7:13053 pubmed publisher
  452. Sheets J, Iwanicki M, Liu J, Howitt B, Hirsch M, Gubbels J, et al. SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance. Oncogenesis. 2016;5:e264 pubmed publisher
  453. Ray S, Chiba N, Yao C, Guan X, McConnell A, Brockway B, et al. Rare SOX2+ Airway Progenitor Cells Generate KRT5+ Cells that Repopulate Damaged Alveolar Parenchyma following Influenza Virus Infection. Stem Cell Reports. 2016;7:817-825 pubmed publisher
  454. Cronan M, Beerman R, ROSENBERG A, Saelens J, Johnson M, Oehlers S, et al. Macrophage Epithelial Reprogramming Underlies Mycobacterial Granuloma Formation and Promotes Infection. Immunity. 2016;45:861-876 pubmed publisher
  455. Zhao X, Li L, Wang X, Fu R, Lv Y, Jin W, et al. Inhibition of Snail Family Transcriptional Repressor 2 (SNAI2) Enhances Multidrug Resistance of Hepatocellular Carcinoma Cells. PLoS ONE. 2016;11:e0164752 pubmed publisher
  456. Che D, Zhou T, Lan Y, Xie J, Gong H, Li C, et al. High glucose-induced epithelial-mesenchymal transition contributes to the upregulation of fibrogenic factors in retinal pigment epithelial cells. Int J Mol Med. 2016;38:1815-1822 pubmed publisher
  457. Busch A, Bauer L, Wardelmann E, Rudack C, Grünewald I, Stenner M. Prognostic relevance of epithelial-mesenchymal transition and proliferation in surgically treated primary parotid gland cancer. J Clin Pathol. 2017;70:403-409 pubmed publisher
  458. Matsuura K, Huang N, Cocce K, Zhang L, Kornbluth S. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin. Oncogene. 2017;36:1698-1706 pubmed publisher
  459. Shenoy A, Jin Y, Luo H, Tang M, Pampo C, Shao R, et al. Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells. J Clin Invest. 2016;126:4174-4186 pubmed publisher
  460. Liu B, Dong H, Lin X, Yang X, Yue X, Yang J, et al. RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion. Oncotarget. 2016;7:82411-82423 pubmed publisher
  461. Mai H, Xu X, Mei G, Hong T, Huang J, Wang T, et al. The interplay between HPIP and casein kinase 1? promotes renal cell carcinoma growth and metastasis via activation of mTOR pathway. Oncogenesis. 2016;5:e260 pubmed publisher
  462. Little A, Sham D, Hristova M, Danyal K, Heppner D, Bauer R, et al. DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties. Oncogenesis. 2016;5:e261 pubmed publisher
  463. Dubail J, Vasudevan D, Wang L, Earp S, Jenkins M, Haltiwanger R, et al. Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome. Sci Rep. 2016;6:33974 pubmed publisher
  464. Matos M, Lapyckyj L, Rosso M, Besso M, Mencucci M, Briggiler C, et al. Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events. J Cell Physiol. 2017;232:1368-1386 pubmed publisher
  465. Dye B, Dedhia P, Miller A, Nagy M, White E, Shea L, et al. A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids. elife. 2016;5: pubmed publisher
  466. Cao R, Meng Z, Liu T, Wang G, Qian G, Cao T, et al. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway. Oncotarget. 2016;7:72941-72960 pubmed publisher
  467. Zimmerlin L, Park T, Huo J, Verma K, Pather S, Talbot C, et al. Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality. Development. 2016;143:4368-4380 pubmed
  468. Runge T, Shaheen N, Djukic Z, Hallquist S, Orlando R. Cleavage of E-Cadherin Contributes to Defective Barrier Function in Neosquamous Epithelium. Dig Dis Sci. 2016;61:3169-3175 pubmed
  469. Lee E, Wang J, Yumoto K, Jung Y, Cackowski F, Decker A, et al. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis. Neoplasia. 2016;18:553-66 pubmed publisher
  470. Kim M, Jeong J, Seo J, Kim H, Kim S, Jin W. Dysregulated JAK2 expression by TrkC promotes metastasis potential, and EMT program of metastatic breast cancer. Sci Rep. 2016;6:33899 pubmed publisher
  471. Hubbs A, Fluharty K, Edwards R, Barnabei J, Grantham J, Palmer S, et al. Accumulation of Ubiquitin and Sequestosome-1 Implicate Protein Damage in Diacetyl-Induced Cytotoxicity. Am J Pathol. 2016;186:2887-2908 pubmed publisher
  472. Wang H, Han X, Bretz C, Becker S, Gambhir D, Smith G, et al. Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization. Mol Ther Methods Clin Dev. 2016;3:16056 pubmed publisher
  473. Hesler R, Huang J, Starr M, Treboschi V, Bernanke A, Nixon A, et al. TGF-?-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3. Carcinogenesis. 2016;37:1041-1051 pubmed publisher
  474. Kong X, Liu F, Gao J. MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathways. Oncotarget. 2016;7:66051-66060 pubmed publisher
  475. Li J, Yang Z, Chen Z, Bao Y, Zhang H, Fang X, et al. ATF3 suppresses ESCC via downregulation of ID1. Oncol Lett. 2016;12:1642-1648 pubmed
  476. Liu P, Wang C, Ma C, Wu Q, Zhang W, Lao G. MicroRNA-23a regulates epithelial-to-mesenchymal transition in endometrial endometrioid adenocarcinoma by targeting SMAD3. Cancer Cell Int. 2016;16:67 pubmed publisher
  477. Chung I, Reichelt M, Shao L, Akita R, Koeppen H, Rangell L, et al. High cell-surface density of HER2 deforms cell membranes. Nat Commun. 2016;7:12742 pubmed publisher
  478. Balusu S, Van Wonterghem E, De Rycke R, Raemdonck K, Stremersch S, Gevaert K, et al. Identification of a novel mechanism of blood-brain communication during peripheral inflammation via choroid plexus-derived extracellular vesicles. EMBO Mol Med. 2016;8:1162-1183 pubmed publisher
  479. Vardaki I, Ceder S, Rutishauser D, Baltatzis G, Foukakis T, Panaretakis T. Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes. Oncotarget. 2016;7:74966-74978 pubmed publisher
  480. Cardoso J, Mesquita M, Dias Pereira A, Bettencourt Dias M, Chaves P, Pereira Leal J. CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett's Esophagus Malignant Progression. PLoS ONE. 2016;11:e0161967 pubmed publisher
  481. Wegwitz F, Lenfert E, Gerstel D, von Ehrenstein L, Einhoff J, Schmidt G, et al. CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo. Oncotarget. 2016;7:63730-63746 pubmed publisher
  482. Jones R, Robinson T, Liu J, Shrestha M, Voisin V, Ju Y, et al. RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation. J Clin Invest. 2016;126:3739-3757 pubmed publisher
  483. Lan A, Blais A, Coelho D, Capron J, Maarouf M, Benamouzig R, et al. Dual effects of a high-protein diet on DSS-treated mice during colitis resolution phase. Am J Physiol Gastrointest Liver Physiol. 2016;311:G624-G633 pubmed publisher
  484. Feringa F, Krenning L, Koch A, van den Berg J, van den Broek B, Jalink K, et al. Hypersensitivity to DNA damage in antephase as a safeguard for genome stability. Nat Commun. 2016;7:12618 pubmed publisher
  485. Tancos Z, Varga E, Kovacs E, Dinnyes A, Kobolak J. Establishment of induced pluripotent stem cell (iPSC) line from a 75-year old patient with late onset Alzheimer's disease (LOAD). Stem Cell Res. 2016;17:81-83 pubmed publisher
  486. Chandrasekaran A, Varga E, Nemes C, Tancos Z, Kobolak J, Dinnyes A. Establishment of induced pluripotent stem cell (iPSC) line from a 63-year old patient with late onset Alzheimer's disease (LOAD). Stem Cell Res. 2016;17:78-80 pubmed publisher
  487. Tancos Z, Varga E, Kovacs E, Dinnyes A, Kobolak J. Establishment of induced pluripotent stem cell (iPSC) line from an 84-year old patient with late onset Alzheimer's disease (LOAD). Stem Cell Res. 2016;17:75-77 pubmed publisher
  488. Ochalek A, Nemes C, Varga E, Tancos Z, Kobolak J, Dinnyes A. Establishment of induced pluripotent stem cell (iPSC) line from a 57-year old patient with sporadic Alzheimer's disease. Stem Cell Res. 2016;17:72-74 pubmed publisher
  489. Ayres Pereira M, Mandel Clausen T, Pehrson C, Mao Y, Resende M, Daugaard M, et al. Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1. PLoS Pathog. 2016;12:e1005831 pubmed publisher
  490. Hong J, Shin M, Douglas I, Chung K, Kim E, Jung J, et al. Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury. Clin Sci (Lond). 2016;130:1993-2003 pubmed
  491. Olsen J, Wong L, Deimling S, Miles A, Guo H, Li Y, et al. G9a and ZNF644 Physically Associate to Suppress Progenitor Gene Expression during Neurogenesis. Stem Cell Reports. 2016;7:454-470 pubmed publisher
  492. Efazat G, Novak M, Kaminskyy V, De Petris L, Kanter L, Juntti T, et al. Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer. Oncotarget. 2016;7:60332-60347 pubmed publisher
  493. Liu L, Phua Y, Lee R, Ma X, Jenkins Y, Novy K, et al. Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases. J Biol Chem. 2016;291:21571-21583 pubmed
  494. Arévalo Romero H, Meza I, Vallejo Flores G, Fuentes Panana E. Helicobacter pylori CagA and IL-1? Promote the Epithelial-to-Mesenchymal Transition in a Nontransformed Epithelial Cell Model. Gastroenterol Res Pract. 2016;2016:4969163 pubmed publisher
  495. Wang R, Ma X, Li Y, He Y, Huang D, Cai S, et al. The Characteristics and Prognostic Effect of E-Cadherin Expression in Colorectal Signet Ring Cell Carcinoma. PLoS ONE. 2016;11:e0160527 pubmed publisher
  496. Hendrick J, Franz Wachtel M, Moeller Y, Schmid S, Macek B, Olayioye M. The polarity protein Scribble positions DLC3 at adherens junctions to regulate Rho signaling. J Cell Sci. 2016;129:3583-3596 pubmed
  497. LAW M, Ferreira R, Davis B, Higgins P, Kim J, Castellano R, et al. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment. Breast Cancer Res. 2016;18:80 pubmed publisher
  498. Oh B, Kim S, Lee Y, Hong H, Kim T, Kim S, et al. Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells. Oncotarget. 2016;7:57066-57076 pubmed publisher
  499. Li C, Li Q, Cai Y, He Y, Lan X, Wang W, et al. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis. Cancer Gene Ther. 2016;23:295-302 pubmed publisher
  500. Huang C, Liu H, Gong X, Wen B, Chen D, Liu J, et al. Analysis of different components in the peritumoral tissue microenvironment of colorectal cancer: A potential prospect in tumorigenesis. Mol Med Rep. 2016;14:2555-65 pubmed publisher
  501. Eom B, Joo J, Park B, Jo M, Choi S, Cho S, et al. Nomogram Incorporating CD44v6 and Clinicopathological Factors to Predict Lymph Node Metastasis for Early Gastric Cancer. PLoS ONE. 2016;11:e0159424 pubmed publisher
  502. Reginensi A, Enderle L, Gregorieff A, Johnson R, Wrana J, McNeill H. A critical role for NF2 and the Hippo pathway in branching morphogenesis. Nat Commun. 2016;7:12309 pubmed publisher
  503. Sengupta D, Deb M, Rath S, Kar S, Parbin S, Pradhan N, et al. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop. Exp Cell Res. 2016;346:176-87 pubmed publisher
  504. Chiang K, Hsu S, Lin S, Yeh C, Pang J, Wang S, et al. PTEN Insufficiency Increases Breast Cancer Cell Metastasis In Vitro and In Vivo in a Xenograft Zebrafish Model. Anticancer Res. 2016;36:3997-4005 pubmed
  505. Kim R, Kaushik N, Suh Y, Yoo K, Cui Y, Kim M, et al. Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer. Oncotarget. 2016;7:53430-53442 pubmed publisher
  506. Chen H, Jia W, Li J. ECM1 promotes migration and invasion of hepatocellular carcinoma by inducing epithelial-mesenchymal transition. World J Surg Oncol. 2016;14:195 pubmed publisher
  507. Ku T, Swaney J, Park J, Albanese A, Murray E, Cho J, et al. Multiplexed and scalable super-resolution imaging of three-dimensional protein localization in size-adjustable tissues. Nat Biotechnol. 2016;34:973-81 pubmed publisher
  508. Jiang S, Gao Y, Hou W, Liu R, Qi X, Xu X, et al. Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway. Oncol Lett. 2016;12:1380-1386 pubmed
  509. Liu Y, Wang K, Xing H, Zhai X, Wang L, Wang W. Attempt towards a novel classification of triple-negative breast cancer using immunohistochemical markers. Oncol Lett. 2016;12:1240-1256 pubmed
  510. Raguz J, Jerić I, Niault T, Nowacka J, Kuzet S, Rupp C, et al. Epidermal RAF prevents allergic skin disease. elife. 2016;5: pubmed publisher
  511. Mihajlovic A, Bruce A. Rho-associated protein kinase regulates subcellular localisation of Angiomotin and Hippo-signalling during preimplantation mouse embryo development. Reprod Biomed Online. 2016;33:381-90 pubmed publisher
  512. Ben Ismail M, Carreiras F, Agniel R, Mili D, Sboui D, Zanina N, et al. Application of APTES-Anti-E-cadherin film for early cancer monitoring. Colloids Surf B Biointerfaces. 2016;146:550-7 pubmed publisher
  513. Fu H, Ma Y, Yang M, Zhang C, Huang H, Xia Y, et al. Persisting and Increasing Neutrophil Infiltration Associates with Gastric Carcinogenesis and E-cadherin Downregulation. Sci Rep. 2016;6:29762 pubmed publisher
  514. Pijuan Galitó S, Tamm C, Schuster J, Sobol M, Forsberg L, Merry C, et al. Human serum-derived protein removes the need for coating in defined human pluripotent stem cell culture. Nat Commun. 2016;7:12170 pubmed publisher
  515. Zhang Y, Velez Delgado A, Mathew E, Li D, Mendez F, Flannagan K, et al. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer. Gut. 2017;66:124-136 pubmed publisher
  516. Virág J, Haberler C, Baksa G, Piurko V, Hegedûs Z, Reiniger L, et al. Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases. Pathol Oncol Res. 2017;23:245-252 pubmed publisher
  517. Grassi M, Palma C, Thomé C, Lanfredi G, Poersch A, Faça V. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control. J Proteomics. 2017;151:2-11 pubmed publisher
  518. Yang S, Tsai C, Pan Y, Yeh C, Pang J, Takano M, et al. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells. Drug Des Devel Ther. 2016;10:1995-2002 pubmed publisher
  519. Wu D, Chen C, Wu Z, Liu B, Gao L, Yang Q, et al. ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma. J Exp Clin Cancer Res. 2016;35:108 pubmed publisher
  520. Zhang Q, Liu S, Parajuli K, Zhang W, Zhang K, Mo Z, et al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene. 2017;36:687-699 pubmed publisher
  521. Hatem R, El Botty R, Chateau Joubert S, Servely J, Labiod D, de Plater L, et al. Targeting mTOR pathway inhibits tumor growth in different molecular subtypes of triple-negative breast cancers. Oncotarget. 2016;7:48206-48219 pubmed publisher
  522. Stock K, Estrada M, Vidic S, Gjerde K, Rudisch A, Santo V, et al. Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery. Sci Rep. 2016;6:28951 pubmed publisher
  523. Schokrpur S, Hu J, Moughon D, Liu P, Lin L, Hermann K, et al. CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma. Sci Rep. 2016;6:29032 pubmed publisher
  524. Xie Y, Lu W, Liu S, Yang Q, Goodwin J, Sathyanarayana S, et al. MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo. Oncotarget. 2016;7:47609-47619 pubmed publisher
  525. Lin X, Yang Z, Zhang P, Liu Y, Shao G. miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2. Oncol Lett. 2016;12:301-306 pubmed
  526. Li H, Mai R, Huang H, Chou C, Chang Y, Chang Y, et al. DDX3 Represses Stemness by Epigenetically Modulating Tumor-suppressive miRNAs in Hepatocellular Carcinoma. Sci Rep. 2016;6:28637 pubmed publisher
  527. Dutta A, Le Magnen C, Mitrofanova A, Ouyang X, Califano A, Abate Shen C. Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation. Science. 2016;352:1576-80 pubmed publisher
  528. Campos Y, Qiu X, Gomero E, Wakefield R, Horner L, Brutkowski W, et al. Alix-mediated assembly of the actomyosin-tight junction polarity complex preserves epithelial polarity and epithelial barrier. Nat Commun. 2016;7:11876 pubmed publisher
  529. Folmsbee S, Wilcox D, Tyberghein K, De Bleser P, Tourtellotte W, van Hengel J, et al. ?T-catenin in restricted brain cell types and its potential connection to autism. J Mol Psychiatry. 2016;4:2 pubmed publisher
  530. Helmke C, Raab M, Rodel F, Matthess Y, Oellerich T, Mandal R, et al. Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8. Cell Res. 2016;26:914-34 pubmed publisher
  531. Chakedis J, French R, Babicky M, Jaquish D, Mose E, Cheng P, et al. Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics. Oncotarget. 2016;7:45959-45975 pubmed publisher
  532. Shriver M, Marimuthu S, Paul C, Geist J, Seale T, Konstantopoulos K, et al. Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunit. Oncotarget. 2016;7:45414-45428 pubmed publisher
  533. Quantius J, Schmoldt C, Vazquez Armendariz A, Becker C, El Agha E, Wilhelm J, et al. Influenza Virus Infects Epithelial Stem/Progenitor Cells of the Distal Lung: Impact on Fgfr2b-Driven Epithelial Repair. PLoS Pathog. 2016;12:e1005544 pubmed publisher
  534. Toneff M, Sreekumar A, Tinnirello A, Hollander P, Habib S, Li S, et al. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states. BMC Biol. 2016;14:47 pubmed publisher
  535. Tisza M, Zhao W, Fuentes J, Prijic S, Chen X, Levental I, et al. Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts. Oncotarget. 2016;7:51553-51568 pubmed publisher
  536. Pomo J, Taylor R, Gullapalli R. Influence of TP53 and CDH1 genes in hepatocellular cancer spheroid formation and culture: a model system to understand cancer cell growth mechanics. Cancer Cell Int. 2016;16:44 pubmed publisher
  537. Li Q, Sodroski C, Lowey B, Schweitzer C, Cha H, Zhang F, et al. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition. Proc Natl Acad Sci U S A. 2016;113:7620-5 pubmed publisher
  538. Zeng L, Yang X, Wen Y, Mail S, Wang M, Zhang M, et al. Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma. Aging (Albany NY). 2016;8:1236-49 pubmed publisher
  539. Dianati E, Poiraud J, Weber Ouellette A, Plante I. Connexins, E-cadherin, Claudin-7 and ?-catenin transiently form junctional nexuses during the post-natal mammary gland development. Dev Biol. 2016;416:52-68 pubmed publisher
  540. Priego N, Arechederra M, Sequera C, Bragado P, Vázquez Carballo A, Gutierrez Uzquiza A, et al. C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38? activation, while it impairs tumor growth through p38?-independent mechanisms. Oncotarget. 2016;7:45060-45078 pubmed publisher
  541. Guo Y, Wang L, Li B, Xu H, Yang J, Zheng L, et al. Wnt/?-catenin pathway transactivates microRNA-150 that promotes EMT of colorectal cancer cells by suppressing CREB signaling. Oncotarget. 2016;7:42513-42526 pubmed publisher
  542. Wuidart A, Ousset M, Rulands S, Simons B, Van Keymeulen A, Blanpain C. Quantitative lineage tracing strategies to resolve multipotency in tissue-specific stem cells. Genes Dev. 2016;30:1261-77 pubmed publisher
  543. Hao Y, Chow A, Yip W, Li C, Wan T, Tong B, et al. G protein-coupled estrogen receptor inhibits the P2Y receptor-mediated Ca(2+) signaling pathway in human airway epithelia. Pflugers Arch. 2016;468:1489-503 pubmed publisher
  544. Chen H, Lorton B, Gupta V, Shechter D. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression. Oncogene. 2017;36:373-386 pubmed publisher
  545. Parang B, Bradley A, Mittal M, Short S, Thompson J, Barrett C, et al. Myeloid translocation genes differentially regulate colorectal cancer programs. Oncogene. 2016;35:6341-6349 pubmed publisher
  546. Yao Y, Cui Y, Qiu X, Zhang L, Zhang W, Li H, et al. Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells. Chin J Cancer. 2016;35:50 pubmed publisher
  547. Andersen A, Flinck M, Oernbo E, Pedersen N, Viuff B, Pedersen S. Roles of acid-extruding ion transporters in regulation of breast cancer cell growth in a 3-dimensional microenvironment. Mol Cancer. 2016;15:45 pubmed publisher
  548. Kuang J, Li L, Guo L, Su Y, Wang Y, Xu Y, et al. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells. J Exp Clin Cancer Res. 2016;35:88 pubmed publisher
  549. Kajiho H, Kajiho Y, Frittoli E, Confalonieri S, Bertalot G, Viale G, et al. RAB2A controls MT1-MMP endocytic and E-cadherin polarized Golgi trafficking to promote invasive breast cancer programs. EMBO Rep. 2016;17:1061-80 pubmed publisher
  550. Liu S, Barry E, Baron J, Rutherford R, Seabrook M, Bostick R. Effects of supplemental calcium and vitamin D on the APC/β-catenin pathway in the normal colorectal mucosa of colorectal adenoma patients. Mol Carcinog. 2017;56:412-424 pubmed publisher
  551. Raman R, Damle I, Rote R, Banerjee S, Dingare C, Sonawane M. aPKC regulates apical localization of Lgl to restrict elongation of microridges in developing zebrafish epidermis. Nat Commun. 2016;7:11643 pubmed publisher
  552. Clark A, Petty H. Identification of lesion subtypes in biopsies of ductal carcinoma in situ of the breast using biomarker ratio imaging microscopy. Sci Rep. 2016;6:27039 pubmed publisher
  553. He Y, Ou Z, Chen X, Zu X, Liu L, Li Y, et al. LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia. Sci Rep. 2016;6:27051 pubmed publisher
  554. Qi J, Li T, Bian H, Li F, Ju Y, Gao S, et al. SNAI1 promotes the development of HCC through the enhancement of proliferation and inhibition of apoptosis. FEBS Open Bio. 2016;6:326-37 pubmed publisher
  555. Lee S, Kim H, Kim K, Lee H, Lee S, Lee D. Arhgap17, a RhoGTPase activating protein, regulates mucosal and epithelial barrier function in the mouse colon. Sci Rep. 2016;6:26923 pubmed publisher
  556. Bai H, Zhu Q, Surcel A, Luo T, Ren Y, Guan B, et al. Yes-associated protein impacts adherens junction assembly through regulating actin cytoskeleton organization. Am J Physiol Gastrointest Liver Physiol. 2016;311:G396-411 pubmed publisher
  557. Hong L, Pan F, Jiang H, Zhang L, Liu Y, Cai C, et al. miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7. Onco Targets Ther. 2016;9:2639-48 pubmed publisher
  558. Chen X, Stauffer S, Chen Y, Dong J. Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis. J Biol Chem. 2016;291:14761-72 pubmed publisher
  559. Chesnokova V, Zonis S, Zhou C, Recouvreux M, Ben Shlomo A, Araki T, et al. Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A. 2016;113:E3250-9 pubmed publisher
  560. Kuga T, Sasaki M, Mikami T, Miake Y, Adachi J, Shimizu M, et al. FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes. Sci Rep. 2016;6:26557 pubmed publisher
  561. Piton N, Wason J, Colasse É, Cornic M, Lemoine F, Le Pessot F, et al. Endoplasmic reticulum stress, unfolded protein response and development of colon adenocarcinoma. Virchows Arch. 2016;469:145-54 pubmed publisher
  562. Kokado M, Okada Y, Miyamoto T, Yamanaka O, Saika S. Effects of epiplakin-knockdown in cultured corneal epithelial cells. BMC Res Notes. 2016;9:278 pubmed publisher
  563. He F, Wei L, Luo W, Liao Z, Li B, Zhou X, et al. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS. Oncotarget. 2016;7:37000-37012 pubmed publisher
  564. Chen C, Wang S, Chan P, Shen M, Chen H. Phosphorylation of E-cadherin at threonine 790 by protein kinase C? reduces ?-catenin binding and suppresses the function of E-cadherin. Oncotarget. 2016;7:37260-37276 pubmed publisher
  565. Chung M, Lee J, Kim S, Suh Y, Choi H. Simple Prediction Model of Axillary Lymph Node Positivity After Analyzing Molecular and Clinical Factors in Early Breast Cancer. Medicine (Baltimore). 2016;95:e3689 pubmed publisher
  566. Petit F, Deng C, Jamin S. Partial Müllerian Duct Retention in Smad4 Conditional Mutant Male Mice. Int J Biol Sci. 2016;12:667-76 pubmed publisher
  567. Morton P, Hicks A, Ortiz Zapater E, Raghavan S, Pike R, Noble A, et al. TNFα promotes CAR-dependent migration of leukocytes across epithelial monolayers. Sci Rep. 2016;6:26321 pubmed publisher
  568. Zhang H, Prado K, Zhang K, Peek E, Lee J, Wang X, et al. Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance. Clin Cancer Res. 2016;22:5349-5361 pubmed
  569. Lin S, Wang B, Lin C, Chien P, Wu Y, Ko J, et al. Chidamide alleviates TGF-?-induced epithelial-mesenchymal transition in lung cancer cell lines. Mol Biol Rep. 2016;43:687-95 pubmed publisher
  570. de Jong P, Taniguchi K, Harris A, Bertin S, Takahashi N, Duong J, et al. ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation. Nat Commun. 2016;7:11551 pubmed publisher
  571. Jehanno C, Flouriot G, Nicol Benoît F, Le Page Y, Le Goff P, Michel D. Envisioning metastasis as a transdifferentiation phenomenon clarifies discordant results on cancer. Breast Dis. 2016;36:47-59 pubmed publisher
  572. Yang Y, Lu Y, Wang L, Mizokami A, Keller E, Zhang J, et al. Skp2 is associated with paclitaxel resistance in prostate cancer cells. Oncol Rep. 2016;36:559-66 pubmed publisher
  573. Lee Y, Kim S, Song S, Hong H, Lee Y, Oh B, et al. Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways. Oncotarget. 2016;7:36842-36853 pubmed publisher
  574. Giovannini C, Minguzzi M, Genovese F, Baglioni M, Gualandi A, Ravaioli M, et al. Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma. Oncotarget. 2016;7:39609-39626 pubmed publisher
  575. Miyawaki S, Kawamura Y, Oiwa Y, Shimizu A, Hachiya T, Bono H, et al. Tumour resistance in induced pluripotent stem cells derived from naked mole-rats. Nat Commun. 2016;7:11471 pubmed publisher
  576. Tsai L, Chang Y, Lee M, Chang Y, Hwang P, Huang Y, et al. Biphasic and Stage-Associated Expression of CPEB4 in Hepatocellular Carcinoma. PLoS ONE. 2016;11:e0155025 pubmed publisher
  577. Teo W, Merino V, Cho S, Korangath P, Liang X, Wu R, et al. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24. Oncogene. 2016;35:5539-5551 pubmed publisher
  578. Lombardo G, Dentelli P, Togliatto G, Rosso A, Gili M, Gallo S, et al. Activated Stat5 trafficking Via Endothelial Cell-derived Extracellular Vesicles Controls IL-3 Pro-angiogenic Paracrine Action. Sci Rep. 2016;6:25689 pubmed publisher
  579. Payan Carreira R, Pires M, Santos C, Holst B, Colaco J, Rodriguez Martinez H. Immunolocalization of E-cadherin and ?-catenin in the cyclic and early pregnant canine endometrium. Theriogenology. 2016;86:1092-1101 pubmed publisher
  580. Marei H, Carpy A, Macek B, Malliri A. Proteomic analysis of Rac1 signaling regulation by guanine nucleotide exchange factors. Cell Cycle. 2016;15:1961-74 pubmed publisher
  581. Vorvis C, Hatziapostolou M, Mahurkar Joshi S, Koutsioumpa M, Williams J, Donahue T, et al. Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. Am J Physiol Gastrointest Liver Physiol. 2016;310:G1124-37 pubmed publisher
  582. Ho T, Guilbaud G, Blow J, Sale J, Watson C. The KRAB Zinc Finger Protein Roma/Zfp157 Is a Critical Regulator of Cell-Cycle Progression and Genomic Stability. Cell Rep. 2016;15:724-734 pubmed publisher
  583. Bie Q, Sun C, Gong A, Li C, Su Z, Zheng D, et al. Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer. Sci Rep. 2016;6:25447 pubmed publisher
  584. Alaee M, Danesh G, Pasdar M. Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53. PLoS ONE. 2016;11:e0154323 pubmed publisher
  585. Jiang S, He X, Xia Y, Hu W, Luo J, Zhang J, et al. MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial-mesenchymal transition. Onco Targets Ther. 2016;9:2305-15 pubmed publisher
  586. Bell C, Hendriks D, Moro S, Ellis E, Walsh J, Renblom A, et al. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep. 2016;6:25187 pubmed publisher
  587. Tokhtaeva E, Sun H, Deiss Yehiely N, Wen Y, Soni P, Gabrielli N, et al. The O-glycosylated ectodomain of FXYD5 impairs adhesion by disrupting cell-cell trans-dimerization of Na,K-ATPase β1 subunits. J Cell Sci. 2016;129:2394-406 pubmed publisher
  588. Jadav R, Kumar D, Buwa N, Ganguli S, Thampatty S, Balasubramanian N, et al. Deletion of inositol hexakisphosphate kinase 1 (IP6K1) reduces cell migration and invasion, conferring protection from aerodigestive tract carcinoma in mice. Cell Signal. 2016;28:1124-36 pubmed publisher
  589. Nietzer S, Baur F, Sieber S, Hansmann J, Schwarz T, Stoffer C, et al. Mimicking Metastases Including Tumor Stroma: A New Technique to Generate a Three-Dimensional Colorectal Cancer Model Based on a Biological Decellularized Intestinal Scaffold. Tissue Eng Part C Methods. 2016;22:621-35 pubmed publisher
  590. Kolahi K, Louey S, Varlamov O, Thornburg K. Real-Time Tracking of BODIPY-C12 Long-Chain Fatty Acid in Human Term Placenta Reveals Unique Lipid Dynamics in Cytotrophoblast Cells. PLoS ONE. 2016;11:e0153522 pubmed publisher
  591. Richardson R, Metzger M, Knyphausen P, Ramezani T, Slanchev K, Kraus C, et al. Re-epithelialization of cutaneous wounds in adult zebrafish combines mechanisms of wound closure in embryonic and adult mammals. Development. 2016;143:2077-88 pubmed publisher
  592. Murray A, Sienerth A, Hemberger M. Plet1 is an epigenetically regulated cell surface protein that provides essential cues to direct trophoblast stem cell differentiation. Sci Rep. 2016;6:25112 pubmed publisher
  593. Inada M, Izawa G, Kobayashi W, Ozawa M. 293 cells express both epithelial as well as mesenchymal cell adhesion molecules. Int J Mol Med. 2016;37:1521-7 pubmed publisher
  594. Thakkar A, Wang B, Picon Ruiz M, Buchwald P, Ince T. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer. Breast Cancer Res Treat. 2016;157:77-90 pubmed publisher
  595. Song M, Park Y, Song H, Park S, Ahn J, Choi K, et al. Prognosis of Pregnancy-Associated Gastric Cancer: An Age-, Sex-, and Stage-Matched Case-Control Study. Gut Liver. 2016;10:731-8 pubmed publisher
  596. Rolo A, Savery D, Escuin S, de Castro S, Armer H, Munro P, et al. Regulation of cell protrusions by small GTPases during fusion of the neural folds. elife. 2016;5:e13273 pubmed publisher
  597. De Boeck M, Cui C, Mulder A, Jost C, Ikeno S, Ten Dijke P. Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft model. Sci Rep. 2016;6:24968 pubmed publisher
  598. Chiang K, Yeh T, Chen S, Pang J, Yeh C, Hsu J, et al. The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential. Int J Mol Sci. 2016;17: pubmed publisher
  599. Lin S, Kao C, Lee H, Creighton C, Ittmann M, Tsai S, et al. Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer. Nat Commun. 2016;7:11418 pubmed publisher
  600. Yan M, Li X, Tong D, Han C, Zhao R, He Y, et al. miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer. Oncol Rep. 2016;36:65-71 pubmed publisher
  601. Leung C, Mak W, Kai A, Chan K, Lee T, Ng I, et al. Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/?-catenin signaling. Oncotarget. 2016;7:29371-86 pubmed publisher
  602. Sato K, Suda K, Shimizu S, Sakai K, Mizuuchi H, Tomizawa K, et al. Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression. PLoS ONE. 2016;11:e0154186 pubmed publisher
  603. Stewart M, Plante I, Penuela S, Laird D. Loss of Panx1 Impairs Mammary Gland Development at Lactation: Implications for Breast Tumorigenesis. PLoS ONE. 2016;11:e0154162 pubmed publisher
  604. Choi V, Herrou J, Hecht A, Teoh W, Turner J, Crosson S, et al. Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice. Nat Med. 2016;22:563-7 pubmed publisher
  605. Liang H, Zhang Q, Lu J, Yang G, Tian N, Wang X, et al. MSX2 Induces Trophoblast Invasion in Human Placenta. PLoS ONE. 2016;11:e0153656 pubmed publisher
  606. Chan C, Chu H, Zhang A, Leung L, Sze K, Kao R, et al. Hemagglutinin of influenza A virus binds specifically to cell surface nucleolin and plays a role in virus internalization. Virology. 2016;494:78-88 pubmed publisher
  607. Waisbourd Zinman O, Koh H, Tsai S, Lavrut P, Dang C, Zhao X, et al. The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17. Hepatology. 2016;64:880-93 pubmed publisher
  608. Montalbano M, Curcurù G, Shirafkan A, Vento R, Rastellini C, Cicalese L. Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion. PLoS ONE. 2016;11:e0153613 pubmed publisher
  609. Hellstrom M, Moreno Moya J, Bandstein S, Bom E, Akouri R, Miyazaki K, et al. Bioengineered uterine tissue supports pregnancy in a rat model. Fertil Steril. 2016;106:487-496.e1 pubmed publisher
  610. Cozzolino A, Noce V, Battistelli C, Marchetti A, Grassi G, Cicchini C, et al. Modulating the Substrate Stiffness to Manipulate Differentiation of Resident Liver Stem Cells and to Improve the Differentiation State of Hepatocytes. Stem Cells Int. 2016;2016:5481493 pubmed publisher
  611. Wang Z, Xie J, Yan M, Wang J, Wang X, Zhang J, et al. Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma. Oncotarget. 2016;7:26765-79 pubmed publisher
  612. Guerrera D, Shah J, Vasileva E, Sluysmans S, Méan I, Jond L, et al. PLEKHA7 Recruits PDZD11 to Adherens Junctions to Stabilize Nectins. J Biol Chem. 2016;291:11016-29 pubmed publisher
  613. Kwon J, Jeong S, Choi I, Kim N. ADAM10 Is Involved in Cell Junction Assembly in Early Porcine Embryo Development. PLoS ONE. 2016;11:e0152921 pubmed publisher
  614. Klinkert K, Rocancourt M, Houdusse A, Echard A. Rab35 GTPase couples cell division with initiation of epithelial apico-basal polarity and lumen opening. Nat Commun. 2016;7:11166 pubmed publisher
  615. Nummela P, Leinonen H, Järvinen P, Thiel A, Jarvinen H, Lepistö A, et al. Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei. Hum Pathol. 2016;54:47-54 pubmed publisher
  616. Yu J, Berga S, Johnston MacAnanny E, Sidell N, Bagchi I, Bagchi M, et al. Endometrial Stromal Decidualization Responds Reversibly to Hormone Stimulation and Withdrawal. Endocrinology. 2016;157:2432-46 pubmed publisher
  617. Hornsveld M, Tenhagen M, van de Ven R, Smits A, van Triest M, van Amersfoort M, et al. Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer. Cell Death Differ. 2016;23:1483-92 pubmed publisher
  618. Ma B, Cheng H, Gao R, Mu C, Chen L, Wu S, et al. Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways. Nat Commun. 2016;7:11123 pubmed publisher
  619. Lee N, Fok K, White A, Wilson N, O Leary C, Cox H, et al. Neogenin recruitment of the WAVE regulatory complex maintains adherens junction stability and tension. Nat Commun. 2016;7:11082 pubmed publisher
  620. Vincent A, Berthel E, Dacheux E, Magnard C, Venezia N. BRCA1 affects protein phosphatase 6 signalling through its interaction with ANKRD28. Biochem J. 2016;473:949-60 pubmed publisher
  621. Wang O, Azizian N, Guo M, Capello M, Deng D, Zang F, et al. Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer. PLoS ONE. 2016;11:e0152300 pubmed publisher
  622. Falcão V, Maschio D, de Fontes C, Oliveira R, Santos Silva J, Almeida A, et al. Reduced insulin secretion function is associated with pancreatic islet redistribution of cell adhesion molecules (CAMS) in diabetic mice after prolonged high-fat diet. Histochem Cell Biol. 2016;146:13-31 pubmed publisher
  623. Holloway K, Sinha V, Bu W, Toneff M, Dong J, Peng Y, et al. Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype. Int J Biol Sci. 2016;12:381-8 pubmed publisher
  624. Yin K, Yin W, Wang Y, Zhou L, Liu Y, Yang G, et al. MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-? signaling in estrogen receptor positive breast cancer cells. Oncotarget. 2016;7:24537-48 pubmed publisher
  625. Chou C, Fan C, Lin P, Liao P, Tung J, Hsieh C, et al. Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis. Oncotarget. 2016;7:25742-54 pubmed publisher
  626. Vermeer D, Coppock J, Zeng E, Lee K, Spanos W, Onken M, et al. Metastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis. Oncotarget. 2016;7:24194-207 pubmed publisher
  627. Wu J, Ivanov A, Fisher P, Fu Z. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling. elife. 2016;5: pubmed publisher
  628. Sugihara T, Nakagawa S, Sasajima Y, Ichinose T, Hiraike H, Kondo F, et al. Loss of the cell polarity determinant human Discs-large is a novel molecular marker of nodal involvement and poor prognosis in endometrial cancer. Br J Cancer. 2016;114:1012-8 pubmed publisher
  629. Li Y, Wang X, He B, Cai H, Gao Y. Downregulation and tumor-suppressive role of XPO5 in hepatocellular carcinoma. Mol Cell Biochem. 2016;415:197-205 pubmed publisher
  630. Bassey Archibong B, Kwiecien J, Milosavljevic S, Hallett R, Rayner L, Erb M, et al. Kaiso depletion attenuates transforming growth factor-? signaling and metastatic activity of triple-negative breast cancer cells. Oncogenesis. 2016;5:e208 pubmed publisher
  631. Park S, Kim J, Kim N, Yang K, Shim J, Heo K. Estradiol, TGF-?1 and hypoxia promote breast cancer stemness and EMT-mediated breast cancer migration. Oncol Lett. 2016;11:1895-1902 pubmed
  632. Yin S, Fan Y, Zhang H, Zhao Z, Hao Y, Li J, et al. Differential TGF? pathway targeting by miR-122 in humans and mice affects liver cancer metastasis. Nat Commun. 2016;7:11012 pubmed publisher
  633. Kurimoto R, Iwasawa S, Ebata T, Ishiwata T, Sekine I, Tada Y, et al. Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation. Int J Oncol. 2016;48:1825-36 pubmed publisher
  634. Schmidt T, Perna A, Fugmann T, Böhm M, Jan Hiss -, Haller S, et al. Identification of E-cadherin signature motifs functioning as cleavage sites for Helicobacter pylori HtrA. Sci Rep. 2016;6:23264 pubmed publisher
  635. Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang Y, et al. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC. Sci Rep. 2016;6:23091 pubmed publisher
  636. Ji X, Liu Y, Hurd R, Wang J, Fitzmaurice B, Nishina P, et al. Retinal Pigment Epithelium Atrophy 1 (rpea1): A New Mouse Model With Retinal Detachment Caused by a Disruption of Protein Kinase C, θ. Invest Ophthalmol Vis Sci. 2016;57:877-88 pubmed publisher
  637. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  638. Tsui K, Lin Y, Chung L, Chuang S, Feng T, Chiang K, et al. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells. Cancer Lett. 2016;375:142-151 pubmed publisher
  639. Koussounadis A, Langdon S, Um I, Kay C, Francis K, Harrison D, et al. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer. 2016;16:205 pubmed publisher
  640. Fiorino C, Harrison R. E-cadherin is important for cell differentiation during osteoclastogenesis. Bone. 2016;86:106-18 pubmed publisher
  641. Hirth S, Bühler A, Bührdel J, Rudeck S, Dahme T, Rottbauer W, et al. Paxillin and Focal Adhesion Kinase (FAK) Regulate Cardiac Contractility in the Zebrafish Heart. PLoS ONE. 2016;11:e0150323 pubmed publisher
  642. Tan S, Krasnow M. Developmental origin of lung macrophage diversity. Development. 2016;143:1318-27 pubmed publisher
  643. Tomann P, Paus R, Millar S, Scheidereit C, Schmidt Ullrich R. Lhx2 is a direct NF-κB target gene that promotes primary hair follicle placode down-growth. Development. 2016;143:1512-22 pubmed publisher
  644. Shukla S, Schmidt J, Goldfarb K, Cech T, Parker R. Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects. Nat Struct Mol Biol. 2016;23:286-92 pubmed publisher
  645. Dhar S, Kumar A, Zhang L, Rimando A, Lage J, Lewin J, et al. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget. 2016;7:18469-84 pubmed publisher
  646. Pattabiraman D, Bierie B, Kober K, Thiru P, Krall J, Zill C, et al. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science. 2016;351:aad3680 pubmed publisher
  647. Goyer M, Loiselet A, Bon F, L Ollivier C, Laue M, Holland G, et al. Intestinal Cell Tight Junctions Limit Invasion of Candida albicans through Active Penetration and Endocytosis in the Early Stages of the Interaction of the Fungus with the Intestinal Barrier. PLoS ONE. 2016;11:e0149159 pubmed publisher
  648. Chang H, Liu Y, Xue M, Liu H, Du S, Zhang L, et al. Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition. Nucleic Acids Res. 2016;44:2514-27 pubmed publisher
  649. Huo L, Wang Y, Gong Y, Krishnamurthy S, Wang J, Diao L, et al. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Mod Pathol. 2016;29:330-46 pubmed publisher
  650. Yang Z, Liu S, Zhu M, Zhang H, Wang J, Xu Q, et al. PS341 inhibits hepatocellular and colorectal cancer cells through the FOXO3/CTNNB1 signaling pathway. Sci Rep. 2016;6:22090 pubmed publisher
  651. Colangelo T, Polcaro G, Ziccardi P, Pucci B, Muccillo L, Galgani M, et al. Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer. Cell Death Dis. 2016;7:e2120 pubmed publisher
  652. Colangelo T, Polcaro G, Ziccardi P, Muccillo L, Galgani M, Pucci B, et al. The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells. Cell Death Dis. 2016;7:e2108 pubmed publisher
  653. Kai T, Tsukamoto Y, Hijiya N, Tokunaga A, Nakada C, Uchida T, et al. Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway. J Pathol. 2016;239:97-108 pubmed publisher
  654. Rodrigues Pinto R, Berry A, Piper Hanley K, Hanley N, Richardson S, Hoyland J. Spatiotemporal analysis of putative notochordal cell markers reveals CD24 and keratins 8, 18, and 19 as notochord-specific markers during early human intervertebral disc development. J Orthop Res. 2016;34:1327-40 pubmed publisher
  655. Zou M, Zhu W, Wang L, Shi L, Gao R, Ou Y, et al. AEG-1/MTDH-activated autophagy enhances human malignant glioma susceptibility to TGF-β1-triggered epithelial-mesenchymal transition. Oncotarget. 2016;7:13122-38 pubmed publisher
  656. Shukla S, Sinha S, Khan S, Kumar S, Singh K, Mitra K, et al. Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis. Sci Rep. 2016;6:21860 pubmed publisher
  657. Jackson S, Olufs Z, Tran K, Zaidan N, Sridharan R. Alternative Routes to Induced Pluripotent Stem Cells Revealed by Reprogramming of the Neural Lineage. Stem Cell Reports. 2016;6:302-11 pubmed publisher
  658. Jung B, Padula D, Burtscher I, Landerer C, Lutter D, Theis F, et al. Pitchfork and Gprasp2 Target Smoothened to the Primary Cilium for Hedgehog Pathway Activation. PLoS ONE. 2016;11:e0149477 pubmed publisher
  659. Song D, Ko G, Lee J, Lee J, Lee G, Kim H, et al. Myoferlin expression in non-small cell lung cancer: Prognostic role and correlation with VEGFR-2 expression. Oncol Lett. 2016;11:998-1006 pubmed
  660. Matsuda Y, Miura K, Yamane J, Shima H, Fujibuchi W, Ishida K, et al. SERPINI1 regulates epithelial-mesenchymal transition in an orthotopic implantation model of colorectal cancer. Cancer Sci. 2016;107:619-28 pubmed publisher
  661. Chung V, Tan T, Tan M, Wong M, Kuay K, Yang Z, et al. GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification. Sci Rep. 2016;6:19943 pubmed publisher
  662. Haraguchi T, Kondo M, Uchikawa R, Kobayashi K, Hiramatsu H, Kobayashi K, et al. Dynamics and plasticity of the epithelial to mesenchymal transition induced by miR-200 family inhibition. Sci Rep. 2016;6:21117 pubmed publisher
  663. Gradiz R, Silva H, Carvalho L, Botelho M, Mota Pinto A. MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors. Sci Rep. 2016;6:21648 pubmed publisher
  664. Hwang S, Lee H, Kim H, Lee H, Shin C, Yun S, et al. Ubiquitin-specific protease 4 controls metastatic potential through β-catenin stabilization in brain metastatic lung adenocarcinoma. Sci Rep. 2016;6:21596 pubmed publisher
  665. He Y, Ryu T, Shrestha N, Yuan T, Kim H, Shrestha H, et al. Interaction of EGFR to δ-catenin leads to δ-catenin phosphorylation and enhances EGFR signaling. Sci Rep. 2016;6:21207 pubmed publisher
  666. Yin G, Liu Z, Wang Y, Dou C, Li C, Yang W, et al. BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma. BMC Cancer. 2016;16:103 pubmed publisher
  667. Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, et al. ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types. Nat Commun. 2016;7:10498 pubmed publisher
  668. Weyemi U, Redon C, Choudhuri R, Aziz T, Maeda D, Boufraqech M, et al. The histone variant H2A.X is a regulator of the epithelial-mesenchymal transition. Nat Commun. 2016;7:10711 pubmed publisher
  669. Du L, Chen X, Cao Y, Lu L, Zhang F, Bornstein S, et al. Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling. Oncogene. 2016;35:4641-52 pubmed publisher
  670. Kim D, Helfman D. Loss of MLCK leads to disruption of cell-cell adhesion and invasive behavior of breast epithelial cells via increased expression of EGFR and ERK/JNK signaling. Oncogene. 2016;35:4495-508 pubmed publisher
  671. Haikala H, Klefström J, Eilers M, Wiese K. MYC-induced apoptosis in mammary epithelial cells is associated with repression of lineage-specific gene signatures. Cell Cycle. 2016;15:316-23 pubmed publisher
  672. Roy J, Kim B, Hill E, Visconti P, Krapf D, Vinegoni C, et al. Tyrosine kinase-mediated axial motility of basal cells revealed by intravital imaging. Nat Commun. 2016;7:10666 pubmed publisher
  673. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  674. Li J, Pan Q, Rowan P, Trotter T, Peker D, Regal K, et al. Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells. Oncotarget. 2016;7:11299-309 pubmed publisher
  675. Howitt M, Lavoie S, Michaud M, Blum A, Tran S, Weinstock J, et al. Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut. Science. 2016;351:1329-33 pubmed publisher
  676. Maiden S, Petrova Y, Gumbiner B. Microtubules Inhibit E-Cadherin Adhesive Activity by Maintaining Phosphorylated p120-Catenin in a Colon Carcinoma Cell Model. PLoS ONE. 2016;11:e0148574 pubmed publisher
  677. Bühler A, Kustermann M, Bummer T, Rottbauer W, Sandri M, Just S. Atrogin-1 Deficiency Leads to Myopathy and Heart Failure in Zebrafish. Int J Mol Sci. 2016;17: pubmed publisher
  678. Vincent K, Cornea V, Jong Y, Laferriere A, Kumar N, Mickeviciute A, et al. Intracellular mGluR5 plays a critical role in neuropathic pain. Nat Commun. 2016;7:10604 pubmed publisher
  679. Patkee W, Carr G, Baker E, Baines D, Garnett J. Metformin prevents the effects of Pseudomonas aeruginosa on airway epithelial tight junctions and restricts hyperglycaemia-induced bacterial growth. J Cell Mol Med. 2016;20:758-64 pubmed publisher
  680. Kuracha M, Thomas P, Loggie B, Govindarajan V. Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment. Cancer Med. 2016;5:711-9 pubmed publisher
  681. Lazarevic I, Engelhardt B. Modeling immune functions of the mouse blood-cerebrospinal fluid barrier in vitro: primary rather than immortalized mouse choroid plexus epithelial cells are suited to study immune cell migration across this brain barrier. Fluids Barriers CNS. 2016;13:2 pubmed publisher
  682. Cheung K, Padmanaban V, Silvestri V, Schipper K, Cohen J, Fairchild A, et al. Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters. Proc Natl Acad Sci U S A. 2016;113:E854-63 pubmed publisher
  683. Shah D, Ali M, Pasha Z, Jaboori A, Jassim S, Jain S, et al. Histatin-1 Expression in Human Lacrimal Epithelium. PLoS ONE. 2016;11:e0148018 pubmed publisher
  684. Sun H, Chen J, Qian W, Kang J, Wang J, Jiang L, et al. Integrated long non-coding RNA analyses identify novel regulators of epithelial-mesenchymal transition in the mouse model of pulmonary fibrosis. J Cell Mol Med. 2016;20:1234-46 pubmed publisher
  685. Wu X, Yang L, Zheng Z, Li Z, Shi J, Li Y, et al. Src promotes cutaneous wound healing by regulating MMP-2 through the ERK pathway. Int J Mol Med. 2016;37:639-48 pubmed publisher
  686. Gao Y, Zhao Y, Zhang J, Lu Y, Liu X, Geng P, et al. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1. Sci Rep. 2016;6:19874 pubmed publisher
  687. Gaide Chevronnay H, Janssens V, Van Der Smissen P, Rocca C, Liao X, Refetoff S, et al. Hematopoietic Stem Cells Transplantation Can Normalize Thyroid Function in a Cystinosis Mouse Model. Endocrinology. 2016;157:1363-71 pubmed publisher
  688. Branco M, King M, Perez García V, Bogutz A, Caley M, Fineberg E, et al. Maternal DNA Methylation Regulates Early Trophoblast Development. Dev Cell. 2016;36:152-63 pubmed publisher
  689. Couderc C, Boin A, Fuhrmann L, Vincent Salomon A, Mandati V, Kieffer Y, et al. AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin. Neoplasia. 2016;18:10-24 pubmed publisher
  690. Guedj N, Vaquero J, Clapéron A, Mergey M, Chrétien Y, Paradis V, et al. Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin. Histopathology. 2016;69:211-21 pubmed publisher
  691. Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam K, et al. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS ONE. 2016;11:e0147344 pubmed publisher
  692. Choi S, Chen Z, Tang L, Fang Y, Shin S, Panarelli N, et al. Bcl-xL promotes metastasis independent of its anti-apoptotic activity. Nat Commun. 2016;7:10384 pubmed publisher
  693. Lu Y, Hu J, Sun W, Li S, Deng S, Li M. MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1. Onco Targets Ther. 2016;9:99-109 pubmed publisher
  694. Nassal D, Wan X, Liu H, Deschenes I. Myocardial KChIP2 Expression in Guinea Pig Resolves an Expanded Electrophysiologic Role. PLoS ONE. 2016;11:e0146561 pubmed publisher
  695. Stahley S, Warren M, Feldman R, Swerlick R, Mattheyses A, Kowalczyk A. Super-Resolution Microscopy Reveals Altered Desmosomal Protein Organization in Tissue from Patients with Pemphigus Vulgaris. J Invest Dermatol. 2016;136:59-66 pubmed publisher
  696. Little E, Camp E, Wang C, Watson P, Watson D, Cole D. The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. Oncogenesis. 2016;5:e182 pubmed publisher
  697. Sun Y, Zhu D, Chen F, Qian M, Wei H, Chen W, et al. SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment. Oncogene. 2016;35:4321-34 pubmed publisher
  698. Chen N, Uddin B, Voit R, Schiebel E. Human phosphatase CDC14A is recruited to the cell leading edge to regulate cell migration and adhesion. Proc Natl Acad Sci U S A. 2016;113:990-5 pubmed publisher
  699. Chen Y, Statt S, Wu R, Chang H, Liao J, Wang C, et al. High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells. Sci Rep. 2016;6:18815 pubmed publisher
  700. Terranova Barberio M, Roca M, Zotti A, Leone A, Bruzzese F, Vitagliano C, et al. Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression. Oncotarget. 2016;7:7715-31 pubmed publisher
  701. Shu S, Lin C, He H, Witwicki R, Tabassum D, Roberts J, et al. Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Nature. 2016;529:413-417 pubmed publisher
  702. Creedon H, Balderstone L, Muir M, Balla J, Gómez Cuadrado L, Tracey N, et al. Use of a genetically engineered mouse model as a preclinical tool for HER2 breast cancer. Dis Model Mech. 2016;9:131-40 pubmed publisher
  703. García Castro I, Garcia Lopez G, Avila González D, Flores Herrera H, Molina Hernández A, Portillo W, et al. Markers of Pluripotency in Human Amniotic Epithelial Cells and Their Differentiation to Progenitor of Cortical Neurons. PLoS ONE. 2015;10:e0146082 pubmed publisher
  704. Benitz S, Regel I, Reinhard T, Popp A, Schäffer I, Raulefs S, et al. Polycomb repressor complex 1 promotes gene silencing through H2AK119 mono-ubiquitination in acinar-to-ductal metaplasia and pancreatic cancer cells. Oncotarget. 2016;7:11424-33 pubmed publisher
  705. Wang F, Feng Y, Li P, Wang K, Feng L, Liu Y, et al. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Oncotarget. 2016;7:4279-97 pubmed publisher
  706. Nishio M, Sugimachi K, Goto H, Wang J, Morikawa T, Miyachi Y, et al. Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice. Proc Natl Acad Sci U S A. 2016;113:E71-80 pubmed publisher
  707. Zhang Y, Fan J, Ho J, Hu T, Kneeland S, Fan X, et al. Crim1 regulates integrin signaling in murine lens development. Development. 2016;143:356-66 pubmed publisher
  708. Smith K, Zhou B, Avdulov S, Benyumov A, Peterson M, Liu Y, et al. Transforming Growth Factor-β1 Induced Epithelial Mesenchymal Transition is blocked by a chemical antagonist of translation factor eIF4E. Sci Rep. 2015;5:18233 pubmed publisher
  709. Yan L, Liu Y, Xiang J, Wu Q, Xu L, Luo X, et al. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Int J Oncol. 2016;48:471-84 pubmed publisher
  710. Nagy N, Barad C, Graham H, Hotta R, Cheng L, Fejszak N, et al. Sonic hedgehog controls enteric nervous system development by patterning the extracellular matrix. Development. 2016;143:264-75 pubmed publisher
  711. Brunati M, Perucca S, Han L, Cattaneo A, Consolato F, Andolfo A, et al. The serine protease hepsin mediates urinary secretion and polymerisation of Zona Pellucida domain protein uromodulin. elife. 2015;4:e08887 pubmed publisher
  712. Terashita K, Chuma M, Hatanaka Y, Hatanaka K, Mitsuhashi T, Yokoo H, et al. ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma. J Clin Pathol. 2016;69:593-9 pubmed publisher
  713. Arévalo Turrubiarte M, Perruchot M, Finot L, Mayeur F, Dessauge F. Phenotypic and functional characterization of two bovine mammary epithelial cell lines in 2D and 3D models. Am J Physiol Cell Physiol. 2016;310:C348-56 pubmed publisher
  714. Osorio L, Farfán N, Castellón E, Contreras H. SNAIL transcription factor increases the motility and invasive capacity of prostate cancer cells. Mol Med Rep. 2016;13:778-86 pubmed publisher
  715. Rafehi S, Ramos Valdes Y, Bertrand M, McGee J, Préfontaine M, Sugimoto A, et al. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids. Endocr Relat Cancer. 2016;23:147-59 pubmed publisher
  716. Batchelder C, Martinez M, Tarantal A. Natural Scaffolds for Renal Differentiation of Human Embryonic Stem Cells for Kidney Tissue Engineering. PLoS ONE. 2015;10:e0143849 pubmed publisher
  717. Kessler M, Hoffmann K, Brinkmann V, Thieck O, Jackisch S, Toelle B, et al. The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids. Nat Commun. 2015;6:8989 pubmed publisher
  718. Bowser J, Blackburn M, Shipley G, Molina J, Dunner K, Broaddus R. Loss of CD73-mediated actin polymerization promotes endometrial tumor progression. J Clin Invest. 2016;126:220-38 pubmed publisher
  719. Qi D, Kaur Gill N, Santiskulvong C, Sifuentes J, Dorigo O, Rao J, et al. Screening cell mechanotype by parallel microfiltration. Sci Rep. 2015;5:17595 pubmed publisher
  720. Huang Y, Lan Q, Ponsonnet L, Blanquet M, Christofori G, Zaric J, et al. The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression. Oncotarget. 2016;7:1663-74 pubmed publisher
  721. Fleury H, Communal L, Carmona E, Portelance L, Arcand S, Rahimi K, et al. Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease. Genes Cancer. 2015;6:378-398 pubmed
  722. Sengupta D, Byrum S, Avaritt N, Davis L, Shields B, Mahmoud F, et al. Quantitative Histone Mass Spectrometry Identifies Elevated Histone H3 Lysine 27 (Lys27) Trimethylation in Melanoma. Mol Cell Proteomics. 2016;15:765-75 pubmed publisher
  723. Faltermeier C, Drake J, Clark P, Smith B, Zong Y, Volpe C, et al. Functional screen identifies kinases driving prostate cancer visceral and bone metastasis. Proc Natl Acad Sci U S A. 2016;113:E172-81 pubmed publisher
  724. Debruyne D, Bhatnagar N, Sharma B, Luther W, Moore N, Cheung N, et al. ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT. Oncogene. 2016;35:3681-91 pubmed publisher
  725. Wang G, Yu Y, Sun C, Liu T, Liang T, Zhan L, et al. STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling. Oncogene. 2016;35:4388-98 pubmed publisher
  726. Cruz L, Vedula P, Gutierrez N, Shah N, Rodriguez S, Ayee B, et al. Balancing spatially regulated β-actin translation and dynamin-mediated endocytosis is required to assemble functional epithelial monolayers. Cytoskeleton (Hoboken). 2015;72:597-608 pubmed publisher
  727. Kühne H, Hause G, Grundmann S, Schutkowski A, Brandsch C, Stangl G. Vitamin D receptor knockout mice exhibit elongated intestinal microvilli and increased ezrin expression. Nutr Res. 2016;36:184-92 pubmed publisher
  728. Tato Costa J, Casimiro S, Pacheco T, Pires R, Fernandes A, Alho I, et al. Therapy-Induced Cellular Senescence Induces Epithelial-to-Mesenchymal Transition and Increases Invasiveness in Rectal Cancer. Clin Colorectal Cancer. 2016;15:170-178.e3 pubmed publisher
  729. Uribe R, Buzzi A, Bronner M, Strobl Mazzulla P. Histone demethylase KDM4B regulates otic vesicle invagination via epigenetic control of Dlx3 expression. J Cell Biol. 2015;211:815-27 pubmed publisher
  730. Hernando H, Gelato K, Lesche R, Beckmann G, Koehr S, Otto S, et al. EZH2 Inhibition Blocks Multiple Myeloma Cell Growth through Upregulation of Epithelial Tumor Suppressor Genes. Mol Cancer Ther. 2016;15:287-98 pubmed publisher
  731. Chow C, Ebine K, Knab L, Bentrem D, Kumar K, Munshi H. Cancer Cell Invasion in Three-dimensional Collagen Is Regulated Differentially by Gα13 Protein and Discoidin Domain Receptor 1-Par3 Protein Signaling. J Biol Chem. 2016;291:1605-18 pubmed publisher
  732. Tan X, Fu Y, Chen L, Lee W, Lai Y, Rezaei K, et al. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer. Oncotarget. 2016;7:293-307 pubmed publisher
  733. Sharmin S, Taguchi A, Kaku Y, Yoshimura Y, Ohmori T, Sakuma T, et al. Human Induced Pluripotent Stem Cell-Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation. J Am Soc Nephrol. 2016;27:1778-91 pubmed publisher
  734. Xu Y, Ma L, Norton M, Stuart C, Zhao Z, Toibero D, et al. Gestation age dependent transfer of human immunoglobulins across placenta in timed-pregnant guinea pigs. Placenta. 2015;36:1370-7 pubmed publisher
  735. Shukla P, Vogl C, Wallner B, Rigler D, Müller M, Macho Maschler S. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells. BMC Genomics. 2015;16:944 pubmed publisher
  736. Fraveto A, Cardinale V, Bragazzi M, Giuliante F, De Rose A, Grazi G, et al. Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures. PLoS ONE. 2015;10:e0142124 pubmed publisher
  737. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed publisher
  738. Kumar N, Richter J, Cutts J, Bush K, Trujillo C, Nigam S, et al. Generation of an expandable intermediate mesoderm restricted progenitor cell line from human pluripotent stem cells. elife. 2015;4: pubmed publisher
  739. Dixon D, Coates J, Del Carpio Pons A, Horabin J, Walker A, Abdul N, et al. A potential mode of action for Anakinra in patients with arthrofibrosis following total knee arthroplasty. Sci Rep. 2015;5:16466 pubmed publisher
  740. Buczek M, Miles A, Green W, Johnson C, Boocock D, Pockley A, et al. Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer. Oncogene. 2016;35:3465-75 pubmed publisher
  741. Wu X, Qi H, Yang Y, Yin Y, Ma D, Li H, et al. Downregulation of matrix metalloproteinase‑19 induced by respiratory syncytial viral infection affects the interaction between epithelial cells and fibroblasts. Mol Med Rep. 2016;13:167-73 pubmed publisher
  742. Bhate A, Parker D, Bebee T, Ahn J, Arif W, Rashan E, et al. ESRP2 controls an adult splicing programme in hepatocytes to support postnatal liver maturation. Nat Commun. 2015;6:8768 pubmed publisher
  743. Valcourt U, Carthy J, Okita Y, Alcaraz L, Kato M, Thuault S, et al. Analysis of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor β. Methods Mol Biol. 2016;1344:147-81 pubmed publisher
  744. McCart Reed A, Kutasovic J, Vargas A, Jayanthan J, Al Murrani A, Reid L, et al. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas. J Pathol. 2016;238:489-94 pubmed publisher
  745. Huang L, Holtzinger A, Jagan I, BeGora M, Lohse I, Ngai N, et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat Med. 2015;21:1364-71 pubmed publisher
  746. Qin W, Li C, Zheng W, Guo Q, Zhang Y, Kang M, et al. Inhibition of autophagy promotes metastasis and glycolysis by inducing ROS in gastric cancer cells. Oncotarget. 2015;6:39839-54 pubmed publisher
  747. Bauer J, Ozden O, Akagi N, Carroll T, Principe D, Staudacher J, et al. Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer. Mol Cancer. 2015;14:182 pubmed publisher
  748. Dong W, Zhang X, Liu W, Chen Y, Huang J, Austin E, et al. A conserved polybasic domain mediates plasma membrane targeting of Lgl and its regulation by hypoxia. J Cell Biol. 2015;211:273-86 pubmed publisher
  749. Chakedis J, French R, Babicky M, Jaquish D, Howard H, Mose E, et al. A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells. Oncogene. 2016;35:3249-59 pubmed publisher
  750. Burns J, Kelly M, Hoa M, Morell R, Kelley M. Single-cell RNA-Seq resolves cellular complexity in sensory organs from the neonatal inner ear. Nat Commun. 2015;6:8557 pubmed publisher
  751. Gökbuget D, Pereira J, Bachofner S, Marchais A, Ciaudo C, Stoffel M, et al. The Lin28/let-7 axis is critical for myelination in the peripheral nervous system. Nat Commun. 2015;6:8584 pubmed publisher
  752. Arya P, Rainey M, Bhattacharyya S, Mohapatra B, George M, Kuracha M, et al. The endocytic recycling regulatory protein EHD1 Is required for ocular lens development. Dev Biol. 2015;408:41-55 pubmed publisher
  753. Barbáchano A, Fernández Barral A, Pereira F, Segura M, Ordóñez Morán P, Carrillo de Santa Pau E, et al. SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150. Oncogene. 2016;35:2991-3003 pubmed publisher
  754. Martínez Revollar G, Garay E, Martín Tapia D, Nava P, Huerta M, Lopez Bayghen E, et al. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Exp Cell Res. 2015;339:67-80 pubmed publisher
  755. Jiang Y, Du M, Wu M, Zhu Y, Zhao X, Cao X, et al. Phosphatidic Acid Improves Reprogramming to Pluripotency by Reducing Apoptosis. Stem Cells Dev. 2016;25:43-54 pubmed publisher
  756. Takasato M, Er P, Chiu H, Maier B, Baillie G, Ferguson C, et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature. 2015;526:564-8 pubmed publisher
  757. Stewart M, Bechberger J, Welch I, Naus C, Laird D. Cx26 knockout predisposes the mammary gland to primary mammary tumors in a DMBA-induced mouse model of breast cancer. Oncotarget. 2015;6:37185-99 pubmed publisher
  758. Hwang J, Sung W, Tu H, Hsieh K, Yeh C, Chen C, et al. The Overexpression of FEN1 and RAD54B May Act as Independent Prognostic Factors of Lung Adenocarcinoma. PLoS ONE. 2015;10:e0139435 pubmed publisher
  759. Abou Kheir W, Eid A, El Merahbi R, Assaf R, Daoud G. A Unique Expression of Keratin 14 in a Subset of Trophoblast Cells. PLoS ONE. 2015;10:e0139939 pubmed publisher
  760. Nath A, Li I, Roberts L, Chan C. Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma. Sci Rep. 2015;5:14752 pubmed publisher
  761. Jeannot P, Callot C, Baer R, Duquesnes N, Guerra C, Guillermet Guibert J, et al. Loss of p27Kip¹ promotes metaplasia in the pancreas via the regulation of Sox9 expression. Oncotarget. 2015;6:35880-92 pubmed publisher
  762. Izumi D, Ishimoto T, Miyake K, Sugihara H, Eto K, Sawayama H, et al. CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer. Int J Cancer. 2016;138:1207-19 pubmed publisher
  763. Nagaoka K, Fujii K, Zhang H, Usuda K, Watanabe G, Ivshina M, et al. CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis. Oncogene. 2016;35:2893-901 pubmed publisher
  764. Lizalek J, McKenna T, Huegel K, Marsh S, Carolan A, Kobliska A, et al. Lysophosphatidic Acid Stimulates Urokinase Receptor (uPAR/CD87) in Ovarian Epithelial Cancer Cells. Anticancer Res. 2015;35:5263-70 pubmed
  765. Yan M, Yao C, Chow J, Chang C, Hwang P, Chuang S, et al. Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma Cells. Mar Drugs. 2015;13:6099-116 pubmed publisher
  766. Werner A, Iwasaki S, McGourty C, Medina Ruiz S, Teerikorpi N, Fedrigo I, et al. Cell-fate determination by ubiquitin-dependent regulation of translation. Nature. 2015;525:523-7 pubmed publisher
  767. Gopal S, Søgaard P, Multhaupt H, Pataki C, Okina E, Xian X, et al. Transmembrane proteoglycans control stretch-activated channels to set cytosolic calcium levels. J Cell Biol. 2015;210:1199-211 pubmed publisher
  768. Yokdang N, Hatakeyama J, Wald J, Simion C, Tellez J, Chang D, et al. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. 2016;35:2932-47 pubmed publisher
  769. Kuang X, Zhu J, Peng Z, Wang J, Chen Z. Transducin (Beta)-Like 1 X-Linked Receptor 1 Correlates with Clinical Prognosis and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Dig Dis Sci. 2016;61:489-500 pubmed publisher
  770. Zhang X, Jung I, Hwang Y. EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression. Tumour Biol. 2016;37:2555-63 pubmed publisher
  771. Gamba C, Rodrigues M, Gomes D, Estrela Lima A, Ferreira E, Cassali G. The Relationship Between E-Cadherin and its Transcriptional Repressors in Spontaneously Arising Canine Invasive Micropapillary Mammary Carcinoma. J Comp Pathol. 2015;153:256-65 pubmed publisher
  772. Brkic M, Balusu S, Van Wonterghem E, Gorlé N, Benilova I, Kremer A, et al. Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases. J Neurosci. 2015;35:12766-78 pubmed publisher
  773. Wei Q, Chen Z, Wang L, Zhang T, Duan L, Behrens C, et al. LZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cells. Oncogene. 2016;35:2655-63 pubmed publisher
  774. Schnerch D, Nigg E. Structural centrosome aberrations favor proliferation by abrogating microtubule-dependent tissue integrity of breast epithelial mammospheres. Oncogene. 2016;35:2711-22 pubmed publisher
  775. Wang H, Li G, Zhang J, Gao F, Li W, Qin Y, et al. Novel WT1 Missense Mutations in Han Chinese Women with Premature Ovarian Failure. Sci Rep. 2015;5:13983 pubmed publisher
  776. Widder M, Lützkendorf J, Caysa H, Unverzagt S, Wickenhauser C, Benndorf R, et al. Multipotent mesenchymal stromal cells promote tumor growth in distinct colorectal cancer cells by a β1-integrin-dependent mechanism. Int J Cancer. 2016;138:964-75 pubmed publisher
  777. Basak P, Dillon R, Leslie H, Raouf A, Mowat M. The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity. BMC Cancer. 2015;15:630 pubmed publisher
  778. Balboa D, Weltner J, Eurola S, Trokovic R, Wartiovaara K, Otonkoski T. Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation. Stem Cell Reports. 2015;5:448-59 pubmed publisher
  779. Reuther C, Heinzle V, Spampatti M, Vlotides G, de Toni E, Spöttl G, et al. Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition. Neuroendocrinology. 2016;103:383-401 pubmed publisher
  780. Mori S, Kodaira M, Ito A, Okazaki M, Kawaguchi N, Hamada Y, et al. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells. PLoS ONE. 2015;10:e0137486 pubmed publisher
  781. Maris P, Blomme A, Palacios A, Costanza B, Bellahcène A, Bianchi E, et al. Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer. PLoS Med. 2015;12:e1001871 pubmed publisher
  782. Brusgard J, Choe M, Chumsri S, Renoud K, MacKerell A, Sudol M, et al. RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells. Oncotarget. 2015;6:28132-50 pubmed publisher
  783. Park S, Kim D, Jung Y, Roh S. Thiazovivin, a Rho kinase inhibitor, improves stemness maintenance of embryo-derived stem-like cells under chemically defined culture conditions in cattle. Anim Reprod Sci. 2015;161:47-57 pubmed publisher
  784. Zhang Y, Wei X, Liang Y, Chen W, Zhang F, Bai J, et al. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation. PLoS ONE. 2015;10:e0135851 pubmed publisher
  785. Mehrabian M, Brethour D, Wang H, Xi Z, Rogaeva E, Schmitt Ulms G. The Prion Protein Controls Polysialylation of Neural Cell Adhesion Molecule 1 during Cellular Morphogenesis. PLoS ONE. 2015;10:e0133741 pubmed publisher
  786. Qu D, Weygant N, May R, Chandrakesan P, Madhoun M, Ali N, et al. Ablation of Doublecortin-Like Kinase 1 in the Colonic Epithelium Exacerbates Dextran Sulfate Sodium-Induced Colitis. PLoS ONE. 2015;10:e0134212 pubmed publisher
  787. Baruch K, Rosenzweig N, Kertser A, Deczkowska A, Sharif A, Spinrad A, et al. Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology. Nat Commun. 2015;6:7967 pubmed publisher
  788. Chiang K, Kuo S, Chen C, Ng S, Lin S, Yeh C, et al. MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential. Cancer Lett. 2015;369:76-85 pubmed publisher
  789. Wang J, Bao L, Yu B, Liu Z, Han W, Deng C, et al. Interleukin-1β Promotes Epithelial-Derived Alveolar Elastogenesis via αvβ6 Integrin-Dependent TGF-β Activation. Cell Physiol Biochem. 2015;36:2198-216 pubmed publisher
  790. Chantzoura E, Skylaki S, Menendez S, Kim S, Johnsson A, Linnarsson S, et al. Reprogramming Roadblocks Are System Dependent. Stem Cell Reports. 2015;5:350-64 pubmed publisher
  791. Ozgüven B, Tuncel D, Polat N, Sakiz D, Kabukcuoglu F, Köksal H, et al. Solid-pseudopapillary neoplasm of the pancreas: Clinicopathologic and immunohistochemical analysis of nine cases. Indian J Pathol Microbiol. 2015;58:292-5 pubmed publisher
  792. Pickup M, Hover L, Guo Y, Gorska A, Chytil A, Novitskiy S, et al. Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis. Oncotarget. 2015;6:22890-904 pubmed
  793. Conigliaro A, Costa V, Lo Dico A, Saieva L, Buccheri S, Dieli F, et al. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Mol Cancer. 2015;14:155 pubmed publisher
  794. Tille J, Ho L, Shah J, Seyde O, McKee T, Citi S. The Expression of the Zonula Adhaerens Protein PLEKHA7 Is Strongly Decreased in High Grade Ductal and Lobular Breast Carcinomas. PLoS ONE. 2015;10:e0135442 pubmed publisher
  795. Archibald A, Al Masri M, Liew Spilger A, McCaffrey L. Atypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling. Mol Biol Cell. 2015;26:3578-95 pubmed publisher
  796. Kumar P, Thirkill T, Ji J, Monte L, Douglas G. Differential Effects of Sodium Butyrate and Lithium Chloride on Rhesus Monkey Trophoblast Differentiation. PLoS ONE. 2015;10:e0135089 pubmed publisher
  797. Li H, Yu P, Huang K, Su H, Hsiao T, Chang C, et al. NKX6.1 functions as a metastatic suppressor through epigenetic regulation of the epithelial-mesenchymal transition. Oncogene. 2016;35:2266-78 pubmed publisher
  798. Liu J, Brzeszczynska J, Samuel K, Black J, Palakkan A, Anderson R, et al. Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism. Exp Cell Res. 2015;338:203-13 pubmed publisher
  799. Ko A, Bekaii Saab T, Van Ziffle J, Mirzoeva O, Joseph N, Talasaz A, et al. A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma. Clin Cancer Res. 2016;22:61-8 pubmed publisher
  800. Tsui K, Hsu S, Chung L, Lin Y, Feng T, Lee T, et al. Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells. Sci Rep. 2015;5:12870 pubmed publisher
  801. Faura Tellez G, Vandepoele K, Brouwer U, Koning H, Elderman R, Hackett T, et al. Protocadherin-1 binds to SMAD3 and suppresses TGF-β1-induced gene transcription. Am J Physiol Lung Cell Mol Physiol. 2015;309:L725-35 pubmed publisher
  802. Takahashi S, Kohashi K, Yamamoto H, Hirahashi M, Kumagai R, Takizawa N, et al. Expression of adhesion molecules and epithelial-mesenchymal transition factors in medullary carcinoma of the colorectum. Hum Pathol. 2015;46:1257-66 pubmed publisher
  803. de Vallière C, Vidal S, Clay I, Jurisic G, Tcymbarevich I, Lang S, et al. The pH-sensing receptor OGR1 improves barrier function of epithelial cells and inhibits migration in an acidic environment. Am J Physiol Gastrointest Liver Physiol. 2015;309:G475-90 pubmed publisher
  804. Cartón García F, Overeem A, Nieto R, Bazzocco S, Dopeso H, Macaya I, et al. Myo5b knockout mice as a model of microvillus inclusion disease. Sci Rep. 2015;5:12312 pubmed publisher
  805. Cho M, Park J, Choi H, Park M, Won H, Park Y, et al. DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression. Nat Commun. 2015;6:7821 pubmed publisher
  806. He D, Lu Y, Hu H, Zhang J, Qin B, Wang Y, et al. The Wnt11 Signaling Pathway in Potential Cellular EMT and Osteochondral Differentiation Progression in Nephrolithiasis Formation. Int J Mol Sci. 2015;16:16313-29 pubmed publisher
  807. Liew P, Hsu C, Liu W, Lee Y, Lee Y, Chen C. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma. Int J Clin Exp Pathol. 2015;8:5642-9 pubmed
  808. Liang S, Marti T, Dorn P, Froment L, Hall S, Berezowska S, et al. Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer. Cell Death Dis. 2015;6:e1824 pubmed publisher
  809. Xu J, Wan P, Wang M, Zhang J, Gao X, Hu B, et al. AIP1-mediated actin disassembly is required for postnatal germ cell migration and spermatogonial stem cell niche establishment. Cell Death Dis. 2015;6:e1818 pubmed publisher
  810. Burkhalter R, Westfall S, Liu Y, Stack M. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma. J Biol Chem. 2015;290:22143-54 pubmed publisher
  811. Nagahara T, Shiraha H, Sawahara H, Uchida D, Takeuchi Y, Iwamuro M, et al. Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells. Oncol Rep. 2015;34:1169-77 pubmed publisher
  812. Haraguchi M, Sato M, Ozawa M. CRISPR/Cas9n-Mediated Deletion of the Snail 1Gene (SNAI1) Reveals Its Role in Regulating Cell Morphology, Cell-Cell Interactions, and Gene Expression in Ovarian Cancer (RMG-1) Cells. PLoS ONE. 2015;10:e0132260 pubmed publisher
  813. Zhao L, Liu S, Che X, Hou K, Ma Y, Li C, et al. Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptors. Int J Mol Med. 2015;36:645-52 pubmed publisher
  814. Atsuta Y, Takahashi Y. FGF8 coordinates tissue elongation and cell epithelialization during early kidney tubulogenesis. Development. 2015;142:2329-37 pubmed publisher
  815. Seo G, Ho M, Bui N, Kim Y, Koh D, Lim Y, et al. Novel naphthochalcone derivative accelerate dermal wound healing through induction of epithelial-mesenchymal transition of keratinocyte. J Biomed Sci. 2015;22:47 pubmed publisher
  816. Cheung S, Boey Y, Koh V, Thike A, Lim J, Iqbal J, et al. Role of epithelial-mesenchymal transition markers in triple-negative breast cancer. Breast Cancer Res Treat. 2015;152:489-98 pubmed publisher
  817. O Shaughnessy Kirwan A, Signolet J, Costello I, Gharbi S, Hendrich B. Constraint of gene expression by the chromatin remodelling protein CHD4 facilitates lineage specification. Development. 2015;142:2586-97 pubmed publisher
  818. Wainwright E, Wilhelm D, Combes A, Little M, Koopman P. ROBO2 restricts the nephrogenic field and regulates Wolffian duct-nephrogenic cord separation. Dev Biol. 2015;404:88-102 pubmed publisher
  819. Sugiyama Y, Shelley E, Badouel C, McNeill H, McAvoy J. Atypical Cadherin Fat1 Is Required for Lens Epithelial Cell Polarity and Proliferation but Not for Fiber Differentiation. Invest Ophthalmol Vis Sci. 2015;56:4099-107 pubmed publisher
  820. Lee Y, Han M, Baek S, Kim S, Oh S. MED30 Regulates the Proliferation and Motility of Gastric Cancer Cells. PLoS ONE. 2015;10:e0130826 pubmed publisher
  821. Bartosch C, Mendes N, Rios E, Rodrigues M, Eloy C, Reis C, et al. Morphological features and mucin expression profile of breast carcinomas with signet-ring cell differentiation. Pathol Res Pract. 2015;211:588-95 pubmed publisher
  822. Nishioka M, Venkatesan N, Dessalle K, Mogas A, Kyoh S, Lin T, et al. Fibroblast-epithelial cell interactions drive epithelial-mesenchymal transition differently in cells from normal and COPD patients. Respir Res. 2015;16:72 pubmed publisher
  823. Ma S, Yin N, Qi X, Pfister S, Zhang M, Ma R, et al. Tyrosine dephosphorylation enhances the therapeutic target activity of epidermal growth factor receptor (EGFR) by disrupting its interaction with estrogen receptor (ER). Oncotarget. 2015;6:13320-33 pubmed
  824. Xu N, Zhou X, Wang S, Xu L, Zhou H, Liu X. Artesunate Induces SKM-1 Cells Apoptosis by Inhibiting Hyperactive β-catenin Signaling Pathway. Int J Med Sci. 2015;12:524-9 pubmed publisher
  825. Preca B, Bajdak K, Mock K, Sundararajan V, Pfannstiel J, Maurer J, et al. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells. Int J Cancer. 2015;137:2566-77 pubmed publisher
  826. Su Y, Chang Y, Lin W, Liang C, Lee J. An aberrant nuclear localization of E-cadherin is a potent inhibitor of Wnt/β-catenin-elicited promotion of the cancer stem cell phenotype. Oncogenesis. 2015;4:e157 pubmed publisher
  827. Zhang Y, Desai A, Yang S, Bae K, Antczak M, Fink S, et al. TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science. 2015;348:aaa2340 pubmed publisher
  828. Kourtidis A, Yanagisawa M, Huveldt D, Copland J, Anastasiadis P. Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer. PLoS ONE. 2015;10:e0129964 pubmed publisher
  829. Koos B, Cane G, Grannas K, Löf L, Arngården L, Heldin J, et al. Proximity-dependent initiation of hybridization chain reaction. Nat Commun. 2015;6:7294 pubmed publisher
  830. Huang R, Kuay K, Tan T, Asad M, Tang H, Ng A, et al. Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120). Oncotarget. 2015;6:22098-113 pubmed
  831. Bag S, Pal M, Chaudhary A, Das R, Paul R, Sengupta S, et al. Connecting cyto-nano-architectural attributes and epithelial molecular expression in oral submucous fibrosis progression to cancer. J Clin Pathol. 2015;68:605-13 pubmed publisher
  832. Berry R, Ozdemir D, Aronow B, Lindström N, Dudnakova T, Thornburn A, et al. Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice. Dis Model Mech. 2015;8:903-17 pubmed publisher
  833. Barber A, Castillo Martin M, Bonal D, Jia A, Rybicki B, Christiano A, et al. PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer. Cancer Med. 2015;4:1258-71 pubmed publisher
  834. Poncy A, Antoniou A, Cordi S, Pierreux C, Jacquemin P, Lemaigre F. Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts. Dev Biol. 2015;404:136-48 pubmed publisher
  835. Gonzalez S, Fernando R, Berthelot J, Perrin Tricaud C, Sarzi E, Chrast R, et al. In vivo time-lapse imaging of mitochondria in healthy and diseased peripheral myelin sheath. Mitochondrion. 2015;23:32-41 pubmed publisher
  836. Jeong Y, Jung M, Son Y, Jang J, Lee Y, Kim S, et al. Coniferyl aldehyde attenuates radiation enteropathy by inhibiting cell death and promoting endothelial cell function. PLoS ONE. 2015;10:e0128552 pubmed publisher
  837. Coulson Thomas V, Chang S, Yeh L, Coulson Thomas Y, Yamaguchi Y, Esko J, et al. Loss of corneal epithelial heparan sulfate leads to corneal degeneration and impaired wound healing. Invest Ophthalmol Vis Sci. 2015;56:3004-14 pubmed publisher
  838. Wei X, Dou X, Bai J, Luo X, Qiu S, Xi D, et al. ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer. Oncotarget. 2015;6:21704-17 pubmed
  839. Kim S, Lee E, Kuh H. Co-culture of 3D tumor spheroids with fibroblasts as a model for epithelial-mesenchymal transition in vitro. Exp Cell Res. 2015;335:187-96 pubmed publisher
  840. Zarkoob H, Bodduluri S, Ponnaluri S, Selby J, Sander E. Substrate Stiffness Affects Human Keratinocyte Colony Formation. Cell Mol Bioeng. 2015;8:32-50 pubmed
  841. Hernández P, Mahlakõiv T, Yang I, Schwierzeck V, Nguyen N, Guendel F, et al. Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection. Nat Immunol. 2015;16:698-707 pubmed publisher
  842. Li L, Qi L, Liang Z, Song W, Liu Y, Wang Y, et al. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells. Int J Mol Med. 2015;36:113-22 pubmed publisher
  843. Cicchini C, de Nonno V, Battistelli C, Cozzolino A, De Santis Puzzonia M, Ciafrè S, et al. Epigenetic control of EMT/MET dynamics: HNF4α impacts DNMT3s through miRs-29. Biochim Biophys Acta. 2015;1849:919-29 pubmed publisher
  844. Izawa G, Kobayashi W, Haraguchi M, Sudo A, Ozawa M. The ectopic expression of Snail in MDBK cells does not induce epithelial-mesenchymal transition. Int J Mol Med. 2015;36:166-72 pubmed publisher
  845. Jackson B, Ivanova I, Dagnino L. An ELMO2-RhoG-ILK network modulates microtubule dynamics. Mol Biol Cell. 2015;26:2712-25 pubmed publisher
  846. Palla A, Piazzolla D, Alcazar N, Cañamero M, Graña O, Gómez López G, et al. The pluripotency factor NANOG promotes the formation of squamous cell carcinomas. Sci Rep. 2015;5:10205 pubmed publisher
  847. Duvall Noelle N, Karwandyar A, Richmond A, Raman D. LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex. Oncogene. 2016;35:1122-33 pubmed publisher
  848. Zhang Y, Fan N, Yang J. Expression and clinical significance of hypoxia-inducible factor 1?, Snail and E-cadherin in human ovarian cancer cell lines. Mol Med Rep. 2015;12:3393-3399 pubmed publisher
  849. Stewart R, Zubek A, Rosowski K, Schreiner S, Horsley V, King M. Nuclear-cytoskeletal linkages facilitate cross talk between the nucleus and intercellular adhesions. J Cell Biol. 2015;209:403-18 pubmed publisher
  850. Grikscheit K, Frank T, Wang Y, Grosse R. Junctional actin assembly is mediated by Formin-like 2 downstream of Rac1. J Cell Biol. 2015;209:367-76 pubmed publisher
  851. Polioudaki H, Agelaki S, Chiotaki R, Politaki E, Mavroudis D, Matikas A, et al. Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer. BMC Cancer. 2015;15:399 pubmed publisher
  852. Cheng J, Yang H, Fang J, Ma L, Gong R, Wang P, et al. Molecular mechanism for USP7-mediated DNMT1 stabilization by acetylation. Nat Commun. 2015;6:7023 pubmed publisher
  853. Mortazavi F, Lu J, Phan R, Lewis M, Trinidad K, Aljilani A, et al. Significance of KRAS/PAK1/Crk pathway in non-small cell lung cancer oncogenesis. BMC Cancer. 2015;15:381 pubmed publisher
  854. Ruscetti M, Quach B, Dadashian E, Mulholland D, Wu H. Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis. Cancer Res. 2015;75:2749-59 pubmed publisher
  855. Bhagirath D, Zhao X, West W, Qiu F, Band H, Band V. Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes. Oncotarget. 2015;6:9018-30 pubmed
  856. Remo A, Simeone I, Pancione M, Parcesepe P, Finetti P, Cerulo L, et al. Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer. J Transl Med. 2015;13:138 pubmed publisher
  857. Brunner S, Weber F, Werner J, Agha A, Farkas S, Schlitt H, et al. Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification. BMC Surg. 2015;15:49 pubmed publisher
  858. Drost J, van Jaarsveld R, Ponsioen B, Zimberlin C, van Boxtel R, Buijs A, et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature. 2015;521:43-7 pubmed publisher
  859. Sato S, Kawamata Y, Takahashi A, Imai Y, Hanyu A, Okuma A, et al. Ablation of the p16(INK4a) tumour suppressor reverses ageing phenotypes of klotho mice. Nat Commun. 2015;6:7035 pubmed publisher
  860. Malik S, Villanova L, Tanaka S, Aonuma M, Roy N, Berber E, et al. SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors. Sci Rep. 2015;5:9841 pubmed publisher
  861. Jang D, Kwon H, Jeong K, Lee J, Pak Y. Essential role of flotillin-1 palmitoylation in the intracellular localization and signaling function of IGF-1 receptor. J Cell Sci. 2015;128:2179-90 pubmed publisher
  862. Lin X, Xu W, Shao M, Fan Q, Wen G, Li C, et al. Shenling Baizhu San supresses colitis associated colorectal cancer through inhibition of epithelial-mesenchymal transition and myeloid-derived suppressor infiltration. BMC Complement Altern Med. 2015;15:126 pubmed publisher
  863. Giribaldi M, Muñoz A, Halvorsen K, Patel A, Rai P. MTH1 expression is required for effective transformation by oncogenic HRAS. Oncotarget. 2015;6:11519-29 pubmed
  864. Flanagan D, Phesse T, Barker N, Schwab R, Amin N, Malaterre J, et al. Frizzled7 functions as a Wnt receptor in intestinal epithelial Lgr5(+) stem cells. Stem Cell Reports. 2015;4:759-67 pubmed publisher
  865. Pilli V, Gupta K, Kotha B, Aradhyam G. Snail-mediated Cripto-1 repression regulates the cell cycle and epithelial-mesenchymal transition-related gene expression. FEBS Lett. 2015;589:1249-56 pubmed publisher
  866. Bettaieb A, Jiang J, Sasaki Y, Chao T, Kiss Z, Chen X, et al. Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice. Gastroenterology. 2015;149:468-80.e10 pubmed publisher
  867. Modepalli V, Hinds L, Sharp J, Lefevre C, Nicholas K. Role of marsupial tammar wallaby milk in lung maturation of pouch young. BMC Dev Biol. 2015;15:16 pubmed publisher
  868. ORELLANA R, Kato S, Erices R, Bravo M, Gonzalez P, Oliva B, et al. Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer. 2015;15:290 pubmed publisher
  869. Chen P, Wu T, Cheng Y, Chen C, Lee H. NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation. Oncotarget. 2015;6:14274-89 pubmed
  870. Sanguinetti A, Santini D, Bonafè M, Taffurelli M, Avenia N. Interleukin-6 and pro inflammatory status in the breast tumor microenvironment. World J Surg Oncol. 2015;13:129 pubmed publisher
  871. Meidhof S, Brabletz S, Lehmann W, Preca B, Mock K, Ruh M, et al. ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. EMBO Mol Med. 2015;7:831-47 pubmed publisher
  872. Maity G, De A, Das A, Banerjee S, Sarkar S, Banerjee S. Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Lab Invest. 2015;95:702-17 pubmed publisher
  873. Ferreira R, Law M, Jahn S, Davis B, Heldermon C, Reinhard M, et al. Novel agents that downregulate EGFR, HER2, and HER3 in parallel. Oncotarget. 2015;6:10445-59 pubmed
  874. Saias L, Gomes A, Cazales M, Ducommun B, Lobjois V. Cell-Cell Adhesion and Cytoskeleton Tension Oppose Each Other in Regulating Tumor Cell Aggregation. Cancer Res. 2015;75:2426-33 pubmed publisher
  875. Janes K. An analysis of critical factors for quantitative immunoblotting. Sci Signal. 2015;8:rs2 pubmed publisher
  876. Buchholz M, Honstein T, Kirchhoff S, Kreider R, Schmidt H, Sipos B, et al. A multistep high-content screening approach to identify novel functionally relevant target genes in pancreatic cancer. PLoS ONE. 2015;10:e0122946 pubmed publisher
  877. Wu S, Yi J, Zhang Y, Zhou J, Sun J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol Rep. 2015;3: pubmed publisher
  878. Mandara M, Reginato A, Foiani G, Baroni M, Poli F, Gasparinetti N, et al. Papillary meningioma in the dog: A clinicopathological case series study. Res Vet Sci. 2015;100:213-9 pubmed publisher
  879. Yarilin D, Xu K, Turkekul M, Fan N, Romin Y, Fijisawa S, et al. Machine-based method for multiplex in situ molecular characterization of tissues by immunofluorescence detection. Sci Rep. 2015;5:9534 pubmed publisher
  880. Cho J, Lee S, Oh A, Yoon M, Woo T, Park B. NF2 blocks Snail-mediated p53 suppression in mesothelioma. Oncotarget. 2015;6:10073-85 pubmed
  881. Savci Heijink C, Halfwerk H, Hooijer G, Horlings H, Wesseling J, van de Vijver M. Retrospective analysis of metastatic behaviour of breast cancer subtypes. Breast Cancer Res Treat. 2015;150:547-57 pubmed publisher
  882. Charest J, Okamoto T, Kitano K, Yasuda A, Gilpin S, Mathisen D, et al. Design and validation of a clinical-scale bioreactor for long-term isolated lung culture. Biomaterials. 2015;52:79-87 pubmed publisher
  883. Li S, Wu X, Dong C, Xie X, Wu J, Zhang X. The differential expression of OCT4 isoforms in cervical carcinoma. PLoS ONE. 2015;10:e0118033 pubmed publisher
  884. Richter E, Harms M, Ventz K, Gierok P, Chilukoti R, Hildebrandt J, et al. A multi-omics approach identifies key hubs associated with cell type-specific responses of airway epithelial cells to staphylococcal alpha-toxin. PLoS ONE. 2015;10:e0122089 pubmed publisher
  885. Bazellières E, Conte V, Elosegui Artola A, Serra Picamal X, Bintanel Morcillo M, Roca Cusachs P, et al. Control of cell-cell forces and collective cell dynamics by the intercellular adhesome. Nat Cell Biol. 2015;17:409-20 pubmed publisher
  886. Verduzco D, Lloyd M, Xu L, Ibrahim Hashim A, Balagurunathan Y, Gatenby R, et al. Intermittent hypoxia selects for genotypes and phenotypes that increase survival, invasion, and therapy resistance. PLoS ONE. 2015;10:e0120958 pubmed publisher
  887. Kim Y, Jin D, Lee B, Cho E, Han J, Shim Y, et al. RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung. Clin Epigenetics. 2015;7:32 pubmed publisher
  888. Kann M, Bae E, Lenz M, Li L, Trannguyen B, Schumacher V, et al. WT1 targets Gas1 to maintain nephron progenitor cells by modulating FGF signals. Development. 2015;142:1254-66 pubmed publisher
  889. Yamada A, Aki T, Unuma K, Funakoshi T, Uemura K. Paraquat induces epithelial-mesenchymal transition-like cellular response resulting in fibrogenesis and the prevention of apoptosis in human pulmonary epithelial cells. PLoS ONE. 2015;10:e0120192 pubmed publisher
  890. Chen X, Liu X, Lang H, Zhang S, Luo Y, Zhang J. S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line. PLoS ONE. 2015;10:e0121319 pubmed publisher
  891. Dicay M, Hirota C, Ronaghan N, Peplowski M, Zaheer R, Carati C, et al. Interferon-γ suppresses intestinal epithelial aquaporin-1 expression via Janus kinase and STAT3 activation. PLoS ONE. 2015;10:e0118713 pubmed publisher
  892. Yan H, Xu J, Fang L, Qiu Y, Lin X, Huang H, et al. Ectopic expression of the WWOX gene suppresses stemness of human ovarian cancer stem cells. Oncol Lett. 2015;9:1614-1620 pubmed
  893. Kawada M, Inoue H, Ohba S, Yoshida J, Masuda T, Yamasaki M, et al. Stromal cells positively and negatively modulate the growth of cancer cells: stimulation via the PGE2-TNFα-IL-6 pathway and inhibition via secreted GAPDH-E-cadherin interaction. PLoS ONE. 2015;10:e0119415 pubmed publisher
  894. Strick Marchand H, Dusséaux M, Darche S, Huntington N, Legrand N, Masse Ranson G, et al. A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS ONE. 2015;10:e0119820 pubmed publisher
  895. Sriraman K, Bhartiya D, Anand S, Bhutda S. Mouse Ovarian Very Small Embryonic-Like Stem Cells Resist Chemotherapy and Retain Ability to Initiate Oocyte-Specific Differentiation. Reprod Sci. 2015;22:884-903 pubmed publisher
  896. Skardal A, Devarasetty M, Rodman C, Atala A, Soker S. Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro. Ann Biomed Eng. 2015;43:2361-73 pubmed publisher
  897. Conn S, Pillman K, Toubia J, Conn V, Salmanidis M, Phillips C, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160:1125-34 pubmed publisher
  898. Qiao Y, Shiue C, Zhu J, Zhuang T, Jonsson P, Wright A, et al. AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFα-induced epithelial-mesenchymal transition in triple-negative breast cancer. Oncotarget. 2015;6:7804-14 pubmed
  899. Chang A, Liu Y, Ayyanathan K, Benner C, Jiang Y, Prokop J, et al. An evolutionarily conserved DNA architecture determines target specificity of the TWIST family bHLH transcription factors. Genes Dev. 2015;29:603-16 pubmed publisher
  900. Tennakoon A, Izawa T, Wijesundera K, Katou Ichikawa C, Tanaka M, Golbar H, et al. Analysis of glial fibrillary acidic protein (GFAP)-expressing ductular cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA). Exp Mol Pathol. 2015;98:476-85 pubmed publisher
  901. Lin Y, Yang Z, Xu A, Dong P, Huang Y, Liu H, et al. PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway. Sci Rep. 2015;5:8997 pubmed publisher
  902. Wang G, Liu G, Ye Y, Fu Y, Zhang X. The role of microRNA-1274a in the tumorigenesis of gastric cancer: accelerating cancer cell proliferation and migration via directly targeting FOXO4. Biochem Biophys Res Commun. 2015;459:629-35 pubmed publisher
  903. Voets E, Wolthuis R. MASTL promotes cyclin B1 destruction by enforcing Cdc20-independent binding of cyclin B1 to the APC/C. Biol Open. 2015;4:484-95 pubmed publisher
  904. Gendronneau G, Sanii S, Dang T, Deshayes F, Delacour D, Pichard E, et al. Overexpression of galectin-7 in mouse epidermis leads to loss of cell junctions and defective skin repair. PLoS ONE. 2015;10:e0119031 pubmed publisher
  905. Rogler A, Kendziorra E, Giedl J, Stoehr C, Taubert H, Goebell P, et al. Functional analyses and prognostic significance of SFRP1 expression in bladder cancer. J Cancer Res Clin Oncol. 2015;141:1779-90 pubmed publisher
  906. Fang J, Zhou H, Zhang C, Shang L, Zhang L, Xu J, et al. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner. Hepatology. 2015;62:452-65 pubmed publisher
  907. Wang H, Bao W, Jiang F, Che Q, Chen Z, Wang F, et al. Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ. Cancer Lett. 2015;360:269-79 pubmed publisher
  908. Song E, Yu W, Xiong X, Kuang X, Ai Y, Xiong X. Astrocyte elevated gene-1 promotes progression of cervical squamous cell carcinoma by inducing epithelial-mesenchymal transition via Wnt signaling. Int J Gynecol Cancer. 2015;25:345-55 pubmed publisher
  909. Rayavarapu R, Heiden B, Pagani N, Shaw M, Shuff S, Zhang S, et al. The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment. J Biol Chem. 2015;290:8722-33 pubmed publisher
  910. Oon M, Thike A, Tan S, Tan P. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat. 2015;150:31-41 pubmed publisher
  911. Kang Y, Cho C, Kwon S. Microcystic stromal tumor of the ovary with mutation in exon 3 of β-catenin: a case report. Int J Gynecol Pathol. 2015;34:121-5 pubmed publisher
  912. Boekhout M, Wolthuis R. Nek2A destruction marks APC/C activation at the prophase-to-prometaphase transition by spindle-checkpoint-restricted Cdc20. J Cell Sci. 2015;128:1639-53 pubmed publisher
  913. Kwon H, Lee J, Jeong K, Jang D, Pak Y. Fatty acylated caveolin-2 is a substrate of insulin receptor tyrosine kinase for insulin receptor substrate-1-directed signaling activation. Biochim Biophys Acta. 2015;1853:1022-34 pubmed publisher
  914. Chen C, Zhao Z, Liu Y, Mu D. microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells. Oncol Lett. 2015;9:1128-1134 pubmed
  915. Kitamura J, Uemura M, Kurozumi M, Sonobe M, Manabe T, Hiai H, et al. Chronic lung injury by constitutive expression of activation-induced cytidine deaminase leads to focal mucous cell metaplasia and cancer. PLoS ONE. 2015;10:e0117986 pubmed publisher
  916. Nguyen D, Rubinstein L, Takebe N, Miele L, Tomaszewski J, Ivy P, et al. Notch1 phenotype and clinical stage progression in non-small cell lung cancer. J Hematol Oncol. 2015;8:9 pubmed publisher
  917. Yui T, Ohmachi T, Matsuda K, Okamoto M, Taniyama H. Histochemical and immunohistochemical characterization of chordoma in ferrets. J Vet Med Sci. 2015;77:467-73 pubmed publisher
  918. Kap M, Lam K, Ewing Graham P, Riegman P. A reference image-based method for optimization of clinical immunohistochemistry. Histopathology. 2015;67:193-205 pubmed publisher
  919. Gu J, Xu F, Zhao G, Lu C, Lin Z, Ding J, et al. Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2. Med Oncol. 2015;32:51 pubmed publisher
  920. Wagner R, Luciani F, Cario André M, Rubod A, Petit V, Benzekri L, et al. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo. J Invest Dermatol. 2015;135:1810-1819 pubmed publisher
  921. Cai K, Wang Y, Smith E, Smedberg J, Yang D, Yang W, et al. Global deletion of Trp53 reverts ovarian tumor phenotype of the germ cell-deficient white spotting variant (Wv) mice. Neoplasia. 2015;17:89-100 pubmed publisher
  922. Liu S, Lee W, Lai D, Wu S, Liu C, Tien H, et al. Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition. Mol Oncol. 2015;9:834-49 pubmed publisher
  923. Bele A, Mirza S, Zhang Y, Ahmad Mir R, Lin S, Kim J, et al. The cell cycle regulator ecdysoneless cooperates with H-Ras to promote oncogenic transformation of human mammary epithelial cells. Cell Cycle. 2015;14:990-1000 pubmed publisher
  924. Hsiao S, Chen M, Chen C, Chien M, Hua K, Hsiao M, et al. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer. Ann Surg Oncol. 2015;22 Suppl 3:S1556-65 pubmed publisher
  925. Kang W, Lee J, Oh S, Lee S, Jung C. Stromal expression of miR-21 in T3-4a colorectal cancer is an independent predictor of early tumor relapse. BMC Gastroenterol. 2015;15:2 pubmed publisher
  926. Schumacher M, Aihara E, Feng R, Engevik A, Shroyer N, Ottemann K, et al. The use of murine-derived fundic organoids in studies of gastric physiology. J Physiol. 2015;593:1809-27 pubmed publisher
  927. Chiappetta G, Valentino T, Vitiello M, Pasquinelli R, Monaco M, Palma G, et al. PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration. Oncotarget. 2015;6:5310-23 pubmed
  928. Traenkle B, Emele F, Anton R, Poetz O, Haeussler R, Maier J, et al. Monitoring interactions and dynamics of endogenous beta-catenin with intracellular nanobodies in living cells. Mol Cell Proteomics. 2015;14:707-23 pubmed publisher
  929. Arriagada A, Albornoz E, Opazo M, Becerra A, Vidal G, Fardella C, et al. Excess iodide induces an acute inhibition of the sodium/iodide symporter in thyroid male rat cells by increasing reactive oxygen species. Endocrinology. 2015;156:1540-51 pubmed publisher
  930. Nykopp T, Pasonen Seppänen S, Tammi M, Tammi R, Kosma V, Anttila M, et al. Decreased hyaluronidase 1 expression is associated with early disease recurrence in human endometrial cancer. Gynecol Oncol. 2015;137:152-9 pubmed publisher
  931. Gurzu S, Kádár Z, Sugimura H, Bara T, Hălmaciu I, Jung I. Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity. APMIS. 2015;123:223-33 pubmed publisher
  932. Kreft M, Jerman U, Lasič E, Hevir Kene N, Rižner T, Peternel L, et al. The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function. Eur J Pharm Sci. 2015;69:1-9 pubmed publisher
  933. Caldwell B, Lucas C, Kee A, Gaus K, Gunning P, Hardeman E, et al. Tropomyosin isoforms support actomyosin biogenesis to generate contractile tension at the epithelial zonula adherens. Cytoskeleton (Hoboken). 2014;71:663-76 pubmed publisher
  934. Tange S, Oktyabri D, Terashima M, Ishimura A, Suzuki T. JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines. PLoS ONE. 2014;9:e115684 pubmed publisher
  935. Olsen P, Solberg N, Lund K, Vehus T, Gelazauskaite M, Wilson S, et al. Implications of targeted genomic disruption of β-catenin in BxPC-3 pancreatic adenocarcinoma cells. PLoS ONE. 2014;9:e115496 pubmed publisher
  936. Gong X, Yi J, Carmon K, Crumbley C, Xiong W, Thomas A, et al. Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness. Oncogene. 2015;34:4692-701 pubmed publisher
  937. Yuan X, Dee M, Altman N, Malek T. IL-2Rβ-dependent signaling and CD103 functionally cooperate to maintain tolerance in the gut mucosa. J Immunol. 2015;194:1334-46 pubmed publisher
  938. Vitiello E, Ferreira J, Maiato H, Balda M, Matter K. The tumour suppressor DLC2 ensures mitotic fidelity by coordinating spindle positioning and cell-cell adhesion. Nat Commun. 2014;5:5826 pubmed publisher
  939. Satelli A, Mitra A, Brownlee Z, Xia X, Bellister S, Overman M, et al. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res. 2015;21:899-906 pubmed publisher
  940. Watari A, Hashegawa M, Yagi K, Kondoh M. Homoharringtonine increases intestinal epithelial permeability by modulating specific claudin isoforms in Caco-2 cell monolayers. Eur J Pharm Biopharm. 2015;89:232-8 pubmed publisher
  941. Dalla Pozza E, Dando I, Biondani G, Brandi J, Costanzo C, Zoratti E, et al. Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells. Int J Oncol. 2015;46:1099-108 pubmed publisher
  942. Powell J, Hess B, Hutchison J, Straub T. Construction of an in vitro primary lung co-culture platform derived from New Zealand white rabbits. In Vitro Cell Dev Biol Anim. 2015;51:433-40 pubmed publisher
  943. Golden D, Cantley L. Casein kinase 2 prevents mesenchymal transformation by maintaining Foxc2 in the cytoplasm. Oncogene. 2015;34:4702-12 pubmed publisher
  944. Smid J, Faulkes S, Rudnicki M. Periostin induces pancreatic regeneration. Endocrinology. 2015;156:824-36 pubmed publisher
  945. Xu M, Zhu C, Zhao X, Chen C, Zhang H, Yuan H, et al. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors. Oncotarget. 2015;6:979-94 pubmed
  946. Carter E, Miron Buchacra G, Goldoni S, Danahay H, Westwick J, Watson M, et al. Phosphoinositide 3-kinase alpha-dependent regulation of branching morphogenesis in murine embryonic lung: evidence for a role in determining morphogenic properties of FGF7. PLoS ONE. 2014;9:e113555 pubmed publisher
  947. Davidson B, Holth A, Hellesylt E, Tan T, Huang R, Tropé C, et al. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions. Hum Pathol. 2015;46:1-8 pubmed publisher
  948. Trasino S, Benoit Y, Gudas L. Vitamin A deficiency causes hyperglycemia and loss of pancreatic β-cell mass. J Biol Chem. 2015;290:1456-73 pubmed publisher
  949. Jannasch K, Wegwitz F, Lenfert E, Maenz C, Deppert W, Alves F. Chemotherapy of WAP-T mouse mammary carcinomas aggravates tumor phenotype and enhances tumor cell dissemination. Int J Cancer. 2015;137:25-36 pubmed publisher
  950. Liu D, Yovchev M, Zhang J, Alfieri A, Tchaikovskaya T, Laconi E, et al. Identification and characterization of mesenchymal-epithelial progenitor-like cells in normal and injured rat liver. Am J Pathol. 2015;185:110-28 pubmed publisher
  951. Figueira A, Gomes C, de Oliveira J, Vilhena H, Carvalheira J, de Matos A, et al. Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas. BMC Vet Res. 2014;10:270 pubmed publisher
  952. Guckenberger D, Berthier E, Beebe D. High-density self-contained microfluidic KOALA kits for use by everyone. J Lab Autom. 2015;20:146-53 pubmed publisher
  953. Easter S, Mitchell E, Baxley S, Desmond R, Frost A, Serra R. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors. PLoS ONE. 2014;9:e113247 pubmed publisher
  954. Raiko L, Leinonen P, Hägg P, Peltonen J, Oikarinen A, Peltonen S. Tight junctions in Hailey-Hailey and Darier's diseases. Dermatol Reports. 2009;1:e1 pubmed publisher
  955. Akgul Y, Word R, Ensign L, Yamaguchi Y, Lydon J, Hanes J, et al. Hyaluronan in cervical epithelia protects against infection-mediated preterm birth. J Clin Invest. 2014;124:5481-9 pubmed publisher
  956. Lee Y, Ehninger D, Zhou M, Oh J, Kang M, Kwak C, et al. Mechanism and treatment for learning and memory deficits in mouse models of Noonan syndrome. Nat Neurosci. 2014;17:1736-43 pubmed publisher
  957. Ciamporcero E, Miles K, Adelaiye R, Ramakrishnan S, Shen L, Ku S, et al. Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models. Mol Cancer Ther. 2015;14:101-10 pubmed publisher
  958. Poidatz D, Dos Santos E, Gronier H, Vialard F, Maury B, De Mazancourt P, et al. Trophoblast syncytialisation necessitates mitochondrial function through estrogen-related receptor-γ activation. Mol Hum Reprod. 2015;21:206-16 pubmed publisher
  959. Kim M, Kim M, Lee M, Kim C, Lim D. The MST1/2-SAV1 complex of the Hippo pathway promotes ciliogenesis. Nat Commun. 2014;5:5370 pubmed publisher
  960. Soh B, Buac K, Xu H, Li E, Ng S, Wu H, et al. N-cadherin prevents the premature differentiation of anterior heart field progenitors in the pharyngeal mesodermal microenvironment. Cell Res. 2014;24:1420-32 pubmed publisher
  961. Chang K, Zollinger D, Susuki K, Sherman D, Makara M, Brophy P, et al. Glial ankyrins facilitate paranodal axoglial junction assembly. Nat Neurosci. 2014;17:1673-81 pubmed publisher
  962. Tao W, Moore R, Smith E, Xu X. Hormonal induction and roles of Disabled-2 in lactation and involution. PLoS ONE. 2014;9:e110737 pubmed publisher
  963. Akoury E, Zhang L, Ao A, Slim R. NLRP7 and KHDC3L, the two maternal-effect proteins responsible for recurrent hydatidiform moles, co-localize to the oocyte cytoskeleton. Hum Reprod. 2015;30:159-69 pubmed publisher
  964. Preda V, Larkin S, Karavitaki N, Ansorge O, Grossman A. The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis. Endocr Pathol. 2015;26:1-8 pubmed publisher
  965. Milne P, Bigley V, Gunawan M, Haniffa M, Collin M. CD1c+ blood dendritic cells have Langerhans cell potential. Blood. 2015;125:470-3 pubmed publisher
  966. Griner N, Young D, Chaudhary P, Mohamed A, Huang W, Chen Y, et al. ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer. Mol Cancer Res. 2015;13:368-79 pubmed publisher
  967. Kunasegaran K, Ho V, Chang T, De Silva D, Bakker M, Christoffels V, et al. Transcriptional repressor Tbx3 is required for the hormone-sensing cell lineage in mammary epithelium. PLoS ONE. 2014;9:e110191 pubmed publisher
  968. Sun Q, Luo T, Ren Y, Florey O, Shirasawa S, Sasazuki T, et al. Competition between human cells by entosis. Cell Res. 2014;24:1299-310 pubmed publisher
  969. Sun Q, Cibas E, Huang H, Hodgson L, Overholtzer M. Induction of entosis by epithelial cadherin expression. Cell Res. 2014;24:1288-98 pubmed publisher
  970. Suh S, Yoo J, Cui R, Kaur B, Huebner K, Lee T, et al. FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs. PLoS Genet. 2014;10:e1004652 pubmed publisher
  971. Soncini D, Caffa I, Zoppoli G, Cea M, Cagnetta A, Passalacqua M, et al. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. J Biol Chem. 2014;289:34189-204 pubmed publisher
  972. Calangiu C, Simionescu C, Stepan A, Cernea D, Zăvoi R, Mărgăritescu C. The expression of CK19, vimentin and E-cadherin in differentiated thyroid carcinomas. Rom J Morphol Embryol. 2014;55:919-25 pubmed
  973. Kocher B, White L, Piwnica Worms D. DAPK3 suppresses acini morphogenesis and is required for mouse development. Mol Cancer Res. 2015;13:358-67 pubmed publisher
  974. Laporta J, Keil K, Vezina C, Hernandez L. Peripheral serotonin regulates maternal calcium trafficking in mammary epithelial cells during lactation in mice. PLoS ONE. 2014;9:e110190 pubmed publisher
  975. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  976. Cai X, Dai Z, Reeves R, Caballero Benítez A, Duran K, Delrow J, et al. Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells. PLoS ONE. 2014;9:e108942 pubmed publisher
  977. Rai S, Tanaka H, Suzuki M, Ogoh H, Taniguchi Y, Morita Y, et al. Clathrin assembly protein CALM plays a critical role in KIT signaling by regulating its cellular transport from early to late endosomes in hematopoietic cells. PLoS ONE. 2014;9:e109441 pubmed publisher
  978. Xia H, Ren X, Bolte C, Ustiyan V, Zhang Y, Shah T, et al. Foxm1 regulates resolution of hyperoxic lung injury in newborns. Am J Respir Cell Mol Biol. 2015;52:611-21 pubmed publisher
  979. Yu S, Yehia G, Wang J, Stypulkowski E, Sakamori R, Jiang P, et al. Global ablation of the mouse Rab11a gene impairs early embryogenesis and matrix metalloproteinase secretion. J Biol Chem. 2014;289:32030-43 pubmed publisher
  980. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  981. Fan C, Jiang G, Zhang X, Miao Y, Lin X, Luan L, et al. Zbed3 contributes to malignant phenotype of lung cancer via regulating β-catenin and P120-catenin 1. Mol Carcinog. 2015;54 Suppl 1:E138-47 pubmed publisher
  982. Sako Kubota K, Tanaka N, Nagae S, Meng W, Takeichi M. Minus end-directed motor KIFC3 suppresses E-cadherin degradation by recruiting USP47 to adherens junctions. Mol Biol Cell. 2014;25:3851-60 pubmed publisher
  983. Matsuyama M, Nomori A, Nakakuni K, Shimono A, Fukushima M. Secreted Frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy. J Biol Chem. 2014;289:31526-33 pubmed publisher
  984. Sonal -, Sidhaye J, Phatak M, Banerjee S, Mulay A, Deshpande O, et al. Myosin Vb mediated plasma membrane homeostasis regulates peridermal cell size and maintains tissue homeostasis in the zebrafish epidermis. PLoS Genet. 2014;10:e1004614 pubmed publisher
  985. Wögenstein K, Szabo S, Lunova M, Wiche G, Haybaeck J, Strnad P, et al. Epiplakin deficiency aggravates murine caerulein-induced acute pancreatitis and favors the formation of acinar keratin granules. PLoS ONE. 2014;9:e108323 pubmed publisher
  986. Cao Y, Slaney C, Bidwell B, Parker B, Johnstone C, Rautela J, et al. BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity. Cancer Res. 2014;74:5091-102 pubmed publisher
  987. Wainwright E, Svingen T, Ng E, Wicking C, Koopman P. Primary cilia function regulates the length of the embryonic trunk axis and urogenital field in mice. Dev Biol. 2014;395:342-54 pubmed publisher
  988. Lee J, Chung L, Chen Y, Feng T, Juang H. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma. Cancer Lett. 2014;355:242-52 pubmed publisher
  989. Rubashkin M, Cassereau L, Bainer R, DuFort C, Yui Y, Ou G, et al. Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate. Cancer Res. 2014;74:4597-611 pubmed publisher
  990. Li J, Liu J, Li P, Mao X, Li W, Yang J, et al. Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion. J Exp Clin Cancer Res. 2014;33:70 pubmed publisher
  991. Hagos Y, Wegner W, Kuehne A, Floerl S, Marada V, Burckhardt G, et al. HNF4α induced chemosensitivity to oxaliplatin and 5-FU mediated by OCT1 and CNT3 in renal cell carcinoma. J Pharm Sci. 2014;103:3326-34 pubmed publisher
  992. Tang J, Shen L, Yang Q, Zhang C. Overexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial-mesenchymal transition. Cell Prolif. 2014;47:427-34 pubmed publisher
  993. Zorin V, Komlev V, Zorina A, Khromova N, Solovieva E, Fedotov A, et al. Octacalcium phosphate ceramics combined with gingiva-derived stromal cells for engineered functional bone grafts. Biomed Mater. 2014;9:055005 pubmed publisher
  994. Wennerström A, Lothe I, Sandhu V, Kure E, Myklebost O, Munthe E. Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines. PLoS ONE. 2014;9:e103873 pubmed publisher
  995. Kreft M, Jerman U, Lasič E, Lanišnik Rižner T, Hevir Kene N, Peternel L, et al. The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model. Pharm Res. 2015;32:665-79 pubmed publisher
  996. Kodama T, Motoi N, Ninomiya H, Sakamoto H, Kitada K, Tsukaguchi T, et al. A novel mechanism of EML4-ALK rearrangement mediated by chromothripsis in a patient-derived cell line. J Thorac Oncol. 2014;9:1638-46 pubmed publisher
  997. Ishii H, Saitoh M, Sakamoto K, Kondo T, Katoh R, Tanaka S, et al. Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms. J Biol Chem. 2014;289:27386-99 pubmed publisher
  998. Thompson L, Bauer J, Chiosea S, McHugh J, Seethala R, Miettinen M, et al. Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature. Head Neck Pathol. 2015;9:181-95 pubmed publisher
  999. Lu G, Zhang Q, Huang Y, Song J, Tomaino R, Ehrenberger T, et al. Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. Cancer Cell. 2014;26:222-34 pubmed publisher
  1000. Bastos L, de Marcondes P, de Freitas Junior J, Leve F, Mencalha A, de Souza W, et al. Progeny from irradiated colorectal cancer cells acquire an EMT-like phenotype and activate Wnt/?-catenin pathway. J Cell Biochem. 2014;115:2175-87 pubmed publisher
  1001. Gwak J, Kim H, Kim E, Chung Y, Yun S, Seo A, et al. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Breast Cancer Res Treat. 2014;147:39-49 pubmed publisher
  1002. Crespi A, Bertoni A, Ferrari I, Padovano V, Della Mina P, Berti E, et al. POF1B localizes to desmosomes and regulates cell adhesion in human intestinal and keratinocyte cell lines. J Invest Dermatol. 2015;135:192-201 pubmed publisher
  1003. Balaji K, French C, Miller J, Colicelli J. The RAB5-GEF function of RIN1 regulates multiple steps during Listeria monocytogenes infection. Traffic. 2014;15:1206-18 pubmed publisher
  1004. Ohta H, Sunden Y, Yokoyama N, Osuga T, Lim S, Tamura Y, et al. Expression of apical junction complex proteins in duodenal mucosa of dogs with inflammatory bowel disease. Am J Vet Res. 2014;75:746-51 pubmed publisher
  1005. Pidoux G, Gerbaud P, Dompierre J, Lygren B, Solstad T, Evain Brion D, et al. A PKA-ezrin-Cx43 signaling complex controls gap junction communication and thereby trophoblast cell fusion. J Cell Sci. 2014;127:4172-85 pubmed publisher
  1006. Syed B, Green A, Nolan C, Morgan D, Ellis I, Cheung K. Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts. PLoS ONE. 2014;9:e100573 pubmed publisher
  1007. Lindström A, Hellberg D. Immunohistochemical LRIG3 expression in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer: association with expression of tumor markers, hormones, high-risk HPV-infection, smoking and patient outcome. Eur J Histochem. 2014;58:2227 pubmed publisher
  1008. Stodden G, Lindberg M, King M, Paquet M, MacLean J, Mann J, et al. Loss of Cdh1 and Trp53 in the uterus induces chronic inflammation with modification of tumor microenvironment. Oncogene. 2015;34:2471-82 pubmed publisher
  1009. Owens P, Pickup M, Novitskiy S, Giltnane J, Gorska A, Hopkins C, et al. Inhibition of BMP signaling suppresses metastasis in mammary cancer. Oncogene. 2015;34:2437-49 pubmed publisher
  1010. Costales M, Lopez F, García Inclán C, Fernandez S, Marcos C, Llorente J, et al. Establishment and characterization of an orthotopic sinonasal squamous cell carcinoma mouse model. Head Neck. 2015;37:1769-75 pubmed publisher
  1011. Liu J, Ke F, Xu Z, Liu Z, Zhang L, Yan S, et al. CCR6 is a prognostic marker for overall survival in patients with colorectal cancer, and its overexpression enhances metastasis in vivo. PLoS ONE. 2014;9:e101137 pubmed publisher
  1012. Fenton S, Hutchens K, Denning M. Targeting Fyn in Ras-transformed cells induces F-actin to promote adherens junction-mediated cell-cell adhesion. Mol Carcinog. 2015;54:1181-93 pubmed publisher
  1013. Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S, et al. YAP/TAZ incorporation in the ?-catenin destruction complex orchestrates the Wnt response. Cell. 2014;158:157-70 pubmed publisher
  1014. Liang W, Hao Z, Han J, Zhu D, Jin Z, Xie W. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Urol Oncol. 2014;32:855-63 pubmed publisher
  1015. McEwen A, Maher M, Mo R, Gottardi C. E-cadherin phosphorylation occurs during its biosynthesis to promote its cell surface stability and adhesion. Mol Biol Cell. 2014;25:2365-74 pubmed publisher
  1016. Dolega M, Wagh J, Gerbaud S, Kermarrec F, Alcaraz J, Martin D, et al. Facile bench-top fabrication of enclosed circular microchannels provides 3D confined structure for growth of prostate epithelial cells. PLoS ONE. 2014;9:e99416 pubmed publisher
  1017. Enjoji S, Ohama T, Sato K. Regulation of epithelial cell tight junctions by protease-activated receptor 2. J Vet Med Sci. 2014;76:1225-9 pubmed
  1018. Kowtharapu B, Stahnke T, Wree A, Guthoff R, Stachs O. Corneal epithelial and neuronal interactions: role in wound healing. Exp Eye Res. 2014;125:53-61 pubmed publisher
  1019. Bassagañas S, Carvalho S, Dias A, Pérez Garay M, Ortiz M, Figueras J, et al. Pancreatic cancer cell glycosylation regulates cell adhesion and invasion through the modulation of ?2?1 integrin and E-cadherin function. PLoS ONE. 2014;9:e98595 pubmed publisher
  1020. Lee M, Kim S, Kim B, Won C, Nam S, Kang S, et al. Snail1 induced in breast cancer cells in 3D collagen I gel environment suppresses cortactin and impairs effective invadopodia formation. Biochim Biophys Acta. 2014;1843:2037-54 pubmed publisher
  1021. Moiola C, De Luca P, Zalazar F, Cotignola J, Rodríguez Seguí S, Gardner K, et al. Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice. Clin Cancer Res. 2014;20:4086-95 pubmed publisher
  1022. Raimondi L, Amodio N, Di Martino M, Altomare E, Leotta M, Caracciolo D, et al. Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity. Oncotarget. 2014;5:3039-54 pubmed
  1023. Zhang C, Zhang H, Yu L, Cao Y. Helicobacter pylori dwelling on the apical surface of gastrointestinal epithelium damages the mucosal barrier through direct contact. Helicobacter. 2014;19:330-42 pubmed publisher
  1024. Elliott V, Rychahou P, Zaytseva Y, Evers B. Activation of c-Met and upregulation of CD44 expression are associated with the metastatic phenotype in the colorectal cancer liver metastasis model. PLoS ONE. 2014;9:e97432 pubmed publisher
  1025. Durak O, de Anda F, Singh K, Leussis M, Petryshen T, Sklar P, et al. Ankyrin-G regulates neurogenesis and Wnt signaling by altering the subcellular localization of ?-catenin. Mol Psychiatry. 2015;20:388-97 pubmed publisher
  1026. Subramani R, Lopez Valdez R, Arumugam A, Nandy S, Boopalan T, Lakshmanaswamy R. Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis. PLoS ONE. 2014;9:e97016 pubmed publisher
  1027. Altshuler A, Lamadrid I, Li D, Ma S, Kurre L, Schmid Schonbein G, et al. Transmural intestinal wall permeability in severe ischemia after enteral protease inhibition. PLoS ONE. 2014;9:e96655 pubmed publisher
  1028. Miki Y, Hamada K, Yoshino T, Miyatani K, Takahashi K. Type AB thymoma is not a mixed tumor of type A and type B thymomas, but a distinct type of thymoma. Virchows Arch. 2014;464:725-34 pubmed publisher
  1029. Jung S, Ohk J, Jeong D, Li C, Lee S, Duan J, et al. Distinct regulatory effect of the p34SEI-1 oncoprotein on cancer metastasis in HER2/neu-positive and -negative cells. Int J Oncol. 2014;45:189-96 pubmed publisher
  1030. Bao Y, Cao X, Luo D, Sun R, Peng L, Wang L, et al. Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis. Cell Cycle. 2014;13:1958-69 pubmed publisher
  1031. Wang R, Dang Y, Zheng R, Li Y, Li W, Lu X, et al. Live cell imaging of in vitro human trophoblast syncytialization. Biol Reprod. 2014;90:117 pubmed publisher
  1032. Rossi G, Pengo G, Caldin M, Palumbo Piccionello A, Steiner J, Cohen N, et al. Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. PLoS ONE. 2014;9:e94699 pubmed publisher
  1033. Ohgami R, Chisholm K, Ma L, Arber D. E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms. Am J Clin Pathol. 2014;141:656-64 pubmed publisher
  1034. Bejarano E, Yuste A, Patel B, Stout R, Spray D, Cuervo A. Connexins modulate autophagosome biogenesis. Nat Cell Biol. 2014;16:401-14 pubmed publisher
  1035. Villarreal Calderon R, Luévano González A, Aragón Flores M, Zhu H, Yuan Y, Xiang Q, et al. Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis. Ann Diagn Pathol. 2014;18:129-35 pubmed publisher
  1036. Truffi M, Dubreuil V, Liang X, Vacaresse N, Nigon F, Han S, et al. RPTP? controls epithelial adherens junctions, linking E-cadherin engagement to c-Src-mediated phosphorylation of cortactin. J Cell Sci. 2014;127:2420-32 pubmed publisher
  1037. Mato E, Gonzalez C, Moral A, Pérez J, Bell O, Lerma E, et al. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1). J Mol Endocrinol. 2014;52:289-300 pubmed publisher
  1038. Wojtalewicz N, Sadeqzadeh E, Weiß J, Tehrani M, Klein Scory S, Hahn S, et al. A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding. PLoS ONE. 2014;9:e90461 pubmed publisher
  1039. Chapnick D, Liu X. Leader cell positioning drives wound-directed collective migration in TGF?-stimulated epithelial sheets. Mol Biol Cell. 2014;25:1586-93 pubmed publisher
  1040. Chen D, Sun Y, Yuan Y, Han Z, Zhang P, Zhang J, et al. miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasion. PLoS Genet. 2014;10:e1004177 pubmed publisher
  1041. Yoshida T, Ozawa Y, Kimura T, Sato Y, Kuznetsov G, Xu S, et al. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states. Br J Cancer. 2014;110:1497-505 pubmed publisher
  1042. Peitsch W, Doerflinger Y, Fischer Colbrie R, Huck V, Bauer A, Utikal J, et al. Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells. PLoS ONE. 2014;9:e89491 pubmed publisher
  1043. Agoston A, Odze R. Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion. Hum Pathol. 2014;45:446-55 pubmed publisher
  1044. Rodrigues M, Rema A, Gartner M, Laufer Amorim R. Role of adhesion molecules and proliferation hyperplasic, pre neoplastic and neoplastic lesions in canine prostate. Pak J Biol Sci. 2013;16:1324-9 pubmed
  1045. Hesami P, Holzapfel B, Taubenberger A, Roudier M, Fazli L, Sieh S, et al. A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone. Clin Exp Metastasis. 2014;31:435-46 pubmed publisher
  1046. Piao H, Yuan Y, Wang M, Sun Y, Liang H, Ma L. ?-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-?B signalling. Nat Cell Biol. 2014;16:245-54 pubmed publisher
  1047. Berkenkamp B, Susnik N, Baisantry A, Kuznetsova I, Jacobi C, Sörensen Zender I, et al. In vivo and in vitro analysis of age-associated changes and somatic cellular senescence in renal epithelial cells. PLoS ONE. 2014;9:e88071 pubmed publisher
  1048. Hilliard S, Yao X, El Dahr S. Mdm2 is required for maintenance of the nephrogenic niche. Dev Biol. 2014;387:1-14 pubmed publisher
  1049. Weng W, Yin J, Zhang Y, Qiu J, Wang X. Metastasis-associated protein 1 promotes tumor invasion by downregulation of E-cadherin. Int J Oncol. 2014;44:812-8 pubmed publisher
  1050. Bordeira Carriço R, Ferreira D, Mateus D, Pinheiro H, Pêgo A, Santos M, et al. Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA. Eur J Hum Genet. 2014;22:1085-92 pubmed publisher
  1051. Moore R, Tao W, Meng Y, Smith E, Xu X. Cell adhesion and sorting in embryoid bodies derived from N- or E-cadherin deficient murine embryonic stem cells. Biol Open. 2014;3:121-8 pubmed publisher
  1052. Miura S, Hamada S, Masamune A, Satoh K, Shimosegawa T. CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cells. Exp Cell Res. 2014;321:209-18 pubmed publisher
  1053. Balko J, Giltnane J, Wang K, Schwarz L, Young C, Cook R, et al. Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets. Cancer Discov. 2014;4:232-45 pubmed publisher
  1054. Christensen I, Gyldenholm T, Damkier H, Praetorius J. Polarization of membrane associated proteins in the choroid plexus epithelium from normal and slc4a10 knockout mice. Front Physiol. 2013;4:344 pubmed publisher
  1055. Yu Y, Xiao C, Tan L, Wang Q, Li X, Feng Y. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-? signalling. Br J Cancer. 2014;110:724-32 pubmed publisher
  1056. Takasato M, Er P, Becroft M, Vanslambrouck J, Stanley E, Elefanty A, et al. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat Cell Biol. 2014;16:118-26 pubmed publisher
  1057. Gao M, Li W, Wang H, Wang G. The distinct expression patterns of claudin-10, -14, -17 and E-cadherin between adjacent non-neoplastic tissues and gastric cancer tissues. Diagn Pathol. 2013;8:205 pubmed publisher
  1058. Kim S, Kim M, Kim M, Kim S, Choi J, Yu E, et al. Pleomorphic solid pseudopapillary neoplasm of the pancreas: degenerative change rather than high-grade malignant potential. Hum Pathol. 2014;45:166-74 pubmed publisher
  1059. Tapias V, Cannon J, Greenamyre J. Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease. Neurobiol Aging. 2014;35:1162-76 pubmed publisher
  1060. Altshuler A, Richter M, Modestino A, Penn A, Heller M, Schmid Schonbein G. Removal of luminal content protects the small intestine during hemorrhagic shock but is not sufficient to prevent lung injury. Physiol Rep. 2013;1:e00109 pubmed publisher
  1061. Jones H, Gold M, Giannico G, Troutman A, Vnencak Jones C, Schultenover S, et al. Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing. Int J Gynecol Pathol. 2014;33:64-73 pubmed publisher
  1062. Basso K, Gomes F, Bracarense A. Deoxynivanelol and fumonisin, alone or in combination, induce changes on intestinal junction complexes and in E-cadherin expression. Toxins (Basel). 2013;5:2341-52 pubmed publisher
  1063. Cañadas I, Rojo F, Taus A, Arpi O, Arumi Uria M, Pijuan L, et al. Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer. Clin Cancer Res. 2014;20:938-50 pubmed publisher
  1064. Hugo H, Pereira L, Suryadinata R, Drabsch Y, Gonda T, Gunasinghe N, et al. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells. Breast Cancer Res. 2013;15:R113 pubmed publisher
  1065. Kasendra M, Barrile R, Leuzzi R, Soriani M. Clostridium difficile toxins facilitate bacterial colonization by modulating the fence and gate function of colonic epithelium. J Infect Dis. 2014;209:1095-104 pubmed publisher
  1066. Shiobara T, Usui T, Han J, Isoda H, Nagumo Y. The reversible increase in tight junction permeability induced by capsaicin is mediated via cofilin-actin cytoskeletal dynamics and decreased level of occludin. PLoS ONE. 2013;8:e79954 pubmed publisher
  1067. Luo W, Yao K. Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma. Virchows Arch. 2014;464:35-43 pubmed publisher
  1068. Zaganjor E, Osborne J, Weil L, Díaz Martínez L, Gonzales J, Singel S, et al. Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells. Oncogene. 2014;33:5457-66 pubmed publisher
  1069. Richter J, Pieper R, Zakrzewski S, Gunzel D, Schulzke J, Van Kessel A. Diets high in fermentable protein and fibre alter tight junction protein composition with minor effects on barrier function in piglet colon. Br J Nutr. 2014;111:1040-9 pubmed publisher
  1070. Dawes L, Sugiyama Y, Lovicu F, Harris C, Shelley E, McAvoy J. Interactions between lens epithelial and fiber cells reveal an intrinsic self-assembly mechanism. Dev Biol. 2014;385:291-303 pubmed publisher
  1071. Wu H, Balsbaugh J, Chandler H, Georgilis A, Zullow H, Shabanowitz J, et al. Mitogen-activated protein kinase signaling mediates phosphorylation of polycomb ortholog Cbx7. J Biol Chem. 2013;288:36398-408 pubmed publisher
  1072. McLaughlin N, Wang F, Saifudeen Z, El Dahr S. In situ histone landscape of nephrogenesis. Epigenetics. 2014;9:222-35 pubmed publisher
  1073. Grivas P, Day K, Karatsinides A, Paul A, Shakir N, Owainati I, et al. Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer. Mol Med. 2013;19:367-76 pubmed publisher
  1074. Formosa A, Markert E, Lena A, Italiano D, Finazzi Agrò E, Levine A, et al. MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene. 2014;33:5173-82 pubmed publisher
  1075. Zheng Q, Wang X, Wen Q, Zhang Y, Chen S, Zhang J, et al. Wt1 deficiency causes undifferentiated spermatogonia accumulation and meiotic progression disruption in neonatal mice. Reproduction. 2014;147:45-52 pubmed publisher
  1076. Yu L, Cheng H, Yang S. Clinicopathological and extensive immunohistochemical study of a type II pleuropulmonary blastoma. Fetal Pediatr Pathol. 2014;33:1-8 pubmed publisher
  1077. Bray K, Gillette M, Young J, Loughran E, Hwang M, Sears J, et al. Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration. Breast Cancer Res. 2013;15:R91 pubmed
  1078. Gu M, Choi J. Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma. J Clin Pathol. 2014;67:229-34 pubmed publisher
  1079. Yasuno K, Nishiyama S, Kobayashi R, Yoshimura H, Takahashi K, Omachi T, et al. Proliferative lesions of intra-epidermal cytokeratin CAM5.2-positive cells in canine nipples. J Comp Pathol. 2014;150:18-26 pubmed publisher
  1080. Haisler W, Timm D, Gage J, Tseng H, Killian T, Souza G. Three-dimensional cell culturing by magnetic levitation. Nat Protoc. 2013;8:1940-9 pubmed publisher
  1081. Karch I, Schipper E, Christgen H, Kreipe H, Lehmann U, Christgen M. Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?. PLoS ONE. 2013;8:e73062 pubmed publisher
  1082. Bracarense A, Yamasaki L, Silva E, Oliveira R, Alfieri A. Helicobacter spp. infection induces changes in epithelial proliferation and E-cadherin expression in the gastric mucosa of pigs. J Comp Pathol. 2013;149:402-9 pubmed publisher
  1083. Findlay V, Moretz R, Wang C, Vaena S, Bandurraga S, Ashenafi M, et al. Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancer. Mol Carcinog. 2014;53 Suppl 1:E130-9 pubmed publisher
  1084. Vlug E, van de Ven R, Vermeulen J, Bult P, van Diest P, Derksen P. Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer. Cell Oncol (Dordr). 2013;36:375-84 pubmed publisher
  1085. Kumar M, Allison D, Baranova N, Wamsley J, Katz A, Bekiranov S, et al. NF-?B regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells. PLoS ONE. 2013;8:e68597 pubmed publisher
  1086. Stewart C, Wang Y, Bonilla Claudio M, Martin J, Gonzalez G, Taketo M, et al. CTNNB1 in mesenchyme regulates epithelial cell differentiation during Müllerian duct and postnatal uterine development. Mol Endocrinol. 2013;27:1442-54 pubmed publisher
  1087. Chang C, Yang X, Pursell B, Mercurio A. Id2 complexes with the SNAG domain of Snai1 inhibiting Snai1-mediated repression of integrin ?4. Mol Cell Biol. 2013;33:3795-804 pubmed publisher
  1088. Yin Y, Betsuyaku T, Garbow J, Miao J, Govindan R, Ornitz D. Rapid induction of lung adenocarcinoma by fibroblast growth factor 9 signaling through FGF receptor 3. Cancer Res. 2013;73:5730-41 pubmed publisher
  1089. Siljamäki E, Raiko L, Toriseva M, Nissinen L, Näreoja T, Peltonen J, et al. p38? mitogen-activated protein kinase regulates the expression of tight junction protein ZO-1 in differentiating human epidermal keratinocytes. Arch Dermatol Res. 2014;306:131-41 pubmed publisher
  1090. Chen J, Erikson D, Piltonen T, Meyer M, Barragan F, McIntire R, et al. Coculturing human endometrial epithelial cells and stromal fibroblasts alters cell-specific gene expression and cytokine production. Fertil Steril. 2013;100:1132-43 pubmed publisher
  1091. Chang C, Chen C, Wu M, Chen Y, Chen C, Sheu S, et al. Active Component of Antrodia cinnamomea Mycelia Targeting Head and Neck Cancer Initiating Cells through Exaggerated Autophagic Cell Death. Evid Based Complement Alternat Med. 2013;2013:946451 pubmed publisher
  1092. Bubis G, Hilly O, Bubis R, Halpern M, Schwartz A, Koren R, et al. A new Ki-67 / E-cadherin cocktail reduces inter-observer variation of the calculated proliferative index. Pathol Oncol Res. 2013;19:875-9 pubmed publisher
  1093. Shields M, Ebine K, Sahai V, Kumar K, Siddiqui K, Hwang R, et al. Snail cooperates with KrasG12D to promote pancreatic fibrosis. Mol Cancer Res. 2013;11:1078-87 pubmed publisher
  1094. Sangar F, Schreurs A, Umana Diaz C, Claperon A, Desbois Mouthon C, Calmel C, et al. Involvement of small ArfGAP1 (SMAP1), a novel Arf6-specific GTPase-activating protein, in microsatellite instability oncogenesis. Oncogene. 2014;33:2758-67 pubmed publisher
  1095. Garcia Murillas I, Sharpe R, Pearson A, Campbell J, Natrajan R, Ashworth A, et al. An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer. Oncogene. 2014;33:2478-86 pubmed publisher
  1096. Tsai Y, Disson O, Bierne H, Lecuit M. Murinization of internalin extends its receptor repertoire, altering Listeria monocytogenes cell tropism and host responses. PLoS Pathog. 2013;9:e1003381 pubmed publisher
  1097. Schackmann R, Klarenbeek S, Vlug E, Stelloo S, van Amersfoort M, Tenhagen M, et al. Loss of p120-catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signaling. Cancer Res. 2013;73:4937-49 pubmed publisher
  1098. Gillette M, Bray K, Blumenthaler A, Vargo Gogola T. P190B RhoGAP overexpression in the developing mammary epithelium induces TGF?-dependent fibroblast activation. PLoS ONE. 2013;8:e65105 pubmed publisher
  1099. Shi Y, Wu H, Zhang M, Ding L, Meng F, Fan X. Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma. Diagn Pathol. 2013;8:89 pubmed publisher
  1100. Harazono Y, Muramatsu T, Endo H, Uzawa N, Kawano T, Harada K, et al. miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2. PLoS ONE. 2013;8:e62757 pubmed publisher
  1101. Ma T, Galimberti F, Erkmen C, Memoli V, Chinyengetere F, SEMPERE L, et al. Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer. Mol Cancer Ther. 2013;12:1545-55 pubmed publisher
  1102. Pinho S, Figueiredo J, Cabral J, Carvalho S, Dourado J, Magalhaes A, et al. E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V. Biochim Biophys Acta. 2013;1830:2690-700 pubmed
  1103. Boehlke C, Kotsis F, Buchholz B, Powelske C, Eckardt K, Walz G, et al. Kif3a guides microtubular dynamics, migration and lumen formation of MDCK cells. PLoS ONE. 2013;8:e62165 pubmed publisher
  1104. Park J, Morley T, Scherer P. Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours. EMBO Mol Med. 2013;5:935-48 pubmed publisher
  1105. Zhou Z, Zhang Q, Lu X, Wang R, Wang Y, Zhu C, et al. The proprotein convertase furin is required for trophoblast syncytialization. Cell Death Dis. 2013;4:e593 pubmed publisher
  1106. Xiao H, Shen H, Liu W, Xiong R, Li P, Meng G, et al. Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy. PLoS ONE. 2013;8:e60173 pubmed publisher
  1107. Sigurdsson V, Ingthorsson S, Hilmarsdottir B, Gustafsdottir S, Franzdóttir S, Arason A, et al. Expression and functional role of sprouty-2 in breast morphogenesis. PLoS ONE. 2013;8:e60798 pubmed publisher
  1108. Reginensi A, Scott R, Gregorieff A, Bagherie Lachidan M, Chung C, Lim D, et al. Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development. PLoS Genet. 2013;9:e1003380 pubmed publisher
  1109. Vasconcelos Nóbrega C, Costa C, Vala H, Colaco A, Santos L, Lopes C, et al. E-cadherin and ?-catenin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in mice. Urol Int. 2013;91:462-6 pubmed publisher
  1110. Weiswald L, Richon S, Massonnet G, Guinebretiere J, Vacher S, Laurendeau I, et al. A short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation. Br J Cancer. 2013;108:1720-31 pubmed publisher
  1111. Griffin J, Wriston C, Peters M, Lehman J. Decreased expression of intercellular adhesion molecules in acantholytic squamous cell carcinoma compared with invasive well-differentiated squamous cell carcinoma of the skin. Am J Clin Pathol. 2013;139:442-7 pubmed publisher
  1112. Sakaguchi K, Iima H, Matsuda K, Okamoto M, Hirayama K, Ikoma S, et al. Intestinal undifferentiated carcinoma in a red-crowned crane (Grus japonensis). J Vet Med Sci. 2013;75:827-30 pubmed
  1113. Dawes L, Sugiyama Y, Tanedo A, Lovicu F, McAvoy J. Wnt-frizzled signaling is part of an FGF-induced cascade that promotes lens fiber differentiation. Invest Ophthalmol Vis Sci. 2013;54:1582-90 pubmed publisher
  1114. Rakha E, Teoh T, Lee A, Nolan C, Ellis I, Green A. Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study. Histopathology. 2013;62:695-701 pubmed publisher
  1115. Taskin S, Dunder I, Erol E, Taşkin E, Kiremitci S, Oztuna D, et al. Roles of E-cadherin and cyclooxygenase enzymes in predicting different survival patterns of optimally cytoreduced serous ovarian cancer patients. Asian Pac J Cancer Prev. 2012;13:5715-9 pubmed
  1116. Shukla S, Sharma H, Abbas A, MacLennan G, Fu P, Danielpour D, et al. Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression. PLoS ONE. 2013;8:e53527 pubmed publisher
  1117. Angelucci C, Maulucci G, Lama G, Proietti G, Colabianchi A, Papi M, et al. Epithelial-stromal interactions in human breast cancer: effects on adhesion, plasma membrane fluidity and migration speed and directness. PLoS ONE. 2012;7:e50804 pubmed publisher
  1118. Majewski I, Kluijt I, Cats A, Scerri T, de Jong D, Kluin R, et al. An ?-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer. J Pathol. 2013;229:621-9 pubmed publisher
  1119. Gordon K, Kochkodan J, Blatt H, Lin S, Kaplan N, Johnston A, et al. Alteration of the EphA2/Ephrin-A signaling axis in psoriatic epidermis. J Invest Dermatol. 2013;133:712-722 pubmed publisher
  1120. Boyd S, Mijatov B, Pupo G, Tran S, Gowrishankar K, Shaw H, et al. Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion. J Invest Dermatol. 2013;133:1269-77 pubmed publisher
  1121. Lawrence B, Pan Z, Rosenblatt M. Silk film topography directs collective epithelial cell migration. PLoS ONE. 2012;7:e50190 pubmed publisher
  1122. de Toledo M, Anguille C, Roger L, Roux P, Gadea G. Cooperative anti-invasive effect of Cdc42/Rac1 activation and ROCK inhibition in SW620 colorectal cancer cells with elevated blebbing activity. PLoS ONE. 2012;7:e48344 pubmed publisher
  1123. Fukuma M, Tanese K, Effendi K, Yamazaki K, Masugi Y, Suda M, et al. Leucine-rich repeat-containing G protein-coupled receptor 5 regulates epithelial cell phenotype and survival of hepatocellular carcinoma cells. Exp Cell Res. 2013;319:113-21 pubmed publisher
  1124. Garnier D, Magnus N, Lee T, Bentley V, Meehan B, Milsom C, et al. Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. J Biol Chem. 2012;287:43565-72 pubmed publisher
  1125. Visciano P, Schirone M, Tofalo R, Berti M, Luciani M, Ferri N, et al. Detection of yessotoxin by three different methods in Mytilus galloprovincialis of Adriatic Sea, Italy. Chemosphere. 2013;90:1077-82 pubmed publisher
  1126. Queen K, Shi M, Zhang F, Cvek U, Scott R. Epstein-Barr virus-induced epigenetic alterations following transient infection. Int J Cancer. 2013;132:2076-86 pubmed publisher
  1127. Lu L, Zhou D, Jiang X, Song K, Li K, Ding W. Loss of E-cadherin in multidrug resistant breast cancer cell line MCF-7/Adr: possible implication in the enhanced invasive ability. Eur Rev Med Pharmacol Sci. 2012;16:1271-9 pubmed
  1128. Spiller C, Feng C, Jackson A, Gillis A, Rolland A, Looijenga L, et al. Endogenous Nodal signaling regulates germ cell potency during mammalian testis development. Development. 2012;139:4123-32 pubmed publisher
  1129. Takahashi Y, Kupferman M, Bell D, Jiffar T, Lee J, Xie T, et al. Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma. Clin Cancer Res. 2012;18:6178-87 pubmed publisher
  1130. Langer M, Duggan E, Booth J, Patel V, Zander R, Silasi Mansat R, et al. Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function. Infect Immun. 2012;80:4374-87 pubmed publisher
  1131. Piao Y, Liang J, Holmes L, Zurita A, Henry V, Heymach J, et al. Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Neuro Oncol. 2012;14:1379-92 pubmed publisher
  1132. Ahearn T, Shaukat A, Flanders W, Rutherford R, Bostick R. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/?-catenin pathway in the normal mucosa of colorectal adenoma patients. Cancer Prev Res (Phila). 2012;5:1247-56 pubmed publisher
  1133. Peramo A, Marcelo C. Visible effects of rapamycin (sirolimus) on human skin explants in vitro. Arch Dermatol Res. 2013;305:163-71 pubmed publisher
  1134. Gil da Costa R, Oliveira P, Bastos M, Lopes C, Lopes C. Ptaquiloside-induced early-stage urothelial lesions show increased cell proliferation and intact ?-catenin and E-cadherin expression. Environ Toxicol. 2014;29:763-9 pubmed publisher
  1135. Veschi S, Lattanzio R, Aceto G, Curia M, Magnasco S, Angelucci D, et al. Alterations of MEN1 and E-cadherin/?-catenin complex in sporadic pulmonary carcinoids. Int J Oncol. 2012;41:1221-8 pubmed publisher
  1136. Tsang J, Mendoza P, Putti T, Karim R, Scolyer R, Lee C, et al. E-cadherin expression in the epithelial components of mammary phyllodes tumors. Hum Pathol. 2012;43:2117-23 pubmed publisher
  1137. Mackowiak I, Gentile L, Chaible L, Nagamine M, Guerra J, Mota E, et al. E-cadherin in canine mast cell tumors: decreased expression and altered subcellular localization in Grade 3 tumors. Vet J. 2012;194:405-11 pubmed publisher
  1138. Stamp L, Braxton D, Wu J, Akopian V, Hasegawa K, Chandrasoma P, et al. The GCTM-5 epitope associated with the mucin-like glycoprotein FCGBP marks progenitor cells in tissues of endodermal origin. Stem Cells. 2012;30:1999-2009 pubmed publisher
  1139. Jang S, Han H, Jun Y, Jang S, Min K, Sim J, et al. Clinicopathological significance of CADM4 expression, and its correlation with expression of E-cadherin and Ki-67 in colorectal adenocarcinomas. J Clin Pathol. 2012;65:902-6 pubmed
  1140. Vermeulen J, van de Ven R, Ercan C, van der Groep P, van der Wall E, Bult P, et al. Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer. PLoS ONE. 2012;7:e37864 pubmed publisher
  1141. Wu C, Tang S, Wang P, Lee H, Ko J. Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation. J Biol Chem. 2012;287:25292-302 pubmed publisher
  1142. Tobin N, Lundgren K, Conway C, Anagnostaki L, Costello S, Landberg G. Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information. Hum Pathol. 2012;43:2053-61 pubmed publisher
  1143. Raiko L, Siljamäki E, Mahoney M, Putaala H, Suominen E, Peltonen J, et al. Hailey-Hailey disease and tight junctions: Claudins 1 and 4 are regulated by ATP2C1 gene encoding Ca(2+) /Mn(2+) ATPase SPCA1 in cultured keratinocytes. Exp Dermatol. 2012;21:586-91 pubmed publisher
  1144. Liu Y, Burkhalter R, Symowicz J, Chaffin K, Ellerbroek S, Stack M. Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells. J Oncol. 2012;2012:501492 pubmed publisher
  1145. Iacopino F, Angelucci C, Sica G. Interactions between normal human fibroblasts and human prostate cancer cells in a co-culture system. Anticancer Res. 2012;32:1579-88 pubmed
  1146. Ahearn T, Shaukat A, Flanders W, Seabrook M, Bostick R. Markers of the APC/?-catenin signaling pathway as potential treatable, preneoplastic biomarkers of risk for colorectal neoplasms. Cancer Epidemiol Biomarkers Prev. 2012;21:969-79 pubmed publisher
  1147. Vincent Salomon A, Hajage D, Rouquette A, Cédenot A, Gruel N, Alran S, et al. High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patients. Breast. 2012;21:380-3 pubmed publisher
  1148. Stoyianni A, Goussia A, Pentheroudakis G, Siozopoulou V, Ioachim E, Krikelis D, et al. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility. Anticancer Res. 2012;32:1273-81 pubmed
  1149. Karlsson H, Fryknäs M, Larsson R, Nygren P. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system. Exp Cell Res. 2012;318:1577-85 pubmed publisher
  1150. Chang D, Pai R, Rybicki L, DiMaio M, Limaye M, Jayachandran P, et al. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Mod Pathol. 2012;25:1128-39 pubmed publisher
  1151. Simões Correia J, Figueiredo J, Lopes R, Stricher F, Oliveira C, Serrano L, et al. E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer. PLoS ONE. 2012;7:e33783 pubmed publisher
  1152. Lisch W, Bron A, Munier F, Schorderet D, Tiab L, Lange C, et al. Franceschetti hereditary recurrent corneal erosion. Am J Ophthalmol. 2012;153:1073-81.e4 pubmed publisher
  1153. Dukes J, Whitley P, Chalmers A. The PIKfyve inhibitor YM201636 blocks the continuous recycling of the tight junction proteins claudin-1 and claudin-2 in MDCK cells. PLoS ONE. 2012;7:e28659 pubmed publisher
  1154. O Mahony F, Faratian D, Varley J, Nanda J, Theodoulou M, Riddick A, et al. The use of automated quantitative analysis to evaluate epithelial-to-mesenchymal transition associated proteins in clear cell renal cell carcinoma. PLoS ONE. 2012;7:e31557 pubmed publisher
  1155. Palka Bayard de Volo C, Alfonsi M, Gatta V, Novelli A, Bernardini L, Fantasia D, et al. 16q22.1 microdeletion detected by array-CGH in a family with mental retardation and lobular breast cancer. Gene. 2012;498:328-31 pubmed publisher
  1156. DesRochers T, Shamis Y, Alt Holland A, Kudo Y, Takata T, Wang G, et al. The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma. Epigenetics. 2012;7:34-46 pubmed publisher
  1157. Zhang J, Liang Z, Gao J, Luo Y, Liu T. Pulmonary adenocarcinoma with a micropapillary pattern: a clinicopathological, immunophenotypic and molecular analysis. Histopathology. 2011;59:1204-14 pubmed publisher
  1158. Zhi W, Xue B, Wang L, Xiao N, He Q, Wang Y, et al. The MLH1 2101C>A (Q701K) variant increases the risk of gastric cancer in Chinese males. BMC Gastroenterol. 2011;11:133 pubmed publisher
  1159. Nguyen Hoang A, Chen P, Juarez J, Sachamitr P, Billing B, Bosnjak L, et al. Dendritic cell functional properties in a three-dimensional tissue model of human lung mucosa. Am J Physiol Lung Cell Mol Physiol. 2012;302:L226-37 pubmed publisher
  1160. Samir R, Asplund A, Tot T, Pekar G, Hellberg D. Oral contraceptive and progestin-only use correlates to tissue tumor marker expression in women with cervical intraepithelial neoplasia. Contraception. 2012;85:288-93 pubmed publisher
  1161. Grabowska M, Sandhu B, Day M. EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cells. Cell Signal. 2012;24:532-8 pubmed publisher
  1162. Schneider D, Wu M, Le T, Cho S, Brenner M, Blackburn M, et al. Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-? production and epithelial to mesenchymal transition. FASEB J. 2012;26:503-12 pubmed publisher
  1163. Nikitas G, Deschamps C, Disson O, Niault T, Cossart P, Lecuit M. Transcytosis of Listeria monocytogenes across the intestinal barrier upon specific targeting of goblet cell accessible E-cadherin. J Exp Med. 2011;208:2263-77 pubmed publisher
  1164. Giricz O, Reynolds P, Ramnauth A, Liu C, Wang T, Stead L, et al. Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity. J Pathol. 2012;226:108-19 pubmed publisher
  1165. Troyanovsky R, Klingelhofer J, Troyanovsky S. ?-Catenin contributes to the strength of E-cadherin-p120 interactions. Mol Biol Cell. 2011;22:4247-55 pubmed publisher
  1166. Bracarense A, Lucioli J, Grenier B, Drociunas Pacheco G, Moll W, Schatzmayr G, et al. Chronic ingestion of deoxynivalenol and fumonisin, alone or in interaction, induces morphological and immunological changes in the intestine of piglets. Br J Nutr. 2012;107:1776-86 pubmed publisher
  1167. Sigurdsson V, Hilmarsdottir B, Sigmundsdottir H, Fridriksdottir A, Ringner M, Villadsen R, et al. Endothelial induced EMT in breast epithelial cells with stem cell properties. PLoS ONE. 2011;6:e23833 pubmed publisher
  1168. de Wit M, Jimenez C, Carvalho B, Belien J, Delis van Diemen P, Mongera S, et al. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression. Gut. 2012;61:855-64 pubmed publisher
  1169. Sin S, Bonin F, Petit V, Meseure D, Lallemand F, Bieche I, et al. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis. J Natl Cancer Inst. 2011;103:1323-37 pubmed publisher
  1170. Ohta H, Yamaguchi T, Rajapakshage B, Murakami M, Sasaki N, Nakamura K, et al. Expression and subcellular localization of apical junction proteins in canine duodenal and colonic mucosa. Am J Vet Res. 2011;72:1046-51 pubmed publisher
  1171. Holbrook E, Wu E, Curry W, Lin D, Schwob J. Immunohistochemical characterization of human olfactory tissue. Laryngoscope. 2011;121:1687-701 pubmed publisher
  1172. Lacher M, Shiina M, Chang P, Keller D, Tiirikainen M, Korn W. ZEB1 limits adenoviral infectability by transcriptionally repressing the coxsackie virus and adenovirus receptor. Mol Cancer. 2011;10:91 pubmed publisher
  1173. Kobayashi Y, Shimizu T, Naoe H, Ueki A, Ishizawa J, Chiyoda T, et al. Establishment of a choriocarcinoma model from immortalized normal extravillous trophoblast cells transduced with HRASV12. Am J Pathol. 2011;179:1471-82 pubmed publisher
  1174. Dukes J, Fish L, Richardson J, Blaikley E, Burns S, Caunt C, et al. Functional ESCRT machinery is required for constitutive recycling of claudin-1 and maintenance of polarity in vertebrate epithelial cells. Mol Biol Cell. 2011;22:3192-205 pubmed publisher
  1175. Essbauer S, Krautkrämer E, Herzog S, Pfeffer M. A new permanent cell line derived from the bank vole (Myodes glareolus) as cell culture model for zoonotic viruses. Virol J. 2011;8:339 pubmed publisher
  1176. Russell S, Lechner M, Gong L, Megiel C, Liebertz D, Masood R, et al. USC-HN2, a new model cell line for recurrent oral cavity squamous cell carcinoma with immunosuppressive characteristics. Oral Oncol. 2011;47:810-7 pubmed publisher
  1177. Goel H, Bae D, Pursell B, Gouvin L, Lu S, Mercurio A. Neuropilin-2 promotes branching morphogenesis in the mouse mammary gland. Development. 2011;138:2969-76 pubmed publisher
  1178. Betge J, Pollheimer M, Schlemmer A, Hoefler G, Langner C. Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis. Oncol Rep. 2011;26:567-75 pubmed publisher
  1179. Lindström A, Asplund A, Hellberg D. Correlation between LRIG1 and LRIG2 expressions and expression of 11 tumor markers, with special reference to tumor suppressors, in CIN and normal cervical epithelium. Gynecol Oncol. 2011;122:372-6 pubmed publisher
  1180. Ding T, Xu J, Zhang Y, Guo R, Wu W, Zhang S, et al. Endothelium-coated tumor clusters are associated with poor prognosis and micrometastasis of hepatocellular carcinoma after resection. Cancer. 2011;117:4878-89 pubmed publisher
  1181. Jovov B, Que J, Tobey N, Djukic Z, Hogan B, Orlando R. Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease. Am J Gastroenterol. 2011;106:1039-47 pubmed publisher
  1182. Hong S, Troyanovsky R, Troyanovsky S. Cadherin exits the junction by switching its adhesive bond. J Cell Biol. 2011;192:1073-83 pubmed publisher
  1183. Eckert M, Lwin T, Chang A, Kim J, Danis E, Ohno Machado L, et al. Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell. 2011;19:372-86 pubmed publisher
  1184. Pigors M, Kiritsi D, Krümpelmann S, Wagner N, He Y, Podda M, et al. Lack of plakoglobin leads to lethal congenital epidermolysis bullosa: a novel clinico-genetic entity. Hum Mol Genet. 2011;20:1811-9 pubmed publisher
  1185. Ferreira E, Gobbi H, Saraiva B, Cassali G. Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs. Vet Pathol. 2012;49:322-9 pubmed publisher
  1186. Chen M, Peyrin Biroulet L, George A, Coste F, Bressenot A, Bossenmeyer Pourié C, et al. Methyl deficient diet aggravates experimental colitis in rats. J Cell Mol Med. 2011;15:2486-97 pubmed publisher
  1187. Diehl H, Stühler K, Klein Scory S, Volmer M, Schöneck A, Bieling C, et al. A catalogue of proteins released by colorectal cancer cells in vitro as an alternative source for biomarker discovery. Proteomics Clin Appl. 2007;1:47-61 pubmed publisher
  1188. Ingthorsson S, Halldorsson T, Sigurdsson V, Friðriksdottir A, Bodvarsdottir S, Steinarsdottir M, et al. Selection for EGFR gene amplification in a breast epithelial cell line with basal-like phenotype and hereditary background. In Vitro Cell Dev Biol Anim. 2011;47:139-48 pubmed publisher
  1189. Gladden A, Hebert A, Schneeberger E, McClatchey A. The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex. Dev Cell. 2010;19:727-39 pubmed publisher
  1190. Lewis Tuffin L, Rodriguez F, Giannini C, Scheithauer B, Necela B, Sarkaria J, et al. Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype. PLoS ONE. 2010;5:e13665 pubmed publisher
  1191. Spencer H, Keramari M, Ward C. Using cadherin expression to assess spontaneous differentiation of embryonic stem cells. Methods Mol Biol. 2011;690:81-94 pubmed publisher
  1192. Ye Y, Tellez J, Durazo M, Belcher M, Yearsley K, Barsky S. E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking. Anticancer Res. 2010;30:3903-10 pubmed
  1193. Mohamet L, Lea M, Ward C. Abrogation of E-cadherin-mediated cellular aggregation allows proliferation of pluripotent mouse embryonic stem cells in shake flask bioreactors. PLoS ONE. 2010;5:e12921 pubmed publisher
  1194. Rakha E, Patel A, Powe D, Benhasouna A, Green A, Lambros M, et al. Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast. Am J Surg Pathol. 2010;34:1472-9 pubmed publisher
  1195. da Cunha C, Oliveira C, Wen X, Gomes B, Sousa S, Suriano G, et al. De novo expression of CD44 variants in sporadic and hereditary gastric cancer. Lab Invest. 2010;90:1604-14 pubmed publisher
  1196. Yong Jiang -, Huawei Liu -, Hu Long -, Yingying Yang -, Dianying Liao -, Xiuhui Zhang -. Goblet cell carcinoid of the appendix: a clinicopathological and immunohistochemical study of 26 cases from southwest china. Int J Surg Pathol. 2010;18:488-92 pubmed publisher
  1197. Loessner D, Stok K, Lutolf M, Hutmacher D, Clements J, Rizzi S. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials. 2010;31:8494-506 pubmed publisher
  1198. Gwin K, Buell Gutbrod R, Tretiakova M, Montag A. Epithelial-to-mesenchymal transition in metaplastic breast carcinomas with chondroid differentiation: expression of the E-cadherin repressor Snail. Appl Immunohistochem Mol Morphol. 2010;18:526-31 pubmed publisher
  1199. Koensgen D, Freitag C, Klaman I, Dahl E, Mustea A, Chekerov R, et al. Expression and localization of e-cadherin in epithelial ovarian cancer. Anticancer Res. 2010;30:2525-30 pubmed
  1200. Rozich R, Mills D, Brilliant K, Callanan H, Yang D, Tantravahi U, et al. Accumulation of neoplastic traits prior to spontaneous in vitro transformation of rat cholangiocytes determines susceptibility to activated ErbB-2/Neu. Exp Mol Pathol. 2010;89:248-59 pubmed publisher
  1201. Dangi Garimella S, Redig A, Shields M, Siddiqui M, Munshi H. Rho-ROCK-myosin signaling mediates membrane type 1 matrix metalloproteinase-induced cellular aggregation of keratinocytes. J Biol Chem. 2010;285:28363-72 pubmed publisher
  1202. Kim H, Kim G, Kim Y, Park Y, Song J, Lim S. Stromal CD10 expression and relationship to the E-cadherin/beta-catenin complex in breast carcinoma. Histopathology. 2010;56:708-19 pubmed publisher
  1203. Smutny M, Cox H, Leerberg J, Kovacs E, Conti M, Ferguson C, et al. Myosin II isoforms identify distinct functional modules that support integrity of the epithelial zonula adherens. Nat Cell Biol. 2010;12:696-702 pubmed publisher
  1204. Alarcon V. Cell polarity regulator PARD6B is essential for trophectoderm formation in the preimplantation mouse embryo. Biol Reprod. 2010;83:347-58 pubmed publisher
  1205. Sato Y, Harada K, Itatsu K, Ikeda H, Kakuda Y, Shimomura S, et al. Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma. Am J Pathol. 2010;177:141-52 pubmed publisher
  1206. Brusevold I, Husvik C, Schreurs O, Schenck K, Bryne M, Søland T. Induction of invasion in an organotypic oral cancer model by CoCl2, a hypoxia mimetic. Eur J Oral Sci. 2010;118:168-76 pubmed publisher
  1207. Qi H, Zheng X, Yuan X, Pflugfelder S, Li D. Potential localization of putative stem/progenitor cells in human bulbar conjunctival epithelium. J Cell Physiol. 2010;225:180-5 pubmed publisher
  1208. Maher M, Mo R, Flozak A, Peled O, Gottardi C. Beta-catenin phosphorylated at serine 45 is spatially uncoupled from beta-catenin phosphorylated in the GSK3 domain: implications for signaling. PLoS ONE. 2010;5:e10184 pubmed publisher
  1209. Wen T, Zhang Z, Yu Y, Qu H, Koch M, Aumailley M. Integrin alpha3 subunit regulates events linked to epithelial repair, including keratinocyte migration and protein expression. Wound Repair Regen. 2010;18:325-34 pubmed publisher
  1210. Blank F, Wehrli M, Lehmann A, Baum O, Gehr P, von Garnier C, et al. Macrophages and dendritic cells express tight junction proteins and exchange particles in an in vitro model of the human airway wall. Immunobiology. 2011;216:86-95 pubmed publisher
  1211. Rosa M, Mohammadi A, Masood S. Lobular neoplasia displaying central necrosis: a potential diagnostic pitfall. Pathol Res Pract. 2010;206:544-9 pubmed publisher
  1212. Flatmark K, Davidson B, Kristian A, Stavnes H, Førsund M, Reed W. Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models. Hum Pathol. 2010;41:1109-19 pubmed publisher
  1213. Giusiano S, Secq V, Carcopino X, Carpentier S, Andrac L, Lavaut M, et al. Immunohistochemical profiling of node negative breast carcinomas allows prediction of metastatic risk. Int J Oncol. 2010;36:889-98 pubmed
  1214. Ferreira E, Gobbi H, Saraiva B, Cassali G. Columnar cell lesions of the canine mammary gland: pathological features and immunophenotypic analysis. BMC Cancer. 2010;10:61 pubmed publisher
  1215. Ghosh S, Koblinski J, Johnson J, Liu Y, Ericsson A, Davis J, et al. Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression. Mol Cancer Res. 2010;8:145-58 pubmed publisher
  1216. Kaarteenaho R, Sormunen R, Paakko P. Variable expression of tenascin-C, osteopontin and fibronectin in inflammatory myofibroblastic tumour of the lung. APMIS. 2010;118:91-100 pubmed publisher
  1217. Suzuki H, Komatsu A, Fujioka Y, Yamashiro K, Takeda H, Hamada T. Angiosarcoma-like metastatic carcinoma of the liver. Pathol Res Pract. 2010;206:484-8 pubmed publisher
  1218. Samir R, Asplund A, Tot T, Pekar G, Hellberg D. Tissue tumor marker expression in smokers, including serum cotinine concentrations, in women with cervical intraepithelial neoplasia or normal squamous cervical epithelium. Am J Obstet Gynecol. 2010;202:579.e1-7 pubmed publisher
  1219. Morales J, Alpaugh M. Gain in cellular organization of inflammatory breast cancer: A 3D in vitro model that mimics the in vivo metastasis. BMC Cancer. 2009;9:462 pubmed publisher
  1220. Asioli S, Erickson L, Sebo T, Zhang J, Jin L, Thompson G, et al. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol. 2010;34:44-52 pubmed publisher
  1221. Lundgren K, Nordenskjold B, Landberg G. Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer. Br J Cancer. 2009;101:1769-81 pubmed publisher
  1222. Zhang D, Lafortune T, Krishnamurthy S, Esteva F, Cristofanilli M, Liu P, et al. Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer. Clin Cancer Res. 2009;15:6639-48 pubmed publisher
  1223. Graesslin O, Antoine M, Chopier J, Seror J, Flahault A, Callard P, et al. Histology after lumpectomy in women with epithelial atypia on stereotactic vacuum-assisted breast biopsy. Eur J Surg Oncol. 2010;36:170-5 pubmed publisher
  1224. Polton G, Brearley M, Green L, Scase T. Expression of E-cadherin in canine anal sac gland carcinoma and its association with survival. Vet Comp Oncol. 2007;5:232-8 pubmed publisher
  1225. Zou J, Yang H, Chen F, Zhao H, Lin P, Zhang J, et al. Prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma. Eur J Cancer Prev. 2010;19:11-7 pubmed publisher
  1226. Zhou Y, Chen S, Ju J, Shen L, Liu Y, Zhen S, et al. Tumor suppressor function of BCSC-1 in nasopharyngeal carcinoma. Cancer Sci. 2009;100:1817-22 pubmed publisher
  1227. Maher M, Flozak A, Stocker A, Chenn A, Gottardi C. Activity of the beta-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion. J Cell Biol. 2009;186:219-28 pubmed publisher
  1228. Weiswald L, Richon S, Validire P, Briffod M, Lai Kuen R, Cordelières F, et al. Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness. Br J Cancer. 2009;101:473-82 pubmed publisher
  1229. Pires I, Queiroga F, Alves A, Silva F, Lopes C. Decrease of E-cadherin expression in canine cutaneous histiocytoma appears to be related to its spontaneous regression. Anticancer Res. 2009;29:2713-7 pubmed
  1230. den Elzen N, Buttery C, Maddugoda M, Ren G, Yap A. Cadherin adhesion receptors orient the mitotic spindle during symmetric cell division in mammalian epithelia. Mol Biol Cell. 2009;20:3740-50 pubmed publisher
  1231. Kim J, Kushiro K, Graham N, Asthagiri A. Tunable interplay between epidermal growth factor and cell-cell contact governs the spatial dynamics of epithelial growth. Proc Natl Acad Sci U S A. 2009;106:11149-53 pubmed publisher
  1232. Zhu Y, Ye D, Yao X, Zhang S, Dai B, Zhang H, et al. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease. Br J Dermatol. 2009;161:577-82 pubmed publisher
  1233. Ohashi M, Kusumi T, Sato F, Kudo Y, Jin H, Akasaka H, et al. Expression of syndecan-1 and E-cadherin is inversely correlated with poor patient's prognosis and recurrent status of extrahepatic bile duct carcinoma. Biomed Res. 2009;30:79-86 pubmed
  1234. Fournier M, Fata J, Martin K, Yaswen P, Bissell M. Interaction of E-cadherin and PTEN regulates morphogenesis and growth arrest in human mammary epithelial cells. Cancer Res. 2009;69:4545-52 pubmed publisher
  1235. Agnarsson B, Ingthorsson S, Gudjonsson T, Leosson K. Evanescent-wave fluorescence microscopy using symmetric planar waveguides. Opt Express. 2009;17:5075-82 pubmed
  1236. Elwi A, Damaraju V, Kuzma M, Mowles D, Baldwin S, Young J, et al. Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3. Am J Physiol Renal Physiol. 2009;296:F1439-51 pubmed publisher
  1237. Charpin C, Giusiano S, Secq V, Carpentier S, Andrac L, Lavaut M, et al. Quantitative immunocytochemical profile to predict early outcome of disease in triple-negative breast carcinomas. Int J Oncol. 2009;34:983-93 pubmed
  1238. Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira Carriço R, Senz J, et al. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology. 2009;136:2137-48 pubmed publisher
  1239. Sarrio D, Palacios J, Hergueta Redondo M, Gomez Lopez G, Cano A, Moreno Bueno G. Functional characterization of E- and P-cadherin in invasive breast cancer cells. BMC Cancer. 2009;9:74 pubmed publisher
  1240. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher
  1241. Rogers S, Box C, Chambers P, Barbachano Y, Nutting C, Rhys Evans P, et al. Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck. J Pathol. 2009;218:122-30 pubmed publisher
  1242. Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, et al. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Diabetes Metab Res Rev. 2009;25:232-41 pubmed publisher
  1243. Pinho S, Osorio H, Nita Lazar M, Gomes J, Lopes C, Gartner F, et al. Role of E-cadherin N-glycosylation profile in a mammary tumor model. Biochem Biophys Res Commun. 2009;379:1091-6 pubmed publisher
  1244. Alanne M, Pummi K, Heape A, Grenman R, Peltonen J, Peltonen S. Tight junction proteins in human Schwann cell autotypic junctions. J Histochem Cytochem. 2009;57:523-9 pubmed publisher
  1245. Charpin C, Secq V, Giusiano S, Carpentier S, Andrac L, Lavaut M, et al. A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays. Int J Cancer. 2009;124:2124-34 pubmed publisher
  1246. Borley A, Hiscox S, Gee J, Smith C, Shaw V, Barrett Lee P, et al. Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells. Breast Cancer Res. 2008;10:R103 pubmed publisher
  1247. Patriarca C, Colombo P, Pio Taronna A, Wesseling J, Franchi G, Guddo F, et al. Cell discohesion and multifocality of carcinoma in situ of the bladder: new insight from the adhesion molecule profile (e-cadherin, Ep-CAM, and MUC1). Int J Surg Pathol. 2009;17:99-106 pubmed publisher
  1248. Li Z, Zhou Z, Welch D, Donahue H. Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clin Exp Metastasis. 2008;25:893-901 pubmed publisher
  1249. Marín Briggiler C, Veiga M, Matos M, Echeverría M, Furlong L, Vazquez Levin M. Expression of epithelial cadherin in the human male reproductive tract and gametes and evidence of its participation in fertilization. Mol Hum Reprod. 2008;14:561-71 pubmed publisher
  1250. Rodriguez F, Scheithauer B, Giannini C, Bryant S, Jenkins R. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer. 2008;113:2779-89 pubmed publisher
  1251. Klein E, Campbell L, Kothapalli D, Fournier A, Assoian R. Joint requirement for Rac and ERK activities underlies the mid-G1 phase induction of cyclin D1 and S phase entry in both epithelial and mesenchymal cells. J Biol Chem. 2008;283:30911-8 pubmed publisher
  1252. Saha B, Kaur P, Tsao Wei D, Naritoku W, Groshen S, Datar R, et al. Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone. Prostate. 2008;68:1681-8 pubmed publisher
  1253. Van Hoof D, Braam S, Dormeyer W, Ward van Oostwaard D, Heck A, Krijgsveld J, et al. Feeder-free monolayer cultures of human embryonic stem cells express an epithelial plasma membrane protein profile. Stem Cells. 2008;26:2777-81 pubmed publisher
  1254. Kiss A, Troyanovsky R, Troyanovsky S. p120-catenin is a key component of the cadherin-gamma-secretase supercomplex. Mol Biol Cell. 2008;19:4042-50 pubmed publisher
  1255. Mosnier J, Kandel C, Cazals Hatem D, Bou Hanna C, Gournay J, Jarry A, et al. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas. Mod Pathol. 2009;22:182-90 pubmed publisher
  1256. Caberg J, Hubert P, Begon D, Herfs M, Roncarati P, Boniver J, et al. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcinogenesis. 2008;29:1441-7 pubmed publisher
  1257. Marchio C, Iravani M, Natrajan R, Lambros M, Savage K, Tamber N, et al. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. J Pathol. 2008;215:398-410 pubmed publisher
  1258. Simpson P, Reis Filho J, Lambros M, Jones C, Steele D, Mackay A, et al. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol. 2008;215:231-44 pubmed publisher
  1259. Laser J, Cangiarella J, Singh B, Melamed J, Chiriboga L, Yee H, et al. Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40. Ann Clin Lab Sci. 2008;38:99-104 pubmed
  1260. Fondrevelle M, Kantelip B, Reiter R, Chopin D, Thiery J, Monnien F, et al. The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status. Urol Oncol. 2009;27:268-76 pubmed publisher
  1261. Najy A, Day K, Day M. The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. J Biol Chem. 2008;283:18393-401 pubmed publisher
  1262. Fevre Montange M, Grand S, Champier J, Hoffmann D, Pasquier B, Jouvet A. Bcl-2 expression in a papillary tumor of the pineal region. Neuropathology. 2008;28:660-3 pubmed publisher
  1263. Rakha E, El Sheikh S, Kandil M, El Sayed M, Green A, Ellis I. Expression of BRCA1 protein in breast cancer and its prognostic significance. Hum Pathol. 2008;39:857-65 pubmed publisher
  1264. MacGrogan G, Arnould L, de Mascarel I, Vincent Salomon A, Penault Llorca F, Lacroix Triki M, et al. Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions. Histopathology. 2008;52:689-97 pubmed publisher
  1265. Bryan R, Atherfold P, Yeo Y, Jones L, Harrison R, Wallace D, et al. Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies. J Pathol. 2008;215:184-94 pubmed publisher
  1266. Boone J, van Hillegersberg R, van Diest P, Offerhaus G, Rinkes I, Kate F. Validation of tissue microarray technology in squamous cell carcinoma of the esophagus. Virchows Arch. 2008;452:507-14 pubmed publisher
  1267. Agarwal S, Lee D, Kiener H, Brenner M. Coexpression of two mesenchymal cadherins, cadherin 11 and N-cadherin, on murine fibroblast-like synoviocytes. Arthritis Rheum. 2008;58:1044-54 pubmed publisher
  1268. Sawada K, Mitra A, Radjabi A, Bhaskar V, Kistner E, Tretiakova M, et al. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Cancer Res. 2008;68:2329-39 pubmed publisher
  1269. McClelland R, Wauthier E, Uronis J, Reid L. Gradients in the liver's extracellular matrix chemistry from periportal to pericentral zones: influence on human hepatic progenitors. Tissue Eng Part A. 2008;14:59-70 pubmed publisher
  1270. Fanelli M, Montt Guevara M, Diblasi A, Gago F, Tello O, Cuello Carrión F, et al. P-cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27. Cell Stress Chaperones. 2008;13:207-20 pubmed publisher
  1271. Liu X, Pan M, Lu Z, Wu B, Rao Q, Zhou Z, et al. Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma. Dig Liver Dis. 2008;40:560-7 pubmed publisher
  1272. Shi S, Liu C, Pootrakul L, Tang L, Young A, Chen R, et al. Evaluation of the value of frozen tissue section used as "gold standard" for immunohistochemistry. Am J Clin Pathol. 2008;129:358-66 pubmed publisher
  1273. Wu J, Yan H, Chen W, Chen W, Wang C, Chi Y, et al. JNK signaling pathway is required for bFGF-mediated surface cadherin downregulation on HUVEC. Exp Cell Res. 2008;314:421-9 pubmed publisher
  1274. Sato Y, Harada K, Ozaki S, Furubo S, Kizawa K, Sanzen T, et al. Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat. Am J Pathol. 2007;171:1859-71 pubmed
  1275. Saha B, Arase A, Imam S, Tsao Wei D, Naritoku W, Groshen S, et al. Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone. Prostate. 2008;68:78-84 pubmed
  1276. Ivascu A, Kubbies M. Diversity of cell-mediated adhesions in breast cancer spheroids. Int J Oncol. 2007;31:1403-13 pubmed
  1277. Akat K, Bleck C, Lee Y, Haselmann Weiss U, Kartenbeck J. Characterization of a novel type of adherens junction in meningiomas and the derived cell line HBL-52. Cell Tissue Res. 2008;331:401-12 pubmed
  1278. Itatsu K, Zen Y, Ohira S, Ishikawa A, Sato Y, Harada K, et al. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis. Liver Int. 2007;27:1174-84 pubmed
  1279. Haga T, Uchide N, Tugizov S, Palefsky J. Role of E-cadherin in the induction of apoptosis of HPV16-positive CaSki cervical cancer cells during multicellular tumor spheroid formation. Apoptosis. 2008;13:97-108 pubmed
  1280. Xie J, Haslam S. Extracellular matrix, Rac1 signaling, and estrogen-induced proliferation in MCF-7 breast cancer cells. Breast Cancer Res Treat. 2008;110:257-68 pubmed
  1281. Karacali B, Vamvakidou A, Tozeren A. Automated recognition of cell phenotypes in histology images based on membrane- and nuclei-targeting biomarkers. BMC Med Imaging. 2007;7:7 pubmed
  1282. Angelucci C, Iacopino F, Ferracuti S, Urbano R, Sica G. Recombinant human IFN-beta affects androgen receptor level, neuroendocrine differentiation, cell adhesion, and motility in prostate cancer cells. J Interferon Cytokine Res. 2007;27:643-52 pubmed
  1283. Troyanovsky R, Laur O, Troyanovsky S. Stable and unstable cadherin dimers: mechanisms of formation and roles in cell adhesion. Mol Biol Cell. 2007;18:4343-52 pubmed
  1284. Goldstein N, Decker D, Severson D, Schell S, Vicini F, Margolis J, et al. Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer. 2007;110:1687-96 pubmed
  1285. Chung Y, Lam A, Luk J, Law S, Chan K, Lee P, et al. Altered E-cadherin expression and p120 catenin localization in esophageal squamous cell carcinoma. Ann Surg Oncol. 2007;14:3260-7 pubmed
  1286. Gama A, Paredes J, Gartner F, Alves A, Schmitt F. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. Vet J. 2008;177:45-53 pubmed
  1287. Pinho S, Matos A, Lopes C, Marcos N, Carvalheira J, Reis C, et al. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression. BMC Cancer. 2007;7:124 pubmed
  1288. Mahomed F, Altini M, Meer S. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis. Oral Dis. 2007;13:386-92 pubmed
  1289. Canavese G, Bernardi A, Candelaresi G, Lovadina P, Amerio S, Rossetti V, et al. Expression of the E-cadherin-catenins complex in sentinel node is related to tumor morphology but not to spread to nonsentinel nodes. Pathol Res Pract. 2007;203:517-23 pubmed
  1290. Leibl S, Regitnig P, Moinfar F. Flat epithelial atypia (DIN 1a, atypical columnar change): an underdiagnosed entity very frequently coexisting with lobular neoplasia. Histopathology. 2007;50:859-65 pubmed
  1291. Norton J, Ham C, Van Dam J, Jeffrey R, Longacre T, Huntsman D, et al. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg. 2007;245:873-9 pubmed
  1292. De Matos A, Lopes C, Faustino A, Carvalheira J, Rutteman G, Gärtner M. E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours. APMIS. 2007;115:327-34 pubmed
  1293. Zhu Y, Zhou X, Yao X, Dai B, Ye D. The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery. BJU Int. 2007;100:204-8 pubmed
  1294. Yates C, Shepard C, Stolz D, Wells A. Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer. 2007;96:1246-52 pubmed
  1295. Stucke V, Timmerman E, Vandekerckhove J, Gevaert K, Hall A. The MAGUK protein MPP7 binds to the polarity protein hDlg1 and facilitates epithelial tight junction formation. Mol Biol Cell. 2007;18:1744-55 pubmed
  1296. Symowicz J, Adley B, Gleason K, Johnson J, Ghosh S, Fishman D, et al. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Cancer Res. 2007;67:2030-9 pubmed
  1297. Endemann M, Bergmeister H, Bidmon B, Boehm M, Csaicsich D, Malaga Dieguez L, et al. Evidence for HSP-mediated cytoskeletal stabilization in mesothelial cells during acute experimental peritoneal dialysis. Am J Physiol Renal Physiol. 2007;292:F47-56 pubmed
  1298. Chang Y, Marlin J, Chance T, Jakobi R. RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility. Cancer Res. 2006;66:11700-8 pubmed
  1299. Rakha E, El Sayed M, Green A, Lee A, Robertson J, Ellis I. Prognostic markers in triple-negative breast cancer. Cancer. 2007;109:25-32 pubmed
  1300. Reis Filho J, Simpson P, Turner N, Lambros M, Jones C, Mackay A, et al. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clin Cancer Res. 2006;12:6652-62 pubmed
  1301. Bobrich E, Braumann C, Opitz I, Menenakos C, Kristiansen G, Jacobi C. Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy. J Surg Res. 2007;137:75-82 pubmed
  1302. Steenvoorden M, Tolboom T, van der Pluijm G, Lowik C, Visser C, Degroot J, et al. Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics. Arthritis Res Ther. 2006;8:R165 pubmed
  1303. Martín Villar E, Megias D, Castel S, Yurrita M, Vilaró S, Quintanilla M. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J Cell Sci. 2006;119:4541-53 pubmed
  1304. Murao K, Kubo Y, Ohtani N, Hara E, Arase S. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways. Br J Dermatol. 2006;155:999-1005 pubmed
  1305. Moreno Bueno G, Cubillo E, Sarrio D, Peinado H, Rodriguez Pinilla S, Villa S, et al. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res. 2006;66:9543-56 pubmed
  1306. Lee T, Poon R, Yuen A, Ling M, Kwok W, Wang X, et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res. 2006;12:5369-76 pubmed
  1307. Baker K, Chong G, Foulkes W, Jass J. Transforming growth factor-beta pathway disruption and infiltration of colorectal cancers by intraepithelial lymphocytes. Histopathology. 2006;49:371-80 pubmed
  1308. Sonne S, Hoei Hansen C, Nielsen J, Herlihy A, Andersson A, Almstrup K, et al. CDH1 (E-cadherin) in testicular germ cell neoplasia: suppressed translation of mRNA in pre-invasive carcinoma in situ but increased protein levels in advanced tumours. APMIS. 2006;114:549-58 pubmed
  1309. Robert G, Gaggioli C, Bailet O, Chavey C, Abbe P, Aberdam E, et al. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development. Cancer Res. 2006;66:7516-23 pubmed
  1310. Rodriguez Sanjuan J, Fontalba A, Mayorga M, Bordin M, Hyland S, Trugeda S, et al. A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain. Eur J Surg Oncol. 2006;32:1110-3 pubmed
  1311. Wood C, Usborne A, Starost M, Tarara R, Hill L, Wilkinson L, et al. Hyperplastic and neoplastic lesions of the mammary gland in macaques. Vet Pathol. 2006;43:471-83 pubmed
  1312. Tabata T, McDonagh S, Kawakatsu H, Pereira L. Cytotrophoblasts infected with a pathogenic human cytomegalovirus strain dysregulate cell-matrix and cell-cell adhesion molecules: a quantitative analysis. Placenta. 2007;28:527-37 pubmed
  1313. Bacani J, Soares M, Zwingerman R, Di Nicola N, Senz J, Riddell R, et al. CDH1/E-cadherin germline mutations in early-onset gastric cancer. J Med Genet. 2006;43:867-72 pubmed
  1314. Katso R, Pardo O, Palamidessi A, Franz C, Marinov M, De Laurentiis A, et al. Phosphoinositide 3-Kinase C2beta regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms. Mol Biol Cell. 2006;17:3729-44 pubmed
  1315. Troyanovsky R, Sokolov E, Troyanovsky S. Endocytosis of cadherin from intracellular junctions is the driving force for cadherin adhesive dimer disassembly. Mol Biol Cell. 2006;17:3484-93 pubmed
  1316. Fujita Y, Hogan C, Braga V. Regulation of cell-cell adhesion by Rap1. Methods Enzymol. 2006;407:359-72 pubmed
  1317. Rao K, Alper O, Opheim K, Bonnet G, Wolfe K, Bryant E, et al. Cytogenetic characterization and H-ras associated transformation of immortalized human mammary epithelial cells. Cancer Cell Int. 2006;6:15 pubmed
  1318. Lascombe I, Clairotte A, Fauconnet S, Bernardini S, Wallerand H, Kantelip B, et al. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin Cancer Res. 2006;12:2780-7 pubmed
  1319. Liu Z, Xiao M, Balint K, Smalley K, Brafford P, Qiu R, et al. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res. 2006;66:4182-90 pubmed
  1320. Lombaerts M, van Wezel T, Philippo K, Dierssen J, Zimmerman R, Oosting J, et al. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer. 2006;94:661-71 pubmed
  1321. Voutilainen K, Anttila M, Sillanpää S, Ropponen K, Saarikoski S, Juhola M, et al. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer. J Clin Pathol. 2006;59:460-7 pubmed
  1322. Rakha E, Putti T, Abd El Rehim D, Paish C, Green A, Powe D, et al. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol. 2006;208:495-506 pubmed
  1323. Guarino M, Ballabio G, Rubino B, Nebuloni M, Tosoni A. Soft tissue sacrococcygeal chordoma with intracytoplasmic filamentous inclusions. Pathol Res Pract. 2005;201:699-704 pubmed
  1324. Harigopal M, Shin S, Murray M, Tickoo S, Brogi E, Rosen P. Aberrant E-cadherin staining patterns in invasive mammary carcinoma. World J Surg Oncol. 2005;3:73 pubmed
  1325. Berglund P, Stighall M, Jirstrom K, Borgquist S, Sjölander A, Hedenfalk I, et al. Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers. Cancer Res. 2005;65:9727-34 pubmed
  1326. Taylor D, Watt N, Perera W, Hooper N. Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copper-stimulated, clathrin-dependent endocytosis. J Cell Sci. 2005;118:5141-53 pubmed
  1327. Han S, Lee H, Lee J, Kim W, Nam H, Kim H, et al. Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma. Ann Surg. 2005;242:676-83 pubmed
  1328. Sakamoto K, Watanabe M, de la Cruz C, Honda H, Ise H, Mitsui K, et al. Primary invasive micropapillary carcinoma of the colon. Histopathology. 2005;47:479-84 pubmed
  1329. Dalrymple S, Antony L, Xu Y, Uzgare A, Arnold J, Savaugeot J, et al. Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells. Cancer Res. 2005;65:9269-79 pubmed
  1330. Asioli S, Marucci G, Ficarra G, Stephens M, Foschini M, Ellis I, et al. Polymorphous adenocarcinoma of the breast. Report of three cases. Virchows Arch. 2006;448:29-34 pubmed
  1331. Veveris Lowe T, Lawrence M, Collard R, Bui L, Herington A, Nicol D, et al. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Endocr Relat Cancer. 2005;12:631-43 pubmed
  1332. Pelosi G, Scarpa A, Veronesi G, Spaggiari L, Del Curto B, Moore P, et al. A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression. Virchows Arch. 2005;447:969-77 pubmed
  1333. Schmidt C, Gi Y, Patel T, Coffey R, Beauchamp R, Pearson A. E-cadherin is regulated by the transcriptional repressor SLUG during Ras-mediated transformation of intestinal epithelial cells. Surgery. 2005;138:306-12 pubmed
  1334. Margulis A, Zhang W, Alt Holland A, Pawagi S, Prabhu P, Cao J, et al. Loss of intercellular adhesion activates a transition from low- to high-grade human squamous cell carcinoma. Int J Cancer. 2006;118:821-31 pubmed
  1335. Köbel M, Pohl G, Schmitt W, Hauptmann S, Wang T, Shih I. Activation of mitogen-activated protein kinase is required for migration and invasion of placental site trophoblastic tumor. Am J Pathol. 2005;167:879-85 pubmed
  1336. Shiraishi K, Tsuzaka K, Yoshimoto K, Kumazawa C, Nozaki K, Abe T, et al. Critical role of the fifth domain of E-cadherin for heterophilic adhesion with alpha E beta 7, but not for homophilic adhesion. J Immunol. 2005;175:1014-21 pubmed
  1337. Bassarova A, Torlakovic E, Sedloev T, Hristova S, Trifonov D, Nesland J. Simultaneous bilateral breast carcinoma: Histopathological characteristics and CD44/catenin-cadherin profile. Histol Histopathol. 2005;20:791-9 pubmed publisher
  1338. Rakha E, Abd El Rehim D, Pinder S, Lewis S, Ellis I. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology. 2005;46:685-93 pubmed
  1339. Vongwiwatana A, Tasanarong A, Rayner D, Melk A, Halloran P. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. Am J Transplant. 2005;5:1367-74 pubmed
  1340. Kuefer R, Hofer M, Zorn C, Engel O, Volkmer B, Juarez Brito M, et al. Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer. Br J Cancer. 2005;92:2018-23 pubmed
  1341. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed
  1342. Kwon G, Yoo B, Koh K, Cho J, Park W, Park C. Promoter methylation of E-cadherin in hepatocellular carcinomas and dysplastic nodules. J Korean Med Sci. 2005;20:242-7 pubmed
  1343. Abd El Rehim D, Ball G, Pinder S, Rakha E, Paish C, Robertson J, et al. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer. 2005;116:340-50 pubmed
  1344. Bendardaf R, Elzagheid A, Lamlum H, Ristamaki R, Collan Y, Pyrhonen S. E-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer. Oncol Rep. 2005;13:831-5 pubmed
  1345. Ivanov A, Hunt D, Utech M, Nusrat A, Parkos C. Differential roles for actin polymerization and a myosin II motor in assembly of the epithelial apical junctional complex. Mol Biol Cell. 2005;16:2636-50 pubmed
  1346. Motti M, Califano D, Baldassarre G, Celetti A, Merolla F, Forzati F, et al. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas. Carcinogenesis. 2005;26:1021-34 pubmed
  1347. Pelosi G, Scarpa A, Puppa G, Veronesi G, Spaggiari L, Pasini F, et al. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Cancer. 2005;103:1154-64 pubmed
  1348. van Velthuysen M, Taal B, van der Hoeven J, Peterse J. Expression of oestrogen receptor and loss of E-cadherin are diagnostic for gastric metastasis of breast carcinoma. Histopathology. 2005;46:153-7 pubmed
  1349. Langner C, Ratschek M, Rehak P, Tsybrovskyy O, Zigeuner R. The pT1a and pT1b category subdivision in renal cell carcinoma: is it reflected by differences in tumour biology?. BJU Int. 2005;95:310-4 pubmed
  1350. Rothen Rutishauser B, Kiama S, Gehr P. A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am J Respir Cell Mol Biol. 2005;32:281-9 pubmed
  1351. Rakha E, Armour J, Pinder S, Paish C, Ellis I. High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry. Int J Cancer. 2005;114:720-9 pubmed
  1352. Bane A, Tjan S, Parkes R, Andrulis I, O Malley F. Invasive lobular carcinoma: to grade or not to grade. Mod Pathol. 2005;18:621-8 pubmed
  1353. Wheeler D, Tai L, Bratthauer G, Waldner D, Tavassoli F. Tubulolobular carcinoma of the breast: an analysis of 27 cases of a tumor with a hybrid morphology and immunoprofile. Am J Surg Pathol. 2004;28:1587-93 pubmed
  1354. Sedivy R, Peters K, Kloppel G. Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas. Virchows Arch. 2005;446:41-5 pubmed
  1355. Rios Doria J, Day M. Truncated E-cadherin potentiates cell death in prostate epithelial cells. Prostate. 2005;63:259-68 pubmed
  1356. Martín Villar E, Scholl F, Gamallo C, Yurrita M, Muñoz Guerra M, Cruces J, et al. Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int J Cancer. 2005;113:899-910 pubmed
  1357. Zeng R, Li X, Gorodeski G. Estrogen abrogates transcervical tight junctional resistance by acceleration of occludin modulation. J Clin Endocrinol Metab. 2004;89:5145-55 pubmed
  1358. Eriksen J, Buffa F, Alsner J, Steiniche T, Bentzen S, Overgaard J. Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas. Radiother Oncol. 2004;72:275-82 pubmed
  1359. Honecker F, Kersemaekers A, Molier M, Van Weeren P, Stoop H, de Krijger R, et al. Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development. J Pathol. 2004;204:167-74 pubmed
  1360. Lyakhovitsky A, Barzilai A, Fogel M, Trau H, Huszar M. Expression of e-cadherin and beta-catenin in cutaneous squamous cell carcinoma and its precursors. Am J Dermatopathol. 2004;26:372-8 pubmed
  1361. Schmidt C, Gi Y, Coffey R, Beauchamp R, Pearson A. Oncogenic Ras dominates overexpression of E-cadherin in malignant transformation of intestinal epithelial cells. Surgery. 2004;136:303-9 pubmed
  1362. Sastre Garau X, Genin P, Rousseau A, Al Ghuzlan A, Nicolas A, Freneaux P, et al. Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breast. Histopathology. 2004;45:142-7 pubmed
  1363. Marques F, Fonsechi Carvasan G, de Angelo Andrade L, Bottcher Luiz F. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Gynecol Oncol. 2004;94:16-24 pubmed
  1364. Kapoor P, Saunders M, Li Z, Zhou Z, Sheaffer N, Kunze E, et al. Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. Int J Cancer. 2004;111:693-7 pubmed
  1365. Li G, Fukunaga M, Herlyn M. Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling. Exp Cell Res. 2004;297:142-51 pubmed
  1366. Aubert S, Duchene F, Augusto D, Llinares K, Lemaitre L, Gosselin B, et al. Low-grade tubular myxoid renal tumors: a clinicopathological study of 3 cases. Int J Surg Pathol. 2004;12:179-83 pubmed
  1367. Andersen K, Nesland J, Holm R, Flørenes V, Fodstad Ø, Maelandsmo G. Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma. Mod Pathol. 2004;17:990-7 pubmed
  1368. Song S, Kim S, Kim D, Son H, Rhee J, Kim Y. Abnormal expression of E-cadherin in early gastric carcinoma: its relationship with macroscopic growth patterns and catenin alpha and beta. J Clin Gastroenterol. 2004;38:252-9 pubmed
  1369. Graziano F, Arduini F, Ruzzo A, Bearzi I, Humar B, More H, et al. Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer. Clin Cancer Res. 2004;10:2784-9 pubmed
  1370. Mérot Y, Métivier R, Penot G, Manu D, Saligaut C, Gannon F, et al. The relative contribution exerted by AF-1 and AF-2 transactivation functions in estrogen receptor alpha transcriptional activity depends upon the differentiation stage of the cell. J Biol Chem. 2004;279:26184-91 pubmed
  1371. Sarrio D, Perez Mies B, Hardisson D, Moreno Bueno G, Suárez A, Cano A, et al. Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene. 2004;23:3272-83 pubmed
  1372. Slobodov G, Feloney M, Gran C, Kyker K, Hurst R, Culkin D. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol. 2004;171:1554-8 pubmed
  1373. Bassarova A, Nesland J, Sedloev T, Danielsen H, Christova S. Pilomatrix carcinoma with lymph node metastases. J Cutan Pathol. 2004;31:330-5 pubmed
  1374. Graziano F, Arduini F, Ruzzo A, Mandolesi A, Bearzi I, Silva R, et al. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs. Ann Oncol. 2004;15:489-92 pubmed
  1375. Mariner D, Davis M, Reynolds A. EGFR signaling to p120-catenin through phosphorylation at Y228. J Cell Sci. 2004;117:1339-50 pubmed
  1376. Chunthapong J, Seftor E, Khalkhali Ellis Z, Seftor R, Amir S, Lubaroff D, et al. Dual roles of E-cadherin in prostate cancer invasion. J Cell Biochem. 2004;91:649-61 pubmed
  1377. Chen Q, Lipkina G, Song Q, Kramer R. Promoter methylation regulates cadherin switching in squamous cell carcinoma. Biochem Biophys Res Commun. 2004;315:850-6 pubmed
  1378. Nishioka H, Haraoka J, Akada K. Fibrous bodies are associated with lower GH production and decreased expression of E-cadherin in GH-producing pituitary adenomas. Clin Endocrinol (Oxf). 2003;59:768-72 pubmed
  1379. Tobey N, Argote C, Hosseini S, Orlando R. Calcium-switch technique and junctional permeability in native rabbit esophageal epithelium. Am J Physiol Gastrointest Liver Physiol. 2004;286:G1042-9 pubmed
  1380. De La Cruz C, Moriya T, Endoh M, Watanabe M, Takeyama J, Yang M, et al. Invasive micropapillary carcinoma of the breast: clinicopathological and immunohistochemical study. Pathol Int. 2004;54:90-6 pubmed
  1381. Kuefer R, Hofer M, Gschwend J, Pienta K, Sanda M, Chinnaiyan A, et al. The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer. Clin Cancer Res. 2003;9:6447-52 pubmed
  1382. Han S, Kim H, Seong D, Kim Y, Park Y, Bang Y, et al. Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene. 2004;23:1333-41 pubmed
  1383. Gottardi C, Gumbiner B. Role for ICAT in beta-catenin-dependent nuclear signaling and cadherin functions. Am J Physiol Cell Physiol. 2004;286:C747-56 pubmed
  1384. Davis M, Ireton R, Reynolds A. A core function for p120-catenin in cadherin turnover. J Cell Biol. 2003;163:525-34 pubmed
  1385. Troyanovsky R, Sokolov E, Troyanovsky S. Adhesive and lateral E-cadherin dimers are mediated by the same interface. Mol Cell Biol. 2003;23:7965-72 pubmed
  1386. Alami J, Williams B, Yeger H. Derivation and characterization of a Wilms' tumour cell line, WiT 49. Int J Cancer. 2003;107:365-74 pubmed
  1387. Ordonez N. Value of E-cadherin and N-cadherin immunostaining in the diagnosis of mesothelioma. Hum Pathol. 2003;34:749-55 pubmed
  1388. Alami J, Williams B, Yeger H. Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms's tumours. Mol Pathol. 2003;56:218-25 pubmed
  1389. Palacios J, Sarrio D, García Macias M, Bryant B, Sobel M, Merino M. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast. Mod Pathol. 2003;16:674-8 pubmed
  1390. Fidder H, Barshack I, Chen Shtoyerman R, Onaca N, Goldberg I, Rath P, et al. Immunohistochemical analyses of colon cancer in I1307K APC mutation carriers compared with noncarriers. Dig Dis Sci. 2003;48:1102-5 pubmed
  1391. Sarrio D, Moreno Bueno G, Hardisson D, Sánchez Estevez C, Guo M, Herman J, et al. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer. 2003;106:208-15 pubmed
  1392. Rocha A, Soares P, Fonseca E, Cameselle Teijeiro J, Oliveira M, Sobrinho Simoes M. E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas. Histopathology. 2003;42:580-7 pubmed
  1393. McGuire J, Li Q, Parks W. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol. 2003;162:1831-43 pubmed
  1394. Kokenyesi R, Murray K, Benshushan A, Huntley E, Kao M. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol. 2003;89:60-72 pubmed
  1395. Offterdinger M, Schneider S, Grunt T. Heregulin and retinoids synergistically induce branching morphogenesis of breast cancer cells cultivated in 3D collagen gels. J Cell Physiol. 2003;195:260-75 pubmed
  1396. Luo Y, Radice G. Cadherin-mediated adhesion is essential for myofibril continuity across the plasma membrane but not for assembly of the contractile apparatus. J Cell Sci. 2003;116:1471-9 pubmed
  1397. Impola U, Toriseva M, Suomela S, Jeskanen L, Hieta N, Jahkola T, et al. Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. Int J Cancer. 2003;103:709-16 pubmed
  1398. Carpenter P, Al Kuran R, Theuer C. Paranuaclear E-cadherin in gastric adenocarcinoma. Am J Clin Pathol. 2002;118:887-94 pubmed
  1399. Kuijper A, Preisler Adams S, Rahusen F, Gille J, van der Wall E, van Diest P. Multiple fibroadenomas harbouring carcinoma in situ in a woman with a family history of breast/ovarian cancer. J Clin Pathol. 2002;55:795-7 pubmed
  1400. Karbova E, Davidson B, Metodiev K, Trope C, Nesland J. Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma. Int J Surg Pathol. 2002;10:175-80 pubmed
  1401. Damiani S, Eusebi V, Peterse J. Malignant neoplasms infiltrating pseudoangiomatous' stromal hyperplasia of the breast: an unrecognized pathway of tumour spread. Histopathology. 2002;41:208-15 pubmed
  1402. Jamal S, Schneider R. UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells. J Clin Invest. 2002;110:443-52 pubmed
  1403. Khorram Manesh A, Ahlman H, Jansson S, Nilsson O. N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinoma. Endocr Pathol. 2002;13:99-110 pubmed
  1404. Bratthauer G, Moinfar F, Stamatakos M, Mezzetti T, Shekitka K, Man Y, et al. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol. 2002;33:620-7 pubmed
  1405. Elzagheid A, Kuopio T, Ilmen M, Collan Y. Prognostication of invasive ductal breast cancer by quantification of E-cadherin immunostaining: the methodology and clinical relevance. Histopathology. 2002;41:127-33 pubmed
  1406. Tran N, Adams D, Vaillancourt R, Heimark R. Signal transduction from N-cadherin increases Bcl-2. Regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. J Biol Chem. 2002;277:32905-14 pubmed
  1407. Kim J, Joo C. Involvement of cell-cell interactions in the rapid stimulation of Cas tyrosine phosphorylation and Src kinase activity by transforming growth factor-beta 1. J Biol Chem. 2002;277:31938-48 pubmed
  1408. Rocha A, Soares P, Machado J, Máximo V, Fonseca E, Franssila K, et al. Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex. Virchows Arch. 2002;440:498-504 pubmed
  1409. Sahai E, Marshall C. ROCK and Dia have opposing effects on adherens junctions downstream of Rho. Nat Cell Biol. 2002;4:408-15 pubmed
  1410. Ferreira Cornwell M, Luo Y, Narula N, Lenox J, Lieberman M, Radice G. Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart. J Cell Sci. 2002;115:1623-34 pubmed
  1411. Paredes J, Milanezi F, Viegas L, Amendoeira I, Schmitt F. P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast. Virchows Arch. 2002;440:16-21 pubmed
  1412. Mert G. National action plan on Breast Cancer Workshop on Multicultural Aspects of Breast Cancer Etiology: recommendations of the workshop. Cancer. 2002;94:2113 pubmed
  1413. Hegerfeldt Y, Tusch M, Brocker E, Friedl P. Collective cell movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-integrin function, and migration strategies. Cancer Res. 2002;62:2125-30 pubmed
  1414. Hajra K, Chen D, Fearon E. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 2002;62:1613-8 pubmed
  1415. Laskin W, Miettinen M. Epithelial-type and neural-type cadherin expression in malignant noncarcinomatous neoplasms with epithelioid features that involve the soft tissues. Arch Pathol Lab Med. 2002;126:425-31 pubmed
  1416. Schreider C, Peignon G, Thenet S, Chambaz J, Pincon Raymond M. Integrin-mediated functional polarization of Caco-2 cells through E-cadherin--actin complexes. J Cell Sci. 2002;115:543-52 pubmed
  1417. Fetsch P, Simsir A, Brosky K, Abati A. Comparison of three commonly used cytologic preparations in effusion immunocytochemistry. Diagn Cytopathol. 2002;26:61-6 pubmed
  1418. Gregoire L, Rabah R, Schmelz E, Munkarah A, Roberts P, Lancaster W. Spontaneous malignant transformation of human ovarian surface epithelial cells in vitro. Clin Cancer Res. 2001;7:4280-7 pubmed
  1419. Parker C, Rampaul R, Pinder S, Bell J, Wencyk P, Blamey R, et al. E-cadherin as a prognostic indicator in primary breast cancer. Br J Cancer. 2001;85:1958-63 pubmed
  1420. Pummi K, Malminen M, Aho H, Karvonen S, Peltonen J, Peltonen S. Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes. J Invest Dermatol. 2001;117:1050-8 pubmed
  1421. Ascaño J, Frierson H, Moskaluk C, Harper J, Roviello F, Jackson C, et al. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Mod Pathol. 2001;14:942-9 pubmed
  1422. Kapiteijn E, Liefers G, Los L, Kranenbarg E, Hermans J, Tollenaar R, et al. Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol. 2001;195:171-8 pubmed
  1423. Krill D, Thomas A, Wu S, Dhir R, Becich M. E-cadherin expression and PSA secretion in human prostate epithelial cells. Urol Res. 2001;29:287-92 pubmed
  1424. Goldstein N, Kestin L, Vicini F. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast. Cancer. 2001;92:738-47 pubmed
  1425. Wheelock M, Soler A, Knudsen K. Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia. 2001;6:275-85 pubmed
  1426. Barshack I, Goldberg I, Chowers Y, Weiss B, Horowitz A, Kopolovic J. Immunohistochemical analysis of candidate gene product expression in the duodenal epithelium of children with coeliac sprue. J Clin Pathol. 2001;54:684-8 pubmed
  1427. Noci I, Borri P, Bonfirraro G, Chieffi O, Arcangeli A, Cherubini A, et al. Longstanding survival without cancer progression in a patient affected by endometrial carcinoma treated primarily with leuprolide. Br J Cancer. 2001;85:333-6 pubmed
  1428. Rubin M, Mucci N, Figurski J, Fecko A, Pienta K, Day M. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum Pathol. 2001;32:690-7 pubmed
  1429. Rocha A, Soares P, Seruca R, Máximo V, Matias Guiu X, Cameselle Teijeiro J, et al. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J Pathol. 2001;194:358-66 pubmed
  1430. Tomlinson J, Alpaugh M, Barsky S. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res. 2001;61:5231-41 pubmed
  1431. Hentula M, Peltonen J, Peltonen S. Expression profiles of cell-cell and cell-matrix junction proteins in developing human epidermis. Arch Dermatol Res. 2001;293:259-67 pubmed
  1432. Rahn J, Dabbagh L, Pasdar M, Hugh J. The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature. Cancer. 2001;91:1973-82 pubmed
  1433. Gottardi C, Wong E, Gumbiner B. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol. 2001;153:1049-60 pubmed
  1434. Spina D, Vindigni C, Presenti L, Schurfeld K, Stumpo M, Tosi P. Cell proliferation, cell death, E-cadherin, metalloproteinase expression and angiogenesis in gastric cancer precursors and early cancer of the intestinal type. Int J Oncol. 2001;18:1251-8 pubmed
  1435. Leong A, Sormunen R, Vinyuvat S, Hamdani R, Suthipintawong C. Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems. Am J Clin Pathol. 2001;115:709-18 pubmed
  1436. Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 2001;61:3819-25 pubmed
  1437. Rieger Christ K, Pezza J, Dugan J, Braasch J, Hughes K, Summerhayes I. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas. Mol Pathol. 2001;54:91-7 pubmed
  1438. Etzell J, DeVries S, Chew K, Florendo C, Molinaro A, Ljung B, et al. Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol. 2001;32:292-6 pubmed
  1439. Waldman F, Hwang E, Etzell J, Eng C, DeVries S, Bennington J, et al. Genomic alterations in tubular breast carcinomas. Hum Pathol. 2001;32:222-6 pubmed
  1440. Rashid M, Sanda M, Vallorosi C, Rios Doria J, Rubin M, Day M. Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate. Cancer Res. 2001;61:489-92 pubmed
  1441. Acs G, Lawton T, Rebbeck T, LiVolsi V, Zhang P. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol. 2001;115:85-98 pubmed
  1442. Maluf H, Swanson P, Koerner F. Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis. Am J Surg Pathol. 2001;25:237-44 pubmed
  1443. Acs G, LiVolsi V. Loss of membrane expression of E-cadherin in leukemic erythroblasts. Arch Pathol Lab Med. 2001;125:198-201 pubmed
  1444. Luo Y, Ferreira Cornwell M, Baldwin H, Kostetskii I, Lenox J, Lieberman M, et al. Rescuing the N-cadherin knockout by cardiac-specific expression of N- or E-cadherin. Development. 2001;128:459-69 pubmed
  1445. Kolby L, Bernhardt P, Ahlman H, Wangberg B, Johanson V, Wigander A, et al. A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake. Am J Pathol. 2001;158:745-55 pubmed
  1446. Corn P, Smith B, Ruckdeschel E, Douglas D, Baylin S, Herman J. E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia. Clin Cancer Res. 2000;6:4243-8 pubmed
  1447. Rechardt O, Elomaa O, Vaalamo M, Pääkkönen K, Jahkola T, Hook Nikanne J, et al. Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines. J Invest Dermatol. 2000;115:778-87 pubmed
  1448. Kaida M, Cao F, Skumatz C, Irving P, Burke J. Time at confluence for human RPE cells: effects on the adherens junction and in vitro wound closure. Invest Ophthalmol Vis Sci. 2000;41:3215-24 pubmed
  1449. Burke J, Cao F, Irving P. High levels of E-/P-cadherin: correlation with decreased apical polarity of Na/K ATPase in bovine RPE cells in situ. Invest Ophthalmol Vis Sci. 2000;41:1945-52 pubmed
  1450. Hsu M, Meier F, Nesbit M, Hsu J, Van Belle P, Elder D, et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol. 2000;156:1515-25 pubmed
  1451. Taraszka K, Higgins J, Tan K, Mandelbrot D, Wang J, Brenner M. Molecular basis for leukocyte integrin alpha(E)beta(7) adhesion to epithelial (E)-cadherin. J Exp Med. 2000;191:1555-67 pubmed
  1452. Bukholm I, Nesland J. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch. 2000;436:224-8 pubmed
  1453. Halachmi S, Demarzo A, Chow N, Halachmi N, Smith A, Linn J, et al. Genetic alterations in urinary bladder carcinosarcoma: evidence of a common clonal origin. Eur Urol. 2000;37:350-7 pubmed
  1454. Vallorosi C, Day K, Zhao X, Rashid M, Rubin M, Johnson K, et al. Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution. J Biol Chem. 2000;275:3328-34 pubmed
  1455. Mueller S, Cadenas E, Schonthal A. p21WAF1 regulates anchorage-independent growth of HCT116 colon carcinoma cells via E-cadherin expression. Cancer Res. 2000;60:156-63 pubmed
  1456. Spirin K, Ljubimov A, Castellon R, Wiedoeft O, Marano M, Sheppard D, et al. Analysis of gene expression in human bullous keratopathy corneas containing limiting amounts of RNA. Invest Ophthalmol Vis Sci. 1999;40:3108-15 pubmed
  1457. Huiping C, Sigurgeirsdottir J, Jonasson J, Eiriksdottir G, Johannsdottir J, Egilsson V, et al. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Br J Cancer. 1999;81:1103-10 pubmed
  1458. Hines M, Jin H, Wheelock M, Jensen P. Inhibition of cadherin function differentially affects markers of terminal differentiation in cultured human keratinocytes. J Cell Sci. 1999;112 ( Pt 24):4569-79 pubmed
  1459. Gomez S, del Mont Llosas M, Verdu J, Roura S, Lloreta J, Fabre M, et al. Independent regulation of adherens and tight junctions by tyrosine phosphorylation in Caco-2 cells. Biochim Biophys Acta. 1999;1452:121-32 pubmed
  1460. Burke J, Cao F, Irving P, Skumatz C. Expression of E-cadherin by human retinal pigment epithelium: delayed expression in vitro. Invest Ophthalmol Vis Sci. 1999;40:2963-70 pubmed
  1461. Peralta Soler A, Knudsen K, Salazar H, Han A, Keshgegian A. P-cadherin expression in breast carcinoma indicates poor survival. Cancer. 1999;86:1263-72 pubmed
  1462. Peltonen S, Hentula M, Hagg P, Ylä Outinen H, Tuukkanen J, Lakkakorpi J, et al. A novel component of epidermal cell-matrix and cell-cell contacts: transmembrane protein type XIII collagen. J Invest Dermatol. 1999;113:635-42 pubmed
  1463. Tran N, Nagle R, Cress A, Heimark R. N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion withStromal cells. Am J Pathol. 1999;155:787-98 pubmed
  1464. Blok P, Craanen M, Dekker W, Tytgat G. Loss of E-cadherin expression in early gastric cancer. Histopathology. 1999;34:410-5 pubmed
  1465. Wong A, Maines Bandiera S, Rosen B, Wheelock M, Johnson K, Leung P, et al. Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history of ovarian cancer. Int J Cancer. 1999;81:180-8 pubmed
  1466. Day M, Zhao X, Vallorosi C, Putzi M, Powell C, Lin C, et al. E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway. J Biol Chem. 1999;274:9656-64 pubmed
  1467. Montonen O, Ezer S, Laurikkala J, Karjalainen Lindsberg M, Thesleff I, Kere J, et al. Expression of the anhidrotic ectodermal dysplasia gene is reduced in skin cancer coinciding with reduced E-cadherin. Exp Dermatol. 1998;7:168-74 pubmed
  1468. St Croix B, Sheehan C, Rak J, Flørenes V, Slingerland J, Kerbel R. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J Cell Biol. 1998;142:557-71 pubmed
  1469. Kantak S, Kramer R. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem. 1998;273:16953-61 pubmed
  1470. Sancho E, Vila M, Sanchez Pulido L, Lozano J, Paciucci R, Nadal M, et al. Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells. Mol Cell Biol. 1998;18:576-89 pubmed
  1471. Laihia J, Jansen C. Up-regulation of human epidermal Langerhans' cell B7-1 and B7-2 co-stimulatory molecules in vivo by solar-simulating irradiation. Eur J Immunol. 1997;27:984-9 pubmed
  1472. Songun I, van de Velde C, Hermans J, Pals S, Verspaget H, Vis A, et al. Expression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer. Dutch Gastric Cancer Group (DGCG). Br J Cancer. 1996;74:1783-8 pubmed
  1473. Cheng L, Nagabhushan M, Pretlow T, Amini S, Pretlow T. Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol. 1996;148:1375-80 pubmed
  1474. Rokhlin O, Cohen M. Expression of cellular adhesion molecules on human prostate tumor cell lines. Prostate. 1995;26:205-12 pubmed